海外医薬品不足状況

更新された供給不足状況を示しています。
ある時点での供給不足の全体的状況は「供給関連情報」に定期的にアップします。

米国

カナダ

オーストラリア

  • 2024.11.11
    Active ingredientsDosage formQuantity of active ingredientsShortage statusAvailabilityReasonLast updated
    bupivacaine hydrochloride monohydrateInjection, solution52.7 mgCurrentUnavailableManufacturing8/11/2024
    amlodipine besilateTablet, uncoated6.94 mgAnticipatedAvailableManufacturing8/11/2024
    midazolamInjection, solution5 mg/mLCurrentLimited AvailabilityManufacturing8/11/2024
    sodium pyrophosphateInjection, powder for30 mgCurrentEmergency Supply OnlyManufacturing8/11/2024
    potassium clavulanate~amoxicillin trihydrateSuspension, powder for7.45 mg/mL~28.7 mg/mLCurrentUnavailableManufacturing8/11/2024
    benzathine benzylpenicillin tetrahydrateInjection, suspension1200000 USP UnitAnticipatedAvailableManufacturing8/11/2024
    iopromideInjection, solution498.72 mg/mLResolvedAvailableUnexpected increase in consumer demand8/11/2024
    hydrocortisone sodium succinateInjection, powder for334.25 mgResolvedAvailableManufacturing8/11/2024
    acetylcysteineInjection, concentrated2 gCurrentUnavailableTransport / Logistic issues / Storage capacity issues8/11/2024
    diazepamTablet, uncoated2 mgAnticipatedAvailableManufacturing8/11/2024
    risperidoneTablet, film coated2 mgAnticipatedAvailableUnexpected increase in consumer demand8/11/2024
    zolmitriptanTablet, film coated2.5 mgCurrentUnavailableManufacturing8/11/2024
    duloxetine hydrochlorideCapsule, enteric33.66 mgCurrentUnavailableUnexpected increase in consumer demand8/11/2024
    citalopram hydrobromideTablet, film coated49.98 mgCurrentUnavailableManufacturing8/11/2024
    meloxicamCapsule, hard15 mgResolvedAvailableManufacturing8/11/2024
    anastrozoleTablet, film coated1 mgCurrentLimited AvailabilityManufacturing8/11/2024
    fluorouracilInjection, solution50 mg/mLCurrentLimited AvailabilityManufacturing8/11/2024
    mesalazineTablet, enteric coated250 mgAnticipatedAvailableManufacturing8/11/2024
    benzathine benzylpenicillin tetrahydrateInjection, suspension600000 USP UnitCurrentUnavailableManufacturing8/11/2024
    nebivolol hydrochlorideTablet1.363 mgCurrentLimited AvailabilityManufacturing8/11/2024
    nebivolol hydrochlorideTablet5.45 mgCurrentLimited AvailabilityManufacturing8/11/2024
    nebivolol hydrochlorideTablet10.9 mgResolvedAvailableManufacturing8/11/2024
    hydrochlorothiazide~amlodipine besilate~olmesartan medoxomilTablet, film coated12.5 mg~6.95 mg~40 mgResolvedAvailableManufacturing8/11/2024
    tamoxifen citrateTablet30.34 mgCurrentLimited AvailabilityManufacturing8/11/2024
    lurasidone hydrochlorideTablet, film coated80 mgResolvedAvailableManufacturing8/11/2024
    lurasidone hydrochlorideTablet, film coated40 mgResolvedAvailableManufacturing8/11/2024
    lanreotide acetateInjection, solution100 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues8/11/2024
    lanreotide acetateInjection, solution66.67 mgAnticipatedAvailableTransport / Logistic issues / Storage capacity issues8/11/2024
    daptomycinInhalation, powder for350 mgCurrentLimited AvailabilityManufacturing8/11/2024
    morphine sulfate pentahydrateTablet, film coated10 mgDiscontinuedUnavailableCommercial Changes / Commercial viability8/11/2024
    clindamycin phosphateCream22.8 mg/gAnticipatedAvailableTransport / Logistic issues / Storage capacity issues8/11/2024
    clonazepamTablet, uncoated.5 mgCurrentLimited AvailabilityManufacturing8/11/2024
    cabergolineTablet, uncoated2 mgCurrentLimited AvailabilityManufacturing8/11/2024
    baclofenTablet, uncoated25 mgResolvedAvailableTransport / Logistic issues / Storage capacity issues8/11/2024
    adrenaline (epinephrine) acid tartrateInjection, solution1.82 mg/mLAnticipatedAvailableManufacturing7/11/2024
    fluconazoleCapsule, hard200 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability7/11/2024
    olanzapineTablet, orally disintegrating20 mgAnticipatedAvailableManufacturing7/11/2024
    dutasteride~tamsulosin hydrochlorideCapsule, modified release500 microgram~400 microgramCurrentLimited AvailabilityManufacturing7/11/2024
    tacrolimus monohydrateCapsule, hard1.022 mgAnticipatedAvailableManufacturing7/11/2024
    bisoprolol fumarateTablet10 mgCurrentUnavailableManufacturing7/11/2024
    levetiracetamTablet, film coated1000 mgCurrentUnavailableManufacturing7/11/2024
    escitalopram oxalateTablet, film coated12.74 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues7/11/2024
    escitalopram oxalateTablet, film coated25.47 mgCurrentUnavailableManufacturing7/11/2024
    carboplatinInjection, solution450 mgAnticipatedAvailableManufacturing7/11/2024
    tadalafilTablet, film coated20 mgCurrentLimited AvailabilityManufacturing7/11/2024
    simvastatinTablet, film coated20 mgCurrentUnavailableManufacturing7/11/2024
    noradrenaline (norepinephrine) acid tartrate monohydrateInjection, concentrated8 mgCurrentLimited AvailabilityManufacturing7/11/2024
    hydrochlorothiazide~irbesartanTablet, film coated12.5 mg~300 mgAnticipatedAvailableManufacturing7/11/2024
    cerliponase alfaInjection, solution30 mg/mLResolvedAvailableManufacturing7/11/2024
    dutasteride~tamsulosin hydrochlorideCapsule, modified release500 microgram~400 microgramResolvedAvailableTransport / Logistic issues / Storage capacity issues7/11/2024
    estradiolDrug delivery system, transdermal.39 mgCurrentUnavailableManufacturing7/11/2024
    estradiolDrug delivery system, transdermal1.56 mgCurrentUnavailableManufacturing7/11/2024
    trimethoprimTablet, uncoated300 mgCurrentLimited AvailabilityManufacturing7/11/2024
    flecainide acetateTablet50 mgCurrentUnavailableManufacturing7/11/2024
    cefaclor monohydrateOral Liquid, powder for52.45 mg/mLCurrentUnavailableUnexpected increase in consumer demand7/11/2024
    potassium clavulanate~amoxicillin trihydrateTablet, film coated149 mg~574 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability7/11/2024
    tirzepatideInjection, solution7.5 mgCurrentUnavailableCommercial Changes / Commercial viability7/11/2024
    tirzepatideInjection, solution12.5 mgCurrentUnavailableCommercial Changes / Commercial viability7/11/2024
    tirzepatideInjection, solution10 mgCurrentUnavailableCommercial Changes / Commercial viability7/11/2024
    tirzepatideInjection, solution2.5 mgCurrentUnavailableCommercial Changes / Commercial viability7/11/2024
    nizatidineCapsule300 mgCurrentUnavailableUnexpected increase in demand due to other sponsors unable to supply7/11/2024
    clarithromycinTablet, film coated250 mgCurrentLimited AvailabilityUnexpected increase in consumer demand7/11/2024
    fluticasone furoateSpray, suspension27.5 microgramAnticipatedAvailableUnexpected increase in consumer demand6/11/2024
    silver sulfadiazineCream10 mg/gCurrentUnavailableManufacturing6/11/2024
    mycophenolate mofetilTablet, film coated500 mgCurrentUnavailableManufacturing6/11/2024
    sildenafil citrateTablet, film coated28.1 mgCurrentLimited AvailabilityManufacturing6/11/2024
    mycophenolate mofetilTablet, film coated500 mgResolvedAvailableManufacturing6/11/2024
    esomeprazoleCapsule, enteric40 mgCurrentLimited AvailabilityManufacturing6/11/2024
    ezetimibeTablet, uncoated10 mgCurrentUnavailableUnexpected increase in consumer demand6/11/2024
    ezetimibeTablet, uncoated10 mgCurrentUnavailableUnexpected increase in consumer demand6/11/2024
    atomoxetine hydrochlorideCapsule, hard91.2 mgResolvedAvailableManufacturing6/11/2024
    atorvastatin calcium trihydrateTablet, film coated86.751 mgCurrentLimited AvailabilityManufacturing6/11/2024
    norethisterone acetate~estradiol~estradiolDrug delivery system, transdermal2.7 mg~.78 mg~.62 mgCurrentLimited AvailabilityManufacturing6/11/2024
    norethisterone acetate~estradiol~estradiolDrug delivery system, transdermal4.8 mg~.512 mg~.78 mgCurrentLimited AvailabilityManufacturing6/11/2024
    estradiolDrug delivery system, transdermal.585 mgCurrentUnavailableManufacturing6/11/2024
    estradiolDrug delivery system, transdermal.78 mgCurrentUnavailableManufacturing6/11/2024
    estradiolDrug delivery system, transdermal1.17 mgCurrentUnavailableManufacturing6/11/2024
    chloramphenicolEye Drops, solution5 mg/mLCurrentUnavailableManufacturing6/11/2024
    melatoninCapsule, hard5 mgCurrentLimited AvailabilityUnexpected increase in consumer demand6/11/2024
    estradiol~norethisterone acetateDrug delivery system, transdermal.62 mg~2.7 mgCurrentUnavailableManufacturing6/11/2024
    norethisterone acetate~estradiolDrug delivery system, transdermal4.8 mg~.512 mgCurrentLimited AvailabilityManufacturing6/11/2024
    risperidoneTablet, film coated4 mgCurrentUnavailableManufacturing5/11/2024
    oxytocinInjection, solution10 IUCurrentUnavailableManufacturing5/11/2024
    progesteronePessary, compressed100 mgCurrentUnavailableManufacturing5/11/2024
    citalopram hydrobromideTablet, film coated12.495 mgAnticipatedAvailableManufacturing5/11/2024
    citalopram hydrobromideTablet, film coated49.98 mgAnticipatedAvailableManufacturing5/11/2024
    azithromycin dihydrateTablet, film coated524 mgCurrentUnavailableManufacturing5/11/2024
    hydrochlorothiazide~irbesartanTablet, film coated25 mg~300 mgAnticipatedAvailableManufacturing5/11/2024
    tenofovir disoproxil fumarate~emtricitabineTablet, film coated300 mg~200 mgResolvedAvailableManufacturing5/11/2024
    tadalafilTablet, film coated10 mgCurrentUnavailableManufacturing5/11/2024
    tadalafilTablet, film coated20 mgCurrentLimited AvailabilityManufacturing5/11/2024
    timolol maleateEye Drops, solution6.83 mg/mLAnticipatedAvailableCommercial Changes / Commercial viability5/11/2024
    levothyroxine sodiumTablet50 microgramCurrentUnavailableManufacturing5/11/2024
    melatoninOral Liquid, solution1 mg/mLCurrentLimited AvailabilityUnexpected increase in consumer demand5/11/2024
    timolol maleateEye Drops, solution6.84 mg/mLCurrentUnavailableManufacturing5/11/2024
    gefitinibTablet, film coated250 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability5/11/2024
    ciprofloxacin hydrochlorideTablet, film coated832.5 mgCurrentUnavailableManufacturing4/11/2024
    morphine hydrochloride trihydrateOral Liquid, solution2 mg/mLResolvedAvailableCommercial Changes / Commercial viability4/11/2024
    morphine hydrochloride trihydrateOral Liquid, solution10 mg/mLCurrentUnavailableCommercial Changes / Commercial viability4/11/2024
    metformin hydrochlorideTablet, film coated1000 mgCurrentLimited AvailabilityManufacturing4/11/2024
    ezetimibeTablet, uncoated10 mgCurrentUnavailableUnexpected increase in demand due to other sponsors unable to supply4/11/2024
    irbesartanTablet, film coated300 mgCurrentUnavailableManufacturing4/11/2024
    pregabalinCapsule, hard150 mgAnticipatedAvailableManufacturing4/11/2024
    quinagolide hydrochlorideTablet, uncoated.0819 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability4/11/2024
    verapamil hydrochlorideTablet, modified release180 mgCurrentLimited AvailabilityManufacturing4/11/2024
    morphine sulfate pentahydrateCapsule, modified release90 mgDiscontinuedUnavailableCommercial Changes / Commercial viability4/11/2024
    clonidine hydrochlorideTablet, uncoated150 microgramCurrentLimited AvailabilityManufacturing4/11/2024
  • 2024.11.04
    Active ingredientsDosage formQuantity of active ingredientsShortage statusAvailabilityReasonLast updated
    primidoneTablet, uncoated250 mgCurrentLimited AvailabilityManufacturing1/11/2024
    gentamicinInjection, solution80 mgCurrentLimited AvailabilityManufacturing1/11/2024
    sodium pyrophosphateInjection, powder for30 mgCurrentEmergency Supply OnlyManufacturing1/11/2024
    Pancreatic extractCapsule, enteric150 mgResolvedAvailableUnexpected increase in consumer demand1/11/2024
    silver sulfadiazineCream10 mg/gCurrentUnavailableManufacturing1/11/2024
    hydrocortisone sodium succinateInjection, powder for134 mgResolvedAvailableManufacturing1/11/2024
    hydrocortisone sodium succinateInjection, powder for334.25 mgCurrentLimited AvailabilityManufacturing1/11/2024
    levetiracetamTablet, film coated500 mgAnticipatedAvailableManufacturing1/11/2024
    ciprofloxacin hydrochlorideTablet, film coated277.5 mgCurrentUnavailableManufacturing1/11/2024
    ciprofloxacin hydrochlorideTablet, film coated555 mgCurrentLimited AvailabilityManufacturing1/11/2024
    ciprofloxacin hydrochlorideTablet, film coated832.5 mgCurrentUnavailableManufacturing1/11/2024
    candesartan cilexetilTablet, uncoated4 mgAnticipatedAvailableManufacturing1/11/2024
    rizatriptan benzoateTablet, orally disintegrating14.53 mgResolvedAvailableManufacturing1/11/2024
    tranexamic acidInjection, solution1000 mgCurrentLimited AvailabilityCommercial Changes / Commercial viability1/11/2024
    acarboseTablet100 mgCurrentLimited AvailabilityManufacturing1/11/2024
    acarboseTablet50 mgCurrentUnavailableManufacturing1/11/2024
    acarboseTablet50 mgCurrentUnavailableManufacturing1/11/2024
    cisatracurium besilateInjection, solution14.07 mgAnticipatedAvailableTransport / Logistic issues / Storage capacity issues1/11/2024
    Follitropin alfaInjection, solution75 IUCurrentUnavailableManufacturing1/11/2024
    noradrenaline (norepinephrine) acid tartrate monohydrateInjection, concentrated8 mgCurrentLimited AvailabilityManufacturing1/11/2024
    anastrozoleTablet, film coated1 mgAnticipatedAvailableManufacturing1/11/2024
    cisplatinInjection, concentrated1 mg/mLCurrentUnavailableUnexpected increase in consumer demand1/11/2024
    lacosamideTablet, film coated100 mgResolvedAvailableCommercial Changes / Commercial viability1/11/2024
    lacosamideTablet, film coated50 mgResolvedAvailableManufacturing1/11/2024
    pregabalinCapsule, hard150 mgAnticipatedAvailableManufacturing1/11/2024
    pregabalinCapsule, hard25 mgAnticipatedAvailableManufacturing1/11/2024
    pregabalinCapsule, hard75 mgAnticipatedAvailableManufacturing1/11/2024
    montelukast sodiumTablet, film coated10.4 mgResolvedAvailableManufacturing1/11/2024
    norethisterone acetate~estradiol~estradiolDrug delivery system, transdermal4.8 mg~.512 mg~.78 mgCurrentLimited AvailabilityManufacturing1/11/2024
    estradiolDrug delivery system, transdermal.585 mgCurrentUnavailableManufacturing1/11/2024
    estradiolDrug delivery system, transdermal1.56 mgCurrentUnavailableManufacturing1/11/2024
    mycophenolate sodiumTablet, enteric coated384.7 mgAnticipatedAvailableManufacturing1/11/2024
    phentermine hydrochlorideTablet, modified release49.7 mgCurrentLimited AvailabilityManufacturing1/11/2024
    flecainide acetateTablet50 mgCurrentUnavailableManufacturing1/11/2024
    carmustineInjection, powder for100 mgCurrentLimited AvailabilityManufacturing1/11/2024
    cefaclor monohydrateOral Liquid, powder for52.45 mg/mLCurrentUnavailableUnexpected increase in consumer demand1/11/2024
    cisplatinInjection, solution1 mg/mLCurrentLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply1/11/2024
    dorzolamide hydrochlorideEye Drops, solution22.26 mg/mLCurrentUnavailableManufacturing1/11/2024
    estradiol hemihydrateDrug delivery system, transdermal2.32 mgCurrentUnavailableUnexpected increase in demand due to other sponsors unable to supply1/11/2024
    oxycodone hydrochlorideOral Liquid, solution1 mg/mLCurrentLimited AvailabilityUnexpected increase in consumer demand1/11/2024
    pravastatin sodiumTablet, uncoated40 mgCurrentUnavailableManufacturing1/11/2024
    terbinafine hydrochlorideTablet, uncoated281.3 mgAnticipatedAvailableManufacturing31/10/2024
    metformin hydrochlorideTablet, film coated500 mgCurrentUnavailableManufacturing31/10/2024
    gabapentinTablet, film coated600 mgAnticipatedAvailableManufacturing31/10/2024
    doxorubicin hydrochlorideInjection, concentrated2 mg/mLAnticipatedAvailableManufacturing31/10/2024
    montelukast sodiumTablet, chewable4.16 mgAnticipatedAvailableManufacturing31/10/2024
    duloxetine hydrochlorideCapsule, enteric33.65 mgCurrentLimited AvailabilityManufacturing31/10/2024
    duloxetine hydrochlorideCapsule, enteric33.65 mgCurrentUnavailableManufacturing31/10/2024
    rizatriptan benzoateWafer14.53 mgAnticipatedAvailableUnexpected increase in demand due to other sponsors unable to supply31/10/2024
    meloxicamCapsule, hard15 mgCurrentUnavailableManufacturing31/10/2024
    azacitidineInjection, powder for100 mgResolvedAvailableManufacturing31/10/2024
    rasagiline mesilateTablet1.56 mgCurrentLimited AvailabilityManufacturing31/10/2024
    bortezomibInjection, solution3.5 mgResolvedAvailableManufacturing31/10/2024
    sitagliptin hydrochloride monohydrate~metformin hydrochlorideTablet, modified release56.685 mg~1000 mgCurrentUnavailableManufacturing31/10/2024
    thiotepaInjection, powder for15 mgCurrentUnavailableCommercial Changes / Commercial viability31/10/2024
    clindamycin phosphateCream22.8 mg/gAnticipatedAvailableTransport / Logistic issues / Storage capacity issues31/10/2024
    tobramycinInhalation, conventional60 mg/mLCurrentUnavailableManufacturing31/10/2024
    clarithromycinTablet, film coated250 mgCurrentLimited AvailabilityManufacturing31/10/2024
    methylphenidate hydrochlorideTablet, modified release18 mgCurrentLimited AvailabilityManufacturing31/10/2024
    morphine sulfate pentahydrateTablet, modified release60 mgCurrentUnavailableManufacturing30/10/2024
    potassium clavulanate~amoxicillin trihydrateSuspension, powder for7.45 mg/mL~28.7 mg/mLCurrentUnavailableManufacturing30/10/2024
    metoprolol succinateTablet, modified release190 mgCurrentUnavailableManufacturing30/10/2024
    galantamine hydrobromideCapsule, modified release30.756 mgCurrentLimited AvailabilityManufacturing30/10/2024
    azithromycin dihydrateTablet, film coated524.05 mgCurrentLimited AvailabilityManufacturing30/10/2024
    tadalafilTablet, film coated20 mgCurrentLimited AvailabilityManufacturing30/10/2024
    cefepime hydrochloride monohydrateInjection, powder for2378.5 mgDiscontinuedUnavailableManufacturing30/10/2024
    cefepime hydrochloride monohydrateInjection, powder for1189.2 mgDiscontinuedUnavailableManufacturing30/10/2024
    ezetimibeTablet, uncoated10 mgCurrentLimited AvailabilityManufacturing30/10/2024
    tadalafilTablet, film coated20 mgCurrentLimited AvailabilityManufacturing30/10/2024
    tadalafilTablet, film coated10 mgAnticipatedAvailableManufacturing30/10/2024
    nebivolol hydrochlorideTablet5.45 mgCurrentLimited AvailabilityManufacturing30/10/2024
    tadalafilTablet, film coated20 mgCurrentLimited AvailabilityManufacturing30/10/2024
    dasatinibTablet, film coated50 mgCurrentUnavailableManufacturing30/10/2024
    dasatinibTablet, film coated100 mgCurrentUnavailableManufacturing30/10/2024
    dasatinibTablet, film coated70 mgCurrentUnavailableCommercial Changes / Commercial viability30/10/2024
    atomoxetine hydrochlorideCapsule, hard45.5 mgResolvedAvailableManufacturing30/10/2024
    gefitinibTablet, film coated250 mgCurrentUnavailableManufacturing30/10/2024
    tamsulosin hydrochloride~dutasterideCapsule, modified release400 microgram~500 microgramCurrentLimited AvailabilityTransport / Logistic issues / Storage capacity issues30/10/2024
    olanzapineTablet, uncoated2.5 mgAnticipatedAvailableManufacturing30/10/2024
    dasatinib propylene glycolTablet, film coated58 mgCurrentUnavailableManufacturing30/10/2024
    dasatinib propylene glycolTablet, film coated23.2 mgDiscontinuedUnavailableManufacturing30/10/2024
    carbacholInjection, solution100 microgram/mLCurrentLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply30/10/2024
    octreotideInjection, solution50 microgram/mLResolvedAvailableUnexpected increase in demand due to other sponsors unable to supply30/10/2024
    clarithromycinOral Liquid, powder for50 mg/mLCurrentLimited AvailabilityUnexpected increase in consumer demand30/10/2024
    Mycobacterium bovis (Bacillus Calmette and Guerin (BCG) strain)Injection, powder for200000000 CFUCurrentLimited AvailabilityUnexpected increase in consumer demand30/10/2024
    clindamycin hydrochlorideSolution10 mg/mLResolvedAvailableManufacturing30/10/2024
    prazosin hydrochlorideTablet, uncoated1.1 mgCurrentUnavailableManufacturing30/10/2024
    prazosin hydrochlorideTablet, uncoated2.2 mgCurrentUnavailableManufacturing30/10/2024
    prazosin hydrochlorideTablet, uncoated5.5 mgCurrentUnavailableManufacturing30/10/2024
    morphine sulfate pentahydrateTablet, modified release10 mgCurrentUnavailableManufacturing29/10/2024
    morphine sulfate pentahydrateTablet, modified release30 mgCurrentUnavailableManufacturing29/10/2024
    levetiracetamTablet, film coated250 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues29/10/2024
    metoprolol succinateTablet, modified release95 mgCurrentUnavailableManufacturing29/10/2024
    zolmitriptanTablet, film coated2.5 mgAnticipatedAvailableManufacturing29/10/2024
    Digoxinspecific antibody fragment F(ab) (Ovine)Injection, powder for40 mgResolvedAvailableManufacturing29/10/2024
    metformin hydrochlorideTablet, modified release1000 mgResolvedAvailableManufacturing29/10/2024
    pemetrexed disodiumInjection, powder for1102.9 mgResolvedAvailableManufacturing29/10/2024
    ezetimibeTablet, uncoated10 mgResolvedAvailableManufacturing29/10/2024
    fluticasone propionateInhalation, pressurised125 microgram/actuationResolvedAvailableManufacturing29/10/2024
    tenofovir disoproxil fumarate~emtricitabineTablet, film coated300 mg~200 mgCurrentLimited AvailabilityManufacturing29/10/2024
    metformin hydrochlorideTablet, film coated500 mgCurrentLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply29/10/2024
    tadalafilTablet, film coated5 mgResolvedAvailableUnexpected increase in demand due to other sponsors unable to supply29/10/2024
    tadalafilTablet, film coated20 mgResolvedAvailableUnexpected increase in consumer demand29/10/2024
    olmesartan medoxomil~amlodipine besilateTablet, film coated40 mg~6.935 mgResolvedAvailableManufacturing29/10/2024
    prasugrelTablet, film coated10 mgCurrentLimited AvailabilityManufacturing29/10/2024
    indometacinCapsule, hard25 mgResolvedAvailableManufacturing29/10/2024
    melatoninCapsule, hard5 mgAnticipatedAvailableUnexpected increase in consumer demand29/10/2024
    melatoninOral Liquid, solution1 mg/mLAnticipatedAvailableUnexpected increase in consumer demand29/10/2024
    iopromideInjection, solution498.72 mg/mLResolvedAvailableUnexpected increase in consumer demand29/10/2024
    diclofenac sodiumSuppository, moulded50 mgCurrentLimited AvailabilityTransport / Logistic issues / Storage capacity issues29/10/2024
    clarithromycinTablet, film coated250 mgResolvedAvailableManufacturing28/10/2024
    morphine sulfate pentahydrateTablet, modified release100 mgCurrentUnavailableManufacturing28/10/2024
    sodium polystyrene sulfonatePowder999.3 mg/gAnticipatedAvailableManufacturing28/10/2024
    acetylcysteineInjection, concentrated2 gCurrentLimited AvailabilityTransport / Logistic issues / Storage capacity issues28/10/2024
    Hepatitis a virus antigenInjection, suspension320 AgU/mLResolvedAvailableManufacturing28/10/2024
    metoprolol succinateTablet, modified release190 mgAnticipatedAvailableManufacturing28/10/2024
    midazolamInjection, solution1 mg/mLDiscontinuedUnavailableCommercial Changes / Commercial viability28/10/2024
    ziprasidone hydrochlorideCapsule, hard65.16 mgResolvedAvailableTransport / Logistic issues / Storage capacity issues28/10/2024
    chromium(51Cr) edetateInjection, solution8 MBq/mLResolvedAvailableManufacturing28/10/2024
    esomeprazoleCapsule, enteric40 mgAnticipatedAvailableManufacturing28/10/2024
    nebivolol hydrochlorideTablet10.9 mgResolvedAvailableManufacturing28/10/2024
    lanreotide acetateInjection, solution133.33 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues28/10/2024
    oxycodone hydrochlorideCapsule, hard10 mgResolvedAvailableCommercial Changes / Commercial viability28/10/2024
    morphine sulfate pentahydrateCapsule, modified release60 mgDiscontinuedUnavailableCommercial Changes / Commercial viability28/10/2024
    pamidronate disodiumInjection, concentrated3 mgResolvedAvailableManufacturing28/10/2024
    pamidronate disodiumInjection, concentrated6 mgResolvedAvailableManufacturing28/10/2024
  • 2024.10.29
    Active ingredientsDosage formQuantity of active ingredientsShortage statusAvailabilityReasonLast updated
    gabapentinCapsule, hard300 mgCurrentLimited AvailabilityManufacturing25/10/2024
    sumatriptan succinateTablet, film coated140 mgCurrentLimited AvailabilityManufacturing25/10/2024
    azithromycin dihydrateTablet, film coated524.1 mgCurrentUnavailableUnexpected increase in demand due to other sponsors unable to supply25/10/2024
    dutasteride~tamsulosin hydrochlorideCapsule, modified release500 microgram~400 microgramCurrentLimited AvailabilityManufacturing25/10/2024
    valsartan~hydrochlorothiazideTablet, film coated320 mg~25 mgCurrentLimited AvailabilityManufacturing25/10/2024
    esomeprazole magnesium dihydrateTablet, enteric coated21.75 mgCurrentLimited AvailabilityTransport / Logistic issues / Storage capacity issues25/10/2024
    clonidine hydrochlorideTablet100 microgramAnticipatedAvailableManufacturing25/10/2024
    fluorouracilInjection, solution50 mg/mLResolvedAvailableManufacturing25/10/2024
    verapamil hydrochlorideTablet, modified release180 mgCurrentLimited AvailabilityManufacturing25/10/2024
    estradiol hemihydrateDrug delivery system, transdermal1.54 mgCurrentLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply25/10/2024
    estradiol hemihydrateDrug delivery system, transdermal.77 mgCurrentLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply25/10/2024
    oxycodone hydrochlorideCapsule, hard5 mgResolvedAvailableManufacturing25/10/2024
    nizatidineCapsule300 mgCurrentLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply25/10/2024
    flecainide acetateInjection, solution10 mg/mLAnticipatedAvailableManufacturing24/10/2024
    topiramateTablet, film coated200 mgAnticipatedAvailableManufacturing24/10/2024
    gliclazideTablet, modified release30 mgResolvedAvailableManufacturing24/10/2024
    donepezil hydrochlorideTablet, film coated5 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues24/10/2024
    bisoprolol fumarateTablet5 mgCurrentUnavailableManufacturing24/10/2024
    bicalutamideTablet, film coated50 mgAnticipatedAvailableManufacturing24/10/2024
    azithromycin dihydrateTablet, film coated524.05 mgCurrentLimited AvailabilityManufacturing24/10/2024
    duloxetine hydrochlorideCapsule, enteric67.3 mgCurrentLimited AvailabilityManufacturing24/10/2024
    quetiapine fumarateTablet, film coated28.78 mgAnticipatedAvailableManufacturing24/10/2024
    rizatriptan benzoateTablet, orally disintegrating14.53 mgResolvedAvailableTransport / Logistic issues / Storage capacity issues24/10/2024
    simvastatinTablet, film coated40 mgCurrentUnavailableManufacturing24/10/2024
    citalopram hydrobromideTablet, film coated49.98 mgCurrentUnavailableManufacturing24/10/2024
    citalopram hydrobromideTablet, film coated49.98 mgAnticipatedAvailableManufacturing24/10/2024
    mitomycinInjection, powder for20 mgResolvedAvailableManufacturing24/10/2024
    ezetimibeTablet, uncoated10 mgCurrentUnavailableUnexpected increase in demand due to other sponsors unable to supply24/10/2024
    emtricitabine~tenofovir disoproxil maleateTablet, film coated200 mg~300 mgCurrentUnavailableManufacturing24/10/2024
    prochlorperazine maleateTablet, uncoated5 mgCurrentUnavailableCommercial Changes / Commercial viability24/10/2024
    nebivolol hydrochlorideTablet1.363 mgCurrentUnavailableManufacturing24/10/2024
    betahistine dihydrochlorideTablet, uncoated16 mgCurrentLimited AvailabilityManufacturing24/10/2024
    cinacalcet hydrochlorideTablet99.191 mgCurrentLimited AvailabilityManufacturing24/10/2024
    dosulepin (dothiepin) hydrochlorideCapsule, hard25 mgCurrentUnavailableManufacturing24/10/2024
    azacitidineInjection, powder for100 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability24/10/2024
    estradiolDrug delivery system, transdermal1.56 mgCurrentLimited AvailabilityManufacturing24/10/2024
    flecainide acetateTablet50 mgCurrentUnavailableManufacturing24/10/2024
    bortezomibInjection, solution3.5 mgCurrentUnavailableManufacturing24/10/2024
    paracetamolTablet, modified release665 mgCurrentLimited AvailabilityTransport / Logistic issues / Storage capacity issues24/10/2024
    norethisterone acetate~estradiolDrug delivery system, transdermal4.8 mg~.512 mgCurrentLimited AvailabilityManufacturing24/10/2024
    metformin hydrochlorideTablet, film coated850 mgCurrentUnavailableManufacturing24/10/2024
    pravastatin sodiumTablet, uncoated40 mgCurrentLimited AvailabilityManufacturing24/10/2024
    medronic acidInjection, powder for10 mgCurrentLimited AvailabilityManufacturing23/10/2024
    donepezil hydrochlorideTablet, film coated10 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues23/10/2024
    levetiracetamTablet, film coated250 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues23/10/2024
    bisoprolol fumarateTablet2.5 mgCurrentUnavailableManufacturing23/10/2024
    bisoprolol fumarateTablet10 mgAnticipatedAvailableManufacturing23/10/2024
    irbesartanTablet, film coated300 mgResolvedAvailableManufacturing23/10/2024
    methotrexateInjection, solution100 mg/mLCurrentUnavailableManufacturing23/10/2024
    epirubicin hydrochlorideInjection, concentrated200 mgCurrentUnavailableManufacturing23/10/2024
    betahistine dihydrochlorideTablet24 mgCurrentLimited AvailabilityUnexpected increase in consumer demand23/10/2024
    ezetimibeTablet, uncoated10 mgCurrentUnavailableManufacturing23/10/2024
    tenofovir disoproxil fumarate~emtricitabineTablet, film coated300 mg~200 mgCurrentUnavailableManufacturing23/10/2024
    tadalafilTablet, film coated10 mgCurrentUnavailableUnexpected increase in demand due to other sponsors unable to supply23/10/2024
    lacosamideTablet, film coated50 mgAnticipatedAvailableManufacturing23/10/2024
    lidocaine hydrochlorideInjection, solution400 mgCurrentUnavailableManufacturing23/10/2024
    amlodipine besilate~olmesartan medoxomil~hydrochlorothiazideTablet, film coated6.95 mg~40 mg~25 mgCurrentUnavailableManufacturing23/10/2024
    amoxicillin trihydrateOral Liquid, powder for114.82 mg/mLResolvedAvailableManufacturing23/10/2024
    cytarabineInjection, solution100 mgCurrentLimited AvailabilityUnexpected increase in consumer demand22/10/2024
    papaverine hydrochlorideInjection, solution12 mg/mLCurrentLimited AvailabilityManufacturing22/10/2024
    clonidine hydrochlorideTablet, uncoated100 microgramResolvedAvailableManufacturing22/10/2024
    ezetimibe~rosuvastatin calciumTablet~Tablet, film coated10 mg~5.198 mgResolvedAvailableManufacturing22/10/2024
    ezetimibe~rosuvastatin calciumTablet~Tablet, film coated10 mg~20.791 mgCurrentLimited AvailabilityManufacturing22/10/2024
    levetiracetamInjection, concentrated500 mgResolvedAvailableManufacturing22/10/2024
    pemetrexed disodiumInjection, powder for1102.9 mgCurrentUnavailableManufacturing22/10/2024
    meloxicamCapsule, hard15 mgAnticipatedAvailableManufacturing22/10/2024
    cisplatinInjection, concentrated1 mg/mLCurrentUnavailableUnexpected increase in consumer demand22/10/2024
    rasagiline mesilateTablet1.56 mgCurrentLimited AvailabilityManufacturing22/10/2024
    celecoxibCapsule, hard100 mgResolvedAvailableManufacturing22/10/2024
    solifenacin succinateTablet, film coated5 mgCurrentUnavailableManufacturing22/10/2024
    solifenacin succinateTablet, film coated10 mgCurrentUnavailableManufacturing22/10/2024
    lacosamideTablet, film coated100 mgResolvedAvailableManufacturing22/10/2024
    modafinilTablet, uncoated100 mgResolvedAvailableManufacturing22/10/2024
    quinagolide hydrochlorideTablet, uncoated.0819 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability22/10/2024
    clarithromycinOral Liquid, powder for50 mg/mLCurrentLimited AvailabilityUnexpected increase in consumer demand22/10/2024
    norethisterone~ethinylestradiolTablet, uncoated1 mg~36 microgramCurrentLimited AvailabilityManufacturing22/10/2024
    clonidine hydrochlorideTablet, uncoated150 microgramResolvedAvailableManufacturing22/10/2024
    methylphenidate hydrochlorideTablet, modified release54 mgCurrentLimited AvailabilityManufacturing22/10/2024
    adrenaline (epinephrine) acid tartrateInjection, solution1.82 mg/mLAnticipatedAvailableManufacturing21/10/2024
    topiramateTablet, film coated25 mgAnticipatedAvailableManufacturing21/10/2024
    pentetic acidInjection, powder for5 mgCurrentLimited AvailabilityManufacturing21/10/2024
    ezetimibe~rosuvastatin calciumTablet~Tablet, film coated10 mg~10.396 mgCurrentLimited AvailabilityManufacturing21/10/2024
    rosuvastatin calcium~ezetimibeTablet~Tablet, film coated20.791 mg~10 mgCurrentLimited AvailabilityManufacturing21/10/2024
    ezetimibe~rosuvastatin calciumTablet~Tablet, film coated10 mg~5.198 mgCurrentLimited AvailabilityManufacturing21/10/2024
    ezetimibe~rosuvastatin calciumTablet~Tablet, film coated10 mg~10.396 mgResolvedAvailableManufacturing21/10/2024
    paclitaxelInjection, concentrated300 mgResolvedAvailableManufacturing21/10/2024
    milrinoneInjection, concentrated10 mgResolvedAvailableManufacturing21/10/2024
    cefepime hydrochloride monohydrateInjection, powder for1189.2 mgCurrentLimited AvailabilityManufacturing21/10/2024
    temozolomideCapsule, hard20 mgAnticipatedAvailableManufacturing21/10/2024
    benzatropine mesilateInjection1 mg/mLAnticipatedAvailableManufacturing21/10/2024
    hydromorphone hydrochlorideInjection, solution2 mgCurrentLimited AvailabilityManufacturing21/10/2024
    atorvastatin calcium trihydrateTablet, film coated86.751 mgAnticipatedAvailableManufacturing21/10/2024
    lenalidomideCapsule, hard5 mgResolvedAvailableUnexpected increase in consumer demand21/10/2024
    levothyroxine sodiumTablet50 microgramCurrentUnavailableManufacturing21/10/2024
    clindamycin hydrochlorideSolution10 mg/mLCurrentUnavailableManufacturing21/10/2024
    sodium pertechnetate(99mTc)Injection, solution20 GBqResolvedAvailableManufacturing21/10/2024
    balsalazide sodiumCapsule750 mgResolvedAvailableCommercial Changes / Commercial viability21/10/2024
  • 2024.10.23
    Active ingredientsDosage formQuantity of active ingredientsShortage statusAvailabilityReasonLast updated
    sumatriptan succinateTablet, film coated140 mgCurrentLimited AvailabilityManufacturing18/10/2024
    topiramateTablet, film coated50 mgAnticipatedAvailableManufacturing18/10/2024
    topiramateTablet, film coated100 mgAnticipatedAvailableManufacturing18/10/2024
    heparin sodiumInjection, solution5000 IU/mLAnticipatedAvailableUnexpected increase in consumer demand18/10/2024
    tamsulosin hydrochloride~dutasterideCapsule, modified release400 microgram~500 microgramCurrentLimited AvailabilityManufacturing18/10/2024
    metformin hydrochlorideTablet, modified release1000 mgCurrentLimited AvailabilityManufacturing18/10/2024
    tadalafilTablet, film coated20 mgCurrentLimited AvailabilityManufacturing18/10/2024
    oxycodone hydrochlorideCapsule, hard10 mgCurrentUnavailableCommercial Changes / Commercial viability18/10/2024
    fenofibrateTablet48 mgResolvedAvailableManufacturing18/10/2024
    tadalafilTablet, film coated20 mgCurrentLimited AvailabilityManufacturing18/10/2024
    latanoprostEye Drops, solution.05 mg/mLResolvedAvailableTransport / Logistic issues / Storage capacity issues18/10/2024
    lacosamideTablet, film coated150 mgCurrentUnavailableManufacturing18/10/2024
    pregabalinCapsule, hard75 mgResolvedAvailableManufacturing18/10/2024
    pregabalinCapsule, hard75 mgResolvedAvailableManufacturing18/10/2024
    atorvastatin calcium trihydrateTablet, film coated86.751 mgCurrentLimited AvailabilityManufacturing18/10/2024
    trimethoprimTablet, uncoated300 mgCurrentLimited AvailabilityManufacturing18/10/2024
    dosulepin (dothiepin) hydrochlorideCapsule, hard25 mgCurrentUnavailableManufacturing18/10/2024
    indometacinCapsule, hard25 mgCurrentUnavailableManufacturing18/10/2024
    octreotideInjection, solution50 microgram/mLCurrentLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply18/10/2024
    clonazepamTablet, uncoated.5 mgCurrentLimited AvailabilityManufacturing18/10/2024
    clonazepamTablet, uncoated2 mgCurrentLimited AvailabilityManufacturing18/10/2024
    estradiol hemihydrateDrug delivery system, transdermal1.54 mgAnticipatedAvailableUnexpected increase in demand due to other sponsors unable to supply18/10/2024
    tobramycinInhalation, conventional60 mg/mLCurrentUnavailableManufacturing18/10/2024
    topiramateTablet, film coated200 mgAnticipatedAvailableManufacturing17/10/2024
    adrenaline (epinephrine)Injection, solution1 mgResolvedAvailableManufacturing17/10/2024
    mitomycinInjection, powder for20 mgCurrentUnavailableManufacturing17/10/2024
    azacitidineInjection, powder for100 mgCurrentUnavailableManufacturing17/10/2024
    irbesartanTablet, film coated150 mgResolvedAvailableManufacturing17/10/2024
    tadalafilTablet, film coated5 mgCurrentUnavailableManufacturing17/10/2024
    lisdexamfetamine dimesilateCapsule, hard60 mgResolvedAvailableUnexpected increase in consumer demand17/10/2024
    letrozoleTablet, film coated2.5 mgCurrentLimited AvailabilityManufacturing17/10/2024
    nebivolol hydrochlorideTablet5.45 mgCurrentLimited AvailabilityManufacturing17/10/2024
    daptomycinInjection, powder for500 mgCurrentUnavailableCommercial Changes / Commercial viability17/10/2024
    tamoxifen citrateTablet30.34 mgCurrentLimited AvailabilityManufacturing17/10/2024
    olanzapine pamoate monohydrateInjection, powder for931 mgCurrentLimited AvailabilityTransport / Logistic issues / Storage capacity issues16/10/2024
    risperidoneTablet, film coated4 mgAnticipatedAvailableManufacturing16/10/2024
    rocuronium bromideInjection, solution50 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability16/10/2024
    adrenaline (epinephrine)Injection, solution1 mgResolvedAvailableUnexpected increase in demand due to other sponsors unable to supply16/10/2024
    atorvastatin calcium trihydrate~ezetimibeTablet, multilayer10.9 mg~10 mgResolvedAvailableManufacturing16/10/2024
    entecavirTablet, film coated1 mgResolvedAvailableManufacturing16/10/2024
    hydrochlorothiazide~irbesartanTablet, film coated25 mg~300 mgAnticipatedAvailableManufacturing16/10/2024
    tadalafilTablet, film coated10 mgAnticipatedAvailableManufacturing16/10/2024
    tadalafilTablet, film coated5 mgResolvedAvailableManufacturing16/10/2024
    cisplatinInjection, concentrated1 mg/mLAnticipatedAvailableManufacturing16/10/2024
    linezolidTablet, film coated600 mgResolvedAvailableUnexpected increase in consumer demand16/10/2024
    latanoprost~timolol maleateEye Drops, solution.05 mg/mL~6.83 mg/mLAnticipatedAvailableManufacturing16/10/2024
    dutasteride~tamsulosin hydrochlorideCapsule, modified release500 microgram~400 microgramAnticipatedAvailableTransport / Logistic issues / Storage capacity issues16/10/2024
    bendamustine hydrochloride monohydrateInjection, powder for100 mgResolvedAvailableUnexpected increase in demand due to other sponsors unable to supply16/10/2024
    amlodipine besilate~olmesartan medoxomilTablet, film coated6.94 mg~40 mgCurrentUnavailableUnexpected increase in consumer demand16/10/2024
    methylphenidate hydrochlorideTablet, modified release27 mgResolvedAvailableManufacturing16/10/2024
    daptomycinInhalation, powder for350 mgAnticipatedAvailableManufacturing16/10/2024
    enoxaparin sodiumInjection, solution20 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability16/10/2024
    ezetimibe~rosuvastatin calciumTablet~Tablet, film coated10 mg~41.6 mgCurrentUnavailableManufacturing16/10/2024
    ezetimibe~rosuvastatin calciumTablet~Tablet, film coated10 mg~20.8 mgResolvedAvailableManufacturing16/10/2024
    nizatidineCapsule, hard300 mgResolvedAvailableManufacturing16/10/2024
    TenecteplaseInjection, powder for50 mgResolvedAvailableUnexpected increase in consumer demand16/10/2024
    sodium pertechnetate(99mTc)Injection370 GBqResolvedAvailableManufacturing16/10/2024
    ciprofloxacin hydrochlorideTablet, film coated873.32 mgAnticipatedAvailableManufacturing16/10/2024
    nizatidineCapsule150 mgCurrentLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply16/10/2024
    nizatidineCapsule, hard300 mgResolvedAvailableManufacturing16/10/2024
    acetylcholine chlorideSolution, powder for irrigation10 mg/mLCurrentUnavailableManufacturing15/10/2024
    daunorubicinInjection, solution20 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability15/10/2024
    anidulafunginInjection, powder for100 mgCurrentLimited AvailabilityManufacturing15/10/2024
    mycophenolate mofetilTablet, film coated500 mgCurrentLimited AvailabilityManufacturing15/10/2024
    duloxetine hydrochlorideCapsule, enteric67.3 mgCurrentLimited AvailabilityManufacturing15/10/2024
    Digoxinspecific antibody fragment F(ab) (Ovine)Injection, powder for40 mgAnticipatedAvailableManufacturing15/10/2024
    duloxetine hydrochlorideCapsule, enteric33.66 mgCurrentUnavailableUnexpected increase in consumer demand15/10/2024
    escitalopram oxalateTablet, film coated12.74 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues15/10/2024
    escitalopram oxalateTablet, film coated25.47 mgCurrentUnavailableManufacturing15/10/2024
    rizatriptan benzoateTablet, orally disintegrating14.53 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues15/10/2024
    Follitropin alfaInjection, solution75 IUCurrentLimited AvailabilityManufacturing15/10/2024
    atorvastatin calcium trihydrateTablet, film coated86.76 mgResolvedAvailableManufacturing15/10/2024
    cinacalcet hydrochlorideTablet99.191 mgCurrentLimited AvailabilityManufacturing15/10/2024
    tadalafilTablet, film coated5 mgCurrentUnavailableUnexpected increase in demand due to other sponsors unable to supply15/10/2024
    tadalafilTablet, film coated20 mgCurrentLimited AvailabilityUnexpected increase in consumer demand15/10/2024
    dosulepin (dothiepin) hydrochlorideCapsule, hard25 mgCurrentUnavailableManufacturing15/10/2024
    prasugrelTablet, film coated5 mgCurrentUnavailableManufacturing15/10/2024
    prasugrelTablet, film coated10 mgCurrentLimited AvailabilityManufacturing15/10/2024
    estradiolDrug delivery system, transdermal.585 mgCurrentUnavailableManufacturing15/10/2024
    estradiolDrug delivery system, transdermal1.17 mgCurrentUnavailableManufacturing15/10/2024
    flecainide acetateTablet50 mgCurrentUnavailableManufacturing15/10/2024
    pegcetacoplanInjection, solution1080 mgResolvedAvailableManufacturing15/10/2024
    rocuronium bromideInjection, solution10 mg/mLDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability15/10/2024
    estradiol~norethisterone acetateDrug delivery system, transdermal.62 mg~2.7 mgResolvedAvailableManufacturing15/10/2024
    pimecrolimusCream10 mg/gResolvedAvailableManufacturing15/10/2024
    clarithromycinTablet, film coated250 mgAnticipatedAvailableUnexpected increase in consumer demand15/10/2024
    griseofulvinTablet, uncoated125 mgResolvedAvailableManufacturing14/10/2024
    olsalazine sodiumCapsule250 mgCurrentUnavailableManufacturing14/10/2024
    iopromideInjection, solution498.72 mg/mLCurrentUnavailableUnexpected increase in consumer demand14/10/2024
    telmisartan~hydrochlorothiazideTablet, film coated80 mg~12.5 mgCurrentLimited AvailabilityManufacturing14/10/2024
    esomeprazole magnesium dihydrateTablet, enteric coated21.75 mgAnticipatedAvailableTransport / Logistic issues / Storage capacity issues14/10/2024
    benzathine benzylpenicillin tetrahydrateInjection, suspension600000 USP UnitCurrentUnavailableManufacturing14/10/2024
    oseltamivir phosphateCapsule, hard98.524 mgAnticipatedAvailableUnexpected increase in consumer demand14/10/2024
    thiotepaInjection, powder for15 mgAnticipatedAvailableCommercial Changes / Commercial viability14/10/2024
    betahistine dihydrochlorideTablet16 mgResolvedAvailableUnexpected increase in consumer demand14/10/2024
    cisplatinInjection, solution1 mg/mLCurrentLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply14/10/2024
    olsalazine sodiumTablet, uncoated500 mgCurrentUnavailableManufacturing14/10/2024
    clarithromycinTablet, film coated250 mgCurrentLimited AvailabilityManufacturing11/10/2024
    primidoneTablet, uncoated250 mgCurrentLimited AvailabilityManufacturing11/10/2024
    neostigmine methylsulfateInjection, solution2.5 mgAnticipatedAvailableManufacturing11/10/2024
    tadalafilTablet5 mgResolvedAvailableUnexpected increase in demand due to other sponsors unable to supply11/10/2024
    tadalafilTablet, film coated5 mgResolvedAvailableManufacturing11/10/2024
    heparin sodiumInjection, solution5000 IU/mLCurrentLimited AvailabilityManufacturing11/10/2024
    midazolamInjection, solution5 mg/mLResolvedAvailableManufacturing11/10/2024
    metoprolol succinateTablet, modified release190 mgAnticipatedAvailableManufacturing10/10/2024
    bisoprolol fumarateTablet5 mgCurrentUnavailableManufacturing10/10/2024
    nebivolol hydrochlorideTablet1.363 mgAnticipatedAvailableManufacturing10/10/2024
  • 2024.10.10
    Active ingredientsDosage formQuantity of active ingredientsShortage statusAvailabilityReasonLast updated
    atropine sulfate monohydrateInjection, solution1.2 mg/mLResolvedAvailableManufacturing9/10/2024
    acetylcysteineInjection, concentrated2 gAnticipatedAvailableManufacturing9/10/2024
    trandolaprilCapsule2 mgResolvedAvailableTransport / Logistic issues / Storage capacity issues9/10/2024
    isosorbide dinitrateTablet, uncoated5 mgCurrentLimited AvailabilityManufacturing9/10/2024
    morphine hydrochloride trihydrateOral Liquid, solution1 mg/mLResolvedAvailableCommercial Changes / Commercial viability9/10/2024
    risperidoneTablet, film coated1 mgCurrentUnavailableManufacturing9/10/2024
    acetylcysteineInjection, concentrated2 gCurrentLimited AvailabilityTransport / Logistic issues / Storage capacity issues9/10/2024
    galantamine hydrobromideCapsule, modified release30.756 mgAnticipatedAvailableManufacturing9/10/2024
    adrenaline (epinephrine) acid tartrateInjection, solution182 microgram/mLCurrentUnavailableManufacturing9/10/2024
    citalopram hydrobromideTablet, film coated49.98 mgAnticipatedAvailableManufacturing9/10/2024
    ezetimibeTablet, uncoated10 mgCurrentUnavailableManufacturing9/10/2024
    ezetimibeTablet, uncoated10 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues9/10/2024
    tadalafilTablet, film coated20 mgCurrentLimited AvailabilityManufacturing9/10/2024
    adrenaline (epinephrine) acid tartrateInjection, solution1.819 mgCurrentUnavailableUnexpected increase in demand due to other sponsors unable to supply9/10/2024
    metformin hydrochlorideTablet, film coated850 mgResolvedAvailableManufacturing9/10/2024
    lacosamideTablet, film coated100 mgResolvedAvailableManufacturing9/10/2024
    codeine phosphate hemihydrate~doxylamine succinate~paracetamolTablet, uncoated30 mg~5 mg~450 mgResolvedAvailableManufacturing9/10/2024
    amlodipine besilate~hydrochlorothiazide~olmesartan medoxomilTablet, film coated6.95 mg~12.5 mg~40 mgCurrentUnavailableManufacturing9/10/2024
    calcium chloride dihydrate~magnesium chloride hexahydrate~sodium lactate~glucose~sodium chlorideSolution, irrigation183 mg/L~50.8 mg/L~4.48 g/L~15 g/L~5.38 g/LCurrentLimited AvailabilityManufacturing8/10/2024
    calcium chloride dihydrate~glucose~sodium lactate~magnesium chloride hexahydrate~sodium chlorideSolution, irrigation183 mg/L~25 g/L~4.48 g/L~50.8 mg/L~5.38 g/LCurrentLimited AvailabilityManufacturing8/10/2024
    levetiracetamTablet, film coated500 mgResolvedAvailableTransport / Logistic issues / Storage capacity issues8/10/2024
    codeine phosphate hemihydrate~doxylamine succinate~paracetamolTablet, uncoated10 mg~5.1 mg~500 mgCurrentUnavailableManufacturing8/10/2024
    paclitaxelInjection, concentrated300 mgCurrentUnavailableManufacturing8/10/2024
    milrinoneInjection, concentrated10 mgCurrentLimited AvailabilityManufacturing8/10/2024
    azithromycin dihydrateTablet, film coated524 mgCurrentUnavailableManufacturing8/10/2024
    cisplatinInjection, concentrated1 mg/mLAnticipatedAvailableManufacturing8/10/2024
    lacosamideTablet, film coated150 mgCurrentUnavailableManufacturing8/10/2024
    gliclazideTablet, uncoated80 mgResolvedAvailableUnexpected increase in consumer demand8/10/2024
    ketorolac trometamolInjection, solution30 mg/mLResolvedAvailableManufacturing8/10/2024
    phentermine hydrochlorideTablet, modified release49.7 mgCurrentLimited AvailabilityManufacturing8/10/2024
    carmustineInjection, powder for100 mgCurrentUnavailableManufacturing8/10/2024
    methotrexateTablet10 mgCurrentLimited AvailabilityManufacturing8/10/2024
    sitagliptin hydrochloride monohydrateTablet, film coated109 mgCurrentUnavailableManufacturing8/10/2024
    sitagliptin hydrochloride monohydrateTablet, film coated54.5 mgCurrentUnavailableManufacturing8/10/2024
    sitagliptin hydrochloride monohydrateTablet, film coated27.25 mgCurrentUnavailableManufacturing8/10/2024
    AdalimumabInjection, solution40 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability8/10/2024
    levothyroxine sodiumTablet, uncoated.05 mgCurrentUnavailableManufacturing8/10/2024
    cisplatinInjection, solution1 mg/mLResolvedAvailableUnexpected increase in consumer demand8/10/2024
    verapamil hydrochlorideTablet, modified release180 mgCurrentLimited AvailabilityManufacturing8/10/2024
    rifabutinCapsule, hard150 mgResolvedAvailableManufacturing8/10/2024
    rizatriptan benzoateWafer14.53 mgResolvedAvailableManufacturing8/10/2024
    pamidronate disodiumInjection, concentrated6 mgCurrentLimited AvailabilityManufacturing8/10/2024
    doxorubicin hydrochlorideInjection, concentrated2 mg/mLResolvedAvailableManufacturing8/10/2024
    pegcetacoplanInjection, solution1080 mgAnticipatedAvailableManufacturing7/10/2024
    duloxetine hydrochlorideCapsule, enteric33.7 mgDiscontinuedUnavailableCommercial Changes / Commercial viability4/10/2024
    duloxetine hydrochlorideCapsule, enteric67.3 mgDiscontinuedUnavailableCommercial Changes / Commercial viability4/10/2024
    medronic acidInjection, powder for10 mgAnticipatedAvailableManufacturing4/10/2024
    fluoxetine hydrochlorideCapsule, hard22.36 mgDiscontinuedUnavailableCommercial Changes / Commercial viability4/10/2024
    LiraglutideInjection, solution6 mg/mLDiscontinuedUnavailableCommercial Changes / Commercial viability4/10/2024
    adrenaline (epinephrine)Injection, solution1 mgCurrentLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply4/10/2024
    Choriogonadotropin alfaInjection, solution250 microgramCurrentEmergency Supply OnlyUnexpected increase in consumer demand4/10/2024
    noradrenaline (norepinephrine) acid tartrate monohydrateInjection, concentrated8 mgCurrentLimited AvailabilityManufacturing4/10/2024
    topotecan hydrochlorideInjection, concentrated4.346 mgCurrentUnavailableManufacturing4/10/2024
    Rabies virusPowder3.25 IUResolvedAvailableUnexpected increase in demand due to other sponsors unable to supply4/10/2024
    sumatriptan succinateTablet, film coated140 mgCurrentLimited AvailabilityManufacturing3/10/2024
    midazolamInjection, solution5 mgCurrentLimited AvailabilityManufacturing3/10/2024
    tamsulosin hydrochloride~dutasterideCapsule, modified release400 microgram~500 microgramCurrentLimited AvailabilityManufacturing3/10/2024
    clonidine hydrochlorideTablet, uncoated100 microgramCurrentLimited AvailabilityManufacturing3/10/2024
    duloxetine hydrochlorideCapsule, enteric33.65 mgCurrentUnavailableManufacturing3/10/2024
    duloxetine hydrochlorideCapsule, enteric67.3 mgCurrentUnavailableManufacturing3/10/2024
    telmisartan~hydrochlorothiazideTablet, film coated80 mg~12.5 mgCurrentLimited AvailabilityManufacturing3/10/2024
    quetiapine fumarateTablet, film coated28.78 mgCurrentLimited AvailabilityManufacturing3/10/2024
    metformin hydrochlorideTablet, modified release1000 mgCurrentLimited AvailabilityManufacturing3/10/2024
    tadalafilTablet, film coated20 mgCurrentLimited AvailabilityManufacturing3/10/2024
    betahistine dihydrochlorideTablet16 mgResolvedAvailableManufacturing3/10/2024
    potassium clavulanate~amoxicillin trihydrateTablet, film coated148.875 mg~1006.25 mgResolvedAvailableManufacturing3/10/2024
    clonidine hydrochlorideTablet100 microgramResolvedAvailableUnexpected increase in consumer demand3/10/2024
    tenofovir disoproxil fumarate~emtricitabineTablet, film coated300 mg~200 mgCurrentUnavailableManufacturing3/10/2024
    cinacalcet hydrochlorideTablet99.191 mgCurrentLimited AvailabilityManufacturing3/10/2024
    celecoxibCapsule, hard100 mgCurrentLimited AvailabilityManufacturing3/10/2024
    apomorphine hydrochloride hemihydrateInjection, solution10 mgCurrentLimited AvailabilityManufacturing3/10/2024
    lacosamideTablet, film coated100 mgCurrentUnavailableManufacturing3/10/2024
    eftrenonacog alfaInjection, powder for4000 IUResolvedAvailableManufacturing3/10/2024
    atorvastatin calcium trihydrateTablet, film coated86.751 mgAnticipatedAvailableManufacturing3/10/2024
    trimethoprimTablet, uncoated300 mgAnticipatedAvailableManufacturing3/10/2024
    dosulepin (dothiepin) hydrochlorideCapsule, hard25 mgCurrentUnavailableManufacturing3/10/2024
    indometacinCapsule, hard25 mgCurrentUnavailableManufacturing3/10/2024
    mycophenolate mofetilSuspension200 mg/mLResolvedAvailableManufacturing3/10/2024
    levothyroxine sodiumTablet, uncoated.075 mgCurrentUnavailableManufacturing3/10/2024
    levothyroxine sodiumTablet, uncoated.2 mgCurrentUnavailableManufacturing3/10/2024
    estradiol hemihydrateDrug delivery system, transdermal1.54 mgAnticipatedAvailableUnexpected increase in demand due to other sponsors unable to supply3/10/2024
    imipramine hydrochlorideTablet, sugar coated25 mgCurrentUnavailableManufacturing3/10/2024
    estradiol hemihydrateDrug delivery system, transdermal.77 mgAnticipatedAvailableUnexpected increase in demand due to other sponsors unable to supply3/10/2024
    estradiol hemihydrateDrug delivery system, transdermal3.09 mgCurrentLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply3/10/2024
    celecoxibCapsule, hard100 mgResolvedAvailableManufacturing3/10/2024
    norethisterone acetate~estradiolDrug delivery system, transdermal2.7 mg~.62 mgCurrentUnavailableManufacturing3/10/2024
    amoxicillin trihydrateTablet, film coated1148 mgResolvedAvailableManufacturing3/10/2024
    ciprofloxacin hydrochlorideTablet, film coated873.32 mgAnticipatedAvailableManufacturing3/10/2024
    nizatidineCapsule150 mgCurrentLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply3/10/2024
    lisinopril dihydrateTablet, uncoated10.89 mgResolvedAvailableManufacturing2/10/2024
    escitalopram oxalateTablet, film coated25.56 mgResolvedAvailableManufacturing2/10/2024
    topiramateTablet, film coated200 mgAnticipatedAvailableManufacturing2/10/2024
    zolpidem tartrateTablet, film coated10 mgAnticipatedAvailableManufacturing2/10/2024
    isoniazidTablet, uncoated100 mgResolvedAvailableManufacturing2/10/2024
    ciprofloxacin hydrochlorideTablet, film coated832.5 mgAnticipatedAvailableManufacturing2/10/2024
    gliclazideTablet, modified release30 mgAnticipatedAvailableManufacturing2/10/2024
    silver sulfadiazineCream10 mg/gCurrentUnavailableManufacturing2/10/2024
    silver sulfadiazineCream10 mg/gCurrentLimited AvailabilityManufacturing2/10/2024
    risperidoneTablet, film coated4 mgAnticipatedAvailableManufacturing2/10/2024
    donepezil hydrochlorideTablet, film coated5 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues2/10/2024
    hydrocortisone sodium succinateInjection, powder for334.25 mgCurrentLimited AvailabilityManufacturing2/10/2024
    bicalutamideTablet, film coated50 mgAnticipatedAvailableManufacturing2/10/2024
    quetiapine fumarateTablet, film coated115.12 mgResolvedAvailableManufacturing2/10/2024
    quetiapine fumarateTablet, film coated345.36 mgCurrentLimited AvailabilityManufacturing2/10/2024
    simvastatinTablet, film coated80 mgAnticipatedAvailableManufacturing2/10/2024
    citalopram hydrobromideTablet, film coated49.98 mgAnticipatedAvailableManufacturing2/10/2024
    fluorouracilInjection, solution50 mg/mLCurrentLimited AvailabilityManufacturing2/10/2024
    dosulepin (dothiepin) hydrochlorideCapsule, hard25 mgCurrentUnavailableManufacturing2/10/2024
    atomoxetine hydrochlorideCapsule, hard45.5 mgCurrentUnavailableManufacturing2/10/2024
    fluconazoleCapsule, hard200 mgAnticipatedAvailableManufacturing2/10/2024
    phenytoin sodiumCapsule, hard100 mgResolvedAvailableManufacturing2/10/2024
    lacosamideTablet, film coated50 mgAnticipatedAvailableManufacturing2/10/2024
    risperidoneOral Liquid, solution1 mg/mLResolvedAvailableManufacturing2/10/2024
    teriflunomideTablet, film coated14 mgAnticipatedAvailableManufacturing2/10/2024
    pregabalinCapsule, hard75 mgAnticipatedAvailableManufacturing2/10/2024
    pregabalinCapsule, hard75 mgAnticipatedAvailableManufacturing2/10/2024
    methylphenidate hydrochlorideTablet, modified release54 mgCurrentUnavailableManufacturing2/10/2024
    captoprilTablet, uncoated25 mgResolvedAvailableManufacturing2/10/2024
    captoprilTablet, uncoated50 mgResolvedAvailableManufacturing2/10/2024
    indapamide hemihydrateTablet2.5 mgResolvedAvailableManufacturing2/10/2024
    metformin hydrochlorideTablet, film coated1000 mgResolvedAvailableManufacturing2/10/2024
    rasagiline mesilateTablet1.56 mgCurrentLimited AvailabilityManufacturing1/10/2024
    Rabies virusInjection, powder for2.5 IUResolvedAvailableManufacturing1/10/2024
    prasugrelTablet, film coated10 mgCurrentLimited AvailabilityManufacturing1/10/2024
    spironolactoneTablet, uncoated100 mgResolvedAvailableManufacturing1/10/2024
    sugammadex sodiumInjection, solution217.6 mgResolvedAvailableCommercial Changes / Commercial viability1/10/2024
    Follitropin betaInjection, solution833 IU/mLDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability1/10/2024
    clonidine hydrochlorideTablet, uncoated150 microgramCurrentLimited AvailabilityManufacturing1/10/2024
    Peginterferon alfa2aInjection, solution135 microgramAnticipatedAvailableUnexpected increase in consumer demand1/10/2024
    Peginterferon alfa2aInjection, solution180 microgramAnticipatedAvailableUnexpected increase in consumer demand1/10/2024
    pimecrolimusCream10 mg/gCurrentLimited AvailabilityManufacturing1/10/2024
    griseofulvinTablet, uncoated125 mgCurrentUnavailableManufacturing30/09/2024
    sodium pyrophosphateInjection, powder for30 mgCurrentLimited AvailabilityManufacturing30/09/2024
    hydrocortisone sodium succinateInjection, powder for134 mgResolvedAvailableManufacturing30/09/2024
    cefepime hydrochloride monohydrateInjection, powder for1189.2 mgAnticipatedAvailableManufacturing30/09/2024
    lacosamideTablet, film coated100 mgCurrentLimited AvailabilityCommercial Changes / Commercial viability30/09/2024
    lacosamideTablet, film coated150 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues30/09/2024
    heparin sodiumInjection, solution5000 IU/mLCurrentLimited AvailabilityManufacturing30/09/2024
  • 2024.09.30
    Active ingredientsDosage formQuantity of active ingredientsShortage statusAvailabilityReasonLast updated
    bupivacaine hydrochloride monohydrateInjection, solution52.7 mgCurrentUnavailableManufacturing27/09/2024
    salbutamol sulfateInhalation, conventional3 mgCurrentUnavailableManufacturing27/09/2024
    framycetin sulfate~dexamethasone~gramicidinEar Drops5 mg/mL~.5 mg/mL~.05 mg/mLCurrentLimited AvailabilityManufacturing27/09/2024
    octreotideInjection, solution100 microgramCurrentLimited AvailabilityManufacturing27/09/2024
    octreotideInjection, solution500 microgramCurrentUnavailableManufacturing27/09/2024
    octreotideInjection, solution50 microgramCurrentUnavailableManufacturing27/09/2024
    buprenorphine hydrochlorideInjection, solution324 microgram/mLCurrentUnavailableManufacturing27/09/2024
    midazolamInjection, solution5 mgCurrentLimited AvailabilityManufacturing27/09/2024
    mycophenolate mofetilTablet, film coated500 mgCurrentLimited AvailabilityManufacturing27/09/2024
    metronidazoleTablet, uncoated400 mgResolvedAvailableManufacturing27/09/2024
    duloxetine hydrochlorideCapsule, enteric33.65 mgCurrentLimited AvailabilityManufacturing27/09/2024
    tranexamic acidInjection, solution1000 mgAnticipatedAvailableCommercial Changes / Commercial viability27/09/2024
    fenofibrateTablet48 mgCurrentLimited AvailabilityManufacturing27/09/2024
    fluticasone propionateInhalation, pressurised125 microgram/actuationCurrentUnavailableManufacturing27/09/2024
    tadalafilTablet5 mgCurrentUnavailableUnexpected increase in demand due to other sponsors unable to supply27/09/2024
    emtricitabine~tenofovir disoproxil fumarateTablet, film coated200 mg~300 mgCurrentUnavailableManufacturing27/09/2024
    phenytoin sodiumCapsule, hard100 mgCurrentLimited AvailabilityManufacturing27/09/2024
    gliclazideTablet, modified release30 mgResolvedAvailableUnexpected increase in demand due to other sponsors unable to supply27/09/2024
    modafinilTablet, uncoated100 mgCurrentLimited AvailabilityManufacturing27/09/2024
    montelukast sodiumTablet, chewable5.2 mgCurrentUnavailableManufacturing27/09/2024
    chloramphenicolEye Drops, solution5 mg/mLCurrentUnavailableManufacturing27/09/2024
    methylphenidate hydrochlorideTablet, modified release54 mgAnticipatedAvailableManufacturing27/09/2024
    methylphenidate hydrochlorideTablet, modified release27 mgAnticipatedAvailableManufacturing27/09/2024
    paracetamolTablet, modified release665 mgCurrentLimited AvailabilityTransport / Logistic issues / Storage capacity issues27/09/2024
    clonazepamTablet, uncoated2 mgCurrentLimited AvailabilityManufacturing27/09/2024
    tobramycinInhalation, conventional60 mg/mLCurrentUnavailableManufacturing27/09/2024
    morphine sulfate pentahydrateCapsule, modified release120 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability27/09/2024
    morphine sulfate pentahydrateCapsule, modified release90 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability27/09/2024
    morphine sulfate pentahydrateCapsule, modified release60 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability27/09/2024
    methylphenidate hydrochlorideTablet, modified release18 mgResolvedAvailableManufacturing27/09/2024
    primidoneTablet, uncoated250 mgCurrentLimited AvailabilityManufacturing26/09/2024
    ramiprilCapsule, hard10 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability26/09/2024
    propofolInjection, emulsion500 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability26/09/2024
    oxytocinInjection, solution10 IUAnticipatedAvailableManufacturing26/09/2024
    temozolomideCapsule, hard100 mgResolvedAvailableTransport / Logistic issues / Storage capacity issues26/09/2024
    lurasidone hydrochlorideTablet, film coated40 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability26/09/2024
    lurasidone hydrochlorideTablet, film coated80 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability26/09/2024
    atorvastatin calcium trihydrate~ezetimibeTablet, multilayer10.9 mg~10 mgCurrentUnavailableManufacturing26/09/2024
    epirubicin hydrochlorideInjection, concentrated200 mgCurrentUnavailableManufacturing26/09/2024
    tadalafilTablet, film coated5 mgCurrentUnavailableManufacturing26/09/2024
    tadalafilTablet, film coated20 mgCurrentUnavailableUnexpected increase in consumer demand26/09/2024
    lidocaine hydrochlorideInjection, solution400 mgCurrentUnavailableManufacturing26/09/2024
    nebivolol hydrochlorideTablet10.9 mgCurrentLimited AvailabilityManufacturing26/09/2024
    montelukast sodiumTablet, film coated10.4 mgCurrentUnavailableManufacturing26/09/2024
    bortezomibInjection, solution3.5 mgCurrentUnavailableManufacturing26/09/2024
    bisoprolol fumarateTablet, film coated2.5 mgDiscontinuedUnavailableCommercial Changes / Commercial viability26/09/2024
    bisoprolol fumarateTablet, film coated5 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability26/09/2024
    bisoprolol fumarateTablet, film coated10 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability26/09/2024
    pamidronate disodiumInjection, concentrated3 mgCurrentUnavailableManufacturing26/09/2024
    ezetimibeTablet, uncoated10 mgCurrentUnavailableUnexpected increase in demand due to other sponsors unable to supply25/09/2024
    Rabies virusInjection, powder for2.5 IUCurrentEmergency Supply OnlyManufacturing25/09/2024
    latanoprost~timolol maleateEye Drops, solution.05 mg/mL~6.83 mg/mLAnticipatedAvailableManufacturing25/09/2024
    nebivolol hydrochlorideTablet5.45 mgCurrentLimited AvailabilityManufacturing25/09/2024
    aciclovirInjection, solution25 mg/mLCurrentUnavailableUnexpected increase in demand due to other sponsors unable to supply25/09/2024
    gefitinibTablet, film coated250 mgCurrentUnavailableManufacturing25/09/2024
    lurasidone hydrochlorideTablet, film coated40 mgResolvedAvailableManufacturing25/09/2024
    Rabies virusPowder3.25 IUCurrentLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply25/09/2024
    AdalimumabInjection, solution40 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability25/09/2024
    propranolol hydrochlorideTablet, film coated40 mgResolvedAvailableManufacturing24/09/2024
    adrenaline (epinephrine)Injection, solution1 mgCurrentLimited AvailabilityManufacturing24/09/2024
    acetylcysteineInjection, concentrated2 gCurrentLimited AvailabilityTransport / Logistic issues / Storage capacity issues24/09/2024
    midazolamInjection, solution5 mg/mLDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability24/09/2024
    midazolamInjection, solution1 mg/mLDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability24/09/2024
    duloxetine hydrochlorideCapsule, enteric33.65 mgCurrentUnavailableManufacturing24/09/2024
    buprenorphineDrug delivery system, transdermal40 mgResolvedAvailableTransport / Logistic issues / Storage capacity issues24/09/2024
    ezetimibeTablet10 mgCurrentUnavailableManufacturing24/09/2024
    ezetimibeTablet, uncoated10 mgCurrentUnavailableManufacturing24/09/2024
    ezetimibeTablet, uncoated10 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues24/09/2024
    ezetimibeTablet, uncoated10 mgCurrentLimited AvailabilityManufacturing24/09/2024
    ezetimibeTablet10 mgCurrentUnavailableUnexpected increase in consumer demand24/09/2024
    ezetimibeTablet10 mgCurrentUnavailableUnexpected increase in consumer demand24/09/2024
    betahistine dihydrochlorideTablet, uncoated16 mgResolvedAvailableManufacturing24/09/2024
    emtricitabine~tenofovir disoproxil fumarateTablet, film coated200 mg~300 mgCurrentUnavailableUnexpected increase in demand due to other sponsors unable to supply24/09/2024
    ezetimibeTablet10 mgCurrentUnavailableManufacturing24/09/2024
    heparin sodiumInjection, solution10 IU/mLCurrentLimited AvailabilityManufacturing24/09/2024
    norethisterone acetate~estradiolDrug delivery system, transdermal2.7 mg~.62 mgCurrentUnavailableManufacturing24/09/2024
    norethisterone acetate~estradiolDrug delivery system, transdermal4.8 mg~.512 mgCurrentLimited AvailabilityManufacturing24/09/2024
    ezetimibeTablet10 mgCurrentUnavailableUnexpected increase in demand due to other sponsors unable to supply24/09/2024
    olanzapine pamoate monohydrateInjection, powder for931 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues23/09/2024
    olanzapine pamoate monohydrateInjection, powder for690 mgCurrentLimited AvailabilityTransport / Logistic issues / Storage capacity issues23/09/2024
    olanzapine pamoate monohydrateInjection, powder for483 mgCurrentLimited AvailabilityTransport / Logistic issues / Storage capacity issues23/09/2024
    esomeprazole magnesium dihydrateTablet, enteric coated21.75 mgResolvedAvailableManufacturing23/09/2024
    tadalafilTablet, film coated20 mgCurrentLimited AvailabilityManufacturing23/09/2024
    milrinoneInjection, concentrated10 mgCurrentLimited AvailabilityManufacturing23/09/2024
    hydromorphone hydrochlorideInjection, solution2 mg/mLDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability23/09/2024
    hydromorphone hydrochlorideInjection, solution10 mg/mLDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability23/09/2024
    hydromorphone hydrochlorideInjection, concentrated50 mg/mLDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability23/09/2024
    levothyroxine sodiumTablet, uncoated.05 mgAnticipatedAvailableManufacturing23/09/2024
    levothyroxine sodiumTablet, uncoated.075 mgAnticipatedAvailableManufacturing23/09/2024
    erythromycin ethyl succinateOral Liquid, powder for468 mgCurrentLimited AvailabilityUnexpected increase in consumer demand23/09/2024
    desmopressin acetateSpray, solution.1 mg/mLCurrentUnavailableProduct recall23/09/2024
    rizatriptan benzoateWafer14.53 mgCurrentLimited AvailabilityManufacturing23/09/2024
    midazolamInjection, solution1 mg/mLCurrentLimited AvailabilityManufacturing23/09/2024
    oxycodone hydrochlorideCapsule, hard5 mgAnticipatedAvailableManufacturing23/09/2024
    nizatidineCapsule150 mgCurrentLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply23/09/2024
    nizatidineCapsule300 mgCurrentLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply23/09/2024
  • 2024.09.24
    Active ingredientsDosage formQuantity of active ingredientsShortage statusAvailabilityReasonLast updated
    dutasteride~tamsulosin hydrochlorideCapsule, modified release500 microgram~400 microgramAnticipatedAvailableTransport / Logistic issues / Storage capacity issues22/09/2024
    gabapentinCapsule, hard300 mgCurrentLimited AvailabilityManufacturing20/09/2024
    sumatriptan succinateTablet, film coated140 mgCurrentLimited AvailabilityManufacturing20/09/2024
    venlafaxineCapsule, modified release75 mgCurrentLimited AvailabilityManufacturing20/09/2024
    venlafaxineCapsule, modified release150 mgCurrentLimited AvailabilityManufacturing20/09/2024
    FilgrastimInjection, solution120 microgramResolvedAvailableTransport / Logistic issues / Storage capacity issues20/09/2024
    FilgrastimInjection, solution480 microgramResolvedAvailableTransport / Logistic issues / Storage capacity issues20/09/2024
    duloxetine hydrochlorideCapsule, enteric67.3 mgCurrentLimited AvailabilityManufacturing20/09/2024
    duloxetine hydrochlorideCapsule, enteric33.66 mgCurrentUnavailableUnexpected increase in consumer demand20/09/2024
    fenofibrateTablet48 mgAnticipatedAvailableManufacturing20/09/2024
    buprenorphineDrug delivery system, transdermal40 mgAnticipatedAvailableTransport / Logistic issues / Storage capacity issues20/09/2024
    emtricitabine~tenofovir disoproxil fumarateTablet, film coated200 mg~300 mgCurrentUnavailableManufacturing20/09/2024
    trimethoprimTablet, uncoated300 mgAnticipatedAvailableManufacturing20/09/2024
    lenalidomideCapsule, hard5 mgCurrentLimited AvailabilityUnexpected increase in consumer demand20/09/2024
    lanreotide acetateInjection, solution133.33 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues20/09/2024
    rosuvastatin calcium~ezetimibeTablet~Tablet, film coated41.6 mg~10 mgCurrentLimited AvailabilityManufacturing20/09/2024
    rosuvastatin calcium~ezetimibeTablet~Tablet, film coated20.8 mg~10 mgCurrentUnavailableManufacturing20/09/2024
    fluticasone propionateInhalation, pressurised125 microgram/actuationCurrentLimited AvailabilityUnexpected increase in consumer demand20/09/2024
    clindamycin phosphateLotion10 mg/mLCurrentLimited AvailabilityManufacturing20/09/2024
    Epoetin lambdaInjection, solution10000 IUResolvedAvailableManufacturing19/09/2024
    omeprazoleCapsule20 mgResolvedAvailableManufacturing19/09/2024
    insulinInjection, solution100 IU/mLDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability19/09/2024
    insulinInjection, suspension100 IU/mLDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability19/09/2024
    insulinInjection, suspension100 IU/mLDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability19/09/2024
    Insulin detemirInjection, solution100 U/mLDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability19/09/2024
    Insulin detemirInjection, solution100 U/mLDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability19/09/2024
    bisoprolol fumarateTablet10 mgAnticipatedAvailableManufacturing19/09/2024
    montelukast sodiumTablet, chewable5.2 mgCurrentUnavailableManufacturing19/09/2024
    quetiapine fumarateTablet, film coated28.784 mgResolvedAvailableUnexpected increase in consumer demand19/09/2024
    paclitaxelInjection, concentrated300 mgCurrentUnavailableManufacturing19/09/2024
    cisatracurium besilateInjection, solution201 mgDiscontinuedUnavailableManufacturing19/09/2024
    Follitropin alfaInjection, solution75 IUAnticipatedAvailableManufacturing19/09/2024
    Follitropin alfaInjection, solution150 IUAnticipatedAvailableManufacturing19/09/2024
    fluticasone propionateInhalation, pressurised125 microgram/actuationCurrentUnavailableManufacturing19/09/2024
    Insulin aspartInjection, solution100 U/mLDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability19/09/2024
    Insulin aspartInjection, solution100 U/mLDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability19/09/2024
    Insulin degludec~Insulin aspartInjection, solution420 nmol/mL~180 nmol/mLDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability19/09/2024
    gliclazideTablet, modified release30 mgCurrentLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply19/09/2024
    atorvastatin calcium trihydrate~ezetimibeTablet, film coated82.725 mg~10 mgCurrentUnavailableManufacturing19/09/2024
    atorvastatin calcium trihydrate~ezetimibeTablet, film coated41.363 mg~10 mgCurrentUnavailableManufacturing19/09/2024
    lurasidone hydrochlorideTablet, film coated80 mgCurrentUnavailableManufacturing19/09/2024
    olmesartan medoxomil~amlodipine besilateTablet, film coated40 mg~6.94 mgCurrentLimited AvailabilityUnexpected increase in consumer demand19/09/2024
    methylphenidate hydrochlorideTablet, modified release18 mgCurrentUnavailableManufacturing19/09/2024
    levothyroxine sodiumTablet, uncoated.1 mgCurrentUnavailableManufacturing19/09/2024
    levothyroxine sodiumTablet, uncoated.2 mgCurrentLimited AvailabilityManufacturing19/09/2024
    Dornase alfaSpray, solution1 mg/mLResolvedAvailableCommercial Changes / Commercial viability19/09/2024
    dorzolamide hydrochlorideEye Drops, solution22.26 mg/mLAnticipatedAvailableManufacturing19/09/2024
    captoprilTablet, uncoated50 mgCurrentUnavailableManufacturing19/09/2024
    clindamycin hydrochlorideSolution10 mg/mLCurrentUnavailableManufacturing19/09/2024
    amoxicillin sodiumInjection, powder for1060 mgCurrentLimited AvailabilityManufacturing19/09/2024
    amoxicillin trihydrateOral Liquid, powder for114.82 mg/mLCurrentUnavailableManufacturing19/09/2024
    tacrolimus monohydrateCapsule, hard1.022 mgAnticipatedAvailableManufacturing18/09/2024
    carmustineInjection, powder for100 mgResolvedAvailableManufacturing18/09/2024
    dulaglutideInjection, solution1.5 mgCurrentLimited AvailabilityManufacturing18/09/2024
    adrenaline (epinephrine) acid tartrateInjection, solution1.819 mgResolvedAvailableManufacturing18/09/2024
    spironolactoneTablet, uncoated100 mgCurrentLimited AvailabilityManufacturing18/09/2024
    chloramphenicolEye Drops, solution5 mg/mLCurrentUnavailableManufacturing18/09/2024
    sitagliptin fumarateTablet, film coated128.497 mgResolvedAvailableUnexpected increase in demand due to other sponsors unable to supply18/09/2024
    indometacinCapsule, hard25 mgCurrentUnavailableManufacturing18/09/2024
    captoprilTablet, uncoated25 mgCurrentUnavailableManufacturing18/09/2024
    estradiol~norethisterone acetateDrug delivery system, transdermal.62 mg~2.7 mgCurrentUnavailableManufacturing18/09/2024
    ciprofloxacin hydrochlorideTablet, film coated873.32 mgAnticipatedAvailableManufacturing18/09/2024
    norethisteroneTablet, uncoated350 microgramCurrentUnavailableManufacturing17/09/2024
    isosorbide dinitrateTablet, uncoated5 mgAnticipatedAvailableManufacturing17/09/2024
    codeine phosphate hemihydrate~ibuprofenTablet, film coated12.8 mg~200 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues17/09/2024
    simvastatinTablet, film coated20 mgAnticipatedAvailableManufacturing17/09/2024
    tenofovir disoproxil maleate~emtricitabineTablet, film coated300 mg~200 mgCurrentUnavailableManufacturing17/09/2024
    atorvastatin calcium trihydrate~ezetimibeTablet, film coated10.341 mg~10 mgAnticipatedAvailableManufacturing17/09/2024
    zolpidem tartrateTablet, film coated10 mgAnticipatedAvailableManufacturing16/09/2024
    medronic acidInjection, powder for10 mgAnticipatedAvailableManufacturing16/09/2024
    gabapentinTablet, film coated600 mgResolvedAvailableManufacturing16/09/2024
    adrenaline (epinephrine)Injection, solution1 mgCurrentLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply16/09/2024
    levetiracetamTablet, film coated1000 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues16/09/2024
    noradrenaline (norepinephrine) acid tartrate monohydrateInjection, concentrated2 mg/mLDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability16/09/2024
    oseltamivir phosphateOral Liquid, powder for7.88 mg/mLResolvedAvailableUnexpected increase in consumer demand16/09/2024
    azithromycin dihydrateTablet, film coated524.05 mgCurrentUnavailableManufacturing16/09/2024
    quetiapine fumarateTablet, film coated345.36 mgCurrentLimited AvailabilityManufacturing16/09/2024
    irbesartanTablet, film coated300 mgAnticipatedAvailableManufacturing16/09/2024
    rizatriptan benzoateTablet, orally disintegrating14.53 mgCurrentUnavailableManufacturing16/09/2024
    olmesartan medoxomilTablet, film coated40 mgAnticipatedAvailableManufacturing16/09/2024
    olmesartan medoxomil~hydrochlorothiazideTablet, film coated40 mg~25 mgAnticipatedAvailableManufacturing16/09/2024
    azacitidineInjection, powder for100 mgCurrentLimited AvailabilityManufacturing16/09/2024
    anastrozoleTablet, film coated1 mgAnticipatedAvailableManufacturing16/09/2024
    irbesartanTablet, film coated150 mgCurrentUnavailableManufacturing16/09/2024
    tadalafilTablet5 mgCurrentUnavailableUnexpected increase in demand due to other sponsors unable to supply16/09/2024
    tadalafilTablet, film coated5 mgCurrentUnavailableManufacturing16/09/2024
    nebivolol hydrochlorideTablet5.45 mgAnticipatedAvailableManufacturing16/09/2024
    tadalafilTablet, film coated5 mgCurrentUnavailableManufacturing16/09/2024
    tadalafilTablet, film coated5 mgCurrentUnavailableManufacturing16/09/2024
    tadalafilTablet, film coated5 mgCurrentUnavailableManufacturing16/09/2024
    tadalafilTablet, film coated5 mgCurrentUnavailableUnexpected increase in demand due to other sponsors unable to supply16/09/2024
    amlodipine besilate~olmesartan medoxomilTablet, film coated6.935 mg~40 mgCurrentUnavailableManufacturing16/09/2024
    lacosamideTablet, film coated150 mgAnticipatedAvailableManufacturing16/09/2024
    ezetimibe~atorvastatin calcium trihydrateTablet, film coated10 mg~10.341 mgCurrentUnavailableManufacturing16/09/2024
    lenalidomideCapsule5 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability16/09/2024
    lenalidomideCapsule10 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability16/09/2024
    lenalidomideCapsule15 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability16/09/2024
    lenalidomideCapsule25 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability16/09/2024
    gefitinibTablet, film coated250 mgCurrentUnavailableManufacturing16/09/2024
    methotrexateTablet10 mgAnticipatedAvailableManufacturing16/09/2024
    heparin sodiumInjection, solution1000 IU/mLCurrentUnavailableManufacturing16/09/2024
    doxorubicin hydrochlorideInjection, concentrated2 mg/mLCurrentUnavailableManufacturing16/09/2024
  • 2024.09.17
    Active ingredientsDosage formQuantity of active ingredientsShortage statusAvailabilityReasonLast updated
    siponimod hemifumarateTablet, film coated.278 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability15/09/2024
    adrenaline (epinephrine)Injection, solution1 mgCurrentLimited AvailabilityManufacturing13/09/2024
    isoniazidTablet, uncoated100 mgCurrentUnavailableManufacturing13/09/2024
    pentetic acidInjection, powder for5 mgAnticipatedAvailableManufacturing13/09/2024
    sodium pyrophosphateInjection, powder for30 mgAnticipatedAvailableManufacturing13/09/2024
    Pancreatic extractCapsule, enteric150 mgCurrentLimited AvailabilityUnexpected increase in consumer demand13/09/2024
    methotrexateInjection, solution100 mg/mLAnticipatedAvailableManufacturing13/09/2024
    acetylcysteineInjection, concentrated2 gAnticipatedAvailableTransport / Logistic issues / Storage capacity issues13/09/2024
    ezetimibe~rosuvastatin calciumTablet~Tablet, film coated10 mg~20.791 mgCurrentLimited AvailabilityManufacturing13/09/2024
    quetiapine fumarateTablet, film coated28.784 mgCurrentLimited AvailabilityUnexpected increase in consumer demand13/09/2024
    simvastatinTablet, film coated40 mgAnticipatedAvailableManufacturing13/09/2024
    acarboseTablet50 mgCurrentUnavailableManufacturing13/09/2024
    hydrochlorothiazide~irbesartanTablet, film coated25 mg~300 mgAnticipatedAvailableManufacturing13/09/2024
    lurasidone hydrochlorideTablet, film coated80 mgAnticipatedAvailableManufacturing13/09/2024
    mycophenolate mofetilInjection, powder for500 mgResolvedAvailableManufacturing13/09/2024
    oseltamivir phosphateCapsule, hard98.524 mgAnticipatedAvailableUnexpected increase in consumer demand13/09/2024
    flucloxacillin sodium monohydrateInjection, powder for1088.1 mgResolvedAvailableTransport / Logistic issues / Storage capacity issues13/09/2024
    methylphenidate hydrochlorideTablet, modified release27 mgAnticipatedAvailableManufacturing13/09/2024
    phenytoin sodiumInjection, solution100 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability13/09/2024
    rifabutinCapsule, hard150 mgAnticipatedAvailableManufacturing13/09/2024
    amoxicillin trihydrateOral Liquid, powder for114.82 mg/mLCurrentUnavailableManufacturing13/09/2024
    clarithromycinTablet, film coated250 mgAnticipatedAvailableUnexpected increase in consumer demand13/09/2024
    primidoneTablet, uncoated250 mgCurrentLimited AvailabilityManufacturing12/09/2024
    topiramateTablet, film coated200 mgAnticipatedAvailableManufacturing12/09/2024
    morphine hydrochloride trihydrateOral Liquid, solution2 mg/mLCurrentUnavailableCommercial Changes / Commercial viability12/09/2024
    morphine hydrochloride trihydrateOral Liquid, solution5 mg/mLCurrentUnavailableCommercial Changes / Commercial viability12/09/2024
    morphine hydrochloride trihydrateOral Liquid, solution10 mg/mLCurrentUnavailableCommercial Changes / Commercial viability12/09/2024
    olanzapineTablet, orally disintegrating20 mgAnticipatedAvailableManufacturing12/09/2024
    mycophenolate mofetilTablet, film coated500 mgCurrentLimited AvailabilityManufacturing12/09/2024
    omeprazoleCapsule20 mgCurrentLimited AvailabilityManufacturing12/09/2024
    adrenaline (epinephrine) acid tartrateInjection, solution182 microgram/mLCurrentUnavailableManufacturing12/09/2024
    simvastatinTablet, film coated10 mgAnticipatedAvailableManufacturing12/09/2024
    citalopram hydrobromideTablet, film coated49.98 mgAnticipatedAvailableManufacturing12/09/2024
    atorvastatin calcium trihydrateTablet, film coated86.76 mgCurrentLimited AvailabilityManufacturing12/09/2024
    nebivolol hydrochlorideTablet1.363 mgAnticipatedAvailableManufacturing12/09/2024
    acamprosate calciumTablet, enteric coated333 mgAnticipatedAvailableManufacturing12/09/2024
    ezetimibe~atorvastatin calcium trihydrateTablet, film coated10 mg~41.363 mgCurrentUnavailableManufacturing12/09/2024
    atorvastatin calcium trihydrate~ezetimibeTablet, film coated20.681 mg~10 mgCurrentUnavailableManufacturing12/09/2024
    ezetimibe~atorvastatin calcium trihydrateTablet, film coated10 mg~82.725 mgCurrentUnavailableManufacturing12/09/2024
    lanreotide acetateInjection, solution133.33 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues12/09/2024
    sitagliptin hydrochloride monohydrateTablet, film coated27.25 mgCurrentUnavailableManufacturing12/09/2024
    aciclovirInjection, solution25 mg/mLCurrentUnavailableManufacturing12/09/2024
    tobramycinInhalation, conventional60 mg/mLCurrentUnavailableManufacturing12/09/2024
    amoxicillin sodiumInjection, powder for1060 mgAnticipatedAvailableManufacturing12/09/2024
    metoprolol succinateTablet, modified release47.5 mgAnticipatedAvailableManufacturing11/09/2024
    metoprolol succinateTablet, modified release190 mgAnticipatedAvailableManufacturing11/09/2024
    metoprolol succinateTablet, modified release95 mgAnticipatedAvailableManufacturing11/09/2024
    bisoprolol fumarateTablet2.5 mgCurrentUnavailableManufacturing11/09/2024
    bisoprolol fumarateTablet5 mgCurrentUnavailableManufacturing11/09/2024
    duloxetine hydrochlorideCapsule, enteric33.65 mgCurrentUnavailableManufacturing11/09/2024
    duloxetine hydrochlorideCapsule, enteric67.3 mgCurrentUnavailableManufacturing11/09/2024
    citalopram hydrobromideTablet, film coated12.495 mgAnticipatedAvailableManufacturing11/09/2024
    ezetimibeTablet, uncoated10 mgCurrentUnavailableManufacturing11/09/2024
    ezetimibeTablet10 mgCurrentUnavailableUnexpected increase in consumer demand11/09/2024
    ezetimibeTablet10 mgCurrentUnavailableUnexpected increase in consumer demand11/09/2024
    tadalafilTablet, film coated20 mgCurrentLimited AvailabilityManufacturing11/09/2024
    tadalafilTablet, film coated10 mgAnticipatedAvailableManufacturing11/09/2024
    nebivolol hydrochlorideTablet10.9 mgCurrentUnavailableManufacturing11/09/2024
    nizatidineCapsule, hard150 mgCurrentUnavailableManufacturing11/09/2024
    dasatinibTablet, film coated100 mgCurrentLimited AvailabilityManufacturing11/09/2024
    ropinirole hydrochlorideTablet, film coated2.28 mgResolvedAvailableManufacturing11/09/2024
    linezolidTablet, film coated600 mgCurrentLimited AvailabilityUnexpected increase in consumer demand11/09/2024
    lacosamideTablet, film coated50 mgAnticipatedAvailableManufacturing11/09/2024
    spironolactoneTablet, uncoated100 mgCurrentLimited AvailabilityManufacturing11/09/2024
    cisplatinInjection, solution1 mg/mLCurrentLimited AvailabilityUnexpected increase in consumer demand11/09/2024
    nizatidineCapsule, hard300 mgCurrentUnavailableManufacturing11/09/2024
    paclitaxelInjection, concentrated6 mg/mLResolvedAvailableManufacturing11/09/2024
    baclofenTablet, uncoated25 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues11/09/2024
    escitalopram oxalateTablet, film coated25.56 mgCurrentLimited AvailabilityManufacturing10/09/2024
    dexamethasone~framycetin sulfate~gramicidinEar Drops.5 mg/mL~5 mg/mL~.05 mg/mLCurrentUnavailableManufacturing10/09/2024
    risperidoneTablet.5 mgResolvedAvailableManufacturing10/09/2024
    risperidoneTablet1 mgResolvedAvailableManufacturing10/09/2024
    gabapentinTablet, film coated800 mgCurrentUnavailableManufacturing10/09/2024
    hydrocortisone sodium succinateInjection, powder for134 mgResolvedAvailableManufacturing10/09/2024
    duloxetine hydrochlorideCapsule, enteric67.3 mgCurrentLimited AvailabilityManufacturing10/09/2024
    duloxetine hydrochlorideCapsule, enteric33.65 mgResolvedAvailableManufacturing10/09/2024
    hydrochlorothiazide~telmisartanTablet, film coated12.5 mg~80 mgCurrentLimited AvailabilityManufacturing10/09/2024
    duloxetine hydrochlorideCapsule, enteric33.66 mgCurrentUnavailableUnexpected increase in consumer demand10/09/2024
    amlodipine besilateTablet13.87 mgResolvedAvailableManufacturing10/09/2024
    ezetimibeTablet, uncoated10 mgResolvedAvailableUnexpected increase in demand due to other sponsors unable to supply10/09/2024
    ezetimibeTablet10 mgCurrentUnavailableManufacturing10/09/2024
    ezetimibeTablet, uncoated10 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues10/09/2024
    ezetimibeTablet, uncoated10 mgCurrentLimited AvailabilityManufacturing10/09/2024
    clonidine hydrochlorideTablet100 microgramCurrentUnavailableUnexpected increase in consumer demand10/09/2024
    cinacalcet hydrochlorideTablet, film coated33 mgResolvedAvailableManufacturing10/09/2024
    tenofovir disoproxil fumarateTablet300 mgCurrentUnavailableManufacturing10/09/2024
    ezetimibe~simvastatinTablet10 mg~20 mgResolvedAvailableManufacturing10/09/2024
    mesalazineTablet, enteric coated1.6 gCurrentUnavailableTransport / Logistic issues / Storage capacity issues10/09/2024
    bendamustine hydrochloride monohydrateInjection, powder for100 mgCurrentUnavailableUnexpected increase in demand due to other sponsors unable to supply10/09/2024
    rosuvastatin calciumTablet, film coated5.21 mgResolvedAvailableManufacturing10/09/2024
    dosulepin (dothiepin) hydrochlorideCapsule, hard25 mgCurrentUnavailableManufacturing10/09/2024
    indometacinCapsule, hard25 mgCurrentLimited AvailabilityManufacturing10/09/2024
    temozolomideCapsule, hard5 mgCurrentLimited AvailabilityManufacturing10/09/2024
    methylphenidate hydrochlorideTablet, modified release18 mgCurrentUnavailableManufacturing10/09/2024
    lanreotide acetateInjection, solution100 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues10/09/2024
    sitagliptin hydrochloride monohydrateTablet, film coated109 mgCurrentUnavailableManufacturing10/09/2024
    sitagliptin hydrochloride monohydrateTablet, film coated54.5 mgCurrentUnavailableManufacturing10/09/2024
    ezetimibe~rosuvastatin calciumTablet10 mg~10.4 mgCurrentUnavailableManufacturing10/09/2024
    ezetimibe~rosuvastatin calciumTablet~Tablet, film coated10 mg~41.6 mgCurrentLimited AvailabilityManufacturing10/09/2024
    ezetimibe~rosuvastatin calciumTablet~Tablet, film coated10 mg~20.8 mgCurrentUnavailableManufacturing10/09/2024
    ezetimibeTablet10 mgCurrentUnavailableManufacturing10/09/2024
    heparin sodiumInjection, solution5000 IU/mLAnticipatedAvailableManufacturing10/09/2024
    clarithromycinOral Liquid, powder for50 mg/mLCurrentLimited AvailabilityUnexpected increase in consumer demand10/09/2024
    azithromycin dihydrateSuspension, powder for209.65 mgCurrentUnavailableUnexpected increase in consumer demand10/09/2024
    indapamide hemihydrateTablet2.5 mgCurrentLimited AvailabilityManufacturing10/09/2024
    salbutamol sulfateInhalation1.2 mg/mLResolvedAvailableManufacturing9/09/2024
    fentanylDrug delivery system, transdermal2.063 mgDiscontinuedUnavailableCommercial Changes / Commercial viability9/09/2024
    fentanylDrug delivery system, transdermal8.25 mgDiscontinuedUnavailableCommercial Changes / Commercial viability9/09/2024
    fentanylDrug delivery system, transdermal12.375 mgDiscontinuedUnavailableCommercial Changes / Commercial viability9/09/2024
    galantamine hydrobromideCapsule, modified release20.512 mgResolvedAvailableManufacturing9/09/2024
    hydrocortisone sodium succinateInjection, powder for334.25 mgCurrentLimited AvailabilityManufacturing9/09/2024
    bosentan monohydrateTablet, film coated64.541 mgResolvedAvailableManufacturing9/09/2024
    midazolamInjection, solution5 mg/mLCurrentLimited AvailabilityManufacturing9/09/2024
    midazolamInjection, solution1 mg/mLAnticipatedAvailableManufacturing9/09/2024
  • 2024.09.09
    Active ingredientsDosage formQuantity of active ingredientsAvailabilityReasonLast updated
    mycophenolate mofetilTablet, film coated500 mgLimited AvailabilityManufacturing6/09/2024
    methotrexateInjection, solution100 mg/mLLimited AvailabilityManufacturing6/09/2024
    Follitropin alfaInjection, solution225 IUReduction in supply until supply is exhaustedCommercial Changes / Commercial viability6/09/2024
    adrenaline (epinephrine) acid tartrateInjection, solution1.819 mgUnavailableManufacturing6/09/2024
    eftrenonacog alfaInjection, powder for4000 IUUnavailableManufacturing6/09/2024
    estradiolDrug delivery system, transdermal1.17 mgUnavailableManufacturing6/09/2024
    iopromideInjection, solution498.72 mg/mLUnavailableUnexpected increase in consumer demand6/09/2024
    ezetimibeTablet10 mgUnavailableUnexpected increase in demand due to other sponsors unable to supply6/09/2024
    norethisteroneTablet, uncoated350 microgramAvailableManufacturing5/09/2024
    bupivacaine hydrochloride monohydrateInjection, solution52.7 mgAvailableManufacturing5/09/2024
    calcium folinateInjection324.1 mgAvailableManufacturing5/09/2024
    lincomycin hydrochloride monohydrateInjection, solution340.26 mg/mLReduction in supply until supply is exhaustedCommercial Changes / Commercial viability5/09/2024
    griseofulvinTablet, uncoated125 mgUnavailableManufacturing5/09/2024
    adrenaline (epinephrine)Injection, solution1 mgLimited AvailabilityManufacturing5/09/2024
    anidulafunginInjection, powder for100 mgLimited AvailabilityManufacturing5/09/2024
    framycetin sulfate~dexamethasone~gramicidinEar Drops5 mg/mL~.5 mg/mL~.05 mg/mLUnavailableManufacturing5/09/2024
    adrenaline (epinephrine)Injection, solution1 mgAvailableManufacturing5/09/2024
    latanoprost~timolol maleateEye Drops, solution50 microgram/mL~6.83 mg/mLAvailableUnexpected increase in consumer demand5/09/2024
    azacitidineInjection, powder for100 mgAvailableManufacturing5/09/2024
    tadalafilTablet, film coated20 mgLimited AvailabilityManufacturing5/09/2024
    flucloxacillin sodium monohydrateInjection, powder for1088.1 mgLimited AvailabilityTransport / Logistic issues / Storage capacity issues5/09/2024
    fluticasone propionateInhalation, pressurised125 microgram/actuationAvailableUnexpected increase in consumer demand5/09/2024
    tobramycinInhalation, conventional60 mg/mLUnavailableManufacturing5/09/2024
    clarithromycinTablet, film coated250 mgLimited AvailabilityManufacturing4/09/2024
    fludarabine phosphateInjection, concentrated50 mgUnavailableManufacturing4/09/2024
    clonidine hydrochlorideTablet, uncoated100 microgramLimited AvailabilityManufacturing4/09/2024
    trandolaprilCapsule, hard1 mgLimited AvailabilityManufacturing4/09/2024
    duloxetine hydrochlorideCapsule, enteric67.3 mgUnavailableManufacturing4/09/2024
    duloxetine hydrochlorideCapsule, enteric33.65 mgUnavailableManufacturing4/09/2024
    OmalizumabInjection, solution150 mgAvailableManufacturing4/09/2024
    levetiracetamInjection, concentrated500 mgAvailableManufacturing4/09/2024
    mitomycinInjection, powder for20 mgLimited AvailabilityManufacturing4/09/2024
    tenofovir disoproxil maleate~emtricitabineTablet, film coated300 mg~200 mgLimited AvailabilityManufacturing4/09/2024
    emtricitabine~tenofovir disoproxil fumarateTablet, film coated200 mg~300 mgLimited AvailabilityCommercial Changes / Commercial viability4/09/2024
    celecoxibCapsule, hard100 mgLimited AvailabilityManufacturing4/09/2024
    busulfanInjection, concentrated60 mgAvailableManufacturing4/09/2024
    emtricitabine~tenofovir disoproxil succinateTablet, film coated200 mg~300.6 mgUnavailableManufacturing4/09/2024
    tenofovir disoproxil fumarate~emtricitabineTablet, film coated300 mg~200 mgUnavailableUnexpected increase in demand due to other sponsors unable to supply4/09/2024
    erythromycin ethyl succinateOral Liquid, powder for468 mgLimited AvailabilityUnexpected increase in consumer demand4/09/2024
    clonazepamTablet, uncoated.5 mgAvailableManufacturing4/09/2024
    captoprilTablet, uncoated25 mgUnavailableManufacturing4/09/2024
    captoprilTablet, uncoated50 mgUnavailableManufacturing4/09/2024
    clindamycin phosphateLotion10 mg/mLAvailableManufacturing4/09/2024
    rizatriptan benzoateWafer14.53 mgLimited AvailabilityManufacturing4/09/2024
    leuprorelin acetateInjection, modified release45 mgAvailableManufacturing3/09/2024
    ondansetron hydrochloride dihydrateInjection, solution5 mgAvailableManufacturing3/09/2024
    magnesium chloride hexahydrate~sodium chloride~sodium lactate~glucose~calcium chloride dihydrateSolution, irrigation50.8 mg/L~5.38 g/L~4.48 g/L~15 g/L~183 mg/LLimited AvailabilityManufacturing3/09/2024
    olanzapineTablet, orally disintegrating10 mgUnavailableCommercial Changes / Commercial viability3/09/2024
    capecitabineTablet, film coated500 mgUnavailableManufacturing3/09/2024
    paracetamolInjection, solution10 mg/mLAvailableUnexpected increase in consumer demand3/09/2024
    rosuvastatin calcium~ezetimibeTablet~Tablet, film coated41.583 mg~10 mgLimited AvailabilityManufacturing3/09/2024
    rosuvastatin calcium~ezetimibeTablet~Tablet, film coated20.791 mg~10 mgLimited AvailabilityManufacturing3/09/2024
    rosuvastatin calcium~ezetimibeTablet~Tablet, film coated20.791 mg~10 mgAvailableManufacturing3/09/2024
    oxytocinInjection, solution10 IU/mLAvailableTransport / Logistic issues / Storage capacity issues3/09/2024
    fluorouracilInjection, solution50 mg/mLUnavailableManufacturing3/09/2024
    lacosamideTablet, film coated50 mgUnavailableManufacturing3/09/2024
    letrozoleTablet, film coated2.5 mgLimited AvailabilityManufacturing3/09/2024
    mesalazineTablet, enteric coated1.6 gAvailableTransport / Logistic issues / Storage capacity issues3/09/2024
    carmustineInjection, powder for100 mgLimited AvailabilityManufacturing3/09/2024
    betahistine dihydrochlorideTablet16 mgUnavailableUnexpected increase in consumer demand3/09/2024
    clonazepamTablet, uncoated2 mgLimited AvailabilityManufacturing3/09/2024
    azithromycin dihydrateTablet, film coated628.93 mgUnavailableManufacturing3/09/2024
    leuprorelin acetateInjection, modified release22.5 mgAvailableManufacturing3/09/2024
    propranolol hydrochlorideTablet, film coated40 mgAvailableManufacturing2/09/2024
    primidoneTablet, uncoated250 mgAvailableManufacturing2/09/2024
    povidoneiodineApplication100 mg/mLAvailableManufacturing2/09/2024
    donepezil hydrochlorideTablet, film coated10 mgUnavailableTransport / Logistic issues / Storage capacity issues2/09/2024
    donepezil hydrochlorideTablet, film coated5 mgAvailableTransport / Logistic issues / Storage capacity issues2/09/2024
    magnesium chloride hexahydrate~calcium chloride dihydrate~sodium lactate~glucose~sodium chlorideSolution, irrigation50.8 mg/L~183 mg/L~4.48 g/L~25 g/L~5.38 g/LLimited AvailabilityManufacturing2/09/2024
    ezetimibe~rosuvastatin calciumTablet~Tablet, film coated10 mg~10.396 mgUnavailableManufacturing2/09/2024
    rosuvastatin calcium~ezetimibeTablet~Tablet, film coated10.396 mg~10 mgUnavailableManufacturing2/09/2024
    solifenacin succinateTablet, film coated5 mgUnavailableManufacturing2/09/2024
    solifenacin succinateTablet, film coated10 mgUnavailableManufacturing2/09/2024
    methylphenidate hydrochlorideTablet, modified release54 mgAvailableManufacturing2/09/2024
    nizatidineCapsule, hard300 mgAvailableManufacturing2/09/2024
    norethisterone acetate~estradiolDrug delivery system, transdermal2.7 mg~.62 mgUnavailableManufacturing2/09/2024
  • 2024.09.02
    Active ingredientsDosage formQuantity of active ingredientsShortage statusAvailabilityReasonLast updated
    pioglitazone hydrochlorideTablet, uncoated33.06 mgAnticipatedAvailableManufacturing1/09/2024
    atropine sulfate monohydrateInjection, solution1.2 mg/mLCurrentUnavailableManufacturing30/08/2024
    gentamicinInjection, solution80 mgAnticipatedAvailableManufacturing30/08/2024
    pantoprazole sodium sesquihydrateInjection, powder for45.12 mgCurrentUnavailableManufacturing30/08/2024
    griseofulvinTablet500 mgResolvedAvailableManufacturing30/08/2024
    silver sulfadiazineCream10 mg/gCurrentUnavailableManufacturing30/08/2024
    silver sulfadiazineCream10 mg/gCurrentUnavailableManufacturing30/08/2024
    adrenaline (epinephrine)Injection, solution1 mgCurrentLimited AvailabilityManufacturing30/08/2024
    Choriogonadotropin alfaInjection, solution250 microgramCurrentLimited AvailabilityUnexpected increase in consumer demand30/08/2024
    AlteplaseInjection, powder for50 mgResolvedAvailableUnexpected increase in consumer demand30/08/2024
    montelukast sodiumTablet, film coated10.4 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability30/08/2024
    hydrochlorothiazide~telmisartanTablet, film coated12.5 mg~80 mgCurrentLimited AvailabilityManufacturing30/08/2024
    temozolomideCapsule, hard100 mgCurrentLimited AvailabilityTransport / Logistic issues / Storage capacity issues30/08/2024
    metformin hydrochlorideTablet, modified release1000 mgCurrentLimited AvailabilityManufacturing30/08/2024
    rizatriptan benzoateTablet, orally disintegrating14.53 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues30/08/2024
    rizatriptan benzoateTablet, orally disintegrating14.53 mgCurrentUnavailableManufacturing30/08/2024
    epirubicin hydrochlorideInjection, concentrated200 mgCurrentUnavailableManufacturing30/08/2024
    azithromycin dihydrateTablet, film coated524 mgAnticipatedAvailableManufacturing30/08/2024
    betahistine dihydrochlorideTablet16 mgCurrentUnavailableManufacturing30/08/2024
    bortezomibInjection, powder for2.5 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability30/08/2024
    tadalafilTablet, film coated10 mgCurrentUnavailableUnexpected increase in demand due to other sponsors unable to supply30/08/2024
    lisdexamfetamine dimesilateCapsule, hard60 mgCurrentUnavailableUnexpected increase in consumer demand30/08/2024
    timolol maleateEye Drops, solution6.83 mg/mLAnticipatedAvailableCommercial Changes / Commercial viability30/08/2024
    ropinirole hydrochlorideTablet, film coated2.28 mgCurrentUnavailableManufacturing30/08/2024
    tenofovir disoproxil fumarateTablet300 mgCurrentLimited AvailabilityManufacturing30/08/2024
    celecoxibCapsule, hard100 mgAnticipatedAvailableManufacturing30/08/2024
    hydromorphone hydrochlorideInjection, solution2 mgAnticipatedAvailableManufacturing30/08/2024
    lenalidomideCapsule, hard5 mgCurrentLimited AvailabilityUnexpected increase in consumer demand30/08/2024
    olmesartan medoxomil~amlodipine besilateTablet, film coated40 mg~13.88 mgCurrentUnavailableManufacturing30/08/2024
    tirzepatideInjection, solution5 mgCurrentLimited AvailabilityCommercial Changes / Commercial viability30/08/2024
    tirzepatideInjection, solution7.5 mgCurrentLimited AvailabilityCommercial Changes / Commercial viability30/08/2024
    tirzepatideInjection, solution12.5 mgCurrentLimited AvailabilityCommercial Changes / Commercial viability30/08/2024
    tirzepatideInjection, solution10 mgCurrentLimited AvailabilityCommercial Changes / Commercial viability30/08/2024
    tirzepatideInjection, solution15 mgCurrentUnavailableCommercial Changes / Commercial viability30/08/2024
    tirzepatideInjection, solution2.5 mgCurrentLimited AvailabilityCommercial Changes / Commercial viability30/08/2024
    amidotrizoate meglumine~sodium amidotrizoateInjection, intravenous infusion260 mg/mL~40 mg/mLCurrentUnavailableManufacturing30/08/2024
    sodium chlorideInjection, solution90 mgCurrentLimited AvailabilityManufacturing30/08/2024
    sodium chlorideInjection, intravenous infusion900 mgCurrentUnavailableManufacturing30/08/2024
    timolol maleateEye Drops, solution6.84 mg/mLCurrentUnavailableManufacturing30/08/2024
    dorzolamide hydrochlorideEye Drops, solution22.26 mg/mLAnticipatedAvailableManufacturing30/08/2024
    AlteplaseDiluent, not applicable10 mgResolvedAvailableUnexpected increase in consumer demand30/08/2024
    timolol maleate~dorzolamide hydrochlorideEye Drops, solution6.83 mg/mL~22.26 mg/mLCurrentUnavailableManufacturing30/08/2024
    rizatriptan benzoateWafer14.53 mgAnticipatedAvailableManufacturing30/08/2024
    prazosin hydrochlorideTablet, uncoated5.5 mgCurrentUnavailableManufacturing30/08/2024
    methylphenidate hydrochlorideTablet, modified release18 mgCurrentLimited AvailabilityManufacturing30/08/2024
    sevelamer hydrochlorideTablet, film coated800 mgResolvedAvailableManufacturing29/08/2024
    bendamustine hydrochloride monohydrateInjection, powder for100 mgCurrentUnavailableUnexpected increase in demand due to other sponsors unable to supply29/08/2024
    fluticasone propionateInhalation, pressurised125 microgram/actuationAnticipatedAvailableUnexpected increase in consumer demand29/08/2024
    phytomenadioneInjection, solution10 mg/mLResolvedAvailableProduct recall29/08/2024
    estradiol hemihydrateDrug delivery system, transdermal2.32 mgCurrentUnavailableUnexpected increase in demand due to other sponsors unable to supply29/08/2024
    zopicloneTablet, film coated7.5 mgResolvedAvailableManufacturing29/08/2024
    escitalopram oxalateTablet, film coated25.56 mgCurrentLimited AvailabilityManufacturing28/08/2024
    amlodipine besilateTablet, uncoated6.94 mgResolvedAvailableManufacturing28/08/2024
    trihexyphenidyl (benzhexol) hydrochlorideTablet, uncoated5 mgResolvedAvailableManufacturing28/08/2024
    ondansetron hydrochloride dihydrateInjection, solution10 mgResolvedAvailableManufacturing28/08/2024
    tamsulosin hydrochloride~dutasterideCapsule, modified release400 microgram~500 microgramResolvedAvailableManufacturing28/08/2024
    clonidine hydrochlorideTablet, uncoated100 microgramAnticipatedAvailableManufacturing28/08/2024
    levetiracetamTablet, film coated1000 mgCurrentUnavailableManufacturing28/08/2024
    bicalutamideTablet, film coated50 mgAnticipatedAvailableManufacturing28/08/2024
    trandolaprilCapsule, hard.5 mgCurrentLimited AvailabilityManufacturing28/08/2024
    trandolaprilCapsule, hard1 mgAnticipatedAvailableManufacturing28/08/2024
    trandolaprilCapsule, hard2 mgCurrentLimited AvailabilityManufacturing28/08/2024
    trandolaprilCapsule, hard4 mgCurrentLimited AvailabilityManufacturing28/08/2024
    AbataceptInjection125.875 mgResolvedAvailableUnexpected increase in consumer demand28/08/2024
    timolol maleate~latanoprostEye Drops, solution6.83 mg/mL~50 microgram/mLCurrentUnavailableUnexpected increase in consumer demand28/08/2024
    paclitaxelInjection, concentrated300 mgCurrentUnavailableManufacturing28/08/2024
    conjugated estrogens~bazedoxifene acetateTablet, modified release.45 mg~22.56 mgCurrentUnavailableCommercial Changes / Commercial viability28/08/2024
    cinacalcet hydrochlorideTablet33.064 mgResolvedAvailableManufacturing28/08/2024
    cinacalcet hydrochlorideTablet99.191 mgCurrentUnavailableManufacturing28/08/2024
    lacosamideTablet, film coated150 mgAnticipatedAvailableManufacturing28/08/2024
    nebivolol hydrochlorideTablet1.363 mgCurrentUnavailableManufacturing28/08/2024
    nebivolol hydrochlorideTablet5.45 mgCurrentLimited AvailabilityManufacturing28/08/2024
    nebivolol hydrochlorideTablet10.9 mgCurrentLimited AvailabilityManufacturing28/08/2024
    mycophenolate mofetilTablet, film coated500 mgResolvedAvailableManufacturing28/08/2024
    mycophenolate mofetilInjection, powder for500 mgCurrentUnavailableManufacturing28/08/2024
    dasatinib propylene glycolTablet, film coated116 mgCurrentLimited AvailabilityManufacturing28/08/2024
    sitagliptin fumarateTablet, film coated128.497 mgCurrentUnavailableUnexpected increase in demand due to other sponsors unable to supply28/08/2024
    lanreotide acetateInjection, solution133.33 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues28/08/2024
    octreotideInjection, solution100 microgram/mLResolvedAvailableUnexpected increase in demand due to other sponsors unable to supply28/08/2024
    cisplatinInjection, solution1 mg/mLCurrentLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply28/08/2024
    vincristine sulfateInjection, solution1 mg/mLDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability28/08/2024
    indapamide hemihydrateTablet2.5 mgAnticipatedAvailableManufacturing28/08/2024
    zolpidem tartrateTablet, film coated10 mgResolvedAvailableManufacturing27/08/2024
    lidocaine hydrochloride monohydrate~adrenaline (epinephrine) acid tartrateInjection, solution21.3 mg/mL~22.7 microgram/mLResolvedAvailableManufacturing27/08/2024
    duloxetine hydrochlorideCapsule, enteric67.3 mgCurrentUnavailableManufacturing27/08/2024
    salbutamol sulfateInhalation1.2 mg/mLAnticipatedAvailableManufacturing27/08/2024
    risperidoneTablet.5 mgCurrentUnavailableManufacturing27/08/2024
    risperidoneTablet1 mgCurrentUnavailableManufacturing27/08/2024
    ondansetron hydrochloride dihydrateInjection, solution5 mgCurrentUnavailableManufacturing27/08/2024
    dopamine hydrochlorideInjection, concentrated40 mg/mLAnticipatedAvailableManufacturing27/08/2024
    levetiracetamTablet, film coated250 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues27/08/2024
    bisoprolol fumarateTablet2.5 mgCurrentLimited AvailabilityManufacturing27/08/2024
    ropivacaine hydrochlorideInjection, solution400 mgResolvedAvailableTransport / Logistic issues / Storage capacity issues27/08/2024
    zolmitriptanTablet, film coated2.5 mgAnticipatedAvailableManufacturing27/08/2024
    quetiapine fumarateTablet, film coated115.12 mgAnticipatedAvailableManufacturing27/08/2024
    simvastatinTablet, film coated20 mgResolvedAvailableManufacturing27/08/2024
    pemetrexed disodiumInjection, powder for110.28 mgCurrentUnavailableManufacturing27/08/2024
    pemetrexed disodiumInjection, powder for551.4 mgCurrentUnavailableManufacturing27/08/2024
    pemetrexed disodiumInjection, powder for1102.8 mgCurrentUnavailableManufacturing27/08/2024
    rosuvastatin calciumTablet, film coated41.68 mgResolvedAvailableCommercial Changes / Commercial viability27/08/2024
    voriconazoleInjection, powder for200 mgCurrentUnavailableManufacturing27/08/2024
    emtricitabine~tenofovir disoproxil fumarateTablet, film coated200 mg~300 mgCurrentLimited AvailabilityCommercial Changes / Commercial viability27/08/2024
    metformin hydrochlorideTablet, film coated500 mgCurrentLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply27/08/2024
    risperidoneOral Liquid, solution1 mg/mLCurrentUnavailableManufacturing27/08/2024
    nebivolol hydrochlorideTablet5.45 mgCurrentLimited AvailabilityManufacturing27/08/2024
    nebivolol hydrochlorideTablet10.9 mgCurrentUnavailableManufacturing27/08/2024
    montelukast sodiumTablet, film coated10.4 mgResolvedAvailableUnexpected increase in consumer demand27/08/2024
    mycophenolate sodiumTablet, enteric coated384.7 mgAnticipatedAvailableManufacturing27/08/2024
    dosulepin (dothiepin) hydrochlorideCapsule, hard25 mgCurrentUnavailableManufacturing27/08/2024
    carmustineInjection, powder for100 mgCurrentLimited AvailabilityManufacturing27/08/2024
    cefaclor monohydrateOral Liquid, powder for26.22 mg/mLResolvedAvailableManufacturing27/08/2024
    sodium valproateTablet, enteric coated500 mgResolvedAvailableManufacturing27/08/2024
    clonazepamTablet, uncoated2 mgCurrentLimited AvailabilityManufacturing27/08/2024
    captoprilTablet, uncoated50 mgCurrentUnavailableManufacturing27/08/2024
    flecainide acetateTablet, uncoated100 mgResolvedAvailableManufacturing27/08/2024
    enalapril maleateTablet, uncoated5 mgResolvedAvailableManufacturing27/08/2024
    ciprofloxacin hydrochlorideTablet, film coated873.32 mgAnticipatedAvailableManufacturing27/08/2024
    metformin hydrochlorideTablet, film coated500 mgResolvedAvailableManufacturing27/08/2024
    metformin hydrochlorideTablet, film coated1000 mgResolvedAvailableManufacturing27/08/2024
    baclofenTablet, uncoated25 mgAnticipatedAvailableTransport / Logistic issues / Storage capacity issues27/08/2024
    famotidineTablet, film coated20 mgCurrentUnavailableManufacturing27/08/2024
    famotidineTablet, film coated40 mgCurrentUnavailableManufacturing27/08/2024
    methylphenidate hydrochlorideTablet, modified release36 mgResolvedAvailableManufacturing27/08/2024
    metformin hydrochlorideTablet, modified release500 mgDiscontinuedUnavailableManufacturing26/08/2024
    perindopril erbumineTablet, uncoated2 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability26/08/2024
    perindopril erbumineTablet, uncoated4 mgDiscontinuedUnavailableCommercial Changes / Commercial viability26/08/2024
    perindopril erbumineTablet, uncoated8 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability26/08/2024
    Epoetin lambdaInjection, solution10000 IUCurrentLimited AvailabilityManufacturing26/08/2024
    gabapentinTablet, film coated600 mgAnticipatedAvailableManufacturing26/08/2024
    insulin~insulinInjection, suspension30 IU/mL~70 IU/mLDiscontinuedUnavailableCommercial Changes / Commercial viability26/08/2024
    perindopril erbumineTablet8 mgResolvedAvailableManufacturing26/08/2024
    bisoprolol fumarateTablet5 mgAnticipatedAvailableManufacturing26/08/2024
    bisoprolol fumarateTablet10 mgAnticipatedAvailableManufacturing26/08/2024
    bosentan monohydrateTablet, film coated64.541 mgCurrentUnavailableManufacturing26/08/2024
    ezetimibeTablet, uncoated10 mgCurrentLimited AvailabilityManufacturing26/08/2024
    tadalafilTablet, film coated20 mgCurrentLimited AvailabilityManufacturing26/08/2024
    tadalafilTablet, film coated5 mgCurrentUnavailableManufacturing26/08/2024
    dasatinibTablet, film coated70 mgCurrentLimited AvailabilityCommercial Changes / Commercial viability26/08/2024
    atomoxetine hydrochlorideCapsule, hard45.5 mgCurrentUnavailableManufacturing26/08/2024
    escitalopram oxalateTablet, film coated25.47 mgCurrentUnavailableManufacturing26/08/2024
    bupivacaine hydrochloride monohydrate~adrenaline (epinephrine) acid tartrateInjection, solution5.27 mg/mL~9.1 microgram/mLDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability26/08/2024
    estradiolDrug delivery system, transdermal1.56 mgCurrentLimited AvailabilityManufacturing26/08/2024
  • 2024.08.26
    Active ingredientsDosage formQuantity of active ingredientsAvailabilityReasonLast updated
    clarithromycinTablet, film coated250 mgLimited AvailabilityManufacturing23/08/2024
    isosorbide dinitrateTablet, uncoated5 mgAvailableManufacturing23/08/2024
    adrenaline (epinephrine)Injection, solution1 mgLimited AvailabilityManufacturing23/08/2024
    gliclazideTablet, modified release30 mgAvailableManufacturing23/08/2024
    oxazepamTablet, uncoated15 mgUnavailableManufacturing23/08/2024
    OmalizumabInjection, solution150 mgUnavailableManufacturing23/08/2024
    efmoroctocog alfaInjection, powder for250 IUAvailableManufacturing23/08/2024
    timolol maleate~latanoprostEye Drops, solution6.83 mg/mL~50 microgram/mLUnavailableUnexpected increase in consumer demand23/08/2024
    olopatadine hydrochlorideEye Drops1.11 mg/mLUnavailableManufacturing23/08/2024
    temozolomideCapsule, hard5 mgUnavailableManufacturing23/08/2024
    ezetimibeTablet, uncoated10 mgUnavailableManufacturing23/08/2024
    tadalafilTablet, film coated5 mgUnavailableManufacturing23/08/2024
    dosulepin (dothiepin) hydrochlorideCapsule, hard25 mgLimited AvailabilityManufacturing23/08/2024
    fenofibrateTablet145 mgAvailableManufacturing23/08/2024
    busulfanInjection, concentrated60 mgUnavailableManufacturing23/08/2024
    letrozoleTablet, film coated2.5 mgAvailableManufacturing23/08/2024
    bendamustine hydrochloride monohydrateInjection, powder for25 mgAvailableUnexpected increase in demand due to other sponsors unable to supply23/08/2024
    difelikefalin acetateInjection, solution55 microgramAvailableManufacturing23/08/2024
    enoxaparin sodiumInjection, solution40 mgReduction in supply until supply is exhaustedCommercial Changes / Commercial viability23/08/2024
    enoxaparin sodiumInjection, solution120 mgReduction in supply until supply is exhaustedCommercial Changes / Commercial viability23/08/2024
    dexamethasone~framycetin sulfate~gramicidinEar Drops.5 mg/mL~5 mg/mL~.05 mg/mLAvailableManufacturing23/08/2024
    tobramycinInhalation, conventional60 mg/mLUnavailableManufacturing23/08/2024
    pamidronate disodiumInjection, concentrated9 mgAvailableManufacturing23/08/2024
    paclitaxelInjection, concentrated6 mg/mLLimited AvailabilityManufacturing23/08/2024
    ampicillinInjection, powder for1 gReduction in supply until supply is exhaustedCommercial Changes / Commercial viability23/08/2024
    FilgrastimInjection, solution480 microgramLimited AvailabilityTransport / Logistic issues / Storage capacity issues22/08/2024
    metoprolol succinateTablet, modified release95 mgAvailableManufacturing22/08/2024
    duloxetine hydrochlorideCapsule, enteric33.65 mgLimited AvailabilityManufacturing22/08/2024
    quetiapine fumarateTablet, film coated115.12 mgAvailableManufacturing22/08/2024
    quetiapine fumarateTablet, film coated345.36 mgUnavailableManufacturing22/08/2024
    prilocaine hydrochloride~felypressinInjection, solution30 mg/mL~.54 microgram/mLAvailableManufacturing22/08/2024
    nizatidineCapsule, hard150 mgUnavailableManufacturing22/08/2024
    ropinirole hydrochlorideTablet, film coated2.28 mgUnavailableManufacturing22/08/2024
    dostarlimabInjection, intravenous infusion500 mg/mLLimited AvailabilityUnexpected increase in consumer demand22/08/2024
    estradiol~norethisterone acetateDrug delivery system, transdermal.512 mg~4.8 mgAvailableManufacturing22/08/2024
    nizatidineCapsule, hard300 mgUnavailableManufacturing22/08/2024
    fentanylDrug delivery system, transdermal4.2 mgUnavailableManufacturing21/08/2024
    fentanylDrug delivery system, transdermal8.4 mgUnavailableManufacturing21/08/2024
    fentanylDrug delivery system, transdermal12.6 mgUnavailableManufacturing21/08/2024
    fentanylDrug delivery system, transdermal16.8 mgUnavailableManufacturing21/08/2024
    fentanylDrug delivery system, transdermal2.1 mgUnavailableManufacturing21/08/2024
    lisdexamfetamine dimesilateCapsule, hard20 mgAvailableUnexpected increase in consumer demand21/08/2024
    cinacalcet hydrochlorideTablet33.064 mgUnavailableManufacturing21/08/2024
    cinacalcet hydrochlorideTablet66.127 mgAvailableManufacturing21/08/2024
    rifampicinCapsule, hard150 mgAvailableManufacturing21/08/2024
    escitalopram oxalateTablet, film coated25.56 mgLimited AvailabilityManufacturing20/08/2024
    amlodipine besilateTablet, uncoated6.94 mgLimited AvailabilityManufacturing20/08/2024
    alendronate sodiumTablet91.37 mgAvailableManufacturing20/08/2024
    galantamine hydrobromideCapsule, modified release20.512 mgUnavailableManufacturing20/08/2024
    FilgrastimInjection, solution120 microgramLimited AvailabilityTransport / Logistic issues / Storage capacity issues20/08/2024
    donepezil hydrochlorideTablet, film coated10 mgAvailableManufacturing20/08/2024
    duloxetine hydrochlorideCapsule, enteric67.3 mgLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply20/08/2024
    oxycodone hydrochlorideCapsule, hard10 mgAvailableCommercial Changes / Commercial viability20/08/2024
    oxycodone hydrochlorideCapsule, hard20 mgUnavailableCommercial Changes / Commercial viability20/08/2024
    oxycodone hydrochlorideCapsule, hard5 mgAvailableCommercial Changes / Commercial viability20/08/2024
    gliclazideTablet, modified release30 mgLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply20/08/2024
    Rabies virusInjection, powder for2.5 IUEmergency Supply OnlyManufacturing20/08/2024
    risperidoneOral Liquid, solution1 mg/mLUnavailableManufacturing20/08/2024
    spironolactoneTablet, uncoated100 mgLimited AvailabilityManufacturing20/08/2024
    dosulepin (dothiepin) hydrochlorideCapsule, hard25 mgUnavailableManufacturing20/08/2024
    flecainide acetateTablet50 mgUnavailableManufacturing20/08/2024
    indometacinCapsule, hard25 mgLimited AvailabilityManufacturing20/08/2024
    paracetamolTablet, modified release665 mgLimited AvailabilityTransport / Logistic issues / Storage capacity issues20/08/2024
    oxazepamTablet, uncoated30 mgUnavailableManufacturing20/08/2024
    captoprilTablet, uncoated25 mgUnavailableManufacturing20/08/2024
    pravastatin sodiumTablet, uncoated40 mgLimited AvailabilityManufacturing20/08/2024
    morphine hydrochloride trihydrateOral Liquid, solution1 mg/mLUnavailableCommercial Changes / Commercial viability19/08/2024
    morphine hydrochloride trihydrateOral Liquid, solution2 mg/mLUnavailableCommercial Changes / Commercial viability19/08/2024
    morphine hydrochloride trihydrateOral Liquid, solution5 mg/mLUnavailableCommercial Changes / Commercial viability19/08/2024
    Choriogonadotropin alfaInjection, solution250 microgramLimited AvailabilityUnexpected increase in consumer demand19/08/2024
    carmustineInjection, powder for100 mgUnavailableManufacturing19/08/2024
    duloxetine hydrochlorideCapsule, enteric33.65 mgUnavailableManufacturing19/08/2024
    duloxetine hydrochlorideCapsule, enteric67.3 mgUnavailableManufacturing19/08/2024
    nortriptyline hydrochlorideTablet, uncoated28.5 mgUnavailableManufacturing19/08/2024
    nortriptyline hydrochlorideTablet, uncoated11.4 mgUnavailableManufacturing19/08/2024
    olmesartan medoxomil~amlodipine besilateTablet, film coated40 mg~6.935 mgAvailableManufacturing19/08/2024
    lacosamideTablet, film coated50 mgAvailableManufacturing19/08/2024
    montelukast sodiumTablet, chewable5.2 mgAvailableManufacturing19/08/2024
    montelukast sodiumTablet, chewable4.16 mgAvailableManufacturing19/08/2024
    carbacholInjection, solution100 microgram/mLLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply19/08/2024
    clonazepamTablet, uncoated2 mgAvailableManufacturing19/08/2024
    mianserin hydrochlorideTablet, film coated20 mgAvailableManufacturing19/08/2024
    estradiol hemihydrateDrug delivery system, transdermal1.54 mgAvailableUnexpected increase in demand due to other sponsors unable to supply19/08/2024
    estradiol hemihydrateDrug delivery system, transdermal.77 mgAvailableCommercial Changes / Commercial viability19/08/2024
    estradiol hemihydrateDrug delivery system, transdermal3.09 mgAvailableUnexpected increase in demand due to other sponsors unable to supply19/08/2024
  • 2024.08.20
    Active ingredientsDosage formQuantity of active ingredientsShortage statusAvailabilityReasonLast updated
    ondansetron hydrochloride dihydrateInjection, solution5 mgCurrentUnavailableManufacturing16/08/2024
    azithromycin dihydrateTablet, film coated524.05 mgAnticipatedAvailableManufacturing16/08/2024
    hydrochlorothiazide~amlodipine besilate~olmesartan medoxomilTablet25 mg~6.944 mg~40 mgCurrentUnavailableManufacturing16/08/2024
    latanoprostEye Drops, solution50 microgram/mLResolvedAvailableUnexpected increase in consumer demand16/08/2024
    acarboseTablet50 mgCurrentUnavailableManufacturing16/08/2024
    ezetimibeTablet, uncoated10 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues16/08/2024
    cefuroxime axetilTablet, film coated300.715 mgResolvedAvailableUnexpected increase in consumer demand16/08/2024
    paracetamolInjection1 gResolvedAvailableUnexpected increase in demand due to other sponsors unable to supply16/08/2024
    dosulepin (dothiepin) hydrochlorideCapsule, hard25 mgCurrentLimited AvailabilityManufacturing16/08/2024
    bupivacaine hydrochloride monohydrate~adrenaline (epinephrine) acid tartrateInjection, solution2.64 mg/mL~4.5 microgram/mLResolvedAvailableManufacturing16/08/2024
    cinacalcet hydrochlorideTablet, film coated33 mgCurrentLimited AvailabilityManufacturing16/08/2024
    lanreotide acetateInjection, solution100 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues16/08/2024
    erythromycin ethyl succinateOral Liquid, powder for468 mgAnticipatedAvailableUnexpected increase in consumer demand16/08/2024
    doxorubicin hydrochlorideInjection, concentrated2 mg/mLResolvedAvailableManufacturing16/08/2024
    clindamycin phosphateLotion10 mg/mLAnticipatedAvailableManufacturing16/08/2024
    pamidronate disodiumInjection, concentrated9 mgCurrentLimited AvailabilityManufacturing16/08/2024
    ezetimibeTablet10 mgResolvedAvailableUnexpected increase in consumer demand16/08/2024
    methylphenidate hydrochlorideTablet, modified release36 mgCurrentLimited AvailabilityManufacturing16/08/2024
    povidoneiodineApplication100 mg/mLCurrentLimited AvailabilityManufacturing15/08/2024
    risperidoneTablet, film coated4 mgAnticipatedAvailableManufacturing15/08/2024
    donepezil hydrochlorideTablet, film coated5 mgAnticipatedAvailableTransport / Logistic issues / Storage capacity issues15/08/2024
    tacrolimus monohydrateCapsule, hard1.022 mgAnticipatedAvailableManufacturing15/08/2024
    valaciclovir hydrochloride monohydrateTablet, film coated611.7 mgDiscontinuedUnavailableCommercial Changes / Commercial viability15/08/2024
    montelukast sodiumTablet, chewable5.2 mgCurrentUnavailableManufacturing15/08/2024
    sildenafil citrateTablet, film coated28.1 mgCurrentLimited AvailabilityManufacturing15/08/2024
    enalapril maleateTablet10 mgResolvedAvailableManufacturing15/08/2024
    quetiapine fumarateTablet, film coated345.36 mgCurrentUnavailableManufacturing15/08/2024
    temozolomideCapsule, hard5 mgCurrentUnavailableManufacturing15/08/2024
    temozolomideCapsule, hard180 mgResolvedAvailableManufacturing15/08/2024
    rosuvastatin calciumTablet, film coated5.21 mgResolvedAvailableManufacturing15/08/2024
    olmesartan medoxomilTablet40 mgResolvedAvailableManufacturing15/08/2024
    ezetimibeTablet, uncoated10 mgAnticipatedAvailableManufacturing15/08/2024
    irbesartanTablet, film coated150 mgAnticipatedAvailableManufacturing15/08/2024
    hydrochlorothiazide~irbesartanTablet, film coated25 mg~300 mgAnticipatedAvailableManufacturing15/08/2024
    tadalafilTablet, film coated20 mgCurrentLimited AvailabilityManufacturing15/08/2024
    metformin hydrochlorideTablet, film coated850 mgCurrentUnavailableManufacturing15/08/2024
    hydrochlorothiazide~olmesartan medoxomilTablet25 mg~40 mgResolvedAvailableManufacturing15/08/2024
    flecainide acetateTablet50 mgCurrentUnavailableManufacturing15/08/2024
    dasatinibTablet, film coated100 mgCurrentLimited AvailabilityManufacturing15/08/2024
    latanoprostEye Drops, solution.05 mg/mLCurrentLimited AvailabilityTransport / Logistic issues / Storage capacity issues15/08/2024
    lacosamideTablet, film coated150 mgAnticipatedAvailableManufacturing15/08/2024
    estradiolDrug delivery system, transdermal.39 mgCurrentUnavailableManufacturing15/08/2024
    estradiolDrug delivery system, transdermal.585 mgCurrentUnavailableManufacturing15/08/2024
    estradiolDrug delivery system, transdermal.78 mgCurrentUnavailableManufacturing15/08/2024
    estradiolDrug delivery system, transdermal1.56 mgCurrentUnavailableManufacturing15/08/2024
    rosuvastatin calcium~ezetimibeTablet~Tablet, film coated41.6 mg~10 mgCurrentLimited AvailabilityManufacturing15/08/2024
    lidocaine hydrochloride~adrenaline (epinephrine) acid tartrateInjection, solution5 mg/mL~9.1 microgram/mLDiscontinuedUnavailableManufacturing14/08/2024
    adrenaline (epinephrine)Injection, solution1 mgCurrentLimited AvailabilityManufacturing14/08/2024
    anidulafunginInjection, powder for100 mgAnticipatedAvailableManufacturing14/08/2024
    adrenaline (epinephrine)Injection, solution1 mgCurrentLimited AvailabilityManufacturing14/08/2024
    efmoroctocog alfaInjection, powder for250 IUCurrentUnavailableManufacturing14/08/2024
    Insulin aspartInjection, solution100 U/mLResolvedAvailableTransport / Logistic issues / Storage capacity issues14/08/2024
    cinacalcet hydrochlorideTablet, film coated66 mgResolvedAvailableManufacturing14/08/2024
    cinacalcet hydrochlorideTablet, film coated99 mgResolvedAvailableManufacturing14/08/2024
    ezetimibeTablet10 mgCurrentUnavailableManufacturing14/08/2024
    nizatidineCapsule, hard300 mgCurrentUnavailableManufacturing14/08/2024
    Coxiella burnetiiInjection5 microgram/mLCurrentLimited AvailabilityManufacturing13/08/2024
    zolpidem tartrateTablet, film coated10 mgDiscontinuedUnavailableCommercial Changes / Commercial viability13/08/2024
    eprosartan mesilate~hydrochlorothiazideTablet, film coated735.8 mg~12.5 mgDiscontinuedUnavailableManufacturing13/08/2024
    insulinInjection, solution100 IU/mLResolvedAvailableManufacturing13/08/2024
    griseofulvinTablet500 mgCurrentUnavailableManufacturing13/08/2024
    papaverine hydrochlorideInjection, solution12 mg/mLAnticipatedAvailableManufacturing13/08/2024
    clonidine hydrochlorideTablet, uncoated100 microgramAnticipatedAvailableManufacturing13/08/2024
    ropivacaine hydrochlorideInjection, solution400 mgCurrentLimited AvailabilityTransport / Logistic issues / Storage capacity issues13/08/2024
    olmesartan medoxomil~hydrochlorothiazide~amlodipine besilateTablet40 mg~12.5 mg~6.944 mgResolvedAvailableManufacturing13/08/2024
    capecitabineTablet, film coated500 mgAnticipatedAvailableManufacturing13/08/2024
    adrenaline (epinephrine) acid tartrateInjection, solution182 microgram/mLCurrentLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply13/08/2024
    codeine phosphate hemihydrate~doxylamine succinate~paracetamolTablet, uncoated10 mg~5.1 mg~500 mgCurrentUnavailableManufacturing13/08/2024
    bosentan monohydrateTablet, film coated64.541 mgCurrentUnavailableManufacturing13/08/2024
    ezetimibeTablet10 mgCurrentUnavailableManufacturing13/08/2024
    cisplatinInjection, concentrated1 mg/mLResolvedAvailableUnexpected increase in consumer demand13/08/2024
    cisplatinInjection, concentrated1 mg/mLCurrentUnavailableUnexpected increase in consumer demand13/08/2024
    dasatinibTablet, film coated70 mgCurrentLimited AvailabilityCommercial Changes / Commercial viability13/08/2024
    mercaptopurine monohydrateTablet50 mgResolvedAvailableManufacturing13/08/2024
    gefitinibTablet, film coated250 mgCurrentUnavailableProduct recall13/08/2024
    iopromideInjection, solution768.86 mg/mLResolvedAvailableUnexpected increase in consumer demand13/08/2024
    tamsulosin hydrochloride~dutasterideCapsule, modified release400 microgram~500 microgramResolvedAvailableManufacturing13/08/2024
    estradiolDrug delivery system, transdermal1.17 mgCurrentLimited AvailabilityManufacturing13/08/2024
    lanreotide acetateInjection, solution133.33 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues13/08/2024
    dasatinibTablet, film coated50 mgCurrentUnavailableUnexpected increase in demand due to other sponsors unable to supply13/08/2024
    tirzepatideInjection, solution5 mgCurrentLimited AvailabilityUnexpected increase in consumer demand13/08/2024
    tirzepatideInjection, solution7.5 mgCurrentLimited AvailabilityUnexpected increase in consumer demand13/08/2024
    tirzepatideInjection, solution12.5 mgCurrentLimited AvailabilityUnexpected increase in consumer demand13/08/2024
    tirzepatideInjection, solution10 mgCurrentLimited AvailabilityUnexpected increase in consumer demand13/08/2024
    tirzepatideInjection, solution15 mgCurrentUnavailableUnexpected increase in consumer demand13/08/2024
    tirzepatideInjection, solution2.5 mgCurrentLimited AvailabilityUnexpected increase in consumer demand13/08/2024
    fluticasone propionateInhalation, pressurised125 microgram/actuationAnticipatedAvailableUnexpected increase in consumer demand13/08/2024
    flecainide acetateTablet, uncoated100 mgCurrentLimited AvailabilityManufacturing13/08/2024
    tobramycinInjection, solution80 mgDiscontinuedUnavailableCommercial Changes / Commercial viability12/08/2024
    fentanylDrug delivery system, transdermal7.65 mgDiscontinuedUnavailableCommercial Changes / Commercial viability12/08/2024
    fentanylDrug delivery system, transdermal1.28 mgDiscontinuedUnavailableCommercial Changes / Commercial viability12/08/2024
    perindopril erbumineTablet8 mgCurrentLimited AvailabilityManufacturing12/08/2024
    betahistine dihydrochlorideTablet, uncoated16 mgDiscontinuedUnavailableManufacturing12/08/2024
    clopidogrel hydrogen sulfate~aspirinTablet97.87 mg~100 mgCurrentLimited AvailabilityManufacturing12/08/2024
    BevacizumabInjection, concentrated25 mg/mLCurrentLimited AvailabilityCommercial Changes / Commercial viability12/08/2024
    cefaclor monohydrateOral Liquid, powder for26.22 mg/mLCurrentUnavailableManufacturing12/08/2024
    bortezomibInjection, solution3.5 mgCurrentUnavailableManufacturing12/08/2024
    fentanyl citrateInjection, solution157 microgramCurrentLimited AvailabilityManufacturing12/08/2024
    eprosartan mesilateTablet, film coated400 mgDiscontinuedUnavailableManufacturing12/08/2024
    doxycycline monohydrateTablet, uncoated104.1 mgResolvedAvailableManufacturing12/08/2024
    heparin sodiumInjection, solution10 IU/mLAnticipatedAvailableManufacturing12/08/2024
    ketamine hydrochlorideInjection, solution115.3 mg/mLResolvedAvailableManufacturing12/08/2024
    norethisterone acetate~estradiolDrug delivery system, transdermal2.7 mg~.62 mgResolvedAvailableManufacturing12/08/2024
  • 2024.08.12
    Active ingredientsDosage formQuantity of active ingredientsShortage statusAvailabilityReasonLast updated
    Coxiella burnetiiInjection50 microgram/mLCurrentLimited AvailabilityManufacturing9/08/2024
    lisinopril dihydrateTablet, uncoated10.89 mgCurrentUnavailableManufacturing9/08/2024
    duloxetine hydrochlorideCapsule, enteric67.3 mgCurrentLimited AvailabilityManufacturing9/08/2024
    sodium fluorideInjection, concentrated1 mg/mLResolvedAvailableManufacturing9/08/2024
    OmalizumabInjection, solution150 mgCurrentEmergency Supply OnlyManufacturing9/08/2024
    metformin hydrochlorideTablet, modified release1000 mgResolvedAvailableManufacturing9/08/2024
    tadalafilTablet, film coated20 mgCurrentLimited AvailabilityManufacturing9/08/2024
    betahistine dihydrochlorideTablet, uncoated16 mgDiscontinuedUnavailableManufacturing9/08/2024
    acarboseTablet50 mgAnticipatedAvailableManufacturing9/08/2024
    mesalazineTablet, enteric coated800 mgResolvedAvailableTransport / Logistic issues / Storage capacity issues9/08/2024
    ezetimibeTablet, uncoated10 mgAnticipatedAvailableManufacturing9/08/2024
    tadalafilTablet, film coated5 mgCurrentUnavailableManufacturing9/08/2024
    cinacalcet hydrochlorideTablet66.127 mgCurrentUnavailableManufacturing9/08/2024
    dasatinibTablet, film coated50 mgCurrentUnavailableManufacturing9/08/2024
    escitalopram oxalateTablet, film coated12.74 mgCurrentUnavailableCommercial Changes / Commercial viability9/08/2024
    amlodipine besilate~olmesartan medoxomil~hydrochlorothiazideTablet, film coated6.95 mg~40 mg~25 mgCurrentUnavailableManufacturing9/08/2024
    hydrochlorothiazide~amlodipine besilate~olmesartan medoxomilTablet, film coated12.5 mg~6.95 mg~40 mgCurrentLimited AvailabilityManufacturing9/08/2024
    gefitinibTablet, film coated250 mgCurrentUnavailableProduct recall9/08/2024
    lacosamideTablet, film coated50 mgResolvedAvailableManufacturing9/08/2024
    atovaquone~proguanil hydrochlorideTablet, film coated62.5 mg~25 mgResolvedAvailableManufacturing9/08/2024
    fluoxetine hydrochlorideCapsule, hard22.36 mgResolvedAvailableManufacturing9/08/2024
    cabergolineTablet, uncoated2 mgAnticipatedAvailableManufacturing9/08/2024
    desonideLotion.5 mg/gResolvedAvailableManufacturing9/08/2024
    rizatriptan benzoateWafer14.53 mgResolvedAvailableUnexpected increase in demand due to other sponsors unable to supply9/08/2024
    sodium oxidronateInjection, powder for3.15 mgResolvedAvailableManufacturing9/08/2024
    methylphenidate hydrochlorideTablet, modified release18 mgAnticipatedAvailableManufacturing9/08/2024
    zopicloneTablet, film coated7.5 mgCurrentUnavailableManufacturing9/08/2024
    bicalutamideTablet, film coated50 mgAnticipatedAvailableManufacturing8/08/2024
    adrenaline (epinephrine) acid tartrateInjection, solution182 microgram/mLCurrentLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply8/08/2024
    temozolomideCapsule, hard100 mgAnticipatedAvailableTransport / Logistic issues / Storage capacity issues8/08/2024
    tenofovir disoproxil fumarate~emtricitabineTablet, film coated300 mg~200 mgCurrentLimited AvailabilityCommercial Changes / Commercial viability8/08/2024
    tadalafilTablet, film coated20 mgCurrentLimited AvailabilityManufacturing8/08/2024
    tadalafilTablet, film coated5 mgCurrentUnavailableManufacturing8/08/2024
    adrenaline (epinephrine) acid tartrateInjection, solution1.819 mgCurrentUnavailableManufacturing8/08/2024
    teriflunomideTablet, film coated14 mgAnticipatedAvailableManufacturing8/08/2024
    olanzapineTablet, uncoated7.5 mgResolvedAvailableManufacturing8/08/2024
    BevacizumabInjection, concentrated25 mg/mLAnticipatedAvailableCommercial Changes / Commercial viability8/08/2024
    sitagliptin fumarateTablet, film coated64.249 mgResolvedAvailableUnexpected increase in demand due to other sponsors unable to supply8/08/2024
    sodium valproateTablet, enteric coated500 mgAnticipatedAvailableManufacturing8/08/2024
    fluorouracilInjection, solution50 mg/mLCurrentLimited AvailabilityManufacturing8/08/2024
    clarithromycinOral Liquid, powder for50 mg/mLCurrentLimited AvailabilityUnexpected increase in consumer demand8/08/2024
    nizatidineCapsule, hard300 mgAnticipatedAvailableManufacturing8/08/2024
    roxithromycinTablet, film coated150 mgDiscontinuedUnavailableManufacturing8/08/2024
    roxithromycinTablet, film coated300 mgDiscontinuedUnavailableManufacturing8/08/2024
    framycetin sulfate~gramicidin~dexamethasoneEar Drops5 mg/mL~.05 mg/mL~.5 mg/mLCurrentUnavailableManufacturing7/08/2024
    fluorouracilCream50 mg/gResolvedAvailableManufacturing7/08/2024
    ketorolac trometamolInjection, solution30 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability7/08/2024
    risperidoneTablet.5 mgCurrentUnavailableManufacturing7/08/2024
    risperidoneTablet1 mgCurrentUnavailableManufacturing7/08/2024
    prochlorperazine maleateTablet5 mgResolvedAvailableManufacturing7/08/2024
    tamsulosin hydrochloride~dutasterideCapsule, modified release400 microgram~500 microgramCurrentUnavailableManufacturing7/08/2024
    fentanylDrug delivery system, transdermal10.2 mgDiscontinuedUnavailableCommercial Changes / Commercial viability7/08/2024
    ondansetronTablet, orally disintegrating4 mgResolvedAvailableManufacturing7/08/2024
    mycophenolate mofetilCapsule, hard250 mgDiscontinuedUnavailableManufacturing7/08/2024
    sildenafil citrateTablet, film coated28.1 mgResolvedAvailableManufacturing7/08/2024
    escitalopram oxalateTablet, film coated12.74 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues7/08/2024
    escitalopram oxalateTablet, film coated25.47 mgCurrentUnavailableManufacturing7/08/2024
    AbataceptInjection125.875 mgResolvedAvailableManufacturing7/08/2024
    ezetimibeTablet, uncoated10 mgCurrentUnavailableUnexpected increase in demand due to other sponsors unable to supply7/08/2024
    imatinib mesilateCapsule, hard119.47 mgResolvedAvailableManufacturing7/08/2024
    clonidine hydrochlorideTablet100 microgramAnticipatedAvailableUnexpected increase in consumer demand7/08/2024
    tadalafilTablet, film coated10 mgCurrentUnavailableManufacturing7/08/2024
    tadalafilTablet, film coated20 mgCurrentUnavailableManufacturing7/08/2024
    ephedrine hydrochlorideInjection, solution30 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability7/08/2024
    nebivolol hydrochlorideTablet5.45 mgResolvedAvailableManufacturing7/08/2024
    tamsulosin hydrochloride~dutasterideCapsule, modified release400 microgram~500 microgramCurrentLimited AvailabilityManufacturing7/08/2024
    hydrocortisone acetateEnema10 % w/wDiscontinuedUnavailableManufacturing7/08/2024
    gramicidin~framycetin sulfate~dexamethasoneEar Drops.05 mg/mL~5 mg/mL~.5 mg/mLCurrentUnavailableManufacturing7/08/2024
    rifampicinCapsule, hard150 mgCurrentUnavailableManufacturing7/08/2024
    eprosartan mesilateTablet, film coated735.8 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability7/08/2024
    alprostadilInjection, powder for40 microgram/mLCurrentUnavailableManufacturing7/08/2024
    sildenafil citrateTablet, film coated28.09 mgCurrentLimited AvailabilityUnexpected increase in consumer demand6/08/2024
    ramiprilTablet, uncoated5 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability6/08/2024
    ramiprilTablet, uncoated10 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability6/08/2024
    isoniazidTablet, uncoated100 mgCurrentUnavailableManufacturing6/08/2024
    prochlorperazine maleateTablet5 mgResolvedAvailableManufacturing6/08/2024
    pramipexole dihydrochloride monohydrateTablet.25 mgResolvedAvailableManufacturing6/08/2024
    oseltamivir phosphateOral Liquid, powder for7.88 mg/mLCurrentEmergency Supply OnlyUnexpected increase in consumer demand6/08/2024
    ropivacaine hydrochlorideInjection, solution400 mgAnticipatedAvailableTransport / Logistic issues / Storage capacity issues6/08/2024
    trandolaprilCapsule, hard2 mgCurrentLimited AvailabilityManufacturing6/08/2024
    trandolaprilCapsule, hard4 mgCurrentLimited AvailabilityManufacturing6/08/2024
    efmoroctocog alfaInjection, powder for250 IUCurrentUnavailableManufacturing6/08/2024
    tadalafilTablet, film coated5 mgCurrentUnavailableUnexpected increase in demand due to other sponsors unable to supply6/08/2024
    tadalafilTablet, film coated20 mgCurrentUnavailableUnexpected increase in consumer demand6/08/2024
    latanoprostEye Drops, solution.05 mg/mLResolvedAvailableManufacturing6/08/2024
    bupivacaine hydrochloride monohydrate~adrenaline (epinephrine) acid tartrateInjection, solution2.64 mg/mL~4.5 microgram/mLCurrentLimited AvailabilityManufacturing6/08/2024
    nebivolol hydrochlorideTablet5.45 mgResolvedAvailableManufacturing6/08/2024
    aciclovirInjection, solution25 mg/mLCurrentUnavailableManufacturing6/08/2024
    iopromideInjection, solution768.86 mg/mLCurrentUnavailableUnexpected increase in consumer demand6/08/2024
    timolol maleateEye Drops, solution6.84 mg/mLDiscontinuedUnavailableCommercial Changes / Commercial viability6/08/2024
    mianserin hydrochlorideTablet, film coated20 mgCurrentLimited AvailabilityManufacturing6/08/2024
    estradiol~norethisterone acetateDrug delivery system, transdermal.512 mg~4.8 mgCurrentUnavailableManufacturing6/08/2024
    alprostadilInjection, powder for20 microgram/mLCurrentUnavailableManufacturing6/08/2024
    metformin hydrochlorideTablet, film coated500 mgCurrentUnavailableManufacturing6/08/2024
    metformin hydrochlorideTablet, film coated1000 mgCurrentUnavailableManufacturing6/08/2024
    zoledronic acid monohydrateInjection, solution5.33 mgResolvedAvailableManufacturing5/08/2024
    olanzapine pamoate monohydrateInjection, powder for931 mgCurrentLimited AvailabilityTransport / Logistic issues / Storage capacity issues5/08/2024
    olanzapine pamoate monohydrateInjection, powder for690 mgCurrentLimited AvailabilityTransport / Logistic issues / Storage capacity issues5/08/2024
    olanzapine pamoate monohydrateInjection, powder for483 mgCurrentLimited AvailabilityTransport / Logistic issues / Storage capacity issues5/08/2024
    fentanylDrug delivery system, transdermal5.1 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability5/08/2024
    fentanylDrug delivery system, transdermal2.55 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability5/08/2024
    mirtazapineTablet, film coated45 mgAnticipatedAvailableManufacturing5/08/2024
    timolol maleate~dorzolamide hydrochlorideEye Drops, solution6.83 mg/mL~22.26 mg/mLDiscontinuedUnavailableCommercial Changes / Commercial viability5/08/2024
    pramipexole dihydrochloride monohydrateTablet1 mgResolvedAvailableManufacturing5/08/2024
    pramipexole dihydrochloride monohydrateTablet.125 mgResolvedAvailableManufacturing5/08/2024
    ezetimibe~rosuvastatin calciumTablet~Tablet, film coated10 mg~5.198 mgCurrentLimited AvailabilityManufacturing5/08/2024
    rosuvastatin calcium~ezetimibeTablet~Tablet, film coated10.396 mg~10 mgCurrentLimited AvailabilityManufacturing5/08/2024
    temozolomideCapsule, hard5 mgCurrentUnavailableManufacturing5/08/2024
    rosuvastatin calciumTablet, film coated10.42 mgResolvedAvailableManufacturing5/08/2024
    cefuroxime axetilTablet, film coated300.715 mgCurrentLimited AvailabilityUnexpected increase in consumer demand5/08/2024
    mupirocinOintment20 mg/gResolvedAvailableManufacturing5/08/2024
    alfentanil hydrochlorideInjection, solution1.09 mgResolvedAvailableManufacturing5/08/2024
    montelukast sodiumTablet, chewable5.2 mgCurrentUnavailableManufacturing5/08/2024
    montelukast sodiumTablet, film coated10.4 mgCurrentLimited AvailabilityUnexpected increase in consumer demand5/08/2024
    mycophenolate mofetilInjection, powder for500 mgCurrentUnavailableManufacturing5/08/2024
    spironolactoneTablet, uncoated100 mgAnticipatedAvailableManufacturing5/08/2024
    flecainide acetateTablet50 mgCurrentUnavailableManufacturing5/08/2024
    indometacinCapsule, hard25 mgCurrentLimited AvailabilityManufacturing5/08/2024
    temozolomideCapsule, hard5 mgAnticipatedAvailableManufacturing5/08/2024
    raltitrexedInjection, powder for2 mgResolvedAvailableUnexpected increase in consumer demand5/08/2024
    captoprilTablet, uncoated25 mgCurrentUnavailableManufacturing5/08/2024
    captoprilTablet, uncoated50 mgCurrentUnavailableManufacturing5/08/2024
    dorzolamide hydrochloride~timolol maleateEye Drops, solution22.26 mg/mL~6.83 mg/mLDiscontinuedUnavailableCommercial Changes / Commercial viability5/08/2024
    flecainide acetateTablet, uncoated100 mgCurrentLimited AvailabilityManufacturing5/08/2024
    midazolamInjection, solution5 mg/mLCurrentUnavailableManufacturing5/08/2024
  • 2024.08.06
    Active ingredientsDosage formQuantity of active ingredientsShortage statusAvailabilityReasonLast updated
    prazosin hydrochlorideTablet, uncoated5.476 mgResolvedAvailableUnexpected increase in consumer demand2/08/2024
    fluorouracilCream50 mg/gCurrentLimited AvailabilityManufacturing2/08/2024
    silver sulfadiazineCream10 mg/gCurrentUnavailableManufacturing2/08/2024
    ondansetron hydrochloride dihydrateTablet, film coated5 mgResolvedAvailableTransport / Logistic issues / Storage capacity issues2/08/2024
    emtricitabine~tenofovir disoproxil fumarateTablet, film coated200 mg~300 mgCurrentLimited AvailabilityCommercial Changes / Commercial viability2/08/2024
    dasatinibTablet, film coated100 mgAnticipatedAvailableManufacturing2/08/2024
    atomoxetine hydrochlorideCapsule, hard45.5 mgCurrentLimited AvailabilityManufacturing2/08/2024
    risperidoneOral Liquid, solution1 mg/mLCurrentUnavailableManufacturing2/08/2024
    olmesartan medoxomil~hydrochlorothiazide~amlodipine besilateTablet, film coated40 mg~25 mg~6.95 mgCurrentUnavailableManufacturing2/08/2024
    mycophenolate sodiumTablet, enteric coated384.7 mgAnticipatedAvailableManufacturing2/08/2024
    dosulepin (dothiepin) hydrochlorideCapsule, hard25 mgCurrentUnavailableManufacturing2/08/2024
    olmesartan medoxomil~amlodipine besilateTablet, film coated40 mg~13.88 mgCurrentLimited AvailabilityManufacturing2/08/2024
    erythromycin ethyl succinateOral Liquid, powder for468 mgAnticipatedAvailableUnexpected increase in consumer demand2/08/2024
    heparin sodiumInjection, solution10 IU/mLAnticipatedAvailableManufacturing2/08/2024
    sodium lactate~icodextrin~magnesium chloride hexahydrate~calcium chloride dihydrate~sodium chlorideSolution, dialysis4.5 g/L~75 g/L~51 mg/L~257 mg/L~5.4 g/LCurrentLimited AvailabilityManufacturing2/08/2024
    medroxyprogesterone acetateInjection, suspension150 mg/mLDiscontinuedUnavailableCommercial Changes / Commercial viability1/08/2024
    gliclazideTablet, modified release30 mgCurrentUnavailableManufacturing1/08/2024
    levetiracetamTablet, film coated250 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues1/08/2024
    enalapril maleateTablet10 mgCurrentUnavailableManufacturing1/08/2024
    duloxetine hydrochlorideCapsule, enteric33.65 mgCurrentUnavailableManufacturing1/08/2024
    tadalafilTablet, film coated20 mgCurrentLimited AvailabilityManufacturing1/08/2024
    rizatriptan benzoateTablet, orally disintegrating14.53 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues1/08/2024
    tranexamic acidInjection, solution1000 mgAnticipatedAvailableCommercial Changes / Commercial viability1/08/2024
    chromium(51Cr) edetateInjection, solution8 MBq/mLCurrentUnavailableManufacturing1/08/2024
    desvenlafaxine benzoateTablet, modified release73.16 mgResolvedAvailableManufacturing1/08/2024
    cefepime hydrochloride monohydrateInjection, powder for2378.5 mgCurrentLimited AvailabilityManufacturing1/08/2024
    ribavirinTablet, film coated200 mgDiscontinuedReduction in supply until supply is exhaustedManufacturing1/08/2024
    ezetimibeTablet, uncoated10 mgCurrentUnavailableUnexpected increase in demand due to other sponsors unable to supply1/08/2024
    imatinib mesilateCapsule, hard119.47 mgAnticipatedAvailableManufacturing1/08/2024
    dosulepin (dothiepin) hydrochlorideCapsule, hard25 mgAnticipatedAvailableManufacturing1/08/2024
    gliclazideTablet, modified release30 mgCurrentLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply1/08/2024
    cinacalcet hydrochlorideTablet, film coated66 mgCurrentUnavailableManufacturing1/08/2024
    ezetimibe~atorvastatin calcium trihydrateTablet, film coated10 mg~82.725 mgCurrentUnavailableManufacturing1/08/2024
    modafinilTablet, uncoated100 mgCurrentLimited AvailabilityManufacturing1/08/2024
    lurasidone hydrochlorideTablet, film coated80 mgCurrentUnavailableManufacturing1/08/2024
    lurasidone hydrochlorideTablet, film coated40 mgCurrentUnavailableManufacturing1/08/2024
    ezetimibe~rosuvastatin calciumTablet~Tablet, film coated10 mg~20.8 mgCurrentLimited AvailabilityManufacturing1/08/2024
    larotrectinib sulfateOral Liquid, solution24.6 mg/mLResolvedAvailableManufacturing1/08/2024
    heparin sodiumInjection, solution1000 IU/mLCurrentUnavailableManufacturing1/08/2024
    doxycycline monohydrateTablet, uncoated104.1 mgCurrentLimited AvailabilityManufacturing1/08/2024
    sodium pertechnetate(99mTc)Injection, solution20 GBqCurrentLimited AvailabilityManufacturing1/08/2024
    sodium pertechnetate(99mTc)Injection370 GBqCurrentLimited AvailabilityManufacturing1/08/2024
    baclofenTablet, uncoated10 mgResolvedAvailableManufacturing1/08/2024
    ethosuximideCapsule, soft250 mgCurrentUnavailableManufacturing1/08/2024
    duloxetine hydrochlorideCapsule, enteric67.3 mgAnticipatedAvailableManufacturing31/07/2024
    griseofulvinTablet, uncoated125 mgCurrentUnavailableManufacturing31/07/2024
    olanzapineTablet, uncoated7.5 mgResolvedAvailableManufacturing31/07/2024
    ezetimibe~rosuvastatin calciumTablet~Tablet, film coated10 mg~5.198 mgCurrentLimited AvailabilityManufacturing31/07/2024
    ezetimibe~rosuvastatin calciumTablet~Tablet, film coated10 mg~20.791 mgResolvedAvailableManufacturing31/07/2024
    entecavirTablet, film coated1 mgCurrentUnavailableManufacturing31/07/2024
    oxycodone hydrochlorideCapsule, hard10 mgCurrentUnavailableCommercial Changes / Commercial viability31/07/2024
    rosuvastatin calciumTablet, film coated5.21 mgCurrentLimited AvailabilityManufacturing31/07/2024
    emtricitabine~tenofovir disoproxil maleateTablet, film coated200 mg~300 mgCurrentLimited AvailabilityManufacturing31/07/2024
    mercaptopurine monohydrateTablet50 mgCurrentLimited AvailabilityManufacturing31/07/2024
    ketorolac trometamolInjection, solution30 mg/mLCurrentUnavailableManufacturing31/07/2024
    Avalglucosidase alfaInjection, powder for100 mgResolvedAvailableManufacturing31/07/2024
    lanreotide acetateInjection, solution133.33 mgCurrentLimited AvailabilityTransport / Logistic issues / Storage capacity issues31/07/2024
    ezetimibe~rosuvastatin calciumTablet10 mg~10.4 mgCurrentLimited AvailabilityManufacturing31/07/2024
    rifampicinCapsule, hard150 mgCurrentUnavailableManufacturing31/07/2024
    clarithromycinOral Liquid, powder for50 mg/mLCurrentLimited AvailabilityUnexpected increase in consumer demand31/07/2024
    varenicline tartrate~varenicline tartrateTablet, film coated.85 mg~1.71 mgCurrentUnavailableManufacturing30/07/2024
    varenicline tartrateTablet, film coated1.71 mgCurrentUnavailableManufacturing30/07/2024
    risperidoneTablet, film coated2 mgCurrentUnavailableManufacturing30/07/2024
    albendazoleTablet, chewable400 mgResolvedAvailableCommercial Changes / Commercial viability30/07/2024
    salbutamol sulfateInhalation, conventional3 mgCurrentUnavailableManufacturing29/07/2024
    sodium pertechnetate(99mTc)Injection, solution18.5 GBqCurrentUnavailableManufacturing29/07/2024
    paliperidoneTablet, modified release6 mgResolvedAvailableManufacturing29/07/2024
    SomatropinInjection, powder for12 mg/mLResolvedAvailableUnexpected increase in consumer demand29/07/2024
    donepezil hydrochlorideTablet, film coated5 mgAnticipatedAvailableTransport / Logistic issues / Storage capacity issues29/07/2024
    omeprazoleCapsule20 mgCurrentLimited AvailabilityManufacturing29/07/2024
    drospirenone~ethinylestradiolTablet3 mg~30 microgramResolvedAvailableManufacturing29/07/2024
    trandolaprilCapsule, hard.5 mgCurrentLimited AvailabilityManufacturing29/07/2024
    trandolaprilCapsule, hard1 mgAnticipatedAvailableManufacturing29/07/2024
    OmalizumabInjection, solution150 mgCurrentEmergency Supply OnlyManufacturing29/07/2024
    quetiapine fumarateTablet, film coated345.36 mgAnticipatedAvailableManufacturing29/07/2024
    adefovir dipivoxilTablet10 mgCurrentUnavailableUnexpected increase in consumer demand29/07/2024
    temozolomideCapsule, hard180 mgAnticipatedAvailableManufacturing29/07/2024
    rosuvastatin calciumTablet, film coated41.68 mgCurrentUnavailableCommercial Changes / Commercial viability29/07/2024
    potassium clavulanate~amoxicillin trihydrateTablet, film coated148.875 mg~1006.25 mgCurrentUnavailableManufacturing29/07/2024
    mesalazineTablet, enteric coated800 mgCurrentLimited AvailabilityTransport / Logistic issues / Storage capacity issues29/07/2024
    tadalafilTablet5 mgCurrentUnavailableUnexpected increase in demand due to other sponsors unable to supply29/07/2024
    tadalafilTablet, film coated5 mgCurrentUnavailableManufacturing29/07/2024
    cisplatinInjection, concentrated1 mg/mLCurrentUnavailableUnexpected increase in consumer demand29/07/2024
    cisplatinInjection, concentrated1 mg/mLCurrentUnavailableUnexpected increase in consumer demand29/07/2024
    ezetimibe~atorvastatin calcium trihydrateTablet, film coated10 mg~41.363 mgCurrentUnavailableManufacturing29/07/2024
    atorvastatin calcium trihydrate~ezetimibeTablet, film coated41.363 mg~10 mgCurrentUnavailableManufacturing29/07/2024
    dimethyl fumarateCapsule, enteric240 mgResolvedAvailableTransport / Logistic issues / Storage capacity issues29/07/2024
    nebivolol hydrochlorideTablet5.45 mgCurrentLimited AvailabilityManufacturing29/07/2024
    nebivolol hydrochlorideTablet5.45 mgCurrentUnavailableManufacturing29/07/2024
    mesalazineTablet, enteric coated1.6 gAnticipatedAvailableTransport / Logistic issues / Storage capacity issues29/07/2024
    lacosamideTablet, film coated50 mgCurrentUnavailableManufacturing29/07/2024
    mycophenolate mofetilSuspension200 mg/mLCurrentLimited AvailabilityManufacturing29/07/2024
    sitagliptin hydrochloride monohydrateTablet, film coated109 mgCurrentUnavailableManufacturing29/07/2024
    sitagliptin hydrochloride monohydrateTablet, film coated54.5 mgCurrentUnavailableManufacturing29/07/2024
    sitagliptin hydrochloride monohydrateTablet, film coated27.25 mgCurrentUnavailableManufacturing29/07/2024
    ezetimibe~rosuvastatin calciumTablet~Tablet, film coated10 mg~41.6 mgCurrentUnavailableManufacturing29/07/2024
    norethisterone acetate~estradiolDrug delivery system, transdermal2.7 mg~.62 mgCurrentUnavailableManufacturing29/07/2024
    baclofenTablet10 mgResolvedAvailableManufacturing29/07/2024
  • 2024.07.29
    Active ingredientsDosage formQuantity of active ingredientsShortage statusAvailabilityReasonLast updated
    isosorbide dinitrateTablet, uncoated5 mgAnticipatedAvailableManufacturing26/07/2024
    fluorouracilCream50 mg/gCurrentLimited AvailabilityManufacturing26/07/2024
    gabapentinTablet, film coated800 mgCurrentUnavailableManufacturing26/07/2024
    codeine phosphate hemihydrate~ibuprofenTablet, film coated12.8 mg~200 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues26/07/2024
    donepezil hydrochlorideTablet, film coated10 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues26/07/2024
    levetiracetamTablet, film coated1000 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues26/07/2024
    montelukast sodiumTablet, chewable4.16 mgResolvedAvailableManufacturing26/07/2024
    betamethasone acetate~betamethasone sodium phosphateInjection, suspension3 mg/mL~3.9 mg/mLResolvedAvailableProduct recall26/07/2024
    gallium (67Ga) citrateInjection, solution74 MBq/mLCurrentUnavailableManufacturing26/07/2024
    zolmitriptanTablet, film coated2.5 mgResolvedAvailableTransport / Logistic issues / Storage capacity issues26/07/2024
    escitalopram oxalateTablet, film coated25.47 mgCurrentUnavailableManufacturing26/07/2024
    simvastatinTablet, film coated20 mgAnticipatedAvailableManufacturing26/07/2024
    fluticasone propionateInhalation, pressurised125 microgram/actuationCurrentUnavailableManufacturing26/07/2024
    tenofovir disoproxil fumarate~emtricitabineTablet, film coated300 mg~200 mgCurrentLimited AvailabilityCommercial Changes / Commercial viability26/07/2024
    tadalafilTablet, film coated5 mgResolvedAvailableTransport / Logistic issues / Storage capacity issues26/07/2024
    nebivolol hydrochlorideTablet10.9 mgAnticipatedAvailableManufacturing26/07/2024
    dasatinibTablet, film coated50 mgCurrentUnavailableManufacturing26/07/2024
    dasatinibTablet, film coated70 mgAnticipatedAvailableCommercial Changes / Commercial viability26/07/2024
    atomoxetine hydrochlorideCapsule, hard45.5 mgCurrentLimited AvailabilityManufacturing26/07/2024
    cinacalcet hydrochlorideTablet, film coated99 mgCurrentUnavailableManufacturing26/07/2024
    cinacalcet hydrochlorideTablet, film coated33 mgCurrentLimited AvailabilityManufacturing26/07/2024
    lacosamideTablet, film coated150 mgAnticipatedAvailableManufacturing26/07/2024
    risperidoneTablet, film coated1 mgCurrentUnavailableManufacturing26/07/2024
    ezetimibe~atorvastatin calcium trihydrateTablet, film coated10 mg~82.725 mgCurrentUnavailableManufacturing26/07/2024
    lidocaine hydrochlorideInjection, solution400 mgCurrentUnavailableManufacturing26/07/2024
    estradiolDrug delivery system, transdermal.39 mgCurrentUnavailableManufacturing26/07/2024
    lanreotide acetateInjection, solution100 mgAnticipatedAvailableTransport / Logistic issues / Storage capacity issues26/07/2024
    doxorubicin hydrochlorideInjection, concentrated2 mg/mLCurrentLimited AvailabilityManufacturing26/07/2024
    idarubicin hydrochlorideInjection, solution1 mg/mLResolvedAvailableManufacturing26/07/2024
    duloxetine hydrochlorideCapsule, enteric67.3 mgAnticipatedAvailableManufacturing25/07/2024
    glimepirideTablet, uncoated3 mgResolvedAvailableManufacturing25/07/2024
    anidulafunginInjection, powder for100 mgAnticipatedAvailableManufacturing25/07/2024
    gabapentinTablet, film coated600 mgAnticipatedAvailableManufacturing25/07/2024
    prochlorperazine maleateTablet5 mgCurrentUnavailableManufacturing25/07/2024
    risperidoneTablet, film coated3 mgCurrentUnavailableManufacturing25/07/2024
    risperidoneTablet, film coated1 mgCurrentUnavailableManufacturing25/07/2024
    risperidoneTablet, film coated2 mgCurrentUnavailableManufacturing25/07/2024
    hydrocortisone sodium succinateInjection, powder for334.25 mgCurrentLimited AvailabilityManufacturing25/07/2024
    Choriogonadotropin alfaInjection, solution250 microgramCurrentLimited AvailabilityUnexpected increase in consumer demand25/07/2024
    sildenafil citrateTablet, film coated28.1 mgCurrentUnavailableManufacturing25/07/2024
    duloxetine hydrochlorideCapsule, enteric33.65 mgResolvedAvailableManufacturing25/07/2024
    duloxetine hydrochlorideCapsule, enteric67.3 mgResolvedAvailableManufacturing25/07/2024
    cefepime hydrochloride monohydrateInjection, powder for2378.5 mgAnticipatedAvailableManufacturing25/07/2024
    olmesartan medoxomilTablet40 mgCurrentLimited AvailabilityManufacturing25/07/2024
    ezetimibeTablet, uncoated10 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues25/07/2024
    latanoprostEye Drops, solution.05 mg/mLCurrentUnavailableManufacturing25/07/2024
    lacosamideTablet, film coated100 mgAnticipatedAvailableManufacturing25/07/2024
    risperidoneTablet, film coated3 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues25/07/2024
    risperidoneTablet, film coated4 mgCurrentUnavailableManufacturing25/07/2024
    ezetimibe~atorvastatin calcium trihydrateTablet, film coated10 mg~10.341 mgCurrentLimited AvailabilityManufacturing25/07/2024
    aciclovirInjection, solution25 mg/mLCurrentUnavailableUnexpected increase in demand due to other sponsors unable to supply25/07/2024
    gliclazideTablet, uncoated80 mgAnticipatedAvailableUnexpected increase in consumer demand25/07/2024
    larotrectinib sulfateOral Liquid, solution24.6 mg/mLAnticipatedAvailableManufacturing25/07/2024
    azithromycin dihydrateTablet, film coated628.93 mgAnticipatedAvailableManufacturing25/07/2024
    zoledronic acid monohydrateInjection, solution5.33 mgResolvedAvailableManufacturing24/07/2024
    ondansetron hydrochloride dihydrateInjection, solution5 mgCurrentLimited AvailabilityManufacturing24/07/2024
    ondansetron hydrochloride dihydrateInjection, solution10 mgCurrentUnavailableManufacturing24/07/2024
    hydrocortisone sodium succinateInjection, powder for134 mgCurrentLimited AvailabilityManufacturing24/07/2024
    rizatriptan benzoateTablet, orally disintegrating14.53 mgAnticipatedAvailableTransport / Logistic issues / Storage capacity issues24/07/2024
    bosentan monohydrateTablet, film coated129.08 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues24/07/2024
    cinacalcet hydrochlorideTablet33.064 mgCurrentUnavailableManufacturing24/07/2024
    cinacalcet hydrochlorideTablet66.127 mgCurrentUnavailableManufacturing24/07/2024
    alfentanil hydrochlorideInjection, solution1.09 mgCurrentLimited AvailabilityManufacturing24/07/2024
    estradiolDrug delivery system, transdermal.78 mgCurrentUnavailableManufacturing24/07/2024
    varenicline tartrate~varenicline tartrateTablet, film coated.855 mg~1.71 mgResolvedAvailableManufacturing24/07/2024
    rifampicinCapsule, hard150 mgCurrentUnavailableManufacturing24/07/2024
    fluoxetine hydrochlorideCapsule, hard22.36 mgCurrentLimited AvailabilityManufacturing24/07/2024
    doxycycline monohydrateTablet, uncoated104.1 mgCurrentLimited AvailabilityManufacturing24/07/2024
    tobramycinInhalation, conventional60 mg/mLCurrentUnavailableManufacturing24/07/2024
    zolpidem tartrateTablet, film coated10 mgCurrentLimited AvailabilityManufacturing23/07/2024
    medroxyprogesterone acetateInjection, suspension150 mg/mLDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability23/07/2024
    bupivacaine hydrochloride~adrenaline (epinephrine) acid tartrateInjection, solution2.5 mg/mL~4.5 microgram/mLResolvedAvailableManufacturing23/07/2024
    perindopril erbumineTablet8 mgCurrentUnavailableManufacturing23/07/2024
    sildenafil citrateTablet, film coated28.1 mgCurrentUnavailableManufacturing23/07/2024
    duloxetine hydrochlorideCapsule, enteric33.65 mgCurrentLimited AvailabilityManufacturing23/07/2024
    ezetimibe~atorvastatin calcium trihydrateTablet, multilayer10 mg~10.9 mgAnticipatedAvailableManufacturing23/07/2024
    vecuronium bromideInjection, powder for10 mgResolvedAvailableManufacturing23/07/2024
    oxycodone hydrochlorideCapsule, hard10 mgCurrentUnavailableCommercial Changes / Commercial viability23/07/2024
    melphalan hydrochlorideInjection, powder for55.97 mgResolvedAvailableManufacturing23/07/2024
    tadalafilTablet, film coated5 mgCurrentUnavailableUnexpected increase in demand due to other sponsors unable to supply23/07/2024
    lurasidone hydrochlorideTablet, film coated80 mgCurrentUnavailableManufacturing23/07/2024
    lurasidone hydrochlorideTablet, film coated40 mgCurrentUnavailableManufacturing23/07/2024
    posaconazoleTablet, modified release100 mgResolvedAvailableManufacturing23/07/2024
    levothyroxine sodiumTablet, uncoated.1 mgCurrentUnavailableManufacturing23/07/2024
    medroxyprogesterone acetateInjection, suspension150 mg/mLDiscontinuedUnavailableCommercial Changes / Commercial viability23/07/2024
    minocycline hydrochloride dihydrateTablet, film coated54 mgResolvedAvailableManufacturing23/07/2024
    ezetimibeTablet10 mgCurrentLimited AvailabilityUnexpected increase in consumer demand23/07/2024
    framycetin sulfate~dexamethasone~gramicidinEar Drops5 mg/mL~.5 mg/mL~.05 mg/mLCurrentUnavailableManufacturing22/07/2024
    sodium pyrophosphateInjection, powder for30 mgResolvedAvailableManufacturing22/07/2024
    vecuronium bromideInjection, powder for10 mgResolvedAvailableUnexpected increase in consumer demand22/07/2024
    donepezil hydrochlorideTablet, film coated10 mgCurrentLimited AvailabilityManufacturing22/07/2024
    pramipexole dihydrochloride monohydrateTablet1 mgCurrentUnavailableManufacturing22/07/2024
    pramipexole dihydrochloride monohydrateTablet.25 mgCurrentUnavailableManufacturing22/07/2024
    pramipexole dihydrochloride monohydrateTablet.125 mgCurrentLimited AvailabilityManufacturing22/07/2024
    latanoprost~timolol maleateEye Drops, solution50 microgram/mL~6.83 mg/mLCurrentUnavailableUnexpected increase in consumer demand22/07/2024
    cinacalcet hydrochlorideTablet99.191 mgCurrentUnavailableManufacturing22/07/2024
    tadalafilTablet, film coated20 mgResolvedAvailableUnexpected increase in consumer demand22/07/2024
    tadalafilTablet, film coated20 mgCurrentUnavailableUnexpected increase in consumer demand22/07/2024
    atorvastatin calcium trihydrate~ezetimibeTablet, film coated20.681 mg~10 mgCurrentUnavailableManufacturing22/07/2024
    morphine sulfate pentahydrateCapsule, modified release30 mgDiscontinuedUnavailableCommercial Changes / Commercial viability22/07/2024
  • 2024.07.22
    Active ingredientsDosage formQuantity of active ingredientsShortage statusAvailabilityReasonLast updated
    acetylcholine chlorideSolution, powder for irrigation10 mg/mLCurrentUnavailableManufacturing19/07/2024
    escitalopram oxalateTablet, film coated25.56 mgCurrentLimited AvailabilityManufacturing19/07/2024
    insulinInjection, solution100 IU/mLCurrentLimited AvailabilityManufacturing19/07/2024
    dutasteride~tamsulosin hydrochlorideCapsule, modified release500 microgram~400 microgramCurrentLimited AvailabilityManufacturing19/07/2024
    esomeprazole magnesium dihydrateTablet, enteric coated21.75 mgAnticipatedAvailableManufacturing19/07/2024
    tadalafilTablet, film coated20 mgCurrentLimited AvailabilityManufacturing19/07/2024
    oxycodone hydrochlorideCapsule, hard10 mgCurrentUnavailableCommercial Changes / Commercial viability19/07/2024
    bupivacaine hydrochloride monohydrate~adrenaline (epinephrine) acid tartrateInjection, solution2.64 mg/mL~4.5 microgram/mLAnticipatedAvailableManufacturing19/07/2024
    tamsulosin hydrochloride~dutasterideCapsule, modified release400 microgram~500 microgramCurrentLimited AvailabilityManufacturing19/07/2024
    ketorolac trometamolInjection, solution30 mg/mLAnticipatedAvailableManufacturing19/07/2024
    cefaclor monohydrateOral Liquid, powder for52.45 mg/mLCurrentLimited AvailabilityUnexpected increase in consumer demand19/07/2024
    dexamethasone~framycetin sulfate~gramicidinEar Drops.5 mg/mL~5 mg/mL~.05 mg/mLCurrentUnavailableManufacturing19/07/2024
    mianserin hydrochlorideTablet, film coated20 mgAnticipatedAvailableManufacturing19/07/2024
    pamidronate disodiumInjection, concentrated3 mgCurrentUnavailableManufacturing19/07/2024
    norethisteroneTablet, uncoated350 microgramAnticipatedAvailableManufacturing18/07/2024
    galantamine hydrobromideCapsule, modified release20.512 mgCurrentUnavailableManufacturing18/07/2024
    sodium oxidronateInjection, powder for3.15 mgCurrentUnavailableManufacturing18/07/2024
    hydrocortisone sodium succinateInjection, powder for334.25 mgCurrentLimited AvailabilityManufacturing18/07/2024
    montelukast sodiumTablet, chewable4.16 mgCurrentUnavailableManufacturing18/07/2024
    montelukast sodiumTablet, film coated10.4 mgResolvedAvailableManufacturing18/07/2024
    oseltamivir phosphateOral Liquid, powder for7.88 mg/mLCurrentEmergency Supply OnlyUnexpected increase in consumer demand18/07/2024
    esomeprazole magnesium dihydrateTablet, enteric coated43.5 mgResolvedAvailableTransport / Logistic issues / Storage capacity issues18/07/2024
    tadalafilTablet, film coated5 mgResolvedAvailableManufacturing18/07/2024
    latanoprostEye Drops, solution50 microgram/mLCurrentUnavailableUnexpected increase in consumer demand18/07/2024
    cefepime hydrochloride monohydrateInjection, powder for2378.5 mgAnticipatedAvailableManufacturing18/07/2024
    adrenaline (epinephrine) acid tartrateInjection, solution1.819 mgCurrentUnavailableManufacturing18/07/2024
    olmesartan medoxomil~amlodipine besilateTablet, film coated20 mg~6.935 mgResolvedAvailableManufacturing18/07/2024
    amiodarone hydrochlorideTablet, uncoated100 mgResolvedAvailableManufacturing18/07/2024
    cefaclor monohydrateOral Liquid, powder for26.22 mg/mLCurrentUnavailableManufacturing18/07/2024
    dostarlimabInjection, intravenous infusion500 mg/mLCurrentLimited AvailabilityUnexpected increase in consumer demand18/07/2024
    captoprilTablet, uncoated50 mgCurrentUnavailableManufacturing18/07/2024
    acamprosate calciumTablet, enteric coated333 mgResolvedAvailableManufacturing18/07/2024
    flecainide acetateTablet, uncoated100 mgCurrentLimited AvailabilityManufacturing18/07/2024
    phytomenadioneInjection, solution10 mg/mLCurrentLimited AvailabilityProduct recall18/07/2024
    sodium oxidronateInjection, powder for3.15 mgCurrentUnavailableManufacturing18/07/2024
    pramipexole dihydrochloride monohydrateTablet1 mgCurrentUnavailableManufacturing17/07/2024
    ezetimibe~rosuvastatin calciumTablet~Tablet, film coated10 mg~10.396 mgCurrentUnavailableManufacturing17/07/2024
    fluorouracilInjection, solution50 mg/mLCurrentUnavailableManufacturing17/07/2024
    tadalafilTablet, film coated20 mgCurrentUnavailableUnexpected increase in consumer demand17/07/2024
    evolocumabInjection, solution420 mgDiscontinuedReduction in supply until supply is exhaustedManufacturing17/07/2024
    dobutamine hydrochlorideInjection, solution14.01 mg/mLResolvedAvailableManufacturing17/07/2024
    minocycline hydrochloride dihydrateTablet, film coated54 mgCurrentLimited AvailabilityManufacturing17/07/2024
    icodextrin~sodium chloride~sodium lactate~calcium chloride dihydrate~magnesium chloride hexahydrateSolution, dialysis75 g/L~5.4 g/L~4.5 g/L~257 mg/L~51 mg/LCurrentLimited AvailabilityManufacturing17/07/2024
    methylphenidate hydrochlorideTablet, modified release54 mgResolvedAvailableManufacturing17/07/2024
    sevelamer hydrochlorideTablet, film coated800 mgCurrentUnavailableManufacturing16/07/2024
    olanzapineTablet, uncoated7.5 mgCurrentUnavailableManufacturing16/07/2024
    montelukast sodiumTablet, chewable5.2 mgCurrentUnavailableManufacturing16/07/2024
    montelukast sodiumTablet, chewable4.16 mgResolvedAvailableManufacturing16/07/2024
    ezetimibeTablet10 mgResolvedAvailableUnexpected increase in consumer demand16/07/2024
    pemetrexed disodiumInjection, powder for551.4 mgCurrentUnavailableManufacturing16/07/2024
    fluticasone propionateInhalation, pressurised125 microgram/actuationResolvedAvailableUnexpected increase in consumer demand16/07/2024
    timolol maleateEye Drops, solution6.83 mg/mLDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability16/07/2024
    mycophenolate mofetilTablet, film coated500 mgCurrentUnavailableManufacturing16/07/2024
    azithromycin dihydrateTablet, film coated628.93 mgAnticipatedAvailableManufacturing16/07/2024
    griseofulvinTablet, uncoated125 mgAnticipatedAvailableManufacturing15/07/2024
    olmesartan medoxomil~amlodipine besilate~hydrochlorothiazideTablet40 mg~6.944 mg~12.5 mgAnticipatedAvailableManufacturing15/07/2024
    olmesartan medoxomil~hydrochlorothiazide~amlodipine besilateTablet40 mg~25 mg~6.944 mgCurrentLimited AvailabilityManufacturing15/07/2024
    amlodipine besilate~atorvastatin calcium trihydrateTablet, film coated6.94 mg~86.751 mgResolvedAvailableManufacturing15/07/2024
    ezetimibeTablet, uncoated10 mgCurrentUnavailableUnexpected increase in demand due to other sponsors unable to supply15/07/2024
    pregabalinCapsule, hard75 mgResolvedAvailableTransport / Logistic issues / Storage capacity issues15/07/2024
    Rabies virusInjection, powder for2.5 IUCurrentEmergency Supply OnlyManufacturing15/07/2024
    norethisterone acetate~estradiol~estradiolDrug delivery system, transdermal4.8 mg~.512 mg~.78 mgResolvedAvailableManufacturing15/07/2024
    estradiolDrug delivery system, transdermal1.17 mgCurrentUnavailableManufacturing15/07/2024
    atovaquone~proguanil hydrochlorideTablet, film coated62.5 mg~25 mgCurrentUnavailableManufacturing15/07/2024
    lanreotide acetateInjection, solution133.33 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues15/07/2024
    cefalexin monohydrateOral Liquid, powder for26.3 mg/mLResolvedAvailableManufacturing15/07/2024
    pravastatin sodiumTablet, uncoated40 mgCurrentLimited AvailabilityManufacturing15/07/2024
  • 2024.07.16
    Active ingredientsDosage formQuantity of active ingredientsShortage statusAvailabilityReasonLast updated
    galantamine hydrobromideCapsule, modified release20.512 mgCurrentUnavailableManufacturing12/07/2024
    haloperidolInjection, solution5 mg/mLResolvedAvailableManufacturing12/07/2024
    pregabalinCapsule, hard75 mgResolvedAvailableCommercial Changes / Commercial viability12/07/2024
    pregabalinCapsule, hard300 mgResolvedAvailableManufacturing12/07/2024
    emtricitabine~tenofovir disoproxil maleateTablet, film coated200 mg~300 mgCurrentLimited AvailabilityManufacturing12/07/2024
    cinacalcet hydrochlorideTablet, film coated66 mgCurrentUnavailableManufacturing12/07/2024
    cinacalcet hydrochlorideTablet, film coated99 mgCurrentUnavailableManufacturing12/07/2024
    ezetimibe~simvastatinTablet10 mg~20 mgCurrentUnavailableManufacturing12/07/2024
    olmesartan medoxomil~amlodipine besilateTablet, film coated20 mg~6.935 mgCurrentUnavailableManufacturing12/07/2024
    mercaptopurine monohydrateTablet50 mgCurrentLimited AvailabilityManufacturing12/07/2024
    gliclazideTablet, modified release30 mgResolvedAvailableManufacturing12/07/2024
    AdalimumabInjection, solution40 mgDiscontinuedUnavailableCommercial Changes / Commercial viability12/07/2024
    AdalimumabInjection, solution40 mgDiscontinuedUnavailableCommercial Changes / Commercial viability12/07/2024
    carbidopa monohydrate~levodopaTablet, modified release54 mg~200 mgResolvedAvailableManufacturing12/07/2024
    adrenaline (epinephrine)Injection, solution300 microgramDiscontinuedReduction in supply until supply is exhaustedManufacturing12/07/2024
    adrenaline (epinephrine)Injection, solution150 microgramDiscontinuedReduction in supply until supply is exhaustedManufacturing12/07/2024
    lacosamideTablet, film coated50 mgCurrentUnavailableManufacturing12/07/2024
    lacosamideTablet, film coated100 mgResolvedAvailableManufacturing12/07/2024
    prucalopride succinateTablet2.642 mgCurrentUnavailableManufacturing12/07/2024
    sitagliptin hydrochloride monohydrateTablet, film coated27.25 mgCurrentUnavailableManufacturing12/07/2024
    ezetimibe~rosuvastatin calciumTablet10 mg~10.4 mgResolvedAvailableManufacturing12/07/2024
    ezetimibe~rosuvastatin calciumTablet~Tablet, film coated10 mg~20.8 mgResolvedAvailableManufacturing12/07/2024
    octreotideInjection, solution50 microgram/mLCurrentLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply12/07/2024
    octreotideInjection, solution100 microgram/mLCurrentLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply12/07/2024
    captoprilTablet, uncoated25 mgCurrentUnavailableManufacturing12/07/2024
    idarubicin hydrochlorideInjection, solution1 mg/mLCurrentLimited AvailabilityManufacturing12/07/2024
    tobramycinInhalation, conventional60 mg/mLCurrentUnavailableManufacturing12/07/2024
    carbamazepineTablet, uncoated200 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability12/07/2024
    carbamazepineTablet, uncoated100 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability12/07/2024
    methylphenidate hydrochlorideTablet, modified release54 mgCurrentLimited AvailabilityManufacturing12/07/2024
    hydroxocobalamin chlorideInjection, solution1.027 mgResolvedAvailableTransport / Logistic issues / Storage capacity issues11/07/2024
    varenicline tartrate~varenicline tartrateTablet, film coated.85 mg~1.71 mgCurrentUnavailableManufacturing11/07/2024
    varenicline tartrateTablet, film coated1.71 mgCurrentUnavailableManufacturing11/07/2024
    ondansetron hydrochloride dihydrateTablet, film coated5 mgCurrentLimited AvailabilityTransport / Logistic issues / Storage capacity issues11/07/2024
    vecuronium bromideInjection, powder for10 mgCurrentLimited AvailabilityUnexpected increase in consumer demand11/07/2024
    carmustineInjection, powder for100 mgCurrentUnavailableManufacturing11/07/2024
    paclitaxelInjection, concentrated300 mgCurrentLimited AvailabilityManufacturing11/07/2024
    modafinilTablet, uncoated100 mgCurrentLimited AvailabilityManufacturing11/07/2024
    montelukast sodiumTablet, chewable5.2 mgCurrentEmergency Supply OnlyManufacturing11/07/2024
    montelukast sodiumTablet, chewable4.16 mgCurrentLimited AvailabilityManufacturing11/07/2024
    estradiolDrug delivery system, transdermal.39 mgCurrentLimited AvailabilityManufacturing11/07/2024
    methotrexateTablet10 mgAnticipatedAvailableManufacturing11/07/2024
    doxorubicin hydrochlorideInjection, concentrated2 mg/mLCurrentUnavailableManufacturing11/07/2024
    potassium clavulanate~amoxicillin trihydrateSuspension, powder for7.45 mg/mL~28.7 mg/mLCurrentLimited AvailabilityManufacturing10/07/2024
    ceftazidime pentahydrateInjection, powder for1.164 gResolvedAvailableManufacturing10/07/2024
    midazolamInjection, solution5 mgResolvedAvailableManufacturing10/07/2024
    diazoxideInjection, solution15 mg/mLResolvedAvailableTransport / Logistic issues / Storage capacity issues10/07/2024
    prochlorperazine maleateTablet5 mgResolvedAvailableCommercial Changes / Commercial viability10/07/2024
    propranolol hydrochlorideTablet, film coated40 mgResolvedAvailableManufacturing10/07/2024
    oxytocinInjection, solution10 IU/mLCurrentUnavailableTransport / Logistic issues / Storage capacity issues10/07/2024
    betahistine dihydrochlorideTablet, uncoated16 mgCurrentUnavailableManufacturing10/07/2024
    tadalafilTablet, film coated5 mgCurrentLimited AvailabilityManufacturing10/07/2024
    tadalafilTablet, film coated20 mgCurrentLimited AvailabilityManufacturing10/07/2024
    betahistine dihydrochlorideTablet, uncoated16 mgCurrentUnavailableManufacturing10/07/2024
    acarboseTablet100 mgCurrentLimited AvailabilityManufacturing10/07/2024
    desvenlafaxine benzoateTablet, modified release73.16 mgCurrentUnavailableManufacturing10/07/2024
    tadalafilTablet, film coated20 mgCurrentUnavailableUnexpected increase in consumer demand10/07/2024
    atorvastatin calcium trihydrate~ezetimibeTablet, film coated41.363 mg~10 mgCurrentUnavailableManufacturing10/07/2024
    nebivolol hydrochlorideTablet5.45 mgCurrentUnavailableManufacturing10/07/2024
    estradiolDrug delivery system, transdermal1.56 mgCurrentLimited AvailabilityManufacturing10/07/2024
    rosuvastatin calciumTablet, film coated5.21 mgCurrentUnavailableManufacturing10/07/2024
    chloramphenicolEye Drops, solution5 mg/mLCurrentUnavailableManufacturing10/07/2024
    paracetamolTablet, modified release665 mgCurrentLimited AvailabilityTransport / Logistic issues / Storage capacity issues10/07/2024
    naproxenTablet, uncoated250 mgResolvedAvailableManufacturing10/07/2024
    medroxyprogesterone acetateInjection, suspension150 mg/mLDiscontinuedUnavailableCommercial Changes / Commercial viability10/07/2024
    doxorubicin hydrochlorideInjection, concentrated2 mg/mLCurrentLimited AvailabilityManufacturing10/07/2024
    norethisterone acetate~estradiolDrug delivery system, transdermal2.7 mg~.62 mgCurrentUnavailableManufacturing10/07/2024
    calcium folinateInjection324.1 mgAnticipatedAvailableManufacturing9/07/2024
    pentetic acidInjection, powder for5 mgResolvedAvailableManufacturing9/07/2024
    olanzapineTablet, film coated7.5 mgResolvedAvailableManufacturing9/07/2024
    methotrexateInjection, solution2.5 mg/mLResolvedAvailableManufacturing9/07/2024
    metoprolol succinateTablet, modified release190 mgAnticipatedAvailableManufacturing9/07/2024
    metoprolol succinateTablet, modified release95 mgAnticipatedAvailableManufacturing9/07/2024
    pramipexole dihydrochloride monohydrateTablet1 mgCurrentUnavailableManufacturing9/07/2024
    pramipexole dihydrochloride monohydrateTablet.25 mgCurrentUnavailableManufacturing9/07/2024
    dexamethasone sodium phosphateInjection, solution4.37 mg/mLCurrentLimited AvailabilityManufacturing9/07/2024
    drospirenone~ethinylestradiolTablet3 mg~30 microgramAnticipatedAvailableManufacturing9/07/2024
    rabeprazole sodiumTablet, enteric coated20 mgResolvedAvailableTransport / Logistic issues / Storage capacity issues9/07/2024
    zolmitriptanTablet, film coated2.5 mgAnticipatedAvailableTransport / Logistic issues / Storage capacity issues9/07/2024
    OmalizumabInjection, solution150 mgCurrentUnavailableManufacturing9/07/2024
    ezetimibe~rosuvastatin calciumTablet~Tablet, film coated10 mg~5.198 mgCurrentUnavailableManufacturing9/07/2024
    quetiapine fumarateTablet, film coated28.78 mgResolvedAvailableManufacturing9/07/2024
    rizatriptan benzoateTablet, orally disintegrating14.53 mgAnticipatedAvailableTransport / Logistic issues / Storage capacity issues9/07/2024
    rizatriptan benzoateTablet, orally disintegrating14.53 mgCurrentUnavailableManufacturing9/07/2024
    aciclovir sodium dihydrateInjection, powder for628.8 mgResolvedAvailableUnexpected increase in demand due to other sponsors unable to supply9/07/2024
    aciclovir sodium dihydrateInjection, powder for314.4 mgResolvedAvailableUnexpected increase in consumer demand9/07/2024
    metformin hydrochlorideTablet, film coated500 mgAnticipatedAvailableManufacturing9/07/2024
    gliclazideTablet, modified release30 mgCurrentLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply9/07/2024
    estradiol~estradiol~norethisterone acetateDrug delivery system, transdermal.62 mg~.78 mg~2.7 mgResolvedAvailableManufacturing9/07/2024
    Avalglucosidase alfaInjection, powder for100 mgAnticipatedAvailableManufacturing9/07/2024
    clindamycin phosphateInjection, solution0 QSResolvedAvailableManufacturing9/07/2024
    doxycycline monohydrateTablet, uncoated104.1 mgCurrentLimited AvailabilityManufacturing9/07/2024
    disulfiramTablet, effervescent200 mgResolvedAvailableManufacturing9/07/2024
    baclofenTablet10 mgAnticipatedAvailableManufacturing9/07/2024
    metformin hydrochlorideTablet, film coated500 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues9/07/2024
    metformin hydrochlorideTablet, film coated1000 mgCurrentUnavailableManufacturing9/07/2024
    ganciclovir sodiumInjection, powder for543 mgResolvedAvailableManufacturing8/07/2024
    prazosin hydrochlorideTablet, uncoated5.476 mgCurrentUnavailableUnexpected increase in consumer demand8/07/2024
    methotrexateInjection, solution50 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability8/07/2024
    human menopausal gonadotrophinInjection, powder for600 IUCurrentLimited AvailabilityManufacturing8/07/2024
    human menopausal gonadotrophinInjection, powder for1200 IUCurrentLimited AvailabilityManufacturing8/07/2024
    ropivacaine hydrochlorideInjection, solution7.5 mg/mLResolvedAvailableManufacturing8/07/2024
    rosuvastatin calcium~ezetimibeTablet~Tablet, film coated5.198 mg~10 mgCurrentUnavailableManufacturing8/07/2024
    duloxetine hydrochlorideCapsule, enteric67.32 mgResolvedAvailableUnexpected increase in consumer demand8/07/2024
    dobutamine hydrochlorideInjection, solution14.01 mg/mLCurrentUnavailableManufacturing8/07/2024
    raltitrexedInjection, powder for2 mgCurrentLimited AvailabilityUnexpected increase in consumer demand8/07/2024
    meropenemInjection, powder for1 gDiscontinuedUnavailableCommercial Changes / Commercial viability8/07/2024
    meropenemInjection, powder for500 mgDiscontinuedUnavailableCommercial Changes / Commercial viability8/07/2024
    aciclovirInjection, solution25 mg/mLResolvedAvailableManufacturing8/07/2024
  • 2024.07.08
    Active ingredientsDosage formQuantity of active ingredientsShortage statusReasonLast updated
    chlorhexidine gluconateSolution, irrigation30 mgCurrentManufacturing5/07/2024
    escitalopram oxalateTablet, film coated25.56 mgAnticipatedManufacturing5/07/2024
    anidulafunginInjection, powder for100 mgAnticipatedManufacturing5/07/2024
    fluorouracilCream50 mg/gAnticipatedManufacturing5/07/2024
    olanzapineTablet, film coated7.5 mgCurrentManufacturing5/07/2024
    enalapril maleateTablet10 mgAnticipatedManufacturing5/07/2024
    morphine sulfate pentahydrateTablet, film coated20 mgDiscontinuedCommercial Changes / Commercial viability5/07/2024
    ezetimibeTablet, uncoated10 mgAnticipatedManufacturing5/07/2024
    ezetimibeTablet, uncoated10 mgAnticipatedTransport / Logistic issues / Storage capacity issues5/07/2024
    cinacalcet hydrochlorideTablet33.064 mgCurrentManufacturing5/07/2024
    cinacalcet hydrochlorideTablet66.127 mgCurrentManufacturing5/07/2024
    cinacalcet hydrochlorideTablet99.191 mgCurrentManufacturing5/07/2024
    latanoprostEye Drops, solution.05 mg/mLCurrentManufacturing5/07/2024
    bupivacaine hydrochloride monohydrate~adrenaline (epinephrine) acid tartrateInjection, solution2.64 mg/mL~4.5 microgram/mLAnticipatedManufacturing5/07/2024
    lacosamideTablet, film coated150 mgAnticipatedManufacturing5/07/2024
    lacosamideTablet, film coated50 mgCurrentManufacturing5/07/2024
    lacosamideTablet, film coated150 mgCurrentTransport / Logistic issues / Storage capacity issues5/07/2024
    sitagliptin hydrochloride monohydrateTablet, film coated28.343 mgDiscontinuedManufacturing5/07/2024
    sitagliptin hydrochloride monohydrateTablet, film coated56.686 mgDiscontinuedManufacturing5/07/2024
    sitagliptin hydrochloride monohydrateTablet, film coated113.373 mgDiscontinuedManufacturing5/07/2024
    olmesartan medoxomil~amlodipine besilate~hydrochlorothiazideTablet, film coated40 mg~6.95 mg~25 mgCurrentManufacturing5/07/2024
    hydrochlorothiazide~amlodipine besilate~olmesartan medoxomilTablet, film coated12.5 mg~6.95 mg~40 mgCurrentManufacturing5/07/2024
    mesalazineTablet, enteric coated1.6 gAnticipatedTransport / Logistic issues / Storage capacity issues5/07/2024
    estradiol~norethisterone acetate~estradiolDrug delivery system, transdermal.78 mg~2.7 mg~.62 mgCurrentManufacturing5/07/2024
    dostarlimabInjection, intravenous infusion500 mg/mLAnticipatedUnexpected increase in consumer demand5/07/2024
    lacosamideTablet, film coated50 mgCurrentManufacturing5/07/2024
    tirzepatideInjection, solution15 mgCurrentUnexpected increase in consumer demand5/07/2024
    dabigatran etexilate mesilateCapsule86.475 mgAnticipatedManufacturing5/07/2024
    mianserin hydrochlorideTablet, film coated20 mgAnticipatedManufacturing5/07/2024
    doxycycline monohydrateTablet, uncoated104.1 mgCurrentManufacturing5/07/2024
    idarubicin hydrochlorideInjection, solution1 mg/mLResolvedManufacturing5/07/2024
    diltiazem hydrochlorideTablet, film coated60 mgResolvedManufacturing5/07/2024
    morphine sulfate pentahydrateTablet, modified release10 mgCurrentManufacturing4/07/2024
    morphine sulfate pentahydrateTablet, modified release30 mgCurrentManufacturing4/07/2024
    morphine sulfate pentahydrateTablet, modified release60 mgCurrentManufacturing4/07/2024
    morphine sulfate pentahydrateTablet, modified release100 mgCurrentManufacturing4/07/2024
    prochlorperazine maleateTablet5 mgAnticipatedManufacturing4/07/2024
    donepezil hydrochlorideTablet, film coated10 mgCurrentTransport / Logistic issues / Storage capacity issues4/07/2024
    hydrocortisone sodium succinateInjection, powder for134 mgCurrentManufacturing4/07/2024
    mycophenolate mofetilInjection, powder for500 mgCurrentManufacturing4/07/2024
    Insulin lisproInjection, solution100 IU/mLResolvedManufacturing4/07/2024
    clarithromycinOral Liquid, powder for50 mg/mLCurrentUnexpected increase in consumer demand4/07/2024
    acamprosate calciumTablet, enteric coated333 mgAnticipatedManufacturing4/07/2024
    antimony trisulfideInjection, solution1.1 mg/mLCurrentCommercial Changes / Commercial viability4/07/2024
    enalapril maleateTablet, uncoated5 mgCurrentManufacturing4/07/2024
    fluticasone propionateInhalation, pressurised50 microgram/actuationResolvedUnexpected increase in consumer demand4/07/2024
    zoledronic acidInjection, concentrated4 mgCurrentCommercial Changes / Commercial viability4/07/2024
    methylphenidate hydrochlorideTablet, modified release18 mgResolvedManufacturing4/07/2024
    clarithromycinTablet, film coated250 mgResolvedUnexpected increase in consumer demand4/07/2024
    atropine sulfate monohydrateInjection, solution1.2 mg/mLCurrentManufacturing3/07/2024
    amlodipine besilateTablet, uncoated6.94 mgCurrentManufacturing3/07/2024
    amlodipine besilateTablet, uncoated6.9335 mgResolvedManufacturing3/07/2024
    sodium pyrophosphateInjection, powder for30 mgCurrentManufacturing3/07/2024
    galantamine hydrobromideCapsule, modified release20.512 mgCurrentManufacturing3/07/2024
    codeine phosphate hemihydrate~ibuprofenTablet, film coated12.8 mg~200 mgAnticipatedTransport / Logistic issues / Storage capacity issues3/07/2024
    remifentanil hydrochlorideInjection, powder for1.097 mgResolvedManufacturing3/07/2024
    donepezil hydrochlorideTablet, film coated5 mgAnticipatedTransport / Logistic issues / Storage capacity issues3/07/2024
    levetiracetamTablet, film coated1000 mgCurrentTransport / Logistic issues / Storage capacity issues3/07/2024
    propranolol hydrochlorideTablet, film coated40 mgCurrentManufacturing3/07/2024
    ropivacaine hydrochlorideInjection, solution7.5 mg/mLCurrentManufacturing3/07/2024
    amlodipine besilate~atorvastatin calcium trihydrateTablet, film coated6.94 mg~86.751 mgCurrentManufacturing3/07/2024
    duloxetine hydrochlorideCapsule, enteric67.3 mgCurrentManufacturing3/07/2024
    duloxetine hydrochlorideCapsule, enteric33.65 mgCurrentManufacturing3/07/2024
    quetiapine fumarateTablet, film coated345.36 mgAnticipatedManufacturing3/07/2024
    ziprasidone hydrochlorideCapsule, hard65.16 mgCurrentTransport / Logistic issues / Storage capacity issues3/07/2024
    fluticasone propionateInhalation, pressurised125 microgram/actuationCurrentUnexpected increase in consumer demand3/07/2024
    tadalafilTablet, film coated5 mgCurrentTransport / Logistic issues / Storage capacity issues3/07/2024
    tadalafilTablet, film coated20 mgCurrentUnexpected increase in consumer demand3/07/2024
    atomoxetine hydrochlorideCapsule, hard45.5 mgAnticipatedTransport / Logistic issues / Storage capacity issues3/07/2024
    latanoprostEye Drops, solution.05 mg/mLCurrentTransport / Logistic issues / Storage capacity issues3/07/2024
    codeine phosphate hemihydrate~doxylamine succinate~paracetamolTablet, uncoated30 mg~5 mg~450 mgCurrentManufacturing3/07/2024
    cefaclor monohydrateOral Liquid, powder for26.22 mg/mLCurrentManufacturing3/07/2024
    fluorouracilInjection, solution50 mg/mLCurrentManufacturing3/07/2024
    captoprilTablet, uncoated25 mgCurrentManufacturing3/07/2024
    captoprilTablet, uncoated50 mgCurrentManufacturing3/07/2024
    risperidoneTablet.5 mgCurrentManufacturing2/07/2024
    risperidoneTablet1 mgCurrentManufacturing2/07/2024
    levetiracetamTablet, film coated500 mgAnticipatedTransport / Logistic issues / Storage capacity issues2/07/2024
    montelukast sodiumTablet, chewable4.16 mgResolvedManufacturing2/07/2024
    betamethasone acetate~betamethasone sodium phosphateInjection, suspension3 mg/mL~3.9 mg/mLCurrentProduct recall2/07/2024
    ezetimibe~rosuvastatin calciumTablet~Tablet, film coated10 mg~20.791 mgCurrentManufacturing2/07/2024
    ezetimibe~rosuvastatin calciumTablet~Tablet, film coated10 mg~10.396 mgCurrentManufacturing2/07/2024
    ezetimibe~atorvastatin calcium trihydrateTablet, multilayer10 mg~43.4 mgCurrentManufacturing2/07/2024
    desvenlafaxine benzoateTablet, modified release73.16 mgAnticipatedManufacturing2/07/2024
    atorvastatin calcium trihydrateTablet, film coated43.38 mgResolvedTransport / Logistic issues / Storage capacity issues2/07/2024
    simvastatin~ezetimibeTablet20 mg~10 mgAnticipatedManufacturing2/07/2024
    lurasidone hydrochlorideTablet, film coated80 mgCurrentManufacturing2/07/2024
    lurasidone hydrochlorideTablet, film coated40 mgCurrentManufacturing2/07/2024
    isotretinoinCapsule, soft10 mgResolvedManufacturing2/07/2024
    evolocumabInjection, solution420 mgDiscontinuedManufacturing2/07/2024
    sitagliptin fumarateTablet, film coated64.249 mgCurrentUnexpected increase in demand due to other sponsors unable to supply2/07/2024
    sitagliptin fumarateTablet, film coated128.497 mgCurrentUnexpected increase in demand due to other sponsors unable to supply2/07/2024
    proguanil hydrochloride~atovaquoneTablet, film coated25 mg~62.5 mgCurrentManufacturing2/07/2024
    sitagliptin hydrochloride monohydrateTablet, film coated27.25 mgAnticipatedManufacturing2/07/2024
    sugammadex sodiumInjection217.6 mgResolvedManufacturing2/07/2024
    adrenaline (epinephrine) acid tartrate~bupivacaine hydrochlorideInjection, solution9.1 microgram/mL~5 mg/mLResolvedManufacturing2/07/2024
    sodium chlorideInjection, solution90 mgCurrentManufacturing2/07/2024
    pamidronate disodiumInjection, concentrated3 mgResolvedManufacturing2/07/2024
    fluoxetine hydrochlorideCapsule, hard22.36 mgResolvedManufacturing1/07/2024
    olanzapineTablet, uncoated7.5 mgCurrentManufacturing1/07/2024
    ropivacaine hydrochlorideInjection, solution2 mg/mLResolvedUnexpected increase in demand due to other sponsors unable to supply1/07/2024
    duloxetine hydrochlorideCapsule, enteric67.3 mgCurrentUnexpected increase in demand due to other sponsors unable to supply1/07/2024
    paracetamolInjection, solution10 mg/mLResolvedUnexpected increase in consumer demand1/07/2024
    rizatriptan benzoateTablet, orally disintegrating14.53 mgAnticipatedTransport / Logistic issues / Storage capacity issues1/07/2024
    bosentan monohydrateTablet, film coated64.541 mgCurrentManufacturing1/07/2024
    adrenaline (epinephrine) acid tartrateInjection, solution1.819 mgAnticipatedManufacturing1/07/2024
    niraparib tosilate monohydrateCapsule, hard159.4 mgDiscontinuedCommercial Changes / Commercial viability1/07/2024
    Avalglucosidase alfaInjection, powder for100 mgAnticipatedManufacturing1/07/2024
    sugammadex sodiumInjection, solution217.6 mgResolvedManufacturing1/07/2024
    varenicline tartrate~varenicline tartrateTablet, film coated.855 mg~1.71 mgCurrentManufacturing1/07/2024
    fluoxetine hydrochlorideTablet, dispersible22.36 mgResolvedManufacturing1/07/2024
  • 2024.07.02
    Active ingredientsDosage formQuantity of active ingredientsShortage statusAvailabilityReasonLast updated
    cefepime hydrochloride monohydrateInjection, powder for2378.5 mgAnticipatedAvailableManufacturing30/06/2024
    dostarlimabInjection, intravenous infusion500 mg/mLAnticipatedAvailableUnexpected increase in consumer demand30/06/2024
    atropine sulfate monohydrateInjection, solution1.2 mg/mLAnticipatedAvailableManufacturing28/06/2024
    metformin hydrochlorideTablet, modified release500 mgCurrentUnavailableManufacturing28/06/2024
    paliperidoneTablet, modified release6 mgCurrentLimited AvailabilityManufacturing28/06/2024
    pentetic acidInjection, powder for5 mgCurrentUnavailableManufacturing28/06/2024
    midazolamInjection, solution5 mgCurrentLimited AvailabilityManufacturing28/06/2024
    Choriogonadotropin alfaInjection, solution250 microgramCurrentLimited AvailabilityUnexpected increase in consumer demand28/06/2024
    perindopril erbumineTablet8 mgCurrentLimited AvailabilityManufacturing28/06/2024
    rabeprazole sodiumTablet, enteric coated20 mgCurrentLimited AvailabilityTransport / Logistic issues / Storage capacity issues28/06/2024
    azithromycinInjection, powder for500 mgCurrentUnavailableCommercial Changes / Commercial viability28/06/2024
    atorvastatin calcium trihydrate~amlodipine besilateTablet, film coated86.751 mg~6.94 mgCurrentUnavailableManufacturing28/06/2024
    esomeprazole magnesium dihydrateTablet, enteric coated43.5 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues28/06/2024
    tadalafilTablet, film coated5 mgCurrentLimited AvailabilityManufacturing28/06/2024
    duloxetine hydrochlorideCapsule, enteric33.65 mgCurrentLimited AvailabilityManufacturing28/06/2024
    duloxetine hydrochlorideCapsule, enteric67.3 mgCurrentUnavailableManufacturing28/06/2024
    tadalafilTablet5 mgCurrentUnavailableUnexpected increase in demand due to other sponsors unable to supply28/06/2024
    tadalafilTablet, film coated5 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues28/06/2024
    tadalafilTablet, film coated5 mgCurrentUnavailableManufacturing28/06/2024
    tadalafilTablet, film coated5 mgCurrentLimited AvailabilityManufacturing28/06/2024
    tadalafilTablet, film coated5 mgCurrentUnavailableManufacturing28/06/2024
    tadalafilTablet, film coated5 mgCurrentUnavailableUnexpected increase in demand due to other sponsors unable to supply28/06/2024
    olmesartan medoxomil~amlodipine besilateTablet, film coated40 mg~6.935 mgResolvedAvailableTransport / Logistic issues / Storage capacity issues28/06/2024
    midodrine hydrochlorideTablet5 mgResolvedAvailableManufacturing28/06/2024
    lurasidone hydrochlorideTablet, film coated40 mgCurrentUnavailableManufacturing28/06/2024
    dasatinib propylene glycolTablet, film coated58 mgCurrentUnavailableManufacturing28/06/2024
    dasatinib propylene glycolTablet, film coated81.2 mgCurrentLimited AvailabilityManufacturing28/06/2024
    dasatinib propylene glycolTablet, film coated23.2 mgCurrentUnavailableManufacturing28/06/2024
    methylphenidate hydrochlorideTablet, modified release36 mgDiscontinuedReduction in supply until supply is exhaustedManufacturing28/06/2024
    isoprenaline hydrochlorideInjection, solution1 mgCurrentUnavailableManufacturing28/06/2024
    rosuvastatin calcium~ezetimibeTablet10.4 mg~10 mgCurrentUnavailableManufacturing28/06/2024
    ezetimibe~rosuvastatin calciumTablet~Tablet, film coated10 mg~20.8 mgCurrentUnavailableManufacturing28/06/2024
    pravastatin sodiumTablet, uncoated40 mgCurrentLimited AvailabilityManufacturing28/06/2024
    trihexyphenidyl (benzhexol) hydrochlorideTablet, uncoated5 mgAnticipatedAvailableManufacturing27/06/2024
    donepezil hydrochlorideTablet, film coated10 mgCurrentLimited AvailabilityManufacturing27/06/2024
    propranolol hydrochlorideTablet, film coated40 mgCurrentLimited AvailabilityManufacturing27/06/2024
    clonidine hydrochlorideTablet, uncoated100 microgramResolvedAvailableManufacturing27/06/2024
    doxylamine succinate~paracetamol~codeine phosphate hemihydrateTablet, uncoated5.1 mg~500 mg~10 mgCurrentUnavailableManufacturing27/06/2024
    simvastatinTablet, film coated40 mgAnticipatedAvailableManufacturing27/06/2024
    rosuvastatin calciumTablet, film coated41.68 mgCurrentUnavailableCommercial Changes / Commercial viability27/06/2024
    fluticasone propionateInhalation, pressurised125 microgram/actuationAnticipatedAvailableUnexpected increase in consumer demand27/06/2024
    tobramycinInhalation, conventional60 mg/mLDiscontinuedUnavailableCommercial Changes / Commercial viability27/06/2024
    gliclazideTablet, modified release30 mgCurrentUnavailableManufacturing27/06/2024
    posaconazoleTablet, modified release100 mgCurrentLimited AvailabilityManufacturing27/06/2024
    lanreotide acetateInjection, solution133.33 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues27/06/2024
    sitagliptin hydrochloride monohydrateTablet, film coated109 mgCurrentUnavailableManufacturing27/06/2024
    sitagliptin hydrochloride monohydrateTablet, film coated54.5 mgCurrentUnavailableManufacturing27/06/2024
    levothyroxine sodiumTablet, uncoated.1 mgAnticipatedAvailableManufacturing27/06/2024
    rifampicinCapsule, hard150 mgCurrentUnavailableManufacturing27/06/2024
    fluticasone propionateInhalation, pressurised50 microgram/actuationAnticipatedAvailableUnexpected increase in consumer demand27/06/2024
    metformin hydrochlorideTablet, film coated1000 mgAnticipatedAvailableManufacturing27/06/2024
    prazosin hydrochlorideTablet, uncoated5.476 mgAnticipatedAvailableUnexpected increase in consumer demand26/06/2024
    duloxetine hydrochlorideCapsule, enteric67.3 mgAnticipatedAvailableManufacturing26/06/2024
    varenicline tartrate~varenicline tartrateTablet, film coated.85 mg~1.71 mgDiscontinuedUnavailableManufacturing26/06/2024
    varenicline tartrateTablet, film coated1.71 mgDiscontinuedUnavailableManufacturing26/06/2024
    quetiapine fumarateTablet, film coated115.12 mgAnticipatedAvailableManufacturing26/06/2024
    amlodipine besilateTablet13.87 mgCurrentLimited AvailabilityManufacturing26/06/2024
    acarboseTablet100 mgCurrentLimited AvailabilityManufacturing26/06/2024
    cinacalcet hydrochlorideTablet66.127 mgCurrentUnavailableManufacturing26/06/2024
    cinacalcet hydrochlorideTablet99.191 mgCurrentLimited AvailabilityManufacturing26/06/2024
    cinacalcet hydrochlorideTablet, film coated66 mgCurrentUnavailableManufacturing26/06/2024
    cinacalcet hydrochlorideTablet, film coated99 mgCurrentUnavailableManufacturing26/06/2024
    lacosamideTablet, film coated100 mgAnticipatedAvailableManufacturing26/06/2024
    amlodipine besilate~olmesartan medoxomilTablet, film coated6.935 mg~20 mgCurrentUnavailableManufacturing26/06/2024
    gliclazideTablet, uncoated80 mgAnticipatedAvailableUnexpected increase in consumer demand26/06/2024
    methylphenidate hydrochlorideTablet, modified release27 mgDiscontinuedReduction in supply until supply is exhaustedManufacturing26/06/2024
    methylphenidate hydrochlorideTablet, modified release18 mgDiscontinuedReduction in supply until supply is exhaustedManufacturing26/06/2024
    methylphenidate hydrochlorideTablet, modified release54 mgDiscontinuedReduction in supply until supply is exhaustedManufacturing26/06/2024
    mycophenolate mofetilSuspension200 mg/mLCurrentLimited AvailabilityManufacturing26/06/2024
    cisplatinInjection, solution1 mg/mLCurrentLimited AvailabilityUnexpected increase in consumer demand26/06/2024
    rifampicinCapsule, hard300 mgResolvedAvailableManufacturing26/06/2024
    phytomenadioneInjection, solution10 mg/mLCurrentLimited AvailabilityProduct recall26/06/2024
    oxycodone hydrochlorideCapsule, hard10 mgCurrentLimited AvailabilityCommercial Changes / Commercial viability26/06/2024
    metformin hydrochlorideTablet, film coated1000 mgAnticipatedAvailableManufacturing26/06/2024
    baclofenTablet, uncoated10 mgCurrentUnavailableManufacturing26/06/2024
    lisinopril dihydrateTablet, uncoated10.89 mgCurrentUnavailableManufacturing25/06/2024
    colestyraminePowder, oral850 mg/gResolvedAvailableManufacturing25/06/2024
    trandolaprilCapsule.5 mgResolvedAvailableManufacturing25/06/2024
    mycophenolate mofetilCapsule250 mgResolvedAvailableManufacturing25/06/2024
    morphine hydrochloride trihydrateOral Liquid, solution1 mg/mLCurrentUnavailableCommercial Changes / Commercial viability25/06/2024
    morphine hydrochloride trihydrateOral Liquid, solution5 mg/mLCurrentUnavailableCommercial Changes / Commercial viability25/06/2024
    morphine hydrochloride trihydrateOral Liquid, solution10 mg/mLCurrentUnavailableCommercial Changes / Commercial viability25/06/2024
    prochlorperazine maleateTablet5 mgCurrentLimited AvailabilityManufacturing25/06/2024
    prochlorperazine maleateTablet5 mgAnticipatedAvailableCommercial Changes / Commercial viability25/06/2024
    ropivacaine hydrochlorideInjection, solution7.5 mg/mLCurrentUnavailableManufacturing25/06/2024
    zoledronic acid monohydrateInjection, concentrated.8528 mg/mLResolvedAvailableUnexpected increase in demand due to other sponsors unable to supply25/06/2024
    quetiapine fumarateTablet, modified release460.52 mgResolvedAvailableTransport / Logistic issues / Storage capacity issues25/06/2024
    duloxetine hydrochlorideCapsule, enteric33.66 mgCurrentUnavailableUnexpected increase in consumer demand25/06/2024
    lisinopril dihydrateTablet, uncoatedQSResolvedAvailableTransport / Logistic issues / Storage capacity issues25/06/2024
    pantoprazole sodium sesquihydrateTablet, enteric coated45.4 mgResolvedAvailableTransport / Logistic issues / Storage capacity issues25/06/2024
    temozolomideCapsule, hard5 mgCurrentUnavailableManufacturing25/06/2024
    pregabalinCapsule, hard75 mgCurrentUnavailableCommercial Changes / Commercial viability25/06/2024
    pregabalinCapsule, hard300 mgCurrentUnavailableManufacturing25/06/2024
    voriconazoleInjection, powder for200 mgCurrentUnavailableManufacturing25/06/2024
    emtricitabine~tenofovir disoproxil maleateTablet, film coated200 mg~300 mgCurrentLimited AvailabilityManufacturing25/06/2024
    tenofovir disoproxil fumarate~emtricitabineTablet, film coated300 mg~200 mgCurrentUnavailableCommercial Changes / Commercial viability25/06/2024
    hydroxocobalamin acetateInjection, solution1.044 mgResolvedAvailableManufacturing25/06/2024
    hydrochlorothiazide~olmesartan medoxomilTablet25 mg~40 mgCurrentLimited AvailabilityManufacturing25/06/2024
    dasatinibTablet, film coated50 mgCurrentUnavailableManufacturing25/06/2024
    dasatinibTablet, film coated70 mgAnticipatedAvailableCommercial Changes / Commercial viability25/06/2024
    atomoxetine hydrochlorideCapsule, hard45.5 mgAnticipatedAvailableTransport / Logistic issues / Storage capacity issues25/06/2024
    latanoprostEye Drops, solution.05 mg/mLAnticipatedAvailableTransport / Logistic issues / Storage capacity issues25/06/2024
    olanzapineTablet, uncoated7.5 mgCurrentUnavailableManufacturing25/06/2024
    nebivolol hydrochlorideTablet5.45 mgCurrentUnavailableManufacturing25/06/2024
    bendamustine hydrochloride monohydrateInjection, powder for25 mgCurrentUnavailableUnexpected increase in demand due to other sponsors unable to supply25/06/2024
    chloramphenicolEye Drops5 mg/mLResolvedAvailableUnexpected increase in demand due to other sponsors unable to supply25/06/2024
    midazolam maleateSolution6.8 mgResolvedAvailableManufacturing25/06/2024
    indometacinCapsule, hard25 mgCurrentLimited AvailabilityManufacturing25/06/2024
    sugammadex sodiumInjection217.6 mgCurrentUnavailableManufacturing25/06/2024
    insulinInjection, suspension100 IU/mLResolvedAvailableManufacturing25/06/2024
    TeriparatideInjection, solution250 microgram/mLResolvedAvailableManufacturing25/06/2024
    amikacinInjection, solution500 mgResolvedAvailableManufacturing25/06/2024
    azithromycin dihydrateTablet, film coated628.93 mgAnticipatedAvailableManufacturing25/06/2024
    flecainide acetateTablet, uncoated100 mgCurrentLimited AvailabilityManufacturing25/06/2024
    tobramycinInhalation, conventional60 mg/mLCurrentUnavailableManufacturing25/06/2024
    oxycodone hydrochlorideCapsule, hard20 mgResolvedAvailableCommercial Changes / Commercial viability25/06/2024
    oxycodone hydrochlorideCapsule, hard5 mgResolvedAvailableCommercial Changes / Commercial viability25/06/2024
    tobramycinInjection, solution40 mg/mLResolvedAvailableManufacturing25/06/2024
    methylphenidate hydrochlorideTablet, modified release18 mgCurrentLimited AvailabilityManufacturing25/06/2024
    amlodipine besilateTablet, uncoated6.94 mgCurrentLimited AvailabilityManufacturing24/06/2024
    sildenafil citrateTablet, film coated28.1 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues24/06/2024
    aciclovir sodium dihydrateInjection, powder for314.4 mgCurrentLimited AvailabilityUnexpected increase in consumer demand24/06/2024
    ezetimibeTablet, uncoated10 mgAnticipatedAvailableTransport / Logistic issues / Storage capacity issues24/06/2024
    ezetimibeTablet, uncoated10 mgResolvedAvailableManufacturing24/06/2024
    lacosamideTablet, film coated50 mgResolvedAvailableManufacturing24/06/2024
    morphine sulfate pentahydrateTablet, film coated10 mgDiscontinuedUnavailableCommercial Changes / Commercial viability24/06/2024
    olanzapineInjection, powder for10 mgResolvedAvailableTransport / Logistic issues / Storage capacity issues24/06/2024
    famotidineTablet, film coated40 mgCurrentUnavailableManufacturing24/06/2024
  • 2024.06.24
    Active ingredientsDosage formQuantity of active ingredientsShortage statusAvailabilityReasonLast updated
    mycophenolate mofetilCapsule250 mgCurrentUnavailableManufacturing21/06/2024
    ondansetron hydrochloride dihydrateInjection, solution5 mgCurrentLimited AvailabilityManufacturing21/06/2024
    donepezil hydrochlorideTablet, film coated10 mgCurrentLimited AvailabilityManufacturing21/06/2024
    perindopril erbumineTablet8 mgCurrentLimited AvailabilityManufacturing21/06/2024
    esomeprazole magnesium dihydrateTablet, enteric coated21.75 mgAnticipatedAvailableManufacturing21/06/2024
    AbataceptInjection125.875 mgCurrentUnavailableManufacturing21/06/2024
    fluoxetine hydrochlorideCapsule, hard22.35 mgResolvedAvailableManufacturing21/06/2024
    teriflunomideTablet, film coated14 mgResolvedAvailableManufacturing21/06/2024
    fingolimod hydrochlorideCapsule560 microgramResolvedAvailableManufacturing21/06/2024
    bendamustine hydrochloride monohydrateInjection, powder for25 mgCurrentUnavailableUnexpected increase in demand due to other sponsors unable to supply21/06/2024
    estradiolDrug delivery system, transdermal1.17 mgCurrentLimited AvailabilityManufacturing21/06/2024
    cefaclor monohydrateOral Liquid, powder for26.22 mg/mLCurrentUnavailableManufacturing21/06/2024
    paracetamolTablet, modified release665 mgCurrentLimited AvailabilityTransport / Logistic issues / Storage capacity issues21/06/2024
    carbacholInjection, solution100 microgram/mLCurrentUnavailableUnexpected increase in demand due to other sponsors unable to supply21/06/2024
    clindamycin phosphateInjection, solution0 QSCurrentLimited AvailabilityManufacturing21/06/2024
    fluoxetine hydrochlorideCapsule, hard22.36 mgCurrentLimited AvailabilityManufacturing21/06/2024
    zopicloneTablet, film coated7.5 mgCurrentUnavailableManufacturing21/06/2024
    lisinopril dihydrateTablet10.89 mgResolvedAvailableManufacturing20/06/2024
    formoterol fumarate dihydrate~budesonideInhalation, pressurised2.25 microgram~40 microgramDiscontinuedUnavailableCommercial Changes / Commercial viability20/06/2024
    midazolamInjection, solution5 mgCurrentLimited AvailabilityManufacturing20/06/2024
    vincristine sulfateInjection, solution1 mg/mLResolvedAvailableManufacturing20/06/2024
    SomatropinInjection, powder for12 mg/mLCurrentLimited AvailabilityUnexpected increase in consumer demand20/06/2024
    hydrocortisone sodium succinateInjection, powder for334.25 mgAnticipatedAvailableManufacturing20/06/2024
    pramipexole dihydrochloride monohydrateTablet.125 mgAnticipatedAvailableManufacturing20/06/2024
    propranolol hydrochlorideTablet, film coated40 mgCurrentLimited AvailabilityManufacturing20/06/2024
    methotrexateInjection, solution100 mg/mLResolvedAvailableManufacturing20/06/2024
    tadalafilTablet, film coated20 mgCurrentLimited AvailabilityManufacturing20/06/2024
    felypressin~prilocaine hydrochlorideInjection, solution.54 microgram/mL~30 mg/mLCurrentUnavailableManufacturing20/06/2024
    prochlorperazine mesilateInjection, solution12.5 mg/mLResolvedAvailableManufacturing20/06/2024
    adrenaline (epinephrine) acid tartrateInjection, solution1.819 mgAnticipatedAvailableManufacturing20/06/2024
    atorvastatin calcium trihydrate~ezetimibeTablet, film coated20.681 mg~10 mgResolvedAvailableTransport / Logistic issues / Storage capacity issues20/06/2024
    chloramphenicolEye Drops5 mg/mLAnticipatedAvailableUnexpected increase in demand due to other sponsors unable to supply20/06/2024
    metoprolol tartrateTablet, uncoated100 mgResolvedAvailableManufacturing20/06/2024
    indometacinCapsule, hard25 mgAnticipatedAvailableManufacturing20/06/2024
    naproxenTablet, uncoated250 mgCurrentUnavailableManufacturing20/06/2024
    dobutamine hydrochlorideInjection, solution14.01 mg/mLAnticipatedAvailableManufacturing20/06/2024
    estradiol hemihydrateDrug delivery system, transdermal1.54 mgCurrentLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply20/06/2024
    estradiol hemihydrateDrug delivery system, transdermal.77 mgCurrentLimited AvailabilityCommercial Changes / Commercial viability20/06/2024
    estradiol hemihydrateDrug delivery system, transdermal3.09 mgCurrentLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply20/06/2024
    acamprosate calciumTablet, enteric coated333 mgAnticipatedAvailableManufacturing20/06/2024
    estradiol hemihydrateDrug delivery system, transdermal2.32 mgCurrentUnavailableUnexpected increase in demand due to other sponsors unable to supply20/06/2024
    clarithromycinTablet, film coated250 mgCurrentUnavailableUnexpected increase in consumer demand20/06/2024
    alendronate sodiumTablet91.37 mgCurrentUnavailableManufacturing19/06/2024
    remifentanil hydrochlorideInjection, powder for1.097 mgCurrentUnavailableManufacturing19/06/2024
    telmisartan~hydrochlorothiazideTablet, film coated80 mg~12.5 mgResolvedAvailableManufacturing19/06/2024
    metformin hydrochlorideTablet, modified release1000 mgCurrentLimited AvailabilityManufacturing19/06/2024
    irbesartanTablet, film coated300 mgCurrentLimited AvailabilityManufacturing19/06/2024
    tenofovir disoproxil fumarate~emtricitabineTablet, film coated300 mg~200 mgCurrentUnavailableCommercial Changes / Commercial viability19/06/2024
    gliclazideTablet, modified release30 mgCurrentUnavailableUnexpected increase in consumer demand19/06/2024
    lacosamideTablet, film coated50 mgCurrentUnavailableManufacturing19/06/2024
    norethisterone acetate~estradiol~estradiolDrug delivery system, transdermal2.7 mg~.62 mg~.78 mgCurrentUnavailableManufacturing19/06/2024
    estradiolDrug delivery system, transdermal.78 mgCurrentLimited AvailabilityManufacturing19/06/2024
    flecainide acetateTablet50 mgCurrentLimited AvailabilityManufacturing19/06/2024
    rifampicinCapsule, hard300 mgCurrentUnavailableManufacturing19/06/2024
    doxycycline hyclateTablet, film coated115 mgResolvedAvailableManufacturing19/06/2024
    estradiol~norethisterone acetateDrug delivery system, transdermal.62 mg~2.7 mgCurrentLimited AvailabilityManufacturing19/06/2024
    mirtazapineTablet, film coated30 mgResolvedAvailableManufacturing19/06/2024
    lidocaine hydrochloride monohydrate~adrenaline (epinephrine) acid tartrateInjection, solution21.3 mg/mL~22.7 microgram/mLCurrentUnavailableManufacturing18/06/2024
    warfarin sodiumTablet, uncoated5 mgResolvedAvailableManufacturing18/06/2024
    methotrexateTablet, uncoated10 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability18/06/2024
    griseofulvinTablet500 mgCurrentUnavailableManufacturing18/06/2024
    vecuronium bromideInjection, powder for10 mgAnticipatedAvailableUnexpected increase in consumer demand18/06/2024
    clonidine hydrochlorideTablet, uncoated100 microgramCurrentUnavailableManufacturing18/06/2024
    quetiapine fumarateTablet, film coated28.78 mgCurrentLimited AvailabilityManufacturing18/06/2024
    vecuronium bromideInjection, powder for10 mgCurrentUnavailableManufacturing18/06/2024
    cyclopentolate hydrochlorideEye Drops, solution10 mg/mLCurrentUnavailableManufacturing18/06/2024
    ganciclovir sodiumInjection, powder for546 mgResolvedAvailableManufacturing18/06/2024
    isotretinoinCapsule, soft10 mgCurrentUnavailableManufacturing18/06/2024
    norethisterone acetate~estradiol~estradiolDrug delivery system, transdermal4.8 mg~.78 mg~.512 mgCurrentUnavailableManufacturing18/06/2024
    proguanil hydrochloride~atovaquoneTablet, film coated25 mg~62.5 mgCurrentUnavailableManufacturing18/06/2024
    sugammadex sodiumInjection217.6 mgCurrentUnavailableManufacturing18/06/2024
    insulinInjection, suspension100 IU/mLCurrentLimited AvailabilityManufacturing18/06/2024
    medroxyprogesterone acetateInjection, suspension150 mg/mLDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability18/06/2024
    lidocaine hydrochloride monohydrateInjection, solution20 mg/mLResolvedAvailableManufacturing18/06/2024
    cefaclor monohydrateOral Liquid, powder for52.45 mg/mLResolvedAvailableManufacturing18/06/2024
    doxorubicin hydrochlorideInjection, concentrated2 mg/mLCurrentLimited AvailabilityManufacturing18/06/2024
    balsalazide sodiumCapsule750 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability18/06/2024
    ciprofloxacin~hydrocortisoneEar Drops, suspension2 mg/mL~10 mg/mLResolvedAvailableManufacturing17/06/2024
    hydrocortisone sodium succinateInjection, powder for134 mgAnticipatedAvailableManufacturing17/06/2024
    ropivacaine hydrochlorideInjection, solution7.5 mg/mLCurrentUnavailableManufacturing17/06/2024
    bortezomibInjection, powder for3.5 mgResolvedAvailableManufacturing17/06/2024
    cisatracurium besilateInjection, solution201 mgCurrentUnavailableManufacturing17/06/2024
    rosuvastatin calciumTablet, film coated10.42 mgResolvedAvailableManufacturing17/06/2024
    olmesartan medoxomilTablet40 mgResolvedAvailableUnexpected increase in consumer demand17/06/2024
    pregabalinCapsule, hard150 mgResolvedAvailableManufacturing17/06/2024
    lisdexamfetamine dimesilateCapsule, hard20 mgCurrentLimited AvailabilityUnexpected increase in consumer demand17/06/2024
    lisdexamfetamine dimesilateCapsule, hard60 mgAnticipatedAvailableUnexpected increase in consumer demand17/06/2024
    nebivolol hydrochlorideTablet5.45 mgCurrentUnavailableManufacturing17/06/2024
    betahistine dihydrochlorideTablet16 mgCurrentUnavailableUnexpected increase in consumer demand17/06/2024
    tretinoinCapsule, soft10 mgResolvedAvailableTransport / Logistic issues / Storage capacity issues17/06/2024
    aciclovirInjection, solution25 mg/mLCurrentLimited AvailabilityManufacturing17/06/2024
    clonidine hydrochlorideTablet, uncoated150 microgramResolvedAvailableManufacturing17/06/2024
    amoxicillin trihydrateOral Liquid, powder for114.82 mg/mLResolvedAvailableManufacturing17/06/2024
  • 2024.06.17
    Active ingredientsDosage formQuantity of active ingredientsShortage statusAvailabilityReasonLast updated
    oxytocinInjection, solution10 IU/mLAnticipatedAvailableManufacturing16/06/2024
    lacosamideTablet, film coated50 mgCurrentUnavailableManufacturing16/06/2024
    lacosamideTablet, film coated150 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues16/06/2024
    clonidine hydrochlorideTablet, uncoated150 microgramCurrentUnavailableManufacturing16/06/2024
    prazosin hydrochlorideTablet, uncoated5.476 mgAnticipatedAvailableUnexpected increase in consumer demand14/06/2024
    amoxicillin trihydrate~potassium clavulanateSuspension, powder for28.7 mg/mL~7.45 mg/mLCurrentLimited AvailabilityManufacturing14/06/2024
    midazolamInjection, solution5 mgResolvedAvailableManufacturing14/06/2024
    clonidine hydrochlorideTablet, uncoated100 microgramCurrentUnavailableManufacturing14/06/2024
    haloperidolInjection, solution5 mg/mLAnticipatedAvailableManufacturing14/06/2024
    valganciclovir hydrochlorideTablet, film coated496.3 mgResolvedAvailableManufacturing14/06/2024
    ezetimibeTablet, uncoated10 mgAnticipatedAvailableUnexpected increase in demand due to other sponsors unable to supply14/06/2024
    cerliponase alfaInjection, solution30 mg/mLAnticipatedAvailableManufacturing14/06/2024
    atorvastatin calcium trihydrate~ezetimibeTablet, film coated41.363 mg~10 mgCurrentLimited AvailabilityManufacturing14/06/2024
    atorvastatin calcium trihydrate~ezetimibeTablet, film coated82.725 mg~10 mgCurrentLimited AvailabilityManufacturing14/06/2024
    clindamycin phosphateInjection, solution0 QSAnticipatedAvailableManufacturing14/06/2024
    melphalanInjection, powder for50 mgResolvedAvailableManufacturing14/06/2024
    medronic acidInjection, powder for10 mgResolvedAvailableManufacturing13/06/2024
    SomatropinInjection, powder for12 mg/mLAnticipatedAvailableUnexpected increase in consumer demand13/06/2024
    donepezil hydrochlorideTablet, film coated5 mgAnticipatedAvailableTransport / Logistic issues / Storage capacity issues13/06/2024
    lercanidipine hydrochlorideTablet, film coated20 mgResolvedAvailableManufacturing13/06/2024
    drospirenone~ethinylestradiolTablet3 mg~30 microgramAnticipatedAvailableManufacturing13/06/2024
    sildenafil citrateTablet, film coated28.1 mgCurrentLimited AvailabilityTransport / Logistic issues / Storage capacity issues13/06/2024
    OmalizumabInjection, solution150 mgAnticipatedAvailableManufacturing13/06/2024
    quetiapine fumarateTablet, film coated345.36 mgAnticipatedAvailableTransport / Logistic issues / Storage capacity issues13/06/2024
    lisinopril dihydrateTablet, uncoatedQSResolvedAvailableTransport / Logistic issues / Storage capacity issues13/06/2024
    pantoprazole sodium sesquihydrateTablet, enteric coated45.4 mgAnticipatedAvailableTransport / Logistic issues / Storage capacity issues13/06/2024
    sodium iodide(131I)Oral Liquid, solution50 MBqResolvedAvailableManufacturing13/06/2024
    sodium iodide(131I)Capsule, hard50 MBqResolvedAvailableManufacturing13/06/2024
    temozolomideCapsule, hard5 mgCurrentUnavailableManufacturing13/06/2024
    latanoprostEye Drops, solution.05 mg/mLAnticipatedAvailableTransport / Logistic issues / Storage capacity issues13/06/2024
    busulfanInjection, concentrated60 mgCurrentUnavailableManufacturing13/06/2024
    levodopa~carbidopa monohydrateTablet, modified release200 mg~54 mgAnticipatedAvailableManufacturing13/06/2024
    estradiolDrug delivery system, transdermal.39 mgCurrentUnavailableManufacturing13/06/2024
    morphine sulfate pentahydrateTablet, film coated10 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability13/06/2024
    sodium iodide(131I)Oral Liquid, solution1201 MBqResolvedAvailableManufacturing13/06/2024
    diltiazem hydrochlorideCapsule, modified release180 mgDiscontinuedReduction in supply until supply is exhaustedManufacturing12/06/2024
    diltiazem hydrochlorideCapsule, modified release240 mgDiscontinuedReduction in supply until supply is exhaustedManufacturing12/06/2024
    diltiazem hydrochlorideCapsule, modified release360 mgDiscontinuedReduction in supply until supply is exhaustedManufacturing12/06/2024
    levetiracetamTablet, film coated500 mgAnticipatedAvailableTransport / Logistic issues / Storage capacity issues12/06/2024
    lomustineCapsule, hard40 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability12/06/2024
    lomustineCapsule, hard10 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability12/06/2024
    quetiapine fumarateTablet, modified release460.52 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues12/06/2024
    lisinopril dihydrateTablet, uncoatedQSCurrentUnavailableTransport / Logistic issues / Storage capacity issues12/06/2024
    escitalopram oxalateTablet, film coated12.74 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues12/06/2024
    rizatriptan benzoateTablet, orally disintegrating14.53 mgAnticipatedAvailableTransport / Logistic issues / Storage capacity issues12/06/2024
    rizatriptan benzoateTablet, orally disintegrating14.53 mgCurrentUnavailableManufacturing12/06/2024
    enoxaparin sodiumInjection, solution60 mgResolvedAvailableTransport / Logistic issues / Storage capacity issues12/06/2024
    timolol maleateEye Drops, solution6.84 mg/mLDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability12/06/2024
    disulfiramTablet, effervescent200 mgCurrentUnavailableManufacturing12/06/2024
    testosteroneDrug delivery system, transdermal24.3 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability12/06/2024
    baclofenTablet, uncoated25 mgAnticipatedAvailableTransport / Logistic issues / Storage capacity issues12/06/2024
    famotidineTablet, film coated20 mgCurrentUnavailableManufacturing12/06/2024
    lisinopril dihydrateTablet, uncoated10.89 mgAnticipatedAvailableTransport / Logistic issues / Storage capacity issues11/06/2024
    povidoneiodineApplication100 mg/mLCurrentUnavailableManufacturing11/06/2024
    isoniazidTablet, uncoated100 mgCurrentUnavailableManufacturing11/06/2024
    levetiracetamTablet, film coated250 mgAnticipatedAvailableTransport / Logistic issues / Storage capacity issues11/06/2024
    levetiracetamTablet, film coated1000 mgAnticipatedAvailableTransport / Logistic issues / Storage capacity issues11/06/2024
    prochlorperazine maleateTablet5 mgAnticipatedAvailableCommercial Changes / Commercial viability11/06/2024
    metoprolol succinateTablet, modified release190 mgResolvedAvailableManufacturing11/06/2024
    rabeprazole sodiumTablet, enteric coated20 mgAnticipatedAvailableTransport / Logistic issues / Storage capacity issues11/06/2024
    zolmitriptanTablet, film coated2.5 mgAnticipatedAvailableTransport / Logistic issues / Storage capacity issues11/06/2024
    methotrexateInjection, solution100 mg/mLCurrentUnavailableManufacturing11/06/2024
    atorvastatin calcium trihydrate~ezetimibeTablet, multilayer86.8 mg~10 mgCurrentUnavailableManufacturing11/06/2024
    ezetimibeTablet, uncoated10 mgAnticipatedAvailableTransport / Logistic issues / Storage capacity issues11/06/2024
    cisplatinInjection, concentrated1 mg/mLCurrentUnavailableUnexpected increase in consumer demand11/06/2024
    atomoxetine hydrochlorideCapsule, hard45.5 mgAnticipatedAvailableTransport / Logistic issues / Storage capacity issues11/06/2024
    sorbitol~activated charcoalSuspension.283 g/mL~.2 g/mLResolvedAvailableManufacturing11/06/2024
    lidocaine hydrochlorideInjection, solution400 mgCurrentUnavailableManufacturing11/06/2024
    TeriparatideInjection, solution250 microgram/mLDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability11/06/2024
    octreotideInjection, solution50 microgram/mLCurrentLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply11/06/2024
    heparin sodiumInjection, solution1000 IU/mLCurrentLimited AvailabilityManufacturing11/06/2024
    olanzapineInjection, powder for10 mgCurrentLimited AvailabilityTransport / Logistic issues / Storage capacity issues11/06/2024
    difelikefalin acetateInjection, solution55 microgramAnticipatedAvailableManufacturing10/06/2024
  • 2024.06.10
    Active ingredientsDosage formQuantity of active ingredientsShortage statusAvailabilityReasonLast updated
    framycetin sulfate~dexamethasone~gramicidinEar Drops5 mg/mL~.5 mg/mL~.05 mg/mLCurrentLimited AvailabilityManufacturing7/06/2024
    sodium fluorideInjection, concentrated1 mg/mLCurrentLimited AvailabilityManufacturing7/06/2024
    olanzapineTablet, film coated7.5 mgCurrentUnavailableManufacturing7/06/2024
    vincristine sulfateInjection, solution1 mg/mLAnticipatedAvailableManufacturing7/06/2024
    ethinylestradiol~drospirenoneTablet30 microgram~3 mgAnticipatedAvailableManufacturing7/06/2024
    carmustineInjection, powder for100 mgAnticipatedAvailableManufacturing7/06/2024
    atorvastatin calcium trihydrate~ezetimibeTablet, multilayer21.7 mg~10 mgCurrentUnavailableManufacturing7/06/2024
    pemetrexed disodiumInjection, powder for1102.9 mgResolvedAvailableUnexpected increase in demand due to other sponsors unable to supply7/06/2024
    desvenlafaxine benzoateTablet, modified release73.16 mgAnticipatedAvailableManufacturing7/06/2024
    clindamycin phosphate~tretinoinGel12 mg~.25 mgResolvedAvailableManufacturing7/06/2024
    hydrochlorothiazide~irbesartanTablet, film coated12.5 mg~150 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability7/06/2024
    amlodipine besilate~olmesartan medoxomilTablet, film coated6.935 mg~40 mgCurrentLimited AvailabilityTransport / Logistic issues / Storage capacity issues7/06/2024
    bortezomibInjection, powder for3.5 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability7/06/2024
    mercaptopurine monohydrateTablet50 mgCurrentLimited AvailabilityManufacturing7/06/2024
    ezetimibe~atorvastatin calcium trihydrateTablet, film coated10 mg~41.363 mgAnticipatedAvailableManufacturing7/06/2024
    prasugrelTablet, film coated5 mgAnticipatedAvailableManufacturing7/06/2024
    thiotepaInjection, powder for100 mgCurrentUnavailableCommercial Changes / Commercial viability7/06/2024
    oxycodone hydrochlorideCapsule, hard10 mgDiscontinuedUnavailableCommercial Changes / Commercial viability7/06/2024
    famotidineTablet, film coated40 mgCurrentLimited AvailabilityManufacturing7/06/2024
    acetylcholine chlorideSolution, powder for irrigation10 mg/mLCurrentUnavailableManufacturing6/06/2024
    adrenaline (epinephrine) acid tartrate~lidocaine hydrochlorideInjection, solution9.1 microgram/mL~20 mg/mLResolvedAvailableManufacturing6/06/2024
    hydroxocobalamin chlorideInjection, solution1.027 mgCurrentLimited AvailabilityTransport / Logistic issues / Storage capacity issues6/06/2024
    insulinInjection, solution100 IU/mLCurrentLimited AvailabilityManufacturing6/06/2024
    methotrexateInjection, solution2.5 mg/mLCurrentLimited AvailabilityManufacturing6/06/2024
    betamethasone acetate~betamethasone sodium phosphateInjection, suspension3 mg/mL~3.9 mg/mLCurrentLimited AvailabilityProduct recall6/06/2024
    quetiapine fumarateTablet, film coated28.78 mgCurrentUnavailableManufacturing6/06/2024
    enoxaparin sodiumInjection, solution60 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues6/06/2024
    arginine hydrochlorideInjection, intravenous infusion600 mg/mLResolvedAvailableManufacturing6/06/2024
    Insulin degludec~Insulin aspartInjection, solution420 nmol/mL~180 nmol/mLCurrentLimited AvailabilityManufacturing6/06/2024
    tadalafilTablet, film coated5 mgCurrentLimited AvailabilityManufacturing6/06/2024
    lidocaine hydrochlorideInjection, solution400 mgCurrentUnavailableManufacturing6/06/2024
    octreotideInjection, modified release10 mgDiscontinuedUnavailableCommercial Changes / Commercial viability6/06/2024
    octreotideInjection, modified release30 mgDiscontinuedUnavailableManufacturing6/06/2024
    octreotideInjection, modified release20 mgDiscontinuedUnavailableCommercial Changes / Commercial viability6/06/2024
    levodopa~carbidopa monohydrateTablet, modified release200 mg~54 mgAnticipatedAvailableManufacturing6/06/2024
    estradiolDrug delivery system, transdermal.78 mgCurrentLimited AvailabilityManufacturing6/06/2024
    cabazitaxelInjection, concentrated60 mgResolvedAvailableManufacturing6/06/2024
    amlodipine besilate~olmesartan medoxomilTablet, film coated6.94 mg~40 mgCurrentLimited AvailabilityUnexpected increase in consumer demand6/06/2024
    bortezomibInjection, powder for3.5 mgDiscontinuedUnavailableCommercial Changes / Commercial viability6/06/2024
    naproxenTablet, uncoated250 mgCurrentUnavailableManufacturing6/06/2024
    diltiazem hydrochlorideCapsule, modified release240 mgResolvedAvailableManufacturing6/06/2024
    sodium oxidronateInjection, powder for3.15 mgCurrentUnavailableManufacturing6/06/2024
    ganciclovir sodiumInjection, powder for543 mgCurrentLimited AvailabilityManufacturing5/06/2024
    hydrochlorothiazide~enalapril maleateTablet, uncoated6 mg~20 mgResolvedAvailableManufacturing5/06/2024
    isoniazidTablet, uncoated100 mgCurrentUnavailableManufacturing5/06/2024
    sodium pyrophosphateInjection, powder for30 mgCurrentUnavailableManufacturing5/06/2024
    midazolamInjection, solution5 mgAnticipatedAvailableManufacturing5/06/2024
    hydrochlorothiazide~telmisartanTablet, film coated12.5 mg~80 mgCurrentUnavailableManufacturing5/06/2024
    metformin hydrochlorideTablet, modified release1000 mgCurrentLimited AvailabilityManufacturing5/06/2024
    entecavirTablet, film coated1 mgResolvedAvailableManufacturing5/06/2024
    Insulin aspartInjection, solution100 U/mLCurrentUnavailableTransport / Logistic issues / Storage capacity issues5/06/2024
    oxycodone hydrochlorideInjection, solution10 mg/mLCurrentUnavailableCommercial Changes / Commercial viability5/06/2024
    ganciclovir sodiumInjection, powder for546 mgAnticipatedAvailableManufacturing5/06/2024
    tadalafilTablet, film coated5 mgCurrentUnavailableManufacturing5/06/2024
    cisplatinInjection, concentrated1 mg/mLCurrentUnavailableUnexpected increase in consumer demand5/06/2024
    cisplatinInjection, concentrated1 mg/mLCurrentUnavailableUnexpected increase in consumer demand5/06/2024
    dasatinibTablet, film coated50 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues5/06/2024
    latanoprostEye Drops, solution.05 mg/mLCurrentUnavailableManufacturing5/06/2024
    timolol maleate~latanoprostEye Drops, solution6.83 mg/mL~.05 mg/mLResolvedAvailableManufacturing5/06/2024
    lacosamideTablet, film coated50 mgCurrentUnavailableManufacturing5/06/2024
    gliclazideTablet, modified release30 mgCurrentUnavailableManufacturing5/06/2024
    acalabrutinibCapsule, hard100 mgDiscontinuedUnavailableTransport / Logistic issues / Storage capacity issues5/06/2024
    medroxyprogesterone acetateTablet, uncoated10 mgResolvedAvailableManufacturing5/06/2024
    cisplatinInjection, solution1 mg/mLAnticipatedAvailableUnexpected increase in consumer demand5/06/2024
    tretinoinCapsule, soft10 mgCurrentLimited AvailabilityTransport / Logistic issues / Storage capacity issues5/06/2024
    clarithromycinOral Liquid, powder for50 mg/mLCurrentLimited AvailabilityUnexpected increase in consumer demand5/06/2024
    ketamine hydrochlorideInjection, solution115.3 mg/mLCurrentLimited AvailabilityManufacturing5/06/2024
    diltiazem hydrochlorideTablet, film coated60 mgAnticipatedAvailableManufacturing5/06/2024
    famotidineTablet, film coated20 mgCurrentLimited AvailabilityManufacturing5/06/2024
    Coxiella burnetiiInjection50 microgram/mLCurrentLimited AvailabilityManufacturing4/06/2024
    Coxiella burnetiiInjection5 microgram/mLCurrentLimited AvailabilityManufacturing4/06/2024
    lisinopril dihydrateTablet, uncoated10.89 mgAnticipatedAvailableTransport / Logistic issues / Storage capacity issues4/06/2024
    fludarabine phosphateInjection, concentrated50 mgCurrentUnavailableManufacturing4/06/2024
    benzathine benzylpenicillin tetrahydrateInjection, suspension1200000 USP UnitResolvedAvailableUnexpected increase in consumer demand4/06/2024
    sildenafil citrateTablet, film coated28.1 mgAnticipatedAvailableTransport / Logistic issues / Storage capacity issues4/06/2024
    candesartan cilexetil~hydrochlorothiazideTablet, uncoated32 mg~25 mgResolvedAvailableTransport / Logistic issues / Storage capacity issues4/06/2024
    ziprasidone hydrochlorideCapsule, hard65.16 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues4/06/2024
    aciclovir sodium dihydrateInjection, powder for628.8 mgAnticipatedAvailableUnexpected increase in demand due to other sponsors unable to supply4/06/2024
    mesalazineTablet, enteric coated800 mgCurrentLimited AvailabilityTransport / Logistic issues / Storage capacity issues4/06/2024
    tadalafilTablet, film coated5 mgCurrentUnavailableUnexpected increase in demand due to other sponsors unable to supply4/06/2024
    teriflunomideTablet, film coated14 mgCurrentLimited AvailabilityManufacturing4/06/2024
    carbetocinInjection, solution100 microgramResolvedAvailableManufacturing4/06/2024
    tazobactam sodium~piperacillin sodiumInjection, powder for536.6 mg~4.17 gResolvedAvailableManufacturing4/06/2024
    isotretinoinCapsule, soft20 mgResolvedAvailableManufacturing4/06/2024
    bendamustine hydrochloride monohydrateInjection, powder for25 mgCurrentLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply4/06/2024
    rifampicinCapsule, hard150 mgCurrentUnavailableManufacturing4/06/2024
    rifampicinCapsule, hard300 mgCurrentLimited AvailabilityManufacturing4/06/2024
    lidocaine hydrochloride monohydrateInjection, solution20 mg/mLAnticipatedAvailableManufacturing4/06/2024
    Insulin lisproInjection, solution100 IU/mLCurrentLimited AvailabilityManufacturing4/06/2024
    raltitrexedInjection, powder for2 mgAnticipatedAvailableUnexpected increase in consumer demand4/06/2024
    desonideLotion.5 mg/gCurrentLimited AvailabilityManufacturing4/06/2024
    midazolamInjection, solution5 mg/mLCurrentLimited AvailabilityManufacturing4/06/2024
    tobramycinInhalation, conventional60 mg/mLCurrentUnavailableManufacturing4/06/2024
    gliclazideTablet, modified release30 mgCurrentLimited AvailabilityManufacturing3/06/2024
    lercanidipine hydrochlorideTablet, film coated20 mgCurrentLimited AvailabilityManufacturing3/06/2024
    duloxetine hydrochlorideCapsule, enteric33.65 mgCurrentUnavailableManufacturing3/06/2024
    cinacalcet hydrochlorideTablet99.191 mgCurrentLimited AvailabilityManufacturing3/06/2024
  • 2024.06.10
    Active ingredientsDosage formQuantity of active ingredientsShortage statusAvailabilityReasonLast updated
    praziquantelTablet, film coated600 mgDiscontinuedReduction in supply until supply is exhaustedManufacturing1/06/2024
    chlorhexidine gluconateSolution, irrigation30 mgAnticipatedAvailableManufacturing31/05/2024
    atropine sulfate monohydrateInjection, solution1.2 mg/mLAnticipatedAvailableManufacturing31/05/2024
    zolpidem tartrateTablet, film coated10 mgCurrentLimited AvailabilityManufacturing31/05/2024
    bupivacaine hydrochloride~adrenaline (epinephrine) acid tartrateInjection, solution2.5 mg/mL~4.5 microgram/mLCurrentLimited AvailabilityManufacturing31/05/2024
    ceftazidime pentahydrateInjection, powder for1.164 gCurrentUnavailableManufacturing31/05/2024
    midazolamInjection, solution5 mgCurrentLimited AvailabilityManufacturing31/05/2024
    remifentanil hydrochlorideInjection, powder for1.097 mgCurrentUnavailableManufacturing31/05/2024
    hydrocortisone sodium succinateInjection, powder for334.25 mgResolvedAvailableManufacturing31/05/2024
    perindopril erbumineTablet8 mgCurrentLimited AvailabilityManufacturing31/05/2024
    ropivacaine hydrochlorideInjection, solution7.5 mg/mLCurrentUnavailableManufacturing31/05/2024
    duloxetine hydrochlorideCapsule, enteric33.65 mgCurrentUnavailableManufacturing31/05/2024
    duloxetine hydrochlorideCapsule, enteric67.3 mgCurrentUnavailableManufacturing31/05/2024
    AbataceptInjection125.875 mgCurrentLimited AvailabilityUnexpected increase in consumer demand31/05/2024
    esomeprazole magnesium dihydrateTablet, enteric coated43.5 mgCurrentLimited AvailabilityTransport / Logistic issues / Storage capacity issues31/05/2024
    cisatracurium besilateInjection, solution201 mgCurrentUnavailableManufacturing31/05/2024
    AbataceptInjection125.875 mgCurrentLimited AvailabilityManufacturing31/05/2024
    ezetimibeTablet, uncoated10 mgAnticipatedAvailableUnexpected increase in demand due to other sponsors unable to supply31/05/2024
    tenofovir disoproxil maleate~emtricitabineTablet, film coated300 mg~200 mgCurrentLimited AvailabilityManufacturing31/05/2024
    fluoxetine hydrochlorideCapsule, hard22.35 mgAnticipatedAvailableTransport / Logistic issues / Storage capacity issues31/05/2024
    cinacalcet hydrochlorideTablet33.064 mgCurrentUnavailableManufacturing31/05/2024
    cinacalcet hydrochlorideTablet66.127 mgCurrentUnavailableManufacturing31/05/2024
    dosulepin (dothiepin) hydrochlorideCapsule, hard25 mgCurrentLimited AvailabilityManufacturing31/05/2024
    sodium chlorideInjection, solution90 mgAnticipatedAvailableManufacturing31/05/2024
    anastrozoleTablet, film coated1 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability31/05/2024
    azithromycin dihydrateSuspension, powder for209.65 mgCurrentLimited AvailabilityUnexpected increase in consumer demand31/05/2024
    albendazoleTablet, chewable400 mgCurrentUnavailableCommercial Changes / Commercial viability31/05/2024
    prazosin hydrochlorideTablet, uncoated5.476 mgResolvedAvailableManufacturing30/05/2024
    calcium folinateInjection324.1 mgAnticipatedAvailableManufacturing30/05/2024
    adrenaline (epinephrine) acid tartrate~lidocaine hydrochloride monohydrateInjection, solution22.7 microgram/mL~21.3 mg/mLAnticipatedAvailableManufacturing30/05/2024
    ondansetron hydrochloride dihydrateInjection, solution5 mgCurrentLimited AvailabilityManufacturing30/05/2024
    propranolol hydrochlorideTablet, film coated40 mgCurrentLimited AvailabilityManufacturing30/05/2024
    atorvastatin calcium trihydrate~amlodipine besilateTablet, film coated86.751 mg~6.94 mgCurrentLimited AvailabilityManufacturing30/05/2024
    tadalafilTablet, film coated5 mgAnticipatedAvailableManufacturing30/05/2024
    rifampicinCapsule150 mgResolvedAvailableManufacturing30/05/2024
    aciclovir sodium dihydrateInjection, powder for314.4 mgAnticipatedAvailableUnexpected increase in consumer demand30/05/2024
    zopicloneTablet, film coated7.5 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability30/05/2024
    amikacin sulfateInjection, solution333.76 mg/mLCurrentUnavailableManufacturing30/05/2024
    bupivacaine hydrochloride~adrenaline (epinephrine) acid tartrateInjection, solution5 mg/mL~9.1 microgram/mLCurrentUnavailableManufacturing30/05/2024
    idarubicin hydrochlorideInjection, solution1 mg/mLCurrentLimited AvailabilityManufacturing30/05/2024
    clonidine hydrochlorideTablet, uncoated150 microgramCurrentUnavailableManufacturing30/05/2024
    mirtazapineTablet, film coated30 mgCurrentUnavailableManufacturing30/05/2024
    pravastatin sodiumTablet, uncoated40 mgCurrentLimited AvailabilityManufacturing30/05/2024
    clopidogrel hydrogen sulfate~aspirinTablet, film coated97.875 mg~100 mgDiscontinuedUnavailableCommercial Changes / Commercial viability29/05/2024
    ibuprofen~codeine phosphate hemihydrateTablet, film coated200 mg~12.8 mgAnticipatedAvailableTransport / Logistic issues / Storage capacity issues29/05/2024
    levetiracetamTablet, film coated250 mgAnticipatedAvailableTransport / Logistic issues / Storage capacity issues29/05/2024
    doxepin hydrochlorideTablet, film coated56.5 mgResolvedAvailableManufacturing29/05/2024
    atorvastatin calcium trihydrateTablet, film coated86.76 mgResolvedAvailableTransport / Logistic issues / Storage capacity issues29/05/2024
    montelukast sodiumTablet, chewable5.2 mgResolvedAvailableManufacturing29/05/2024
    zoledronic acid monohydrateInjection, concentrated.8528 mg/mLCurrentUnavailableUnexpected increase in demand due to other sponsors unable to supply29/05/2024
    cefepime hydrochloride monohydrateInjection, powder for2.378 gResolvedAvailableUnexpected increase in consumer demand29/05/2024
    duloxetine hydrochlorideCapsule, enteric33.65 mgCurrentLimited AvailabilityManufacturing29/05/2024
    pregabalinCapsule, hard300 mgResolvedAvailableCommercial Changes / Commercial viability29/05/2024
    ezetimibeTablet, uncoated10 mgAnticipatedAvailableTransport / Logistic issues / Storage capacity issues29/05/2024
    ezetimibeTablet10 mgResolvedAvailableManufacturing29/05/2024
    tadalafilTablet, film coated5 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues29/05/2024
    atomoxetine hydrochlorideCapsule, hard45.5 mgAnticipatedAvailableTransport / Logistic issues / Storage capacity issues29/05/2024
    lacosamideTablet, film coated100 mgResolvedAvailableManufacturing29/05/2024
    rosuvastatin calciumTablet, film coated41.68 mgResolvedAvailableManufacturing29/05/2024
    mycophenolate sodiumTablet, enteric coated384.8 mgResolvedAvailableManufacturing29/05/2024
    TeriparatideInjection, solution250 microgram/mLAnticipatedAvailableManufacturing29/05/2024
    melphalanInjection, powder for50 mgCurrentUnavailableManufacturing29/05/2024
    warfarin sodiumTablet, uncoated5 mgCurrentLimited AvailabilityManufacturing28/05/2024
    ciprofloxacin hydrochlorideTablet, film coated832.5 mgResolvedAvailableTransport / Logistic issues / Storage capacity issues28/05/2024
    ciprofloxacin~hydrocortisoneEar Drops, suspension2 mg/mL~10 mg/mLCurrentLimited AvailabilityManufacturing28/05/2024
    rocuronium bromideInjection, solution50 mgResolvedAvailableManufacturing28/05/2024
    amlodipine besilateTablet13.87 mgCurrentLimited AvailabilityManufacturing28/05/2024
    codeine phosphate hemihydrate~paracetamol~doxylamine succinateTablet, uncoated10 mg~500 mg~5.1 mgCurrentUnavailableManufacturing28/05/2024
    felypressin~prilocaine hydrochlorideInjection, solution.54 microgram/mL~30 mg/mLAnticipatedAvailableManufacturing28/05/2024
    voriconazoleInjection, powder for200 mgCurrentUnavailableCommercial Changes / Commercial viability28/05/2024
    atorvastatin calcium trihydrateTablet, film coated10.845 mgResolvedAvailableTransport / Logistic issues / Storage capacity issues28/05/2024
    nebivolol hydrochlorideTablet5.45 mgCurrentUnavailableManufacturing28/05/2024
    lacosamideTablet, film coated100 mgCurrentLimited AvailabilityManufacturing28/05/2024
    cisplatinInjection, solution1 mg/mLResolvedAvailableManufacturing28/05/2024
    heparin sodiumInjection, solution1000 IU/mLCurrentUnavailableManufacturing28/05/2024
    felodipine~ramiprilTablet, modified release2.5 mg~2.5 mgDiscontinuedUnavailableCommercial Changes / Commercial viability28/05/2024
    epoprostenol sodiumInjection, powder for.531 mgDiscontinuedReduction in supply until supply is exhaustedManufacturing28/05/2024
    epoprostenol sodiumInjection, powder for1.593 mgDiscontinuedReduction in supply until supply is exhaustedManufacturing28/05/2024
    trandolaprilCapsule2 mgAnticipatedAvailableTransport / Logistic issues / Storage capacity issues27/05/2024
    imatinib mesilateTablet, film coated119.5 mgResolvedAvailableManufacturing27/05/2024
    metformin hydrochlorideTablet, film coated1000 mgAnticipatedAvailableManufacturing27/05/2024
  • 2024.05.27
    Active ingredientsDosage formQuantity of active ingredientsShortage statusSupply impact start dateSupply impact end dateAvailabilityReasonLast updated
    clonidine hydrochlorideTablet, uncoated150 microgramAnticipated27/05/20247/06/2024AvailableManufacturing26/05/2024
    medronic acidInjection, powder for10 mgCurrent1/12/20237/06/2024UnavailableManufacturing24/05/2024
    risperidoneTablet, film coated3 mgCurrent14/12/202319/07/2024Limited AvailabilityManufacturing24/05/2024
    bortezomibInjection, powder for3.5 mgCurrent15/03/202415/06/2024Limited AvailabilityManufacturing24/05/2024
    rosuvastatin calciumTablet, film coated41.68 mgCurrent24/03/202315/07/2024UnavailableCommercial Changes / Commercial viability24/05/2024
    pregabalinCapsule, hard75 mgCurrent24/03/202330/06/2024UnavailableCommercial Changes / Commercial viability24/05/2024
    pregabalinCapsule, hard300 mgCurrent1/08/202330/06/2024UnavailableCommercial Changes / Commercial viability24/05/2024
    methylphenidate hydrochlorideCapsule, modified release60 mgResolved30/04/20248/05/2024AvailableManufacturing24/05/2024
    tadalafilTablet, film coated5 mgCurrent17/05/202414/06/2024Limited AvailabilityTransport / Logistic issues / Storage capacity issues24/05/2024
    tadalafilTablet, film coated5 mgCurrent16/10/202331/07/2024UnavailableManufacturing24/05/2024
    cinacalcet hydrochlorideTablet, film coated66 mgCurrent20/12/202331/08/2024UnavailableManufacturing24/05/2024
    cinacalcet hydrochlorideTablet, film coated99 mgCurrent25/08/202331/08/2024UnavailableManufacturing24/05/2024
    olmesartan medoxomil~amlodipine besilateTablet, film coated20 mg~6.935 mgCurrent1/02/202430/06/2024UnavailableManufacturing24/05/2024
    ezetimibe~atorvastatin calcium trihydrateTablet, film coated10 mg~82.725 mgCurrent21/05/202414/06/2024Limited AvailabilityManufacturing24/05/2024
    ezetimibe~atorvastatin calcium trihydrateTablet, film coated10 mg~20.681 mgCurrent16/04/202421/06/2024Limited AvailabilityTransport / Logistic issues / Storage capacity issues24/05/2024
    potassium chlorideInjection, concentrated75 mg/mLCurrent22/04/202431/12/2024UnavailableCommercial Changes / Commercial viability24/05/2024
    methylphenidate hydrochlorideTablet, modified release27 mgResolved20/02/202422/05/2024AvailableTransport / Logistic issues / Storage capacity issues24/05/2024
    mycophenolate mofetilSuspension200 mg/mLCurrent20/12/202331/07/2024Limited AvailabilityManufacturing24/05/2024
    sitagliptin hydrochloride monohydrateTablet, film coated109 mgCurrent15/07/202331/07/2024UnavailableManufacturing24/05/2024
    sitagliptin hydrochloride monohydrateTablet, film coated54.5 mgCurrent15/08/202331/07/2024Emergency Supply OnlyManufacturing24/05/2024
    rosuvastatin calcium~ezetimibeTablet10.4 mg~10 mgCurrent15/03/202415/07/2024UnavailableManufacturing24/05/2024
    rosuvastatin calcium~ezetimibeTablet~Tablet, film coated20.8 mg~10 mgCurrent30/01/202415/07/2024UnavailableManufacturing24/05/2024
    octreotideInjection, solution100 microgram/mLCurrent1/02/202412/07/2024Limited AvailabilityUnexpected increase in demand due to other sponsors unable to supply24/05/2024
    medroxyprogesterone acetateTablet, uncoated10 mgCurrent23/05/202415/06/2024Limited AvailabilityManufacturing24/05/2024
    doxorubicin hydrochlorideInjection, solution2 mg/mLResolved3/05/202424/05/2024AvailableManufacturing24/05/2024
    olanzapineInjection, powder for10 mgAnticipated30/05/202414/06/2024AvailableTransport / Logistic issues / Storage capacity issues24/05/2024
    ethosuximideCapsule, soft250 mgCurrent26/02/202431/01/2025UnavailableManufacturing24/05/2024
    clarithromycinTablet, film coated250 mgCurrent20/05/202421/06/2024Limited AvailabilityManufacturing24/05/2024
    duloxetine hydrochlorideCapsule, enteric33.7 mgCurrent29/04/20241/05/2025UnavailableManufacturing23/05/2024
    isoniazidTablet, uncoated100 mgAnticipated24/05/20249/08/2024AvailableManufacturing23/05/2024
    ciprofloxacin hydrochlorideTablet, film coated832.5 mgCurrent17/05/202421/06/2024Limited AvailabilityTransport / Logistic issues / Storage capacity issues23/05/2024
    ondansetron hydrochloride dihydrateInjection, solution5 mgAnticipated31/05/202415/08/2024AvailableManufacturing23/05/2024
    midazolamInjection, solution5 mgCurrent20/05/202410/06/2024Limited AvailabilityManufacturing23/05/2024
    levetiracetamTablet, film coated500 mgAnticipated26/06/202423/08/2024AvailableTransport / Logistic issues / Storage capacity issues23/05/2024
    noradrenaline (norepinephrine) acid tartrate monohydrateInjection, concentrated2 mg/mLDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability23/05/2024
    duloxetine hydrochlorideCapsule, enteric33.65 mgCurrent4/12/202330/08/2024UnavailableManufacturing23/05/2024
    duloxetine hydrochlorideCapsule, enteric33.65 mgCurrent19/03/202431/05/2024UnavailableManufacturing23/05/2024
    duloxetine hydrochlorideCapsule, enteric33.65 mgCurrent29/02/202429/05/2024UnavailableManufacturing23/05/2024
    zolmitriptanTablet, film coated2.5 mgAnticipated18/10/202428/03/2025AvailableTransport / Logistic issues / Storage capacity issues23/05/2024
    duloxetine hydrochlorideCapsule, enteric33.66 mgCurrent14/05/202431/07/2024UnavailableManufacturing23/05/2024
    duloxetine hydrochlorideCapsule, enteric67.32 mgCurrent15/05/202415/06/2024UnavailableUnexpected increase in consumer demand23/05/2024
    ezetimibeTablet, uncoated10 mgAnticipated26/07/202423/08/2024AvailableTransport / Logistic issues / Storage capacity issues23/05/2024
    imatinib mesilateTablet, film coated478 mgResolved15/03/202420/05/2024AvailableManufacturing23/05/2024
    tenofovir disoproxil fumarate~emtricitabineTablet, film coated300 mg~200 mgAnticipated14/06/20245/07/2024AvailableCommercial Changes / Commercial viability23/05/2024
    risperidoneTablet, film coated4 mgCurrent17/05/202420/09/2024UnavailableTransport / Logistic issues / Storage capacity issues23/05/2024
    fluorouracilInjection, solution50 mg/mLAnticipated9/09/202415/11/2024AvailableManufacturing23/05/2024
    sodium oxidronateInjection, powder for3.15 mgCurrent7/02/20243/06/2024UnavailableManufacturing23/05/2024
    griseofulvinTablet500 mgCurrent21/05/202415/06/2024UnavailableManufacturing22/05/2024
    duloxetine hydrochlorideCapsule, enteric67.3 mgCurrent26/03/20241/07/2024UnavailableManufacturing22/05/2024
    enoxaparin sodiumInjection, solution60 mgCurrent16/05/20246/06/2024UnavailableTransport / Logistic issues / Storage capacity issues22/05/2024
    fluoxetine hydrochlorideCapsule, hard22.35 mgResolved12/04/202417/05/2024AvailableManufacturing22/05/2024
    fluoxetine hydrochlorideCapsule, hard22.35 mgResolved12/04/202417/05/2024AvailableManufacturing22/05/2024
    dasatinibTablet, film coated70 mgAnticipated21/06/202423/08/2024AvailableCommercial Changes / Commercial viability22/05/2024
    clobazamTablet, uncoated10 mgResolved19/03/202420/05/2024AvailableTransport / Logistic issues / Storage capacity issues22/05/2024
    pegcetacoplanInjection, solution1080 mgResolved16/05/202416/05/2024AvailableManufacturing22/05/2024
    lidocaine hydrochloride monohydrateInjection, solution10 mg/mLCurrent21/05/202430/11/2024UnavailableManufacturing22/05/2024
    tretinoinCapsule, soft10 mgCurrent21/05/20247/06/2024Limited AvailabilityTransport / Logistic issues / Storage capacity issues22/05/2024
    lisinopril dihydrateTablet, uncoated10.89 mgAnticipated9/08/202422/11/2024AvailableTransport / Logistic issues / Storage capacity issues21/05/2024
    hydroxocobalamin chlorideInjection, solution1.027 mgCurrent3/05/202414/06/2024Limited AvailabilityTransport / Logistic issues / Storage capacity issues21/05/2024
    gliclazideTablet, modified release30 mgCurrent20/10/202321/06/2024Limited AvailabilityManufacturing21/05/2024
    ceftazidime pentahydrateInjection, powder for1.164 gCurrent9/04/202410/07/2024UnavailableManufacturing21/05/2024
    remifentanil hydrochlorideInjection, powder for1.097 mgCurrent15/04/202412/06/2024UnavailableManufacturing21/05/2024
    oxytocinInjection, solution10 IUResolved26/02/202421/05/2024AvailableManufacturing21/05/2024
    pramipexole dihydrochloride monohydrateTablet1 mgCurrent10/05/20246/09/2024Limited AvailabilityManufacturing21/05/2024
    pramipexole dihydrochloride monohydrateTablet.25 mgCurrent16/04/20246/09/2024UnavailableManufacturing21/05/2024
    oxazepamTablet, uncoated15 mgCurrent2/11/202330/09/2024UnavailableManufacturing21/05/2024
    doxepin hydrochlorideTablet, film coated56.5 mgCurrent17/05/20237/06/2024Limited AvailabilityManufacturing21/05/2024
    amlodipine besilate~atorvastatin calcium trihydrateTablet, film coated6.94 mg~86.751 mgCurrent23/04/202422/07/2024Limited AvailabilityManufacturing21/05/2024
    quetiapine fumarateTablet, modified release460.52 mgCurrent19/04/202419/07/2024UnavailableTransport / Logistic issues / Storage capacity issues21/05/2024
    hydrochlorothiazide~telmisartanTablet, film coated12.5 mg~80 mgCurrent9/05/20243/06/2024UnavailableManufacturing21/05/2024
    escitalopram oxalateTablet, film coated25.548 mgResolved26/04/202417/05/2024AvailableTransport / Logistic issues / Storage capacity issues21/05/2024
    valganciclovir hydrochlorideTablet, film coated496.3 mgCurrent25/10/202331/05/2024UnavailableManufacturing21/05/2024
    temozolomideCapsule, hard5 mgCurrent19/04/20244/10/2024UnavailableManufacturing21/05/2024
    temozolomideCapsule, hard100 mgAnticipated30/08/202420/09/2024AvailableTransport / Logistic issues / Storage capacity issues21/05/2024
    tretinoin~clindamycin phosphateGel.25 mg~12 mgCurrent22/03/20245/06/2024Limited AvailabilityManufacturing21/05/2024
    emtricitabine~tenofovir disoproxil maleateTablet, film coated200 mg~300 mgCurrent20/05/202430/06/2024Limited AvailabilityManufacturing21/05/2024
    irbesartanTablet, film coated300 mgAnticipated28/06/202412/07/2024AvailableTransport / Logistic issues / Storage capacity issues21/05/2024
    hydroxocobalamin acetateInjection, solution1.044 mgCurrent1/11/202320/06/2024UnavailableManufacturing21/05/2024
    atorvastatin calcium trihydrateTablet, film coated10.845 mgAnticipated28/06/202420/09/2024AvailableTransport / Logistic issues / Storage capacity issues21/05/2024
    cisplatinInjection, concentrated1 mg/mLCurrent9/04/202430/06/2024UnavailableUnexpected increase in consumer demand21/05/2024
    chloramphenicolEye Drops5 mg/mLAnticipated17/06/202431/07/2024AvailableUnexpected increase in demand due to other sponsors unable to supply21/05/2024
    metoprolol tartrateTablet, uncoated100 mgCurrent10/05/202414/06/2024Limited AvailabilityManufacturing21/05/2024
    bortezomibInjection, solution3.5 mgCurrent26/03/202416/08/2024Limited AvailabilityManufacturing21/05/2024
    oxazepamTablet, uncoated30 mgCurrent22/02/202430/09/2024UnavailableManufacturing21/05/2024
    ezetimibeTablet10 mgCurrent9/05/20249/08/2024UnavailableManufacturing21/05/2024
    tobramycinInhalation, conventional60 mg/mLCurrent5/12/202315/06/2024UnavailableManufacturing21/05/2024
    zopicloneTablet, film coated7.5 mgCurrent4/03/20246/09/2024Limited AvailabilityManufacturing21/05/2024
    zolpidem tartrateTablet, film coated10 mgAnticipated31/05/202430/08/2024AvailableManufacturing20/05/2024
    oxaliplatinInjection, intravenous infusion100 mgResolved18/03/202417/05/2024AvailableUnexpected increase in demand due to other sponsors unable to supply20/05/2024
    amlodipine besilateTablet, uncoated6.9335 mgCurrent11/04/202428/06/2024UnavailableManufacturing20/05/2024
    gemcitabine hydrochlorideInjection, solution1.139 gResolved26/03/202417/05/2024AvailableManufacturing20/05/2024
    fentanyl citrateInjection, solution.785 mgResolved11/04/202415/05/2024AvailableManufacturing20/05/2024
    rosuvastatin calcium~ezetimibeTablet~Tablet, film coated10.396 mg~10 mgResolved26/03/202417/05/2024AvailableManufacturing20/05/2024
    rosuvastatin calcium~ezetimibeTablet~Tablet, film coated20.791 mg~10 mgCurrent17/05/202428/06/2024UnavailableManufacturing20/05/2024
    ezetimibe~rosuvastatin calciumTablet~Tablet, film coated10 mg~5.198 mgResolved26/03/202417/05/2024AvailableManufacturing20/05/2024
    rosuvastatin calcium~ezetimibeTablet~Tablet, film coated10.396 mg~10 mgCurrent17/05/202430/06/2024UnavailableManufacturing20/05/2024
    escitalopram oxalateTablet, film coated12.74 mgCurrent12/04/202412/07/2024UnavailableTransport / Logistic issues / Storage capacity issues20/05/2024
    mercaptopurine monohydrateOral Liquid, suspension20 mg/mLResolved17/05/202417/05/2024AvailableManufacturing20/05/2024
    tadalafilTablet, film coated5 mgAnticipated28/06/202431/07/2024AvailableManufacturing20/05/2024
    mesalazineTablet, enteric coated800 mgAnticipated3/06/202431/07/2024AvailableTransport / Logistic issues / Storage capacity issues20/05/2024
    sodium nitriteSolution300 mgResolved3/05/202314/05/2024AvailableManufacturing20/05/2024
    metformin hydrochlorideTablet, film coated500 mgResolved10/01/202417/05/2024AvailableManufacturing20/05/2024
    latanoprostEye Drops, solution.05 mg/mLCurrent1/02/20243/06/2024UnavailableManufacturing20/05/2024
    hydrochlorothiazide~irbesartanTablet, film coated12.5 mg~300 mgResolved14/03/20249/05/2024AvailableManufacturing20/05/2024
    SemaglutideInjection, solution1.34 mg/mLCurrent15/04/202231/12/2024Limited AvailabilityUnexpected increase in consumer demand20/05/2024
    lacosamideTablet, film coated50 mgCurrent28/03/20243/06/2024UnavailableManufacturing20/05/2024
    hydrochlorothiazide~olmesartan medoxomil~amlodipine besilateTablet, film coated12.5 mg~40 mg~6.95 mgCurrent31/07/202320/09/2024Limited AvailabilityManufacturing20/05/2024
    SemaglutideInjection, solution1.34 mg/mLCurrent15/04/202231/12/2024Limited AvailabilityUnexpected increase in consumer demand20/05/2024
    bendamustine hydrochloride monohydrateInjection, powder for25 mgCurrent7/03/202429/05/2024Limited AvailabilityUnexpected increase in demand due to other sponsors unable to supply20/05/2024
    doxycycline hyclateTablet, film coated115 mgCurrent10/05/202421/06/2024Limited AvailabilityManufacturing20/05/2024
    indometacinCapsule, hard25 mgResolved14/03/202417/05/2024AvailableManufacturing20/05/2024
    amoxicillin trihydrateOral Liquid, powder for114.82 mg/mLCurrent29/07/20223/06/2024UnavailableManufacturing20/05/2024
  • 2024.05.20
    Active ingredientsDosage formQuantity of active ingredientsShortage statusSupply impact start dateSupply impact end dateAvailabilityReasonLast updated
    aciclovirInjection, solution25 mg/mLCurrent22/08/202310/01/2025UnavailableManufacturing19/05/2024
    daunorubicinInjection, solution20 mgResolved28/03/202417/05/2024AvailableManufacturing17/05/2024
    amlodipine besilateTablet, uncoated6.94 mgCurrent13/05/202414/06/2024Limited AvailabilityManufacturing17/05/2024
    risperidoneTablet, film coated1 mgCurrent14/12/202320/09/2024UnavailableManufacturing17/05/2024
    risperidoneTablet, film coated2 mgCurrent5/01/202420/09/2024Limited AvailabilityManufacturing17/05/2024
    propranolol hydrochlorideTablet, film coated40 mgAnticipated28/05/202421/06/2024AvailableManufacturing17/05/2024
    perindopril erbumineTablet8 mgAnticipated7/06/202430/06/2024AvailableManufacturing17/05/2024
    montelukast sodiumTablet, chewable5.2 mgCurrent5/02/20247/06/2024Limited AvailabilityManufacturing17/05/2024
    cefepime hydrochloride monohydrateInjection, powder for2.378 gCurrent17/05/202431/05/2024Limited AvailabilityUnexpected increase in consumer demand17/05/2024
    quetiapine fumarateTablet, film coated28.78 mgResolved28/03/20249/05/2024AvailableManufacturing17/05/2024
    esomeprazole magnesium dihydrateTablet, enteric coated43.5 mgCurrent10/05/202431/05/2024Limited AvailabilityTransport / Logistic issues / Storage capacity issues17/05/2024
    escitalopram oxalateTablet, film coated25.548 mgCurrent26/04/202424/05/2024Limited AvailabilityTransport / Logistic issues / Storage capacity issues17/05/2024
    betahistine dihydrochlorideTablet, uncoated16 mgCurrent28/07/202320/12/2024UnavailableManufacturing17/05/2024
    temozolomideCapsule, hard100 mgAnticipated30/08/20244/10/2024AvailableTransport / Logistic issues / Storage capacity issues17/05/2024
    olanzapineTablet, uncoated7.5 mgCurrent8/12/202312/07/2024Limited AvailabilityTransport / Logistic issues / Storage capacity issues17/05/2024
    risperidoneTablet, film coated3 mgCurrent1/03/202420/09/2024UnavailableTransport / Logistic issues / Storage capacity issues17/05/2024
    metronidazoleInjection, solution500 mgResolved6/05/202414/05/2024AvailableTransport / Logistic issues / Storage capacity issues17/05/2024
    aciclovirInjection, solution25 mg/mLCurrent15/05/20241/08/2024UnavailableUnexpected increase in demand due to other sponsors unable to supply17/05/2024
    dosulepin (dothiepin) hydrochlorideCapsule, hard25 mgCurrent10/05/202412/07/2024Limited AvailabilityManufacturing17/05/2024
    lidocaine hydrochloride monohydrateInjection, solution42.64 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability17/05/2024
    lidocaine hydrochloride monohydrateInjection, solution21.32 mgDiscontinuedUnavailableCommercial Changes / Commercial viability17/05/2024
    Vibrio choleraeSuspension, powder for400000000 CFUResolved15/03/202430/04/2024AvailableUnexpected increase in demand due to other sponsors unable to supply17/05/2024
    calcium folinateInjection, solution54 mgResolved11/01/202417/05/2024AvailableManufacturing17/05/2024
    raltitrexedInjection, powder for2 mgResolved16/04/202417/05/2024AvailableManufacturing17/05/2024
    aciclovirInjection, solution25 mg/mLCurrent28/07/202328/06/2024UnavailableUnexpected increase in demand due to other sponsors unable to supply17/05/2024
    rizatriptan benzoateWafer14.53 mgCurrent15/01/20245/08/2024Limited AvailabilityUnexpected increase in demand due to other sponsors unable to supply17/05/2024
    ganirelixInjection, solution.5 mg/mLResolved10/05/202416/05/2024AvailableManufacturing17/05/2024
    olanzapineInjection, powder for10 mgAnticipated27/05/20247/06/2024AvailableTransport / Logistic issues / Storage capacity issues17/05/2024
    duloxetine hydrochlorideCapsule, enteric33.7 mgCurrent29/04/20241/05/2025UnavailableManufacturing16/05/2024
    povidoneiodineApplication100 mg/mLCurrent27/05/20221/07/2024UnavailableCommercial Changes / Commercial viability16/05/2024
    metoprolol succinateTablet, modified release190 mgCurrent11/04/202421/06/2024Limited AvailabilityManufacturing16/05/2024
    duloxetine hydrochlorideCapsule, enteric33.65 mgCurrent19/03/202431/05/2024UnavailableManufacturing16/05/2024
    bortezomibInjection, powder for3.5 mgCurrent15/03/202431/05/2024Limited AvailabilityManufacturing16/05/2024
    entecavirTablet, film coated1 mgCurrent14/03/202430/07/2024UnavailableManufacturing16/05/2024
    epirubicin hydrochlorideInjection, concentrated200 mgCurrent9/04/20246/09/2024UnavailableManufacturing16/05/2024
    temozolomideCapsule, hard5 mgCurrent19/04/202420/09/2024Limited AvailabilityManufacturing16/05/2024
    latanoprostEye Drops, solution.05 mg/mLCurrent1/02/202424/05/2024UnavailableManufacturing16/05/2024
    atomoxetine hydrochlorideCapsule, hard45.5 mgAnticipated30/08/202420/12/2024AvailableTransport / Logistic issues / Storage capacity issues16/05/2024
    clobazamTablet, uncoated10 mgCurrent19/03/202420/05/2024UnavailableTransport / Logistic issues / Storage capacity issues16/05/2024
    deferasiroxTablet, film coated360 mgResolved16/10/202315/05/2024AvailableManufacturing16/05/2024
    estradiol~estradiol~norethisterone acetateDrug delivery system, transdermal.62 mg~.78 mg~2.7 mgCurrent14/02/202417/06/2024UnavailableManufacturing16/05/2024
    metoprolol succinateTablet, modified release190 mgResolved10/04/202415/05/2024AvailableManufacturing16/05/2024
    lidocaine hydrochloride monohydrateInjection, solution20 mg/mLCurrent28/03/202430/11/2024UnavailableManufacturing16/05/2024
    fluoxetine hydrochlorideCapsule, hard22.36 mgCurrent15/04/202430/06/2024Limited AvailabilityManufacturing16/05/2024
    anastrozoleTablet, film coated1 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability16/05/2024
    desonideLotion.5 mg/gAnticipated31/05/202415/08/2024AvailableManufacturing16/05/2024
    disulfiramTablet, effervescent200 mgCurrent14/09/202323/08/2024UnavailableManufacturing16/05/2024
    diltiazem hydrochlorideTablet, film coated60 mgAnticipated18/07/202418/09/2024AvailableManufacturing16/05/2024
    mirtazapineTablet, film coated30 mgCurrent12/03/202431/05/2024UnavailableManufacturing16/05/2024
    zopicloneTablet, film coated7.5 mgCurrent4/03/202431/07/2024Limited AvailabilityManufacturing16/05/2024
    hydrogen peroxideSolution30 mg/mLResolved30/08/202314/05/2024AvailableCommercial Changes / Commercial viability15/05/2024
    carvedilolTablet, film coated12.5 mgResolved2/11/202310/05/2024AvailableManufacturing15/05/2024
    iopromideInjection, solution498.72 mg/mLResolved29/01/202414/05/2024AvailableUnexpected increase in consumer demand15/05/2024
    remifentanil hydrochlorideInjection, powder for1.097 mgCurrent15/04/202431/05/2024Limited AvailabilityManufacturing15/05/2024
    montelukast sodiumTablet, chewable4.16 mgCurrent12/09/20237/06/2024UnavailableManufacturing15/05/2024
    amlodipine besilate~atorvastatin calcium trihydrateTablet, film coated6.94 mg~86.751 mgCurrent23/04/202415/07/2024Limited AvailabilityManufacturing15/05/2024
    AbataceptInjection125.875 mgCurrent8/05/202430/09/2024Limited AvailabilityUnexpected increase in consumer demand15/05/2024
    escitalopram oxalateTablet, film coated12.774 mgResolved19/04/202410/05/2024AvailableTransport / Logistic issues / Storage capacity issues15/05/2024
    pregabalinCapsule, hard25 mgResolved1/07/202315/02/2024AvailableManufacturing15/05/2024
    AbataceptInjection125.875 mgCurrent8/05/202430/08/2024Limited AvailabilityManufacturing15/05/2024
    ezetimibeTablet10 mgCurrent4/12/20239/08/2024UnavailableManufacturing15/05/2024
    imatinib mesilateTablet, film coated478 mgCurrent15/03/202420/05/2024UnavailableManufacturing15/05/2024
    fluoxetine hydrochlorideCapsule, hard22.35 mgCurrent12/04/20242/08/2024Limited AvailabilityManufacturing15/05/2024
    fluoxetine hydrochlorideCapsule, hard22.35 mgCurrent12/04/202421/06/2024Limited AvailabilityManufacturing15/05/2024
    imatinib mesilateTablet, film coated119.5 mgCurrent10/04/202420/05/2024Limited AvailabilityManufacturing15/05/2024
    fluorouracilInjection, solution50 mg/mLCurrent11/04/202422/07/2024UnavailableManufacturing15/05/2024
    mercaptopurine monohydrateTablet50 mgCurrent10/05/202414/06/2024Limited AvailabilityManufacturing15/05/2024
    amlodipine besilate~hydrochlorothiazide~olmesartan medoxomilTablet, film coated6.95 mg~25 mg~40 mgCurrent31/07/202320/09/2024UnavailableManufacturing15/05/2024
    varenicline tartrate~varenicline tartrateTablet, film coated1.71 mg~.855 mgResolved15/03/202431/03/2024AvailableManufacturing15/05/2024
    iopromideInjection, solution768.86 mg/mLResolved18/03/202414/05/2024AvailableUnexpected increase in consumer demand15/05/2024
    metformin hydrochlorideTablet, film coated500 mgCurrent26/04/202423/08/2024Limited AvailabilityTransport / Logistic issues / Storage capacity issues15/05/2024
    ganciclovir sodiumInjection, powder for543 mgAnticipated30/05/202414/06/2024AvailableManufacturing14/05/2024
    gentamicinInjection, solution80 mgAnticipated1/11/202431/03/2025AvailableManufacturing14/05/2024
    warfarin sodiumTablet, uncoated5 mgCurrent23/04/202431/05/2024Limited AvailabilityManufacturing14/05/2024
    fluoxetine hydrochlorideCapsule, hard22.36 mgCurrent7/05/20241/06/2025UnavailableManufacturing14/05/2024
    galantamine hydrobromideCapsule, modified release30.768 mgResolved6/06/202214/05/2024AvailableManufacturing14/05/2024
    galantamine hydrobromideCapsule, modified release10.256 mgResolved31/05/202314/05/2024AvailableManufacturing14/05/2024
    midazolamInjection, solution5 mgResolved2/04/202410/05/2024AvailableManufacturing14/05/2024
    SomatropinInjection, solution5.83 mg/mLResolved23/04/20249/05/2024AvailableTransport / Logistic issues / Storage capacity issues14/05/2024
    donepezil hydrochlorideTablet, film coated10 mgCurrent8/03/202430/06/2024Limited AvailabilityManufacturing14/05/2024
    pramipexole dihydrochloride monohydrateTablet1 mgCurrent10/05/20247/07/2024Limited AvailabilityManufacturing14/05/2024
    doxepin hydrochlorideTablet, film coated56.5 mgCurrent17/05/202324/05/2024Limited AvailabilityManufacturing14/05/2024
    allopurinolTablet300 mgResolved14/02/202414/05/2024AvailableManufacturing14/05/2024
    atorvastatin calcium trihydrateTablet, film coated86.76 mgCurrent13/03/202417/05/2024UnavailableTransport / Logistic issues / Storage capacity issues14/05/2024
    ciprofloxacin hydrochlorideTablet, film coated555 mgCurrent10/05/202431/12/2024Limited AvailabilityManufacturing14/05/2024
    duloxetine hydrochlorideCapsule, enteric67.3 mgCurrent9/02/202414/06/2024UnavailableUnexpected increase in demand due to other sponsors unable to supply14/05/2024
    clindamycin phosphate~tretinoinGel12 mg~.25 mgCurrent22/03/202424/05/2024Limited AvailabilityManufacturing14/05/2024
    pemetrexed disodiumInjection, powder for110.28 mgCurrent23/11/202231/08/2024UnavailableManufacturing14/05/2024
    pemetrexed disodiumInjection, powder for551.4 mgCurrent1/08/202319/07/2024UnavailableManufacturing14/05/2024
    pemetrexed disodiumInjection, powder for1102.8 mgCurrent1/11/202330/08/2024UnavailableManufacturing14/05/2024
    mupirocinOintment20 mg/gCurrent9/05/202431/07/2024Limited AvailabilityManufacturing14/05/2024
    risperidoneTablet, film coated1 mgCurrent6/10/202320/09/2024UnavailableManufacturing14/05/2024
    risperidoneTablet, film coated2 mgCurrent6/10/202320/09/2024Limited AvailabilityManufacturing14/05/2024
    codeine phosphate hemihydrate~paracetamol~doxylamine succinateTablet, uncoated30 mg~450 mg~5 mgCurrent20/10/20239/08/2024UnavailableManufacturing14/05/2024
    isotretinoinCapsule, soft20 mgCurrent24/01/20247/06/2024UnavailableManufacturing14/05/2024
    metoprolol tartrateTablet, uncoated100 mgCurrent10/05/202431/05/2024Limited AvailabilityManufacturing14/05/2024
    flecainide acetateTablet50 mgCurrent10/05/202414/06/2024Limited AvailabilityManufacturing14/05/2024
    cefaclor monohydrateOral Liquid, powder for52.45 mg/mLCurrent18/01/202331/12/2024Limited AvailabilityUnexpected increase in consumer demand14/05/2024
    cefaclor monohydrateOral Liquid, powder for26.22 mg/mLCurrent7/06/202330/10/2024UnavailableManufacturing14/05/2024
    prucalopride succinateTablet2.642 mgCurrent9/05/202431/07/2024UnavailableManufacturing14/05/2024
    naproxenTablet500 mgResolved26/01/202413/05/2024AvailableManufacturing14/05/2024
    cefaclor monohydrateOral Liquid, powder for52.45 mg/mLCurrent10/05/202431/12/2024Limited AvailabilityManufacturing14/05/2024
    mupirocin calciumCream20.7683 mg/gResolved22/04/20249/05/2024AvailableUnexpected increase in consumer demand14/05/2024
    cefalexin monohydrateOral Liquid, powder for26.3 mg/mLCurrent10/05/202430/09/2024Limited AvailabilityManufacturing14/05/2024
    pravastatin sodiumTablet, uncoated40 mgCurrent10/05/202430/08/2024Limited AvailabilityManufacturing14/05/2024
    tobramycinInjection, solution80 mgResolved29/06/20239/05/2024AvailableManufacturing13/05/2024
    gliclazideTablet, modified release30 mgCurrent20/10/202321/06/2024Limited AvailabilityManufacturing13/05/2024
    ropivacaine hydrochlorideInjection, solution20 mgResolved26/04/202413/05/2024AvailableTransport / Logistic issues / Storage capacity issues13/05/2024
    vecuronium bromideInjection, powder for10 mgCurrent1/11/202331/07/2024UnavailableManufacturing13/05/2024
    atorvastatin calcium trihydrate~ezetimibeTablet, film coated82.725 mg~10 mgAnticipated14/06/202412/07/2024AvailableManufacturing13/05/2024
    bendamustine hydrochloride monohydrateInjection, powder for25 mgCurrent7/03/202419/05/2024Limited AvailabilityUnexpected increase in demand due to other sponsors unable to supply13/05/2024
    pegcetacoplanInjection, solution1080 mgAnticipated1/06/202430/06/2024AvailableManufacturing13/05/2024
    hydralazine hydrochlorideTablet, film coated50 mgResolved25/01/202410/05/2024AvailableManufacturing13/05/2024
    ketamine hydrochlorideInjection, solution115.3 mg/mLCurrent18/08/202331/10/2024UnavailableManufacturing13/05/2024
    clonidine hydrochlorideTablet, uncoated150 microgramAnticipated20/05/20247/06/2024AvailableManufacturing13/05/2024
  • 2024.05.13
    Active ingredientsDosage formQuantity of active ingredientsShortage statusSupply impact start dateAvailabilityReasonLast updated
    betiatideInjection, powder for1 mgCurrent30/04/2024UnavailableManufacturing10/05/2024
    eplerenoneTablet, film coated25 mgResolved2/04/2024AvailableUnexpected increase in consumer demand10/05/2024
    paracetamol~codeine phosphate hemihydrate~doxylamine succinateTablet, uncoated450 mg~30 mg~5 mgResolved2/05/2024AvailableManufacturing10/05/2024
    morphine sulfate pentahydrateInjection, solution15 mgDiscontinuedReduction in supply until supply is exhaustedUnexpected increase in demand due to other sponsors unable to supply10/05/2024
    lisinopril dihydrateTablet, uncoated10.89 mgAnticipated13/09/2024AvailableUnexpected increase in demand due to other sponsors unable to supply10/05/2024
    fosamprenavir calciumTablet, film coated853.2 mgDiscontinuedReduction in supply until supply is exhaustedManufacturing10/05/2024
    gabapentinCapsule, hard400 mgResolved21/02/2024AvailableManufacturing10/05/2024
    irbesartanTablet, film coated75 mgDiscontinuedReduction in supply until supply is exhaustedUnexpected increase in consumer demand10/05/2024
    irbesartanTablet, film coated75 mgDiscontinuedReduction in supply until supply is exhaustedManufacturing10/05/2024
    levonorgestrel~levonorgestrel~levonorgestrel~ethinylestradiol~ethinylestradiolTablet, sugar coated.05 mg~.075 mg~.125 mg~.04 mg~.03 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability10/05/2024
    bortezomibInjection, powder for3.5 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability10/05/2024
    indometacinSuppository, moulded100 mgResolved14/03/2024AvailableManufacturing10/05/2024
    cilastatin~imipenemInjection, powder for500 mg~500 mgDiscontinuedReduction in supply until supply is exhaustedUnexpected increase in consumer demand10/05/2024
    paclitaxelInjection, concentrated6 mg/mLResolved29/02/2024AvailableManufacturing9/05/2024
    fulvestrantInjection, solution50 mg/mLDiscontinuedReduction in supply until supply is exhaustedManufacturing9/05/2024
    prazosin hydrochlorideTablet, uncoated5.476 mgCurrent3/04/2024Limited AvailabilityUnexpected increase in consumer demand9/05/2024
    tobramycinInjection, solution80 mgCurrent29/06/2023UnavailableManufacturing9/05/2024
    methotrexateInjection, solution1000 mgDiscontinuedReduction in supply until supply is exhaustedManufacturing9/05/2024
    potassium chlorideInjection, concentrated750 mgResolved5/05/2023AvailableManufacturing9/05/2024
    sodium chlorideInjection, intravenous infusion450 mgDiscontinuedReduction in supply until supply is exhaustedManufacturing9/05/2024
    amantadine hydrochlorideCapsule, soft100 mgResolved8/02/2024AvailableCommercial Changes / Commercial viability9/05/2024
    tetracosactideInjection, modified release1 mg/mLCurrent1/02/2019UnavailableUnexpected increase in demand due to other sponsors unable to supply9/05/2024
    chlorhexidine gluconateSolution, irrigation30 mgAnticipated1/06/2024AvailableTransport / Logistic issues / Storage capacity issues9/05/2024
    thallous(201Tl) chlorideInjection, solution74 MBq/mLCurrent1/08/2021UnavailableManufacturing9/05/2024
    sodium chlorideSolution, irrigation270 mgResolved17/02/2023AvailableManufacturing9/05/2024
    atropine sulfate monohydrateInjection, solution1.2 mg/mLAnticipated31/05/2024AvailableTransport / Logistic issues / Storage capacity issues9/05/2024
    bupivacaine hydrochloride monohydrateInjection, solution52.7 mgResolved11/03/2024AvailableTransport / Logistic issues / Storage capacity issues9/05/2024
    bupivacaine hydrochloride monohydrateInjection, solution52.8 mgResolved25/09/2023AvailableUnexpected increase in consumer demand9/05/2024
    cytarabineInjection, solution1 gDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability9/05/2024
    povidoneiodineApplication50 mg/mLDiscontinuedReduction in supply until supply is exhaustedManufacturing9/05/2024
    gentamicinInjection, solution80 mgAnticipated1/11/2024AvailableManufacturing9/05/2024
    hydrogen peroxideSolution30 mg/mLCurrent30/08/2023UnavailableTransport / Logistic issues / Storage capacity issues8/05/2024
    indapamide hemihydrate~perindopril erbumineTablet, uncoated1.25 mg~4 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability8/05/2024
    erlotinib hydrochlorideTablet, film coated27.32 mgDiscontinuedReduction in supply until supply is exhaustedManufacturing8/05/2024
    erlotinib hydrochlorideTablet, film coated109.29 mgDiscontinuedUnavailableManufacturing8/05/2024
    erlotinib hydrochlorideTablet, film coated163.93 mgDiscontinuedReduction in supply until supply is exhaustedManufacturing8/05/2024
    salbutamol sulfateInhalation, conventional3 mgCurrent30/12/2022UnavailableManufacturing8/05/2024
    calcium folinateInjection324.1 mgResolved27/06/2023AvailableManufacturing8/05/2024
    clarithromycinTablet, film coated250 mgDiscontinuedReduction in supply until supply is exhaustedManufacturing8/05/2024
    acetylcholine chlorideSolution, powder for irrigation10 mg/mLCurrent15/09/2023UnavailableTransport / Logistic issues / Storage capacity issues8/05/2024
    colestyraminePowder, oral850 mg/gCurrent30/03/2023Limited AvailabilityManufacturing8/05/2024
    adrenaline (epinephrine) acid tartrate~lidocaine hydrochlorideInjection, solution9.1 microgram/mL~5 mg/mLCurrent22/12/2021UnavailableUnexpected increase in consumer demand8/05/2024
    adrenaline (epinephrine) acid tartrate~lidocaine hydrochlorideInjection, solution9.1 microgram/mL~20 mg/mLCurrent19/10/2023UnavailableTransport / Logistic issues / Storage capacity issues8/05/2024
    duloxetine hydrochlorideCapsule, enteric33.7 mgCurrent29/04/2024Limited AvailabilityManufacturing8/05/2024
    duloxetine hydrochlorideCapsule, enteric67.3 mgAnticipated15/08/2024AvailableManufacturing8/05/2024
    metformin hydrochlorideTablet, modified release500 mgCurrent16/04/2020UnavailableManufacturing8/05/2024
    hydroxocobalamin chlorideInjection, solution1.027 mgCurrent3/05/2024Limited AvailabilityTransport / Logistic issues / Storage capacity issues8/05/2024
    perindopril erbumineTablet, uncoated2 mgDiscontinuedReduction in supply until supply is exhaustedManufacturing8/05/2024
    perindopril erbumineTablet, uncoated4 mgDiscontinuedUnavailableManufacturing8/05/2024
    perindopril erbumineTablet, uncoated8 mgDiscontinuedReduction in supply until supply is exhaustedManufacturing8/05/2024
    glimepirideTablet, uncoated1 mgResolved13/10/2023AvailableUnexpected increase in demand due to other sponsors unable to supply8/05/2024
    glimepirideTablet, uncoated2 mgResolved3/11/2023AvailableCommercial Changes / Commercial viability8/05/2024
    glimepirideTablet, uncoated3 mgCurrent14/04/2023UnavailableCommercial Changes / Commercial viability8/05/2024
    medroxyprogesterone acetateInjection, suspension150 mg/mLDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability8/05/2024
    ciprofloxacinInjection, solution200 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability8/05/2024
    ciprofloxacinInjection, solution400 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability8/05/2024
    carvedilolTablet, film coated12.5 mgCurrent2/11/2023UnavailableCommercial Changes / Commercial viability8/05/2024
    varenicline tartrate~varenicline tartrateTablet, film coated1.71 mg~.85 mgCurrent4/06/2021UnavailableCommercial Changes / Commercial viability8/05/2024
    varenicline tartrateTablet, film coated1.71 mgCurrent4/06/2021UnavailableCommercial Changes / Commercial viability8/05/2024
    warfarin sodiumTablet, uncoated1 mgResolved19/01/2024AvailableManufacturing7/05/2024
    warfarin sodiumTablet, uncoated5 mgCurrent23/04/2024Limited AvailabilityTransport / Logistic issues / Storage capacity issues7/05/2024
    amisulprideTablet, uncoated100 mgDiscontinuedReduction in supply until supply is exhaustedManufacturing7/05/2024
    efavirenzTablet, film coated200 mgDiscontinuedReduction in supply until supply is exhaustedManufacturing7/05/2024
    salbutamol sulfateInhalation1.2 mg/mLResolved15/11/2023AvailableTransport / Logistic issues / Storage capacity issues7/05/2024
    trandolaprilCapsule.5 mgCurrent13/02/2024Limited AvailabilityUnexpected increase in demand due to other sponsors unable to supply7/05/2024
    perindopril erbumineTablet, uncoated4 mgDiscontinuedUnavailableManufacturing7/05/2024
    perindopril erbumineTablet, uncoated8 mgDiscontinuedUnavailableTransport / Logistic issues / Storage capacity issues7/05/2024
    metformin hydrochlorideTablet, film coated850 mgResolved13/10/2023AvailableManufacturing7/05/2024
    water for injections~Mumps virus~Rubella virus~Measles virus~live varicella vaccineInjection, diluent for~Injection, powder for.75 mL~4.3 TCID50~3 TCID50~3 TCID50~3.99 PFUCurrent30/06/2023UnavailableManufacturing7/05/2024
    risperidoneTablet, film coated3 mgResolved13/10/2023AvailableManufacturing7/05/2024
    meloxicamTablet, uncoated7.5 mgDiscontinuedReduction in supply until supply is exhaustedManufacturing7/05/2024
    meloxicamTablet, uncoated15 mgDiscontinuedReduction in supply until supply is exhaustedManufacturing7/05/2024
    povidoneiodineApplication100 mg/mLCurrent27/05/2022UnavailableManufacturing7/05/2024
    hydrochlorothiazide~enalapril maleateTablet, uncoated6 mg~20 mgCurrent23/03/2021UnavailableManufacturing7/05/2024
    daunorubicinInjection, solution20 mgCurrent28/03/2024Limited AvailabilityTransport / Logistic issues / Storage capacity issues7/05/2024
    bupivacaine hydrochloride monohydrateInjection, solution105.4 mgDiscontinuedReduction in supply until supply is exhaustedManufacturing7/05/2024
    meloxicamTablet, uncoated15 mgResolved3/01/2024AvailableManufacturing7/05/2024
    lisinopril dihydrateTablet, uncoated21.78 mgDiscontinuedUnavailableManufacturing7/05/2024
    phenoxybenzamine hydrochlorideCapsule, hard10 mgCurrent1/10/2008UnavailableManufacturing7/05/2024
    ramiprilTablet, uncoated1.25 mgDiscontinuedReduction in supply until supply is exhaustedManufacturing7/05/2024
    ramiprilTablet, uncoated2.5 mgDiscontinuedReduction in supply until supply is exhaustedManufacturing7/05/2024
    live varicella vaccineInjection, powder for19400 PFUDiscontinuedUnavailableManufacturing7/05/2024
    sodium pertechnetate(99mTc)Injection, solution18.5 GBqCurrent30/11/2020UnavailableManufacturing6/05/2024
    diltiazem hydrochlorideCapsule, modified release180 mgDiscontinuedReduction in supply until supply is exhaustedManufacturing6/05/2024
    diltiazem hydrochlorideCapsule, modified release240 mgDiscontinuedReduction in supply until supply is exhaustedManufacturing6/05/2024
    diltiazem hydrochlorideCapsule, modified release360 mgDiscontinuedReduction in supply until supply is exhaustedManufacturing6/05/2024
    paracetamol~codeine phosphate hemihydrateOral Liquid24 mg/mL~1 mg/mLDiscontinuedReduction in supply until supply is exhaustedManufacturing6/05/2024
    oxaliplatinInjection, intravenous infusion100 mgCurrent18/03/2024Limited AvailabilityProduct recall6/05/2024
    morphine sulfate pentahydrateTablet, modified release10 mgCurrent10/05/2022UnavailableManufacturing6/05/2024
    morphine sulfate pentahydrateTablet, modified release30 mgCurrent18/11/2022UnavailableManufacturing6/05/2024
    morphine sulfate pentahydrateTablet, modified release60 mgCurrent14/02/2023UnavailableManufacturing6/05/2024
    morphine sulfate pentahydrateTablet, modified release100 mgCurrent19/04/2023Limited AvailabilityUnexpected increase in consumer demand6/05/2024
    sitagliptin phosphate monohydrateTablet, film coated128.5 mgDiscontinuedReduction in supply until supply is exhaustedUnexpected increase in consumer demand6/05/2024
    sitagliptin phosphate monohydrateTablet, film coated64.25 mgDiscontinuedReduction in supply until supply is exhaustedManufacturing6/05/2024
    sitagliptin phosphate monohydrateTablet, film coated32.13 mgDiscontinuedReduction in supply until supply is exhaustedUnexpected increase in consumer demand6/05/2024
    quinapril hydrochlorideTablet, film coated21.664 mgDiscontinuedUnavailableManufacturing6/05/2024
    sodium thiosulfate pentahydrateInjection, solution2.5 gResolved7/08/2023AvailableManufacturing6/05/2024
    Interferon beta1aInjection, solution88 microgram/mLDiscontinuedReduction in supply until supply is exhaustedManufacturing6/05/2024TGAオーストラリア供給不足情報(4月22日~4月28日)
  • 2024.05.06
    Active ingredientsDosage formQuantity of active ingredientsShortage statusSupply impact start dateAvailabilityReasonLast updated
    paracetamol~codeine phosphate hemihydrate~doxylamine succinateTablet, uncoated450 mg~30 mg~5 mgResolved2/05/2024AvailableManufacturing6/05/2024
    fluoxetine hydrochlorideCapsule, hard22.36 mgAnticipated13/05/2024AvailableManufacturing6/05/2024
    gliclazideTablet, modified release30 mgCurrent20/10/2023Limited AvailabilityManufacturing6/05/2024
    silver sulfadiazineCream10 mg/gCurrent31/01/2024UnavailableManufacturing6/05/2024
    betamethasone sodium phosphate~betamethasone acetateInjection, suspension3.9 mg/mL~3 mg/mLCurrent1/02/2023Limited AvailabilityProduct recall6/05/2024
    rosuvastatin calcium~ezetimibeTablet~Tablet, film coated10.396 mg~10 mgCurrent26/03/2024Limited AvailabilityManufacturing6/05/2024
    cisplatinInjection, concentrated1 mg/mLCurrent9/04/2024UnavailableUnexpected increase in consumer demand6/05/2024
    cisplatinInjection, concentrated1 mg/mLCurrent9/04/2024UnavailableUnexpected increase in consumer demand6/05/2024
    rosuvastatin calciumTablet, film coated5.21 mgCurrent26/04/2024Limited AvailabilityManufacturing6/05/2024
    thiotepaInjection, powder for100 mgCurrent3/05/2024UnavailableUnexpected increase in consumer demand6/05/2024
    ketoprofenCapsule, modified release185.8 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability6/05/2024
    cisplatinInjection, solution1 mg/mLCurrent2/04/2024Limited AvailabilityManufacturing6/05/2024
    ethinylestradiol~norethisteroneTablet, uncoated36 microgram~1 mgCurrent26/04/2024Limited AvailabilityManufacturing6/05/2024
    amoxicillin trihydrateOral Liquid, powder for114.82 mg/mLCurrent29/07/2022UnavailableManufacturing6/05/2024
    Interferon beta1aInjection, solution88 microgram/mLDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability5/05/2023
    estradiol hemihydrateDrug delivery system, transdermal3.09 mgCurrent23/04/2024Limited AvailabilityUnexpected increase in demand due to other sponsors unable to supply5/05/2024
    bupivacaine hydrochloride monohydrateInjection, solution52.7 mgResolved11/03/2024AvailableUnexpected increase in consumer demand3/05/2024
    hydrochlorothiazide~enalapril maleateTablet, uncoated6 mg~20 mgCurrent23/03/2021UnavailableManufacturing3/05/2024
    diazoxideInjection, solution15 mg/mLAnticipated1/08/2024AvailableTransport / Logistic issues / Storage capacity issues3/05/2024
    betahistine dihydrochlorideTablet, uncoated16 mgCurrent28/07/2023UnavailableManufacturing3/05/2024
    fentanyl citrateTablet.4713 mgCurrent4/04/2024Limited AvailabilityTransport / Logistic issues / Storage capacity issues3/05/2024
    metformin hydrochlorideTablet, film coated500 mgCurrent10/01/2024UnavailableManufacturing3/05/2024
    Insulin lisproInjection, solution100 IU/mLCurrent3/05/2024Limited AvailabilityManufacturing3/05/2024
    cefalexin monohydrateSuspension, powder for26.288 mg/mLCurrent13/01/2023Limited AvailabilityManufacturing3/05/2024
    nifedipineTablet, modified release60 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability3/05/2023
    bortezomibInjection, powder for3.5 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability2/05/2024
    duloxetine hydrochlorideCapsule, enteric33.7 mgCurrent29/04/2024Limited AvailabilityManufacturing2/05/2024
    duloxetine hydrochlorideCapsule, enteric67.3 mgAnticipated15/08/2024AvailableManufacturing2/05/2024
    Insulin glargineInjection, solution3.6378 mg/mLAnticipated14/06/2024AvailableManufacturing2/05/2024
    silver sulfadiazineCream10 mg/gCurrent31/01/2024UnavailableManufacturing2/05/2024
    levetiracetamTablet, film coated1000 mgAnticipated12/07/2024AvailableTransport / Logistic issues / Storage capacity issues2/05/2024
    montelukast sodiumTablet, chewable5.2 mgCurrent20/03/2024UnavailableManufacturing2/05/2024
    montelukast sodiumTablet, chewable4.16 mgCurrent9/01/2024UnavailableManufacturing2/05/2024
    levetiracetamTablet, film coated500 mgResolved13/12/2023AvailableManufacturing2/05/2024
    carmustineInjection, powder for100 mgAnticipated30/05/2024AvailableManufacturing2/05/2024
    quetiapine fumarateTablet, modified release460.52 mgCurrent19/04/2024UnavailableTransport / Logistic issues / Storage capacity issues2/05/2024
    paracetamolInjection, solution10 mg/mLCurrent1/03/2024Limited AvailabilityUnexpected increase in consumer demand2/05/2024
    quetiapine fumarateTablet, film coated115.12 mgResolved8/12/2023AvailableManufacturing2/05/2024
    escitalopram oxalateTablet, film coated25.548 mgCurrent26/04/2024Limited AvailabilityTransport / Logistic issues / Storage capacity issues2/05/2024
    lisinopril dihydrateTablet, uncoatedQSCurrent12/04/2024Limited AvailabilityTransport / Logistic issues / Storage capacity issues2/05/2024
    lisinopril dihydrateTablet, uncoatedQSCurrent29/03/2024Limited AvailabilityTransport / Logistic issues / Storage capacity issues2/05/2024
    paracetamolInjection, solution10 mg/mLCurrent20/02/2024UnavailableUnexpected increase in consumer demand2/05/2024
    pemetrexed disodiumInjection, powder for1102.9 mgCurrent30/04/2024UnavailableUnexpected increase in demand due to other sponsors unable to supply2/05/2024
    Follitropin alfaInjection, solution300 IUResolved2/02/2024AvailableManufacturing2/05/2024
    irbesartan~hydrochlorothiazideTablet, film coated300 mg~25 mgResolved3/04/2024AvailableManufacturing2/05/2024
    lidocaine hydrochlorideInjection, solution400 mgCurrent14/06/2023Limited AvailabilityManufacturing2/05/2024
    insulinInjection, suspension100 IU/mLCurrent23/10/2023Limited AvailabilityManufacturing2/05/2024
    octreotideInjection, solution100 microgram/mLCurrent1/02/2024Limited AvailabilityUnexpected increase in demand due to other sponsors unable to supply2/05/2024
    famotidineTablet, film coated20 mgCurrent10/08/2023Limited AvailabilityManufacturing2/05/2024
    famotidineTablet, film coated40 mgCurrent10/08/2023Limited AvailabilityManufacturing2/05/2024
    lisinopril dihydrateTablet, uncoated10.89 mgAnticipated4/10/2024AvailableTransport / Logistic issues / Storage capacity issues1/05/2024
    methotrexateInjection, solution1000 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability1/05/2023
    bupivacaine hydrochloride monohydrateInjection, solution52.8 mgResolved25/09/2023AvailableManufacturing1/05/2024
    acetylcholine chlorideSolution, powder for irrigation10 mg/mLCurrent15/09/2023UnavailableTransport / Logistic issues / Storage capacity issues1/05/2024
    midazolamInjection, solution5 mg/mLResolved8/04/2024AvailableTransport / Logistic issues / Storage capacity issues1/05/2024
    sodium fluorideInjection, concentrated1 mg/mLCurrent30/11/2023UnavailableManufacturing1/05/2024
    valganciclovirSolution, powder for5 gResolved22/03/2024AvailableManufacturing1/05/2024
    rocuronium bromideInjection, solution50 mgCurrent18/12/2023UnavailableManufacturing1/05/2024
    donepezil hydrochlorideTablet, film coated10 mgAnticipated26/07/2024AvailableTransport / Logistic issues / Storage capacity issues1/05/2024
    levetiracetamTablet, film coated250 mgAnticipated16/08/2024AvailableTransport / Logistic issues / Storage capacity issues1/05/2024
    imatinib mesilateTablet, film coated478 mgResolved25/01/2024AvailableManufacturing1/05/2024
    primaquine phosphateTablet, uncoated13.2 mgResolved1/04/2024AvailableManufacturing1/05/2024
    olmesartan medoxomilTablet40 mgCurrent1/03/2024UnavailableUnexpected increase in consumer demand1/05/2024
    pregabalinCapsule, hard150 mgCurrent30/01/2024Limited AvailabilityManufacturing1/05/2024
    imatinib mesilateTablet, film coated478 mgCurrent15/03/2024UnavailableManufacturing1/05/2024
    irbesartan~hydrochlorothiazideTablet, film coated300 mg~12.5 mgResolved14/07/2023AvailableManufacturing1/05/2024
    tadalafilTablet5 mgCurrent29/01/2024UnavailableUnexpected increase in demand due to other sponsors unable to supply1/05/2024
    imatinib mesilateTablet, film coated119.5 mgCurrent10/04/2024Limited AvailabilityManufacturing1/05/2024
    atorvastatin calcium trihydrateTablet, film coated10.845 mgAnticipated5/07/2024AvailableTransport / Logistic issues / Storage capacity issues1/05/2024
    cinacalcet hydrochlorideTablet, film coated66 mgCurrent20/12/2023UnavailableManufacturing1/05/2024
    carbetocinInjection, solution100 microgramCurrent11/12/2023UnavailableManufacturing1/05/2024
    atorvastatin calcium trihydrate~ezetimibeTablet, film coated41.363 mg~10 mgCurrent24/04/2024Limited AvailabilityManufacturing1/05/2024
    ezetimibe~atorvastatin calcium trihydrateTablet, film coated10 mg~20.681 mgCurrent24/04/2024Limited AvailabilityManufacturing1/05/2024
    ezetimibe~atorvastatin calcium trihydrateTablet, film coated10 mg~41.363 mgAnticipated31/05/2024AvailableManufacturing1/05/2024
    hydrochlorothiazide~amlodipine besilate~olmesartan medoxomilTablet, film coated25 mg~6.95 mg~40 mgCurrent31/07/2023UnavailableManufacturing1/05/2024
    prasugrelTablet, film coated10 mgCurrent11/04/2024Limited AvailabilityManufacturing1/05/2024
    metformin hydrochlorideTablet, modified release500 mgResolved10/04/2024AvailableManufacturing1/05/2024
    colchicineTablet, uncoated500 microgramResolved1/04/2024AvailableManufacturing1/05/2024
    flucloxacillin sodium monohydrateInjection, powder for1088.1 mgCurrent29/02/2024Limited AvailabilityTransport / Logistic issues / Storage capacity issues1/05/2024
    methylphenidate hydrochlorideTablet, modified release27 mgCurrent20/02/2024UnavailableTransport / Logistic issues / Storage capacity issues1/05/2024
    flecainide acetateTablet50 mgAnticipated15/05/2024AvailableManufacturing1/05/2024
    rosuvastatin calcium~ezetimibeTablet10.4 mg~10 mgCurrent15/03/2024UnavailableManufacturing1/05/2024
    rosuvastatin calcium~ezetimibeTablet~Tablet, film coated20.8 mg~10 mgCurrent30/01/2024UnavailableManufacturing1/05/2024
    mycophenolate sodiumTablet, enteric coated384.8 mgCurrent27/03/2024UnavailableManufacturing1/05/2024
    folic acid~riboflavine sodium phosphate~cyanocobalamin~thiamine nitrate~pyridoxine hydrochloride~Biotin~nicotinamide~sodium ascorbate~sodium pantothenateInjection, powder for.4 mg~4.9 mg~5 microgram~3.1 mg~4.9 mg~60 microgram~40 mg~113 mg~16.5 mgCurrent30/04/2024Limited AvailabilityManufacturing1/05/2024
    naproxenTablet, uncoated250 mgCurrent22/04/2024Limited AvailabilityManufacturing1/05/2024
    mupirocin calciumCream20.7683 mg/gCurrent22/04/2024Limited AvailabilityUnexpected increase in consumer demand1/05/2024
    midazolamInjection, solution5 mg/mLCurrent29/04/2024Limited AvailabilityManufacturing1/05/2024
    diazepamTablet, uncoated5 mgCurrent2/02/2024Limited AvailabilityManufacturing1/05/2024
    metformin hydrochlorideTablet, film coated500 mgCurrent26/04/2024Limited AvailabilityTransport / Logistic issues / Storage capacity issues1/05/2024
    Vibrio cholerae~Vibrio choleraeOral Liquid, suspension31.25 billion organisms~1 mgResolved18/12/2023AvailableManufacturing1/05/2024
    cilastatin~imipenemInjection, powder for500 mg~500 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability30/04/2024
    paclitaxelInjection, concentrated6 mg/mLResolved29/02/2024AvailableManufacturing30/04/2024
    amlodipine besilateTablet, uncoated6.9335 mgCurrent11/04/2024UnavailableManufacturing30/04/2024
    fluoxetine hydrochlorideCapsule, hard22.36 mgCurrent10/01/2024UnavailableManufacturing30/04/2024
    fentanylDrug delivery system, transdermal1.28 mgCurrent24/04/2024Limited AvailabilityCommercial Changes / Commercial viability30/04/2024
    clonidine hydrochlorideTablet, uncoated100 microgramCurrent18/03/2024Limited AvailabilityManufacturing30/04/2024
    ropivacaine hydrochlorideInjection, solution150 mgResolved2/04/2024AvailableTransport / Logistic issues / Storage capacity issues30/04/2024
    codeine phosphate hemihydrate~paracetamol~promethazine hydrochlorideOral Liquid, solution1 mg/mL~24 mg/mL~1.3 mg/mLDiscontinuedReduction in supply until supply is exhaustedManufacturing30/04/2024
    epirubicin hydrochlorideInjection, concentrated200 mgCurrent9/04/2024Limited AvailabilityManufacturing30/04/2024
    rifampicinCapsule300 mgResolved17/10/2023AvailableManufacturing30/04/2024
    rosuvastatin calciumTablet, film coated41.68 mgCurrent24/03/2023UnavailableCommercial Changes / Commercial viability30/04/2024
    rosuvastatin calciumTablet, film coated10.42 mgCurrent1/01/2024Limited AvailabilityManufacturing30/04/2024
    pregabalinCapsule, hard75 mgCurrent24/03/2023UnavailableCommercial Changes / Commercial viability30/04/2024
    tranexamic acidTablet, film coated500 mgCurrent18/03/2024UnavailableManufacturing30/04/2024
    lisdexamfetamine dimesilateCapsule, hard40 mgResolved22/01/2024AvailableUnexpected increase in consumer demand30/04/2024
    lisdexamfetamine dimesilateCapsule, hard60 mgResolved18/12/2023AvailableManufacturing30/04/2024
    hydrochlorothiazide~olmesartan medoxomilTablet12.5 mg~40 mgResolved1/07/2023AvailableManufacturing30/04/2024
    solifenacin succinateTablet, film coated5 mgCurrent1/11/2023UnavailableManufacturing30/04/2024
    solifenacin succinateTablet, film coated10 mgCurrent1/12/2023UnavailableManufacturing30/04/2024
    amlodipine besilate~olmesartan medoxomilTablet, film coated6.935 mg~20 mgCurrent1/02/2024UnavailableManufacturing30/04/2024
    suxamethonium chloride dihydrateInjection, solution100 mgResolved28/03/2023AvailableTransport / Logistic issues / Storage capacity issues30/04/2024
    isotretinoinCapsule, soft10 mgCurrent6/12/2023UnavailableManufacturing30/04/2024
    isotretinoinCapsule, soft20 mgCurrent24/01/2024UnavailableManufacturing30/04/2024
    deferasiroxTablet, film coated360 mgCurrent16/10/2023Emergency Supply OnlyManufacturing30/04/2024
    pegcetacoplanInjection, solution1080 mgAnticipated15/05/2024AvailableManufacturing30/04/2024
    olmesartan medoxomil~amlodipine besilateTablet, film coated40 mg~6.94 mgCurrent30/04/2024Limited AvailabilityUnexpected increase in consumer demand30/04/2024
    lidocaine hydrochloride monohydrateInjection, solution20 mg/mLAnticipated1/06/2024AvailableManufacturing30/04/2024
    estradiol hemihydrateDrug delivery system, transdermal1.54 mgCurrent29/04/2024Limited AvailabilityUnexpected increase in demand due to other sponsors unable to supply30/04/2024
    aciclovirInjection, solution25 mg/mLCurrent28/07/2023UnavailableUnexpected increase in demand due to other sponsors unable to supply30/04/2024
    diltiazem hydrochlorideCapsule, modified release240 mgResolved21/11/2022AvailableManufacturing30/04/2024
    estradiol hemihydrateDrug delivery system, transdermal2.32 mgCurrent29/04/2024UnavailableUnexpected increase in demand due to other sponsors unable to supply30/04/2024
    chlorhexidine gluconateSolution, irrigation30 mgAnticipated1/06/2024AvailableManufacturing29/04/2024
    ropivacaine hydrochlorideInjection, solution20 mgCurrent26/04/2024Limited AvailabilityTransport / Logistic issues / Storage capacity issues29/04/2024
    mercaptopurine monohydrateOral Liquid, suspension20 mg/mLAnticipated31/05/2024AvailableManufacturing29/04/2024
    amlodipine besilateTablet13.87 mgResolved12/04/2024AvailableManufacturing29/04/2024
    naloxone hydrochloride dihydrateSpray, nasal2.2 mg/actuationResolved11/03/2024AvailableTransport / Logistic issues / Storage capacity issues29/04/2024
    hydrocortisone acetateEnema10 % w/wCurrent1/01/2018UnavailableManufacturing29/04/2024
    sodium chlorideInjection, solution90 mgAnticipated31/05/2024AvailableManufacturing29/04/2024
    captoprilTablet, uncoated25 mgCurrent30/06/2023UnavailableManufacturing29/04/2024
    captoprilTablet, uncoated50 mgCurrent19/12/2023UnavailableManufacturing29/04/2024
    cefaclor monohydrateOral Liquid, powder for52.45 mg/mLAnticipated10/05/2024AvailableManufacturing29/04/2024
  • 2024.04.29

     

    Active ingredientsDosage formQuantity of active ingredientsShortage statusSupply impact start dateAvailabilityReasonLast updated
    mercaptopurine monohydrateOral Liquid, suspension20 mg/mLAnticipated31/05/2024AvailableManufacturing29/04/2024
    sodium chlorideInjection, solution90 mgAnticipated31/05/2024AvailableManufacturing29/04/2024
    cefaclor monohydrateOral Liquid, powder for52.45 mg/mLAnticipated10/05/2024AvailableManufacturing29/04/2024
    ropivacaine hydrochlorideInjection, solution20 mgCurrent26/04/2024Limited AvailabilityTransport / Logistic issues / Storage capacity issues29/04/2024
    captoprilTablet, uncoated25 mgCurrent30/06/2023UnavailableManufacturing29/04/2024
    captoprilTablet, uncoated50 mgCurrent19/12/2023UnavailableManufacturing29/04/2024
    ethinylestradiol~norethisteroneTablet, uncoated36 microgram~1 mgCurrent26/04/2024Limited AvailabilityManufacturing29/04/2024
    pramipexole dihydrochloride monohydrateTablet1 mgAnticipated10/05/2024AvailableManufacturing26/04/2024
    ciprofloxacin hydrochlorideTablet, film coated555 mgAnticipated10/05/2024AvailableManufacturing26/04/2024
    AbataceptInjection125.875 mgAnticipated17/06/2024AvailableUnexpected increase in consumer demand26/04/2024
    pemetrexed disodiumInjection, powder for1102.9 mgAnticipated1/05/2024AvailableUnexpected increase in demand due to other sponsors unable to supply26/04/2024
    AbataceptInjection125.875 mgAnticipated3/06/2024AvailableManufacturing26/04/2024
    atorvastatin calcium trihydrateTablet, film coated43.38 mgAnticipated28/06/2024AvailableTransport / Logistic issues / Storage capacity issues26/04/2024
    sodium pantothenate~cyanocobalamin~nicotinamide~thiamine nitrate~sodium ascorbate~folic acid~riboflavine sodium phosphate~pyridoxine hydrochloride~BiotinInjection, powder for16.5 mg~5 microgram~40 mg~3.1 mg~113 mg~.4 mg~4.9 mg~4.9 mg~60 microgramAnticipated30/04/2024AvailableManufacturing26/04/2024
    dobutamine hydrochlorideInjection, solution14.01 mg/mLAnticipated24/06/2024AvailableManufacturing26/04/2024
    estradiol hemihydrateDrug delivery system, transdermal1.54 mgAnticipated1/05/2024AvailableUnexpected increase in demand due to other sponsors unable to supply26/04/2024
    pravastatin sodiumTablet, uncoated40 mgAnticipated10/05/2024AvailableManufacturing26/04/2024
    carvedilolTablet, film coated12.5 mgCurrent2/11/2023UnavailableManufacturing26/04/2024
    morphine hydrochloride trihydrateOral Liquid, solution10 mg/mLCurrent12/04/2024UnavailableCommercial Changes / Commercial viability26/04/2024
    gliclazideTablet, modified release30 mgCurrent20/10/2023UnavailableManufacturing26/04/2024
    ceftazidime pentahydrateInjection, powder for1.164 gCurrent9/04/2024Limited AvailabilityManufacturing26/04/2024
    galantamine hydrobromideCapsule, modified release30.768 mgCurrent6/06/2022UnavailableManufacturing26/04/2024
    galantamine hydrobromideCapsule, modified release10.256 mgCurrent31/05/2023UnavailableManufacturing26/04/2024
    prochlorperazine maleateTablet5 mgCurrent3/03/2023Limited AvailabilityManufacturing26/04/2024
    donepezil hydrochlorideTablet, film coated10 mgCurrent8/03/2024Limited AvailabilityManufacturing26/04/2024
    allopurinolTablet300 mgCurrent14/02/2024Limited AvailabilityManufacturing26/04/2024
    ropivacaine hydrochlorideInjection, solution150 mgCurrent2/04/2024Limited AvailabilityTransport / Logistic issues / Storage capacity issues26/04/2024
    amlodipine besilate~atorvastatin calcium trihydrateTablet, film coated6.94 mg~86.751 mgCurrent23/04/2024Limited AvailabilityManufacturing26/04/2024
    quetiapine fumarateTablet, modified release460.52 mgCurrent19/04/2024UnavailableTransport / Logistic issues / Storage capacity issues26/04/2024
    quetiapine fumarateTablet, film coated28.78 mgCurrent28/03/2024UnavailableManufacturing26/04/2024
    methotrexateInjection, solution100 mg/mLCurrent23/04/2024Limited AvailabilityManufacturing26/04/2024
    latanoprost~timolol maleateEye Drops, solution50 microgram/mL~6.83 mg/mLCurrent14/11/2023UnavailableUnexpected increase in consumer demand26/04/2024
    latanoprostEye Drops, solution50 microgram/mLCurrent22/11/2023UnavailableUnexpected increase in consumer demand26/04/2024
    valganciclovir hydrochlorideTablet, film coated496.3 mgCurrent25/10/2023Limited AvailabilityManufacturing26/04/2024
    clopidogrel hydrogen sulfate~aspirinTablet97.87 mg~100 mgCurrent23/02/2024Limited AvailabilityManufacturing26/04/2024
    temozolomideCapsule, hard5 mgCurrent19/04/2024UnavailableManufacturing26/04/2024
    sitagliptin hydrochloride monohydrateTablet, film coated28.343 mgCurrent31/03/2024UnavailableManufacturing26/04/2024
    activated charcoal~sorbitolSuspension.2 g/mL~.283 g/mLCurrent20/05/2021UnavailableManufacturing26/04/2024
    betahistine dihydrochlorideTablet16 mgCurrent22/04/2024Limited AvailabilityUnexpected increase in consumer demand26/04/2024
    naproxenTablet500 mgCurrent26/01/2024Limited AvailabilityManufacturing26/04/2024
    fluoxetine hydrochlorideCapsule, hard22.36 mgCurrent15/04/2024Limited AvailabilityManufacturing26/04/2024
    hydralazine hydrochlorideTablet, film coated50 mgCurrent25/01/2024Limited AvailabilityManufacturing26/04/2024
    amoxicillin trihydrateTablet, film coated1148 mgCurrent29/07/2022UnavailableManufacturing26/04/2024
    gabapentinTablet, film coated800 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability26/04/2024
    levetiracetamTablet, film coated1000 mgAnticipated12/07/2024AvailableTransport / Logistic issues / Storage capacity issues24/04/2024
    lacosamideTablet, film coated200 mgAnticipated2/08/2024AvailableTransport / Logistic issues / Storage capacity issues24/04/2024
    rosuvastatin calciumTablet, film coated5.21 mgAnticipated26/04/2024AvailableManufacturing24/04/2024
    ganirelixInjection, solution.5 mg/mLAnticipated30/04/2024AvailableManufacturing24/04/2024
    trandolaprilCapsule.5 mgCurrent13/02/2024Limited AvailabilityManufacturing24/04/2024
    water for injections~Mumps virus~Rubella virus~Measles virus~live varicella vaccineInjection, diluent for~Injection, powder for.75 mL~4.3 TCID50~3 TCID50~3 TCID50~3.99 PFUCurrent30/06/2023UnavailableCommercial Changes / Commercial viability24/04/2024
    amlodipine besilateTablet, uncoated6.9335 mgCurrent11/04/2024UnavailableManufacturing24/04/2024
    olanzapine pamoate monohydrateInjection, powder for931 mgCurrent5/10/2023Limited AvailabilityTransport / Logistic issues / Storage capacity issues24/04/2024
    olanzapine pamoate monohydrateInjection, powder for690 mgCurrent5/10/2023Limited AvailabilityTransport / Logistic issues / Storage capacity issues24/04/2024
    olanzapine pamoate monohydrateInjection, powder for483 mgCurrent5/10/2023Limited AvailabilityTransport / Logistic issues / Storage capacity issues24/04/2024
    octreotideInjection, solution100 microgramCurrent19/12/2023Limited AvailabilityManufacturing24/04/2024
    valganciclovirSolution, powder for5 gCurrent22/03/2024Limited AvailabilityManufacturing24/04/2024
    ondansetron hydrochloride dihydrateInjection, solution10 mgCurrent10/04/2024Limited AvailabilityManufacturing24/04/2024
    galantamine hydrobromideCapsule, modified release20.512 mgCurrent14/11/2023UnavailableManufacturing24/04/2024
    midazolamInjection, solution5 mgCurrent2/04/2024Limited AvailabilityManufacturing24/04/2024
    SomatropinInjection, solution5.83 mg/mLCurrent23/04/2024Limited AvailabilityTransport / Logistic issues / Storage capacity issues24/04/2024
    levetiracetamTablet, film coated500 mgCurrent19/04/2024Limited AvailabilityTransport / Logistic issues / Storage capacity issues24/04/2024
    escitalopram oxalateTablet, film coated12.774 mgCurrent19/04/2024Limited AvailabilityTransport / Logistic issues / Storage capacity issues24/04/2024
    rizatriptan benzoateTablet, orally disintegrating14.53 mgCurrent12/01/2024Limited AvailabilityManufacturing24/04/2024
    entecavirTablet, film coated1 mgCurrent22/03/2024UnavailableManufacturing24/04/2024
    fluoxetine hydrochlorideCapsule, hard22.35 mgCurrent12/04/2024Limited AvailabilityManufacturing24/04/2024
    hydrochlorothiazide~olmesartan medoxomilTablet25 mg~40 mgCurrent20/04/2024Limited AvailabilityManufacturing24/04/2024
    atorvastatin calcium trihydrate~ezetimibeTablet, film coated20.681 mg~10 mgCurrent16/04/2024Limited AvailabilityTransport / Logistic issues / Storage capacity issues24/04/2024
    amlodipine besilate~hydrochlorothiazide~olmesartan medoxomilTablet, film coated6.95 mg~12.5 mg~40 mgCurrent31/07/2023UnavailableManufacturing24/04/2024
    metformin hydrochlorideTablet, modified release500 mgCurrent10/04/2024Emergency Supply OnlyManufacturing24/04/2024
    estradiol~estradiol~norethisterone acetateDrug delivery system, transdermal.62 mg~.78 mg~2.7 mgCurrent14/02/2024UnavailableManufacturing24/04/2024
    cisplatinInjection, solution1 mg/mLCurrent2/04/2024Limited AvailabilityManufacturing24/04/2024
    famotidineTablet, film coated20 mgCurrent10/08/2023Limited AvailabilityManufacturing24/04/2024
    famotidineTablet, film coated40 mgCurrent10/08/2023Limited AvailabilityManufacturing24/04/2024
    bendamustine hydrochlorideInjection, powder for100 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability24/04/2024
    clindamycin phosphateInjection, solution0 QSAnticipated14/06/2024AvailableManufacturing23/04/2024
    cefalexin monohydrateOral Liquid, powder for26.3 mg/mLAnticipated15/05/2024AvailableManufacturing23/04/2024
    warfarin sodiumTablet, uncoated5 mgCurrent23/04/2024Limited AvailabilityManufacturing23/04/2024
    pramipexole dihydrochloride monohydrateTablet.25 mgCurrent16/04/2024Limited AvailabilityManufacturing23/04/2024
    duloxetine hydrochlorideCapsule, enteric67.3 mgCurrent15/09/2023UnavailableManufacturing23/04/2024
    primaquine phosphateTablet, uncoated13.2 mgCurrent1/04/2024UnavailableManufacturing23/04/2024
    deferasiroxTablet, film coated360 mgCurrent16/10/2023Emergency Supply OnlyManufacturing23/04/2024
    rosuvastatin calciumTablet, film coated41.68 mgCurrent11/04/2024Limited AvailabilityManufacturing23/04/2024
    metoprolol succinateTablet, modified release190 mgCurrent10/04/2024Emergency Supply OnlyManufacturing23/04/2024
    propofolInjection, emulsion200 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability23/04/2024
    metoprolol tartrateTablet, uncoated100 mgAnticipated13/05/2024AvailableManufacturing22/04/2024
    gemcitabine hydrochlorideInjection, solution1.139 gCurrent26/03/2024Limited AvailabilityManufacturing22/04/2024
    remifentanil hydrochlorideInjection, powder for1.097 mgCurrent15/04/2024Limited AvailabilityManufacturing22/04/2024
    ketamine hydrochlorideInjection, solution115.3 mg/mLCurrent18/08/2023UnavailableManufacturing22/04/2024
    pamidronate disodiumInjection, concentrated3 mgCurrent31/01/2024UnavailableManufacturing22/04/2024
    quinapril hydrochlorideTablet, film coated5.42 mgDiscontinuedUnavailableProduct recall22/04/2024
    bosentan monohydrateTablet, film coated64.54 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability22/04/2024
    bosentan monohydrateTablet, film coated129.08 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability22/04/2024

ドイツ

  • 2024.11.11
    Active ingredientsMessage typeType of reasonDate of the last message
    Eletriptan hydrobromideChange notificationOther08.11.2024
    Terazosin hydrochloride dihydrateInitial notificationOther08.11.2024
    CinacalcethydrochlorideChange notificationOther08.11.2024
    ParicalcitolChange notificationOther08.11.2024
    Vinblastine sulfateChange notificationProduction problem08.11.2024
    Sodium thiosulphate (Ph.Eur.)Change notificationOther07.11.2024
    Sodium thiosulphate (Ph.Eur.)Initial notificationOther07.11.2024
    MetronidazoleChange notificationOther06.11.2024
    Fosfomycin sodium (Ph.Eur.)Initial notificationProduction problem06.11.2024
    Atenolol; chlorthalidoneChange notificationOther06.11.2024
    Insulin aspartChange notificationOther06.11.2024
    Buprenorphine hydrochlorideChange notificationProduction problem06.11.2024
    Clobetasol propionate (Ph.Eur.)Change notificationOther06.11.2024
    Lanthanum(III) carbonate x H<2>OChange notificationOther06.11.2024
    Haloperidol decanoateInitial notificationProduction problem06.11.2024
    CarbamazepineChange notificationProduction problem05.11.2024
    Ciprofloxacin hydrochloride (1:1) 1 H<2>OChange notificationProduction problem05.11.2024
    Phenoxymethylpenicillin potassiumChange notificationOther05.11.2024
    CarboplatinChange notificationOther05.11.2024
    Cefadroxil monohydrateChange notificationOther05.11.2024
    Amoxicillin trihydrateChange notificationOther05.11.2024
    OxcarbazepineChange notificationOther05.11.2024
    Azithromycin dihydrateChange notificationOther05.11.2024
    EthosuximideChange notificationOther05.11.2024
    CandesartancilexetilChange notificationOther05.11.2024
    AlprostadilChange notificationOther05.11.2024
    LevetiracetamInitial notificationOther05.11.2024
    OxazepamInitial notificationOther05.11.2024
    DexamethasoneInitial notificationOther05.11.2024
    Insulin aspartChange notificationOther05.11.2024
    Azithromycin dihydrateChange notificationOther05.11.2024
    Hydromorphone hydrochlorideChange notificationOther05.11.2024
    Azithromycin dihydrateChange notificationOther05.11.2024
    Phenoxymethylpenicillin potassiumChange notificationProduction problem05.11.2024
    Ciprofloxacin hydrochloride (1:1) 1 H<2>OChange notificationOther05.11.2024
    Azithromycin dihydrateChange notificationOther05.11.2024
    Minocycline hydrochloride ((anhydrous, not pharmacopoeia compliant))Change notificationOther05.11.2024
    MesalazineChange notificationOther04.11.2024
    PhenytoinInitial notificationOther04.11.2024
    Timolol maleateChange notificationProduction problem04.11.2024
    Phenylephrine hydrochlorideInitial notificationProduction problem04.11.2024
    Darifenacin hydrobromideInitial notificationOther04.11.2024
    AcemetacinChange notificationProduction problem04.11.2024
  • 2024.11.04
    Active ingredientsDate of the last messageType of reasonType of notification
    Erythromycin estolate01.11.2024OtherInitial notification
    Poly(styrene-co-divinylbenzene)sulfonic acid-(x:y)-((81)Rb)rubidium salt01.11.2024OtherChange notification
    Iron(III) sodium D-gluconate hydroxide oxide complex (approx. 2:1:1:x:y)01.11.2024OtherChange notification
    Iron(III) sodium D-gluconate hydroxide oxide complex (approx. 2:1:1:x:y)01.11.2024OtherChange notification
    Acetylcholine chloride01.11.2024Production problemInitial notification
    Prednisolone acetate01.11.2024Production problemInitial notification
    Hydromorphone hydrochloride01.11.2024Production problemChange notification
    Doxorubicin hydrochloride31.10.2024Production problemInitial notification
    Hydromorphone hydrochloride31.10.2024OtherInitial notification
    Oxycodone hydrochloride (Ph.Eur.)31.10.2024OtherChange notification
    Clarithromycin31.10.2024OtherChange notification
    Oxazepam31.10.2024OtherInitial notification
    Oxazepam31.10.2024OtherInitial notification
    Clioquinol; flumetasone pivalate (Ph.Eur.)31.10.2024OtherChange notification
    Insulin aspart31.10.2024OtherChange notification
    Glucagon30.10.2024Production problemInitial notification
    Azithromycin dihydrate30.10.2024OtherChange notification
    Buprenorphine hydrochloride30.10.2024Production problemChange notification
    Salbutamol sulfate29.10.2024OtherChange notification
    Phenoxymethylpenicillin potassium29.10.2024OtherChange notification
    Amoxicillin trihydrate29.10.2024OtherChange notification
    Doxycycline monohydrate29.10.2024OtherChange notification
    Doxycycline monohydrate29.10.2024OtherChange notification
    Azithromycin dihydrate29.10.2024OtherChange report
    Sodium valproate; valproic acid29.10.2024OtherChange report
    Medroxyprogesterone acetate29.10.2024OtherChange report
    Clarithromycin29.10.2024OtherChange report
    Azacitidine29.10.2024OtherChange report
    Paricalcitol29.10.2024OtherChange report
    Oxcarbazepine29.10.2024OtherChange report
    Atomoxetine hydrochloride29.10.2024Production problemChange report
    Atomoxetine hydrochloride29.10.2024Production problemChange report
    Atomoxetine hydrochloride29.10.2024Production problemChange report
    Atomoxetine hydrochloride29.10.2024Production problemChange report
    Atomoxetine hydrochloride29.10.2024Production problemChange report
    Atomoxetine hydrochloride29.10.2024Production problemChange report
    Atomoxetine hydrochloride29.10.2024Production problemInitial report
    Olanzapine embonate monohydrate29.10.2024Production problemChange report
    Hydromorphone hydrochloride29.10.2024OtherChange report
    Ethosuximide29.10.2024OtherInitial report
    Hydrocortisone29.10.2024OtherChange report
    Benzyl benzoate29.10.2024Production problemChange report
    Salbutamol sulfate29.10.2024OtherChange report
    Dexamethasone; gentamicin sulphate29.10.2024Production problemChange report
    Mesalazine28.10.2024OtherChange report
    Remifentanil hydrochloride28.10.2024OtherInitial report
    Dutasteride; tamsulosin hydrochloride28.10.2024OtherChange report
    Risperidone28.10.2024Production problemChange report
    Vinblastine sulfate28.10.2024Production probleminitial report
    Ezetimibe28.10.2024Otherinitial report
  • 2024.10.29
    Active ingredientsDate of the last messageType of reasonMessage type
    Salbutamol sulfate25.10.2024OtherInitial notification
    Samarium-((153)Sm)-Lexidronam pentasodium25.10.2024Production problemInitial notification
    Tobramycin25.10.2024OtherChange notification
    Betamethasone25.10.2024OtherInitial notification
    Metoprolol succinate (Ph.Eur.)25.10.2024OtherChange notification
    Phenoxymethylpenicillin potassium25.10.2024OtherChange notification
    Ciprofloxacin hydrochloride (1:1) 1 H<2>O25.10.2024OtherChange notification
    Amoxicillin trihydrate25.10.2024OtherChange notification
    Fluticasone propionate (Ph.Eur.)25.10.2024OtherInitial notification
    Cefaclor monohydrate24.10.2024OtherChange notification
    Clarithromycin24.10.2024OtherChange notification
    Phenoxymethylpenicillin potassium24.10.2024OtherChange notification
    Oxcarbazepine24.10.2024OtherChange notification
    Paricalcitol24.10.2024OtherChange notification
    Tacrolimus monohydrate24.10.2024OtherChange notification
    Doxycycline hyclate24.10.2024OtherChange notification
    Amoxicillin trihydrate24.10.2024OtherChange notification
    Phenoxymethylpenicillin potassium24.10.2024OtherChange notification
    Sodium (methylprednisolone-21-succinate)23.10.2024OtherInitial notification
    Clonazepam23.10.2024OtherInitial notification
    Levetiracetam23.10.2024OtherChange notification
    Ciprofloxacin lactate23.10.2024OtherChange notification
    Timolol maleate23.10.2024Production problemChange notification
    Proxymetacaine hydrochloride23.10.2024Production problemChange notification
    Atropine sulphate (Ph.Eur.)23.10.2024Production problemChange notification
    Fluorometholone23.10.2024Production problemChange notification
    ofloxacin23.10.2024Production problemChange notification
    Hydrocortisone acetate (Ph.Eur.)23.10.2024Production problemChange notification
    Dexamethasone; gentamicin sulphate23.10.2024Production problemChange notification
    Anidulafungin22.10.2024Production problemInitial notification
    Sodium((99)Mo)molybdate; sodium((99m)Tc)pertechnetate22.10.2024Production problemInitial notification
    Buprenorphine22.10.2024OtherChange notification
    Hydromorphone hydrochloride22.10.2024OtherChange notification
    Buprenorphine22.10.2024OtherChange notification
    [(186)Re]Rhenium sulfide o.w.A.21.10.2024Production problemInitial notification
    ((169)Er)Erbium citrate21.10.2024Production problemInitial notification
    ((90)Y)Yttrium citrate21.10.2024Production problemInitial notification
    Morphine sulphate (Ph.Eur.)21.10.2024Production problemChange notification
    Buprenorphine hydrochloride21.10.2024Production problemInitial notification
    Olanzapine embonate monohydrate21.10.2024Production problemChange notification
    Hydrocortisone21.10.2024OtherInitial notification
    Fluorouracil21.10.2024OtherChange notification
    Flunisolide hemihydrate21.10.2024OtherInitial notification
    Tobramycin21.10.2024OtherChange notification
  • 2024.10.23
    Active ingredientsMessage typeType of reasonDate of the last message
    Venlafaxine hydrochlorideChange notificationProduction problem18.10.2024
    Venlafaxine hydrochlorideInitial notificationProduction problem18.10.2024
    Venlafaxine hydrochlorideInitial notificationProduction problem18.10.2024
    LevetiracetamChange notificationOther18.10.2024
    Hydromorphone hydrochlorideChange notificationOther18.10.2024
    LinezolidInitial notificationOther17.10.2024
    CiclosporinInitial notificationOther17.10.2024
    Azithromycin dihydrateChange notificationOther17.10.2024
    Azithromycin dihydrateChange notificationOther17.10.2024
    Amoxicillin trihydrateInitial notificationOther17.10.2024
    Amoxicillin trihydrate; potassium clavulanateInitial notificationOther17.10.2024
    EverolimusInitial notificationOther16.10.2024
    OxcarbazepineInitial notificationOther16.10.2024
    Urea; tretinoinChange notificationOther16.10.2024
    Azithromycin monohydrateChange notificationOther16.10.2024
    Phenoxymethylpenicillin potassiumChange notificationOther16.10.2024
    PhenobarbitalChange notificationOther16.10.2024
    HaloperidolInitial notificationOther16.10.2024
    EthosuximideChange notificationOther16.10.2024
    Amoxicillin trihydrateChange notificationOther16.10.2024
    Minocycline hydrochloride ((anhydrous, not pharmacopoeia compliant))Change notificationOther16.10.2024
    Solifenacin succinateInitial notificationProduction problem15.10.2024
    Eletriptan hydrobromideChange notificationOther15.10.2024
    LevetiracetamChange notificationProduction problem14.10.2024
    Insulin aspartChange notificationOther14.10.2024
    Insulin aspartChange notificationOther14.10.2024
    Remifentanil hydrochlorideChange notificationOther14.10.2024
    Oxycodone hydrochloride (Ph.Eur.)Initial notificationOther14.10.2024
    Pramipexole dihydrochloride monohydrateInitial notificationOther14.10.2024
    Pramipexole dihydrochloride monohydrateChange notificationOther14.10.2024
    Pramipexole dihydrochloride monohydrateChange notificationOther14.10.2024
    EtoricoxibInitial notificationOther14.10.2024
    Eletriptan hydrobromideInitial notificationOther14.10.2024
    Oxycodone hydrochloride (Ph.Eur.)Change notificationOther14.10.2024
    TopiramateChange notificationOther14.10.2024
    Lanthanum(III) carbonate x H<2>OInitial notificationOther14.10.2024
    OmeprazoleChange notificationOther14.10.2024
    PhenytoinInitial notificationOther14.10.2024
    Ciprofloxacin hydrochloride (1:1) 1 H<2>OChange notificationOther14.10.2024
    ParicalcitolChange notificationOther14.10.2024
    OxcarbazepineChange notificationOther14.10.2024
    Phenoxymethylpenicillin potassiumChange notificationOther14.10.2024
    Phenoxymethylpenicillin potassiumChange notificationOther14.10.2024
    Phenoxymethylpenicillin benzathineInitial notificationOther14.10.2024
    ItraconazoleChange notificationOther14.10.2024
    Hydromorphone hydrochlorideChange notificationOther14.10.2024
    UrapidilChange notificationOther11.10.2024
    Amoxicillin trihydrateChange notificationOther11.10.2024
    Hydrochlorothiazide; metoprolol tartrate (Ph.Eur.)Change notificationOther11.10.2024
    Sodium hydrogen carbonateChange notificationOther11.10.2024
    Methylphenidate hydrochlorideChange notificationOther11.10.2024
    Methylphenidate hydrochlorideChange notificationOther11.10.2024
    Methylphenidate hydrochlorideChange notificationOther11.10.2024
    Methylphenidate hydrochlorideChange notificationOther11.10.2024
    Turoctocog alfaInitial notificationOther10.10.2024
    Eptacog alfa (activated)Initial notificationOther10.10.2024
    PhenprocoumonChange notificationProduction problem10.10.2024
    Estradiol hemihydrateInitial notificationProduction problem10.10.2024
    Tenofovir disoproxilChange notificationOther10.10.2024
    Rasagiline mesilateChange notificationProduction problem10.10.2024
    Salbutamol sulfateChange notificationOther10.10.2024
    Amoxicillin trihydrateChange notificationOther10.10.2024
    Ciprofloxacin hydrochloride (1:1) 1 H<2>OChange notificationOther10.10.2024
    Metoprolol tartrate (Ph.Eur.)Change notificationOther10.10.2024
  • 2024.10.10
    有効成分投与形態理由メッセージの種類最後のメッセージの日付
    オランザピンエンボン酸一水和物Erhte 需要変更通知09.10.2024
    オランザピンエンボン酸一水和物パウダーメーカー変更変更通知09.10.2024
    インスリンアスパルトInjektionslungその他変更通知09.10.2024
    ベタメタゾン酢酸エステル(Ph.Eur.);ベタメタゾンリン酸二水素二ナトリウム(Ph.Eur.)インジェクション・サスペンション生産能力不足最初の通知09.10.2024
    アジスロマイシン一水和物フィルムコート錠Erhte 需要変更通知09.10.2024
    コレカルシフェロール経口ドロップ生産能力不足最初の通知09.10.2024
    クエン酸スフェンタニルInjektionslung生産における問題最初の通知08.10.2024
    エゼチミブタブレットErhte 需要変更通知08.10.2024
    エプタコグ アルファ(活性化)パウダー生産能力不足最初の通知08.10.2024
    アモキシシリン三水和物経口懸濁液調製用粉末Erhte 需要変更通知08.10.2024
    セマグルチドInjektionslungErhte 需要変更通知08.10.2024
    フマル酸クエチアピン(欧州製薬)徐放錠生産における問題最初の通知07.10.2024
    オメプラゾール腸溶性コーティング・ハードカプセルErhte 需要変更通知07.10.2024
    トブラマイシン注射用LungErhte 需要最初の通知07.10.2024
    フェノキシメチルペニシリンカリウム経口用 Lung 調製用粉末Erhte 需要変更通知07.10.2024
    フマル酸クエチアピン(欧州製薬)徐放錠生産における問題変更通知07.10.2024
    アトモキセチン塩酸塩ハードカプセル生産における問題変更通知07.10.2024
    リザトリプタン安息香酸塩タブレット生産における問題変更通知07.10.2024
    リザトリプタン安息香酸塩溶解タブレット生産における問題変更通知07.10.2024
    リザトリプタン安息香酸塩タブレット生産における問題変更通知07.10.2024
    リネゾリドフィルムコート錠Erhte 需要変更通知07.10.2024
    エゼチミブタブレットErhte 需要変更通知07.10.2024
    エゼチミブ; シンバスタチンタブレットバッチテストの問題点変更通知07.10.2024
    ヒドロモルフォン塩酸塩ハードカプセル生産能力不足最初の通知07.10.2024
    塩酸ベナゼプリル変更通知07.10.2024
    <2>シトロネン舫-レ-ビスマス-カリウム塩(2:1:5)×H O; メトロニダゾール; 塩酸テトラサイクリンハードカプセルErhte 需要変更通知04.10.2024
    塩酸レミフェンタニル粉末・・・注射剤/輸液用濃縮液ungErhte 需要変更通知04.10.2024
    トラゾドン塩酸塩タブレット生産能力不足変更通知04.10.2024
    フェノキシメチルペニシリンカリウムフィルムコート錠その他変更通知04.10.2024
    オクスカルバゼピン経口懸濁液その他変更通知04.10.2024
    クラリスロマイシン経口懸濁液調製用顆粒Erhte 需要変更通知04.10.2024
    アジスロマイシン二水和物経口懸濁液調製用粉末Erhte 需要変更通知04.10.2024
    ラモトリギンタブレット生産能力不足変更通知04.10.2024
    パリカルシトールInjektionslungErhte 需要変更通知04.10.2024
    ジヒドロコデイン[(R変更通知03.10.2024
    ウロキナーゼ注射剤/輸液用粉末ungErhte 需要変更通知02.10.2024
    オランザピンエンボン酸一水和物パウダーメーカー変更最初の通知02.10.2024
    エトスクシミドソフトカプセルErhte 需要変更通知02.10.2024
    硫酸フラマイセチン(1:x) ((硫黄含有量の詳細))肌に塗布するパウダー生産能力不足変更通知02.10.2024
    フシジン(Ph.Eur.)クリーム生産能力不足変更通知02.10.2024
    ドキシサイクリン一水和物タブレット生産能力不足最初の通知02.10.2024
    モメタゾンフロエート(Ph.Eur.)L、皮膚に塗布する。生産能力不足変更通知01.10.2024
    プレドニカルベートL、皮膚に塗布する。生産能力不足最初の通知01.10.2024
    タクロリムス一水和物軟膏Erhte 需要変更通知01.10.2024
    ヒドロモルフォン塩酸塩徐放錠Erhte 需要変更通知01.10.2024
    酢酸プレドニゾロン点眼液懸濁液生産における問題変更通知01.10.2024
    カスポファンギンジアセテート01.10.2024最初の通知01.10.2024
    アトモキセチン塩酸塩ハードカプセル生産における問題変更通知01.10.2024
    アトモキセチン塩酸塩ハードカプセル生産における問題変更通知01.10.2024
    クラリスロマイシン経口懸濁液調製用顆粒Erhte 需要変更通知30.09.2024
    塩酸バンコマイシンハードカプセルErhte 需要変更通知30.09.2024
    塩酸シナカルセスフィルムコート錠生産における問題最初の通知30.09.2024
    ヒドロモルフォン塩酸塩徐放錠生産における問題変更通知30.09.2024
    ニクロサミドチュアブル錠その他最初の通知30.09.2024
    塩酸レミフェンタニル粉末・・・注射剤/輸液用濃縮液ungErhte 需要変更通知27.09.2024
    アモキシシリン三水和物経口懸濁液調製用粉末Erhte 需要変更通知27.09.2024
    エプタコグ アルファ(活性化)パウダー生産能力不足最初の通知27.09.2024
    硫酸ビンクリスチンInjektionslung生産における問題最初の通知27.09.2024
    アトモキセチン塩酸塩ハードカプセル生産における問題変更通知26.09.2024
    メトロニダゾールタブレット生産における問題変更通知26.09.2024
    クラリスロマイシンフィルムコート錠生産能力不足最初の通知26.09.2024
    ノナコグ・ベータ・ペゴルパウダー生産能力不足最初の通知26.09.2024
    塩酸シナカルセスその他変更通知25.09.2024
    リスペリドンデポー注射用懸濁液調製用粉末Erhte 需要最初の通知25.09.2024
    チモロールマレイン酸塩目薬生産における問題変更通知25.09.2024
    クロモグリク酸ナトリウム(Ph.Eur.);塩酸レプロテロール生産における問題変更通知25.09.2024
    タクロリムス一水和物生産における問題変更通知25.09.2024
    塩酸メチルフェニデートタブレットその他変更通知24.09.2024
    フェノキシメチルペニシリンカリウムタブレットErhte 需要最初の通知24.09.2024
    ドキシサイクリン塩酸塩タブレットErhte 需要最初の通知24.09.2024
    <2>シプロフロキサシン塩酸塩(1:1) 1 H Oフィルムコート錠Erhte 需要変更通知23.09.2024
    硫酸サルブタモールLung f・ネブライザー生産能力不足最初の通知23.09.2024
    ラモトリギンタブレット生産における問題最初の通知23.09.2024
    レベチラセタムフィルムコート錠生産における問題変更通知23.09.2024
  • 2024.09.24
    有効成分投与形態理由メッセージの種類最後のメッセージの日付
    ポリ(スチレン-co-ジビニルベンゼン)スルホン舫-re(x:y)-((81)Rb)ルビジウム塩最初の通知20.09.2024
    ((201)Tl)塩化タリウム(I)最初の通知20.09.2024
    ナトリウム(メチルプレドニゾロン-21-コハク酸塩)注射剤または輸液用粉末ungメーカー変更変更通知20.09.2024
    乳酸シプロフロキサシンInfusionslungErhte 需要最初の通知20.09.2024
    バルプロ酸ナトリウム;バルプロイン舫レ徐放錠その他最初の通知20.09.2024
    <2>シプロフロキサシン塩酸塩(1:1) 1 H Oフィルムコート錠その他最初の通知20.09.2024
    トブラマイシン注射/輸液ung生産能力不足変更通知20.09.2024
    アモキシシリン三水和物フィルムコート錠Erhte 需要最初の通知20.09.2024
    クラリスロマイシンフィルムコート錠Erhte 需要変更通知20.09.2024
    アシクロビル眼軟膏生産における問題変更通知20.09.2024
    硫酸ゲンタマイシン目薬生産における問題変更通知20.09.2024
    <2>シプロフロキサシン塩酸塩(1:1) 1 H Oフィルムコート錠その他最初の通知20.09.2024
    セファクロル一水和物フィルムコート錠Erhte 需要最初の通知20.09.2024
    アジスロマイシン二水和物フィルムコート錠その他最初の通知20.09.2024
    アモキシシリン三水和物フィルムコート錠その他最初の通知20.09.2024
    パリカルシトールInjektionslungErhte 需要変更通知19.09.2024
    尿素;トレチノインクリーム生産能力不足最初の通知18.09.2024
    フシジン(Ph.Eur.)クリーム生産能力不足最初の通知18.09.2024
    エピネフリン/アドレナリンInjektionslungメーカー変更最初の通知18.09.2024
    アテノロール; クロルタリドンフィルムコート錠Erhte 需要最初の通知18.09.2024
    葉酸カルシウムInjektionslung他メーカーとの問題変更通知18.09.2024
    硫酸ビンブラスチンInjektionslung 調製用粉末生産における問題最初の通知18.09.2024
    アセメタシンハードカプセル生産における問題最初の通知18.09.2024
    イソトレチノインソフトカプセル最終リリースの問題点最初の通知17.09.2024
    硫酸サルブタモール加圧ガスの吸入Erhte 需要変更通知17.09.2024
    塩化カルシウム二水和物;ヒスチジン;ヒスチジン塩酸塩一水和物;2-オキソペンタンジオ酸水素カリウム;塩化カリウム;塩化マグネシウム六水和物;マンニトール(Ph.Eur.);塩化ナトリウム;トリプトファン生産における問題最初の通知17.09.2024
    ラモトリギンタブレット生産能力不足最初の通知17.09.2024
    シクロピロックス・オラミンL、皮膚に塗布する。生産能力不足変更通知17.09.2024
  • 2024.09.17
    有効成分投与形態理由最後のメッセージの日付
    ウロキナーゼ注射剤/輸液用粉末ungErhte 需要16.09.2024
    硫酸モルヒネ(Ph.Eur.)徐放錠バッチテストの問題点16.09.2024
    塩酸メルペロンフィルムコート錠生産能力不足16.09.2024
    アトモキセチン塩酸塩ハードカプセル生産における問題16.09.2024
    クエン酸スフェンタニルInjektionslung生産における問題16.09.2024
    アモキシシリン三水和物経口懸濁液調製用粉末Erhte 需要16.09.2024
    硫酸ゲンタマイシン眼軟膏生産における問題16.09.2024
    デキサメタゾン;硫酸ゲンタマイシン眼軟膏生産における問題16.09.2024
    塩酸プリロカインInjektionslung生産における問題14.09.2024
    タクロリムス一水和物軟膏Erhte 需要13.09.2024
    硫酸フラマイセチン(1:x) ((硫黄含有量の詳細))肌に塗布するパウダー生産能力不足13.09.2024
    エゼチミブタブレットErhte 需要13.09.2024
    エリスロマイシンエストレート経口懸濁液調製用粉末Erhte 需要13.09.2024
    シプロフロキサシン硫酸塩(1:1)Infusionslung生産における問題13.09.2024
    グルカゴン点鼻薬他メーカーとの問題12.09.2024
    塩酸メチルフェニデート徐放錠その他12.09.2024
    フォスカルネットナトリウム六水和物Infusionslungその他12.09.2024
    タクロリムス一水和物生産における問題12.09.2024
    メトホルミン塩酸塩;シタグリプチン塩酸塩一水和物フィルムコート錠その他12.09.2024
    クリンダマイシン-2-リン酸二水素塩膣乳頭Erhte 需要12.09.2024
    硫酸ビンブラスチンInjektionslung最終リリースの問題点12.09.2024
    ニトラゼパムタブレットErhte 需要12.09.2024
    オランザピンエンボン酸一水和物Erhte 需要12.09.2024
    臭化水素酸エレトリプタンフィルムコート錠その他11.09.2024
    トロクトコグ・アルファ・ペゴルInjektionslung 調製用粉末生産能力不足11.09.2024
    ナロキソン塩酸塩二水和物;オキシコドン塩酸塩(Ph.Eur.)徐放錠生産能力不足11.09.2024
    エストラジオール半水和物;酢酸ノルエチステロンフィルムコート錠その他11.09.2024
    インスリンアスパルトInjektionslung他メーカーとの問題11.09.2024
    塩酸ベタヒスチンタブレットErhte 需要11.09.2024
    <2>イバンドロン酸ナトリウム 1 H OInfusionsl調製用濃縮液ungErhte 需要11.09.2024
    セレギリン塩酸塩タブレットErhte 需要11.09.2024
    ヒドロモルフォン塩酸塩徐放錠Erhte 需要11.09.2024
    アジスロマイシン一水和物フィルムコート錠Erhte 需要11.09.2024
    クラリスロマイシンフィルムコート錠Erhte 需要11.09.2024
    インスリン グラルギンInjektionslung他メーカーとの問題11.09.2024
    エトポシドInfusionsl調製用濃縮液ung生産における問題11.09.2024
    アジスロマイシン二水和物フィルムコート錠Erhte 需要11.09.2024
    フェノキシメチルペニシリンカリウムフィルムコート錠生産における問題11.09.2024
    アジスロマイシン二水和物フィルムコート錠Erhte 需要11.09.2024
    アモキシシリン三水和物フィルムコート錠Erhte 需要11.09.2024
    臭化ロクロニウム注射/輸液ung生産における問題10.09.2024
    クラリスロマイシン経口懸濁液調製用顆粒生産能力不足10.09.2024
    パリカルシトールInjektionslungErhte 需要09.09.2024
    オクスカルバゼピン経口懸濁液その他09.09.2024
    インスリンリスプロInjektionslung 完成したペンの中生産能力不足09.09.2024
    インスリンアスパルトInjektionslungその他09.09.2024
    ペグインターフェロン アルファ-2aInjektionslungメーカー変更09.09.2024
    デュロキセチン腸溶性コーティング・ハードカプセルErhte 需要09.09.2024
    レナリドミドハードカプセルErhte 需要09.09.2024
    硫酸サルブタモール加圧ガスの吸入Erhte 需要08.09.2024
    硫酸サルブタモール加圧ガスの吸入Erhte 需要08.09.2024
    ヨウ化ナトリウム((123)I)06.09.2024
    鉄(III) D-グルコン酸ナトリウム水酸化物酸化物錯体 (約2:1:1:x:y)Injektionslung有効成分メーカーの問題06.09.2024
    デキサメタゾン;硫酸ゲンタマイシン眼軟膏生産における問題06.09.2024
    硫酸ゲンタマイシン眼軟膏生産における問題06.09.2024
    チモロールマレイン酸塩目薬生産における問題06.09.2024
    塩酸キナプリルフィルムコート錠その他06.09.2024
    ヒドロクロロチアジド;塩酸キナプリルフィルムコート錠その他06.09.2024
    硫酸サルブタモール加圧ガスの吸入Erhte 需要06.09.2024
    エゼチミブタブレットErhte 需要05.09.2024
    ブプレノルフィン経皮吸収パッチErhte 需要05.09.2024
    リスペリドンデポー注射用懸濁液調製用粉末生産における問題05.09.2024
    硫酸ゲンタマイシンInjektionslung生産における問題05.09.2024
    フェンプロクーモンタブレット生産における問題05.09.2024
    エピネフリン/アドレナリンInjektionslungメーカー変更04.09.2024
    モメタゾンフロエート(Ph.Eur.)L、皮膚に塗布する。生産能力不足04.09.2024
    ヒドロモルフォン塩酸塩徐放錠Erhte 需要04.09.2024
    エトスクシミドLungメーカー変更04.09.2024
    酢酸メドロキシプロゲステロンタブレットその他04.09.2024
    クラリスロマイシンフィルムコート錠Erhte 需要04.09.2024
    アジスロマイシン二水和物経口懸濁液調製用粉末Erhte 需要04.09.2024
    塩酸レボメタドンタブレットその他04.09.2024
    アモキシシリン三水和物フィルムコート錠Erhte 需要04.09.2024
    エトポシドInfusionsl調製用濃縮液ung生産能力不足03.09.2024
    リネゾリドInfusionslung生産における問題03.09.2024
    プレドニカルベートL、皮膚に塗布する。生産能力不足03.09.2024
    塩酸シナカルセスフィルムコート錠Erhte 需要03.09.2024
    オキシコドン塩酸塩(Ph.Eur.)徐放錠Erhte 需要03.09.2024
    エスケタミン塩酸塩Injektionslungその他02.09.2024
    エストラジオール半水和物;酢酸ノルエチステロンフィルムコート錠その他02.09.2024
    プレガバリン02.09.202402.09.2024
    オメプラゾール腸溶性コーティング・ハードカプセルErhte 需要02.09.2024
  • 2024.09.02
    活性物質剤形理由最終届出日
    Risedronat-Natrium-230.08.2024
    イバンドロン酸ナトリウム一水和物フィルムコーティング錠Erhte 需要30.08.2024
    エトスクシミドソフトカプセルErhte Demand2024.08.30
    ヒドロモルフォン塩酸塩徐放錠Erhte 需要2024.08.30
    Hydromorphone hydrochlorideProlonged-release tabletErhte demand30.08.2024
    メトトレキサート二ナトリウムInjektionslungChange of manufacturer2024.08.30
    Prednisolone acetate貼付剤製造上の問題30.08.2024
    アトモキセチン塩酸塩予定info@heumann.de2024.08.29
    Metronidazol予定info@heumann.de29.08.2024
    Esketamine hydrochlorideInjektionslungOther29.08.2024
    Tacrolimus-MonohydratSalbeProbleme in der Herstellung29.08.2024
    アモキシシリン三水和物経口懸濁液用粉末Erhte demand29.08.2024
    BetahistindihydrochloridTabletteErhte Nachfrage29.08.2024
    Azithromycin-DihydratFilmtabletteErhte Nachfrage29.08.2024
    Azithromycin-MonohydratFilmtabletteErhte Nachfrage29.08.2024
    CarbamazepineProlonged-release tabletErhte request29.08.2024
    ヒドロモルフォン塩酸塩徐放錠 製造上の問題29.08.2024
    Hydromorphone hydrochlorideProlonged-release tabletManufacturing issues29.08.2024
    塩酸レミフェンタニル粉末・濃縮注射剤/輸液ungErhte demand29.08.2024
    Amitriptyline hydrochlorideProlonged release tabletOther29.08.2024
    シナカルセット塩酸塩フィルムコーティング錠Erhte request28.08.2024
    VandetanibManufacturing issues2024.08.28
    ヒドロモルフォン塩酸塩徐放錠製造上の問題28.08.2024
    セファドロキシル一水和物経口懸濁液用粉末剤Erhte 需要28.08.2024
    オクスカルバゼピン経口懸濁液その他2024.08.28
    レミフェンタニル塩酸塩注射用濃縮製剤または輸液用粉末ungProblems with the other manufacturer27.08.2024
    Remifentanil hydrochloridePowder f・a concentrate for preparation of injection/InfusionlungErhte demand27.08.2024
    ヒドロモルフォン塩酸塩徐放錠Erhte Demand27.08.2024
    オフロキサシン点眼薬Manufacturing における問題2024.08.27
    Valganciclovir hydrochloridePowder for oral preparation LungProblems in manufacture26.08.2024
    メサラジン徐放錠Erhte request26.08.2024
    Morphinsulfat (Ph.Eur.)徐放性錠剤生産能力不足26.08.2024
    BuprenorphinhydrochloridSublingualtabletteProbleme in der Herstellung26.08.2024
    Salbutamolsulfatなしservice.info@gsk.com25.08.2024
    Cyclopentolate hydrochlorideEye dropsManufacturing issues23.08.2024
    Remifentanil hydrochloridePowder f・a concentrate for preparation of injection/InfusionlungErhte demand23.08.2024
  • 2024.08.23
    有効成分投与形態理由最後のメッセージの日付
    ノナコグ・ベータ・ペゴルパウダーerung 生産能力が予想を下回ったため22.08.2024
    トロクトコグ アルファパウダーerung 生産能力が予想を下回ったため22.08.2024
    アジスロマイシン二水和物フィルムコート錠一次包装の在庫不足。22.08.2024
    メトホルミン塩酸塩;シタグリプチン塩酸塩一水和物フィルムコート錠これ以上の情報はない22.08.2024
    オフロキサシン目薬該当なし22.08.2024
    フルオロメトロン目薬該当なし22.08.2024
    メサラジン徐放性有効成分含有錠剤該当なし22.08.2024
    クロラムフェニコール眼軟膏該当なし22.08.2024
    アジスロマイシン二水和物フィルムコート錠該当なし21.08.2024
    アモキシシリン三水和物タブレット該当なし21.08.2024
    ヒドロモルフォン塩酸塩徐放錠該当なし21.08.2024
    <2>シプロフロキサシン塩酸塩(1:1) 1 H Oフィルムコート錠該当なし21.08.2024
    アジスロマイシン二水和物フィルムコート錠該当なし21.08.2024
    プロピオン酸クロベタゾール(Ph.Eur.)Lung該当なし21.08.2024
    硫酸ゲンタマイシン眼軟膏該当なし21.08.2024
    デキサメタゾン;硫酸ゲンタマイシン眼軟膏該当なし21.08.2024
    硫酸サルブタモール加圧ガスの吸入ALBVVGは経済的な継続を保証するものではない。20.08.2024
    デキサメタゾンリン酸二水素二ナトリウム(Ph.Eur.)Injektionslung該当なし20.08.2024
    アモキシシリン三水和物フィルムコート錠該当なし20.08.2024
    クリンダマイシン塩酸塩一水和物ハードカプセル該当なし20.08.2024
    塩酸バンコマイシンハードカプセル競合他社の在庫切れにより、12月と1月にerhteの販売が好調だった。20.08.2024
    オランザピンエンボン酸一水和物パウダー供給ボトルネックの原因は、針の供給問題である。19.08.2024
    イバンドロン酸ナトリウム一水和物フィルムコート錠Erhte アレンドロン舫の配送ボトルネックによる需要19.08.2024
    リセドロン酸ナトリウム-219.08.2024
    ポサコナゾール経口懸濁液調製用粉末Erhte 需要19.08.2024
    エゼチミブタブレット該当なし19.08.2024
    塩化ミバキュリウムInjektionslung該当なし19.08.2024
    塩酸プリロカインInjektionslung該当なし19.08.2024
    塩酸ミノサイクリン((無水19.08.2024
    メタミゾールナトリウム一水和物Injektionslung供給されたアンプルの品質問題19.08.2024
    ヒドロモルフォン塩酸塩徐放錠該当なし16.08.2024
    フェンプロクーモンタブレット該当なし15.08.2024
    パルミチン酸レチノール経口ドロップ該当なし15.08.2024
    トピラマートフィルムコート錠該当なし15.08.2024
    フォスカルネットナトリウム六水和物Infusionslung該当なし15.08.2024
    ノナコグ・ベータ・ペゴルパウダーerung 生産能力が予想を下回ったため15.08.2024
    オクスカルバゼピン徐放性有効成分含有錠剤該当なし15.08.2024
    オクスカルバゼピン経口懸濁液該当なし15.08.2024
    イトラコナゾールハードカプセル該当なし14.08.2024
    クラリスロマイシン経口懸濁液調製用顆粒該当なし14.08.2024
    アジスロマイシン二水和物フィルムコート錠該当なし14.08.2024
    トロクトコグ・アルファ・ペゴルInjektionslung 調製用粉末erung 生産能力が予想を下回ったため14.08.2024
    ブプレノルフィン経皮吸収パッチ該当なし14.08.2024
    シクロピロックス・オラミンL、皮膚に塗布する。該当なし13.08.2024
    アニデュラファンギン粉末・・・輸液用濃縮液ung該当なし13.08.2024
    ブプレノルフィン経皮吸収パッチ該当なし13.08.2024
    ヒドロモルフォン塩酸塩徐放錠該当なし13.08.2024
    アトモキセチン塩酸塩ハードカプセル該当なし13.08.2024
    ベタメタゾン・バレレート(Ph.Eur.)エマルジョン該当なし13.08.2024
    ノナコグ・ガンマパウダー該当なし12.08.2024
    塩酸レミフェンタニル粉末・・・注射剤/輸液用濃縮液ung該当なし12.08.2024
    エピネフリン酒石酸水素塩/アドレナリン酒石酸水素塩;プリロカイン塩酸塩Injektionslung該当なし12.08.2024
    アバカビル塩酸塩;ラミブジンフィルムコート錠該当なし12.08.2024
    アモキシシリン三水和物経口懸濁液調製用粉末該当なし12.08.2024
    塩酸ブプレノルフィン舌下錠該当なし12.08.2024
  • 2024.08.12
    有効成分投与形態理由メッセージの種類最後のメッセージの日付
    塩酸メチルフェニデート徐放錠その他変更通知11.08.2024
    クエン酸スフェンタニルInjektionslung生産における問題最初の通知09.08.2024
    タクロリムス一水和物軟膏生産における問題変更通知08.08.2024
    インスリン・デグルデクInjektionslung最終リリースの問題点最初の通知08.08.2024
    トロクトコグ アルファパウダー生産能力不足最初の通知08.08.2024
    フェンプロクーモンタブレット生産における問題変更通知08.08.2024
    セマグルチドInjektionslungErhte 需要最初の通知08.08.2024
    カルバマゼピン徐放錠その他変更通知07.08.2024
    塩酸メルペロンフィルムコート錠生産能力不足変更通知07.08.2024
    フルオロウラシルInjektionslung生産における問題変更通知07.08.2024
    リセドロン酸ナトリウム-2変更通知07.08.2024
    リスペリドンフィルムコート錠生産における問題変更通知07.08.2024
    ブプレノルフィン経皮吸収パッチErhte 需要最初の通知07.08.2024
    アザシチジン注射懸濁液調製用粉末その他最初の通知07.08.2024
    ブプレノルフィン経皮吸収パッチErhte 需要最初の通知07.08.2024
    アトモキセチン塩酸塩ハードカプセルその他最初の通知07.08.2024
    ブプレノルフィン経皮吸収パッチErhte 需要変更通知07.08.2024
    アトモキセチン塩酸塩ハードカプセルその他最初の通知07.08.2024
    クリンダマイシン塩酸塩一水和物ハードカプセルErhte 需要変更通知07.08.2024
    アモキシシリン三水和物フィルムコート錠Erhte 需要変更通知07.08.2024
    セファドロキシル一水和物経口懸濁液調製用粉末Erhte 需要変更通知07.08.2024
    カルボプラチンInfusionsl調製用濃縮液ungその他最初の通知06.08.2024
    アトモキセチン塩酸塩ハードカプセル生産における問題変更通知06.08.2024
    レベチラセタムフィルムコート錠生産における問題変更通知06.08.2024
    ラモトリギンタブレット生産における問題変更通知06.08.2024
    フォスカルネットナトリウム六水和物Infusionslungその他最初の通知06.08.2024
    ヒドロモルフォン塩酸塩徐放錠Erhte 需要変更通知06.08.2024
    メトプロロール酒石酸塩(Ph.Eur.)徐放錠Erhte 需要変更通知06.08.2024
    塩酸シナカルセスフィルムコート錠Erhte 需要変更通知06.08.2024
    <2>シプロフロキサシン塩酸塩(1:1) 1 H Oフィルムコート錠Erhte 需要変更通知06.08.2024
    アモキシシリン三水和物フィルムコート錠Erhte 需要変更通知06.08.2024
    モメタゾンフロエート(Ph.Eur.)軟膏生産能力不足最初の通知06.08.2024
    メシル酸ラサギリンタブレット生産における問題変更通知06.08.2024
    フルニソリド半水和物鼻腔スプレー生産能力不足変更通知06.08.2024
    <2>シプロフロキサシン塩酸塩(1:1) 1 H Oフィルムコート錠Erhte 需要変更通知06.08.2024
    アモキシシリン三水和物タブレットErhte 需要変更通知06.08.2024
    メサラジン腸溶性フィルムコーティング錠Erhte 需要最初の通知05.08.2024
    フェノキシメチルペニシリンカリウム経口用 Lung 調製用粉末Erhte 需要変更通知05.08.2024
    セファクロル一水和物ハードカプセル生産能力不足変更通知05.08.2024
    フェノキシメチルペニシリンカリウム経口用L製剤用顆粒ungErhte 需要変更通知05.08.2024
    ヒドロクロロチアジド;塩酸キナプリルフィルムコート錠その他変更通知05.08.2024
    塩酸キナプリルフィルムコート錠その他変更通知05.08.2024
    ヒドロコルチゾン-17-ブタン酸エステルL、皮膚に塗布する。Erhte 需要最初の通知05.08.2024
    ラモトリギン経口懸濁液調製用錠剤生産能力不足変更通知05.08.2024
    ウラピジルハードカプセル他メーカーとの問題変更通知05.08.2024
    硫酸サルブタモール加圧ガスの吸入その他変更通知05.08.2024
    イトラコナゾールハードカプセルその他変更通知05.08.2024
    クリンダマイシン塩酸塩一水和物ハードカプセルErhte 需要変更通知05.08.2024
    エゼチミブタブレットErhte 需要変更通知05.08.2024
    塩酸レボメタドンタブレットその他変更通知05.08.2024
    塩酸ブプレノルフィン舌下錠生産における問題変更通知05.08.2024
    葉酸カルシウム変更通知05.08.2024
  • 2024.08.06
    有効成分投与形態理由メッセージの種類最後のメッセージの日付
    葉酸カルシウム変更通知05.08.2024
    ジプロピオン酸ベタメタゾン(Ph.Eur.);サリチル酸舫レL、皮膚に塗布する。生産能力不足変更通知02.08.2024
    アトモキセチン塩酸塩ハードカプセル生産における問題最初の通知02.08.2024
    ペリンドプリル-tert-ブチルアミンタブレットErhte 需要最初の通知02.08.2024
    トラゾドン塩酸塩タブレット生産能力不足最初の通知02.08.2024
    リザトリプタン安息香酸塩タブレット生産における問題変更通知02.08.2024
    リザトリプタン安息香酸塩溶解タブレット生産における問題変更通知02.08.2024
    フマル酸クエチアピン(欧州製薬)徐放錠生産における問題変更通知02.08.2024
    エゼチミブ; シンバスタチンタブレットバッチテストの問題点変更通知02.08.2024
    ブプレノルフィン経皮吸収パッチ生産における問題変更通知02.08.2024
    オランザピンエンボン酸一水和物パウダーその他最初の通知01.08.2024
    モメタゾンフロエート(Ph.Eur.)L、皮膚に塗布する。生産能力不足最初の通知01.08.2024
    トロクトコグ アルファパウダー生産能力不足最初の通知01.08.2024
    酢酸メドロキシプロゲステロンタブレットその他最初の通知01.08.2024
    カンデサルタンシレキセチルタブレットその他変更通知01.08.2024
    カルバマゼピン該当なし変更通知31.07.2024
    塩酸プロプラノロールハードカプセル生産能力不足最初の通知30.07.2024
    ナロキソン塩酸塩二水和物;オキシコドン塩酸塩(Ph.Eur.)徐放錠生産能力不足変更通知30.07.2024
    インスリン グラルギンInjektionslung他メーカーとの問題変更通知30.07.2024
    ジヒドロコデイン[(R変更通知29.07.2024
    硫酸ゲンタマイシン目薬生産における問題変更通知29.07.2024
  • 2024.07.29
    有効成分投与形態理由メッセージタイプ最後のメッセージの日付
    アモキシシリン三水和物フィルムコート錠需要変更通知26.07.2024
    ドキシサイクリン一水和物タブレット生産能力不足変更通知26.07.2024
    アジスロマイシン二水和物経口懸濁液調製用粉末需要変更通知26.07.2024
    アジスロマイシン二水和物フィルムコート錠その他変更通知26.07.2024
    セファドロキシル一水和物経口懸濁液調製用粉末需要変更通知26.07.2024
    <2>シプロフロキサシン塩酸塩(1:1) 1 H Oフィルムコート錠需要変更通知26.07.2024
    パリカルシトールInjektionslung需要変更通知26.07.2024
    フェノキシメチルペニシリンカリウム経口用L製剤用粉末ung需要変更通知26.07.2024
    アモキシシリン三水和物経口懸濁液調製用粉末需要変更通知26.07.2024
    アジスロマイシン二水和物フィルムコート錠生産能力不足初回通知25.07.2024
    クラリスロマイシン13.05.2024変更通知25.07.2024
    トロクトコグ アルファパウダー生産能力不足初回通知25.07.2024
    アムロジピンベシル酸塩;バルサルタン01.07.2024変更通知25.07.2024
    レベチラセタムLung 摂取用需要変更通知24.07.2024
    アジスロマイシン二水和物フィルムコート錠生産における問題初回通知24.07.2024
    アバカビル塩酸塩;ラミブジンフィルムコート錠需要初回通知24.07.2024
    クリンダマイシン塩酸塩ハードカプセル需要変更通知24.07.2024
    イベルメクチンタブレット需要変更通知24.07.2024
    アダパレン;過酸化ベンゾイルゲル需要変更通知24.07.2024
    ニモジピンフィルムコート錠その他初回通知24.07.2024
    アトモキセチン塩酸塩ハードカプセル生産における問題初回通知23.07.2024
    フェンプロクーモンタブレット生産における問題変更通知23.07.2024
    塩酸ブプレノルフィン舌下錠生産における問題変更通知23.07.2024
    ニモジピンフィルムコート錠その他変更通知23.07.2024
    モメタゾンフロエート(Ph.Eur.)L。生産能力不足初回通知23.07.2024
    デキサメタゾン; ゲンタマイシン硫酸塩眼軟膏生産における問題変更通知23.07.2024
    アテノロールフィルムコート錠需要初回通知23.07.2024
    塩酸メチルフェニデート徐放錠その他変更通知23.07.2024
    アトモキセチン塩酸塩ハードカプセル生産における問題変更通知22.07.2024
    ラタノプロスト目薬生産における問題変更通知22.07.2024
    メタミゾールナトリウム一水和物Injektionslungその他変更通知22.07.2024
    アテノロールフィルムコート錠需要初回通知22.07.2024
    ベバシズマブInfusionsl調製用濃縮液ung生産における問題変更通知22.07.2024
    アテノロールフィルムコート錠需要初回通知22.07.2024
    リセドロン酸ナトリウム-2変更通知22.07.2024
    イトラコナゾールハードカプセルその他変更通知22.07.2024
    アジスロマイシン二水和物フィルムコート錠需要初回通知22.07.2024
    塩酸ベタヒスチンタブレット需要変更通知22.07.2024
  • 2024.07.22
    有効成分投与形態理由メッセージタイプ最後のメッセージの日付
    塩酸ベタヒスチンタブレット需要変更通知22.07.2024
    硫酸モルヒネ(Ph.Eur.)Injektionslung生産能力不足初回通知19.07.2024
    メサラジン徐放錠需要初回通知19.07.2024
    カルシトリオールInjektionslung生産能力不足初回通知19.07.2024
    酢酸ヒドロコルチゾン(Ph.Eur.)眼軟膏生産における問題初回通知19.07.2024
    塩酸シナカルセスフィルムコート錠その他変更通知18.07.2024
    塩酸メチルフェニデート有効成分を長時間放出するハードカプセル生産における問題変更通知18.07.2024
    アムロジピンベシル酸塩;ペリンドプリル-tert-ブチルアミンタブレット生産における問題変更通知18.07.2024
    フェンプロクーモンタブレット生産における問題変更通知17.07.2024
    ヒドロコルチゾンカプセル除去用顆粒包装業者における5mg製品の供給問題。初回通知17.07.2024
    アジスロマイシン二水和物フィルムコート錠需要変更通知17.07.2024
    メトプロロール酒石酸塩(Ph.Eur.)徐放錠需要変更通知17.07.2024
    オキシコドン塩酸塩(Ph.Eur.)徐放錠生産施設の能力変更通知17.07.2024
    ミルタザピンフィルムコート錠需要変更通知17.07.2024
    オランザピンエンボン酸一水和物パウダー他メーカーとの問題変更通知16.07.2024
    トロクトコグ アルファパウダー生産における問題初回通知16.07.2024
    アジスロマイシン一水和物フィルムコート錠需要初回通知16.07.2024
    メトロニダゾールタブレット生産における問題変更通知16.07.2024
    アプレピタント経口懸濁液調製用粉末需要変更通知16.07.2024
    トロクトコグ アルファパウダー生産における問題変更通知15.07.2024
    ヒドロモルフォン塩酸塩徐放錠その他変更通知15.07.2024
    プロゲステロンソフトカプセル生産における問題初回通知15.07.2024
    ベタメタゾン酢酸エステル(Ph.Eur.);ベタメタゾンリン酸二水素二ナトリウム(Ph.Eur.)インジェクション・サスペンション生産能力不足変更通知15.07.2024
    アトモキセチン塩酸塩ハードカプセル生産における問題変更通知15.07.2024
    メトホルミン塩酸塩;シタグリプチン塩酸塩一水和物該当なし変更通知15.07.2024
    アトモキセチン塩酸塩ハードカプセル生産における問題初回通知15.07.2024
    塩酸ブプレノルフィン舌下錠生産における問題変更通知15.07.2024
  • 2024.07.16
    有効成分投与形態理由メッセージタイプ最後のメッセージの日付
    ベバシズマブInfusionsl調製用濃縮液ung生産における問題初回通知12.07.2024
    アモキシシリン三水和物経口懸濁液調製用粉末需要変更通知12.07.2024
    フェノキシメチルペニシリン-ベンザチン経口懸濁液需要初回通知12.07.2024
    フェノキシメチルペニシリンカリウム経口用L製剤用顆粒ung需要変更通知12.07.2024
    アテノロール; クロルタリドンフィルムコート錠需要初回通知12.07.2024
    アジスロマイシン二水和物フィルムコート錠その他変更通知12.07.2024
    アジスロマイシン二水和物経口懸濁液調製用粉末需要変更通知12.07.2024
    アレンドロン酸ナトリウム(Ph.Eur.)フィルムコート錠その他変更通知12.07.2024
    <2>シプロフロキサシン塩酸塩(1:1) 1 H Oフィルムコート錠需要変更通知12.07.2024
    パリカルシトールInjektionslung需要変更通知12.07.2024
    メトホルミン塩酸塩;シタグリプチン塩酸塩一水和物フィルムコート錠その他変更通知11.07.2024
    アルギニン塩酸塩Infusionsl調製用濃縮液ungその他変更通知11.07.2024
    炭酸水素ナトリウム腸溶錠需要初回通知10.07.2024
    ベタメタゾン・バレレート(Ph.Eur.)エマルジョン需要初回通知10.07.2024
    ラベプラゾールナトリウム腸溶錠需要変更通知10.07.2024
    ナロキソン塩酸塩二水和物;オキシコドン塩酸塩(Ph.Eur.)徐放錠生産能力不足変更通知10.07.2024
    セファクロル一水和物ハードカプセル生産能力不足初回通知09.07.2024
    オランザピンエンボン酸一水和物パウダー針の供給問題変更通知09.07.2024
    リセドロン酸ナトリウム-2初回通知09.07.2024
    硫酸サルブタモール加圧ガスの吸入需要変更通知09.07.2024
    塩酸ラニチジンフィルムコート錠その他変更通知09.07.2024
    スルバクタムナトリウム注射剤または輸液用粉末ung需要変更通知09.07.2024
    ピルフェニドン08.07.2024初回通知08.07.2024
    セファクロル一水和物経口懸濁液調製用顆粒その他変更通知08.07.2024
    ジメンヒドリナートInjektionslungその他変更通知08.07.2024
  • 2024.07.08
    有効成分投与形態理由メッセージタイプ最後のメッセージの日付
    アジスロマイシン二水和物フィルムコート錠一次包装の在庫不足。変更通知05.07.2024
    フェノキシメチルペニシリンカリウム経口用L製剤用粉末ung需要変更通知05.07.2024
    インスリン・ヒト((製造の詳細を含む)Injektionslung生産における問題初回通知05.07.2024
    酢酸ヒドロコルチゾン(Ph.Eur.)眼軟膏生産における問題変更通知04.07.2024
    塩酸ランジオロールInjektionslung 調製用濃縮液Behdlichは電話を要請した。変更通知04.07.2024
    ジヒドロコデイン[(R初回通知04.07.2024
    アダパレン;過酸化ベンゾイルゲル需要初回通知04.07.2024
    塩酸メチルフェニデート有効成分を長時間放出するハードカプセル生産における問題変更通知04.07.2024
    オメプラゾール腸溶性ハードカプセル需要変更通知04.07.2024
    ブプレノルフィン経皮吸収パッチ需要変更通知03.07.2024
    <2>シプロフロキサシン塩酸塩(1:1) 1 H Oフィルムコート錠需要変更通知03.07.2024
    メシル酸ラサギリンタブレット生産における問題変更通知03.07.2024
    アモキシシリン三水和物タブレット需要変更通知03.07.2024
    メトプロロール酒石酸塩(Ph.Eur.)徐放錠需要変更通知03.07.2024
    <2>シプロフロキサシン塩酸塩(1:1) 1 H Oフィルムコート錠需要変更通知03.07.2024
    塩酸シナカルセスフィルムコート錠需要変更通知03.07.2024
    ブプレノルフィン経皮吸収パッチ需要変更通知03.07.2024
    アモキシシリン三水和物;クラブラン酸カリウム経口懸濁液調製用粉末需要変更通知03.07.2024
    パリカルシトールInjektionslung生産能力不足初回通知03.07.2024
    トロピカミド他の製品の製造中止のため変更通知03.07.2024
    フルオロウラシルナトリウム注射/輸液ung生産能力不足初回通知03.07.2024
    ロスバスタチン-ヘミカルシウム変更通知03.07.2024
    4-ヒドロキシブタン舫レ ナトリウム塩Lung 摂取用API不足初回通知03.07.2024
    リスペリドンLung 摂取用需要変更通知03.07.2024
    ロスバスタチン-ヘミカルシウム変更通知03.07.2024
    カンデサルタンシレキセチルタブレット該当なし変更通知03.07.2024
    パリカルシトールInjektionslung需要変更通知03.07.2024
    ドキシサイクリン一水和物タブレット生産能力不足変更通知02.07.2024
    リザトリプタン安息香酸塩タブレット生産における問題変更通知02.07.2024
    フマル酸クエチアピン(欧州製薬)徐放錠生産における問題初回通知02.07.2024
    リネゾリドフィルムコート錠需要初回通知02.07.2024
    酢酸イカティバン(1:x) ((酢酸含有量の詳細))Injektionslung プレフィルドシリンジ入り需要変更通知02.07.2024
    エゼチミブ; シンバスタチンタブレット生産における問題初回通知02.07.2024
    ブプレノルフィン経皮吸収パッチ生産における問題初回通知02.07.2024
    塩化ナトリウムガラス瓶納入業者における納入ボトルネック。生産設備の稼働率が高いため(生産能力の限界に達している)、Mlichkeit変更通知02.07.2024
    フェノキシメチルペニシリンカリウムフィルムコート錠その他変更通知02.07.2024
    塩酸レボメタドンタブレットその他変更通知02.07.2024
    クラリスロマイシンフィルムコート錠需要変更通知02.07.2024
    プレドニカルベートL。生産能力不足変更通知02.07.2024
    ネオスチグミンメチル硫酸塩生産能力不足。初回通知01.07.2024
    ベタメタゾン酢酸エステル(Ph.Eur.);ベタメタゾンリン酸二水素二ナトリウム(Ph.Eur.)インジェクション・サスペンション生産能力不足変更通知01.07.2024
    レベチラセタムLung 摂取用需要初回通知01.07.2024
    テノホビル ジソプロキシルフィルムコート錠他メーカーとの問題初回通知01.07.2024
    アムロジピンベシル酸塩;バルサルタン01.07.2024kundenservice@viatris.com初回通知01.07.2024
    葉酸カルシウム変更通知01.07.2024
    硫酸モルヒネ(Ph.Eur.)Lung 摂取用地域代表における複雑な変化と現代の変化(共同配信者)変更通知01.07.2024
    硫酸ゲンタマイシン眼軟膏生産における問題変更通知01.07.2024
    ウラピジルハードカプセル他メーカーとの問題変更通知01.07.2024
    塩酸ブプレノルフィン舌下錠生産における問題変更通知01.07.2024
  • 2024.07.02
    有効成分投与形態理由メッセージタイプ最後のメッセージの日付
    塩酸レミフェンタニル注射剤または輸液用濃縮製剤調製用粉末ung該当なし変更通知30.06.2024
    フェノキシメチルペニシリンカリウム経口用L製剤用粉末ung該当なし変更通知28.06.2024
    セファドロキシル一水和物経口懸濁液調製用粉末該当なし変更通知28.06.2024
    パリカルシトールInjektionslung該当なし変更通知28.06.2024
    フェノキシメチルペニシリンカリウム経口用L製剤用顆粒ungErhte 競合他社の供給能力不足による需要変更通知28.06.2024
    ドンペリドン内服薬製造業者における移管検証バッチの製造工程における検証erung変更通知28.06.2024
    ダントロレンナトリウム-3初回通知28.06.2024
    エファビレンツ;エムトリシタビン;コハク酸テノホビルジソプロキシルシナプスはこの研究を認めなくなった。初回通知28.06.2024
    コハク酸ソリフェナシンフィルムコート錠競合他社3社が4月以降、納品不能に初回通知28.06.2024
    オメプラゾール腸溶性ハードカプセル該当なし変更通知28.06.2024
    セマグルチドInjektionslungドイツの需要は部分的にしか満たせない変更通知27.06.2024
    トロクトコグ アルファパウダー充填ラインの問題初回通知27.06.2024
    豚膵臓粉末;パンクレアチン((使用動物種の表示あり)腸溶性ハードカプセル該当なし変更通知27.06.2024
    ヒドロモルフォン塩酸塩徐放錠該当なし変更通知27.06.2024
    臭化水素酸エレトリプタンフィルムコート錠該当なし変更通知27.06.2024
    硫酸モルヒネ(Ph.Eur.)徐放錠該当なし初回通知27.06.2024
    <2>ナロキソン塩酸塩二水和物;オキシコドン塩酸塩 1 H O徐放錠該当なし変更通知27.06.2024
    酢酸フレカイニドタブレット該当なし変更通知27.06.2024
    イベルメクチンタブレット該当なし初回通知27.06.2024
    硫酸モルヒネ(Ph.Eur.)徐放錠該当なし変更通知27.06.2024
    ラモトリギンタブレット該当なし初回通知26.06.2024
    塩酸レミフェンタニル粉末・・・注射剤/輸液用濃縮液ung該当なし変更通知26.06.2024
    プレドニカルベートクリーム該当なし初回通知26.06.2024
    サリチル舫レ;トリアムシノロンアセトニドL。該当なし初回通知26.06.2024
    タクロリムス一水和物軟膏該当なし変更通知26.06.2024
    フェンプロクーモンタブレット該当なし変更通知26.06.2024
    ベシル酸シサトラキュリウム注射/輸液ung該当なし変更通知26.06.2024
    酢酸カルシウム;酢酸カリウム;酢酸マグネシウム四水和物;酢酸ナトリウム三水和物;塩化ナトリウムPZN 00541612は部分的に供給可能である。供給量は過去数ヶ月の平均需要の90%である。ボトルネックは代替品で部分的に埋めることができる。変更通知25.06.2024
    ドキシサイクリン一水和物タブレット該当なし初回通知25.06.2024
    セレギリン塩酸塩タブレット該当なし変更通知25.06.2024
    ドキシサイクリン一水和物タブレット該当なし初回通知25.06.2024
    <2>イバンドロン酸ナトリウム 1 H OInfusionsl調製用濃縮液ung該当なし変更通知25.06.2024
    ドキシサイクリン一水和物タブレット該当なし初回通知25.06.2024
    アモキシシリン三水和物経口懸濁液調製用粉末該当なし変更通知25.06.2024
    塩酸バンコマイシンハードカプセル競合品の在庫切れにより、2023年末以降のバンコマイシン全SKUのerhte売上が好調に推移。初回通知24.06.2024
    ラモトリギン経口懸濁液調製用錠剤該当なし変更通知24.06.2024
    デキサメタゾン; ゲンタマイシン硫酸塩眼軟膏該当なし変更通知24.06.2024
  • 2024.06.24
    有効成分投与形態理由最後のメッセージの日付
    レベチラセタムLung 摂取用生産における問題23.06.2024
    メトホルミン塩酸塩;シタグリプチン塩酸塩一水和物フィルムコート錠詳細は不明21.06.2024
    アルギニン塩酸塩Infusionsl調製用濃縮液ungその他21.06.2024
    アルギニン塩酸塩Infusionsl調製用濃縮液ungその他21.06.2024
    フルオロウラシル21.06.2024
    ラモトリギンタブレット生産における問題21.06.2024
    カルバマゼピン該当なし21.06.2024
    トブラマイシン注射/輸液ung生産能力不足21.06.2024
    オンダンセトロン塩酸塩二水和物Lungその他21.06.2024
    イトラコナゾールハードカプセルその他21.06.2024
    セファクロル一水和物経口懸濁液調製用顆粒その他21.06.2024
    アモキシシリン三水和物経口懸濁液調製用粉末需要21.06.2024
    アジスロマイシン二水和物フィルムコート錠需要21.06.2024
    アルテプラーゼ注射剤調製用粉末 /Infusionslung生産における問題21.06.2024
    硫酸ゲンタマイシン目薬生産における問題21.06.2024
    オランザピンエンボン酸一水和物パウダー需要20.06.2024
    塩酸メチルフェニデート徐放錠その他20.06.2024
    シプロフロキサシン塩酸塩(1:1) 1 H Oフィルムコート錠需要20.06.2024
    塩酸ミノサイクリン((無水20.06.2024
    アジスロマイシン二水和物フィルムコート錠需要19.06.2024
    硫酸サルブタモール加圧ガスの吸入需要19.06.2024
    インスリンアスパルトInjektionslungその他19.06.2024
    エムトリシタビン; テノホビルジソプロキシルマレイン酸塩19.06.202419.06.2024
    アモキシシリン三水和物フィルムコート錠需要19.06.2024
    ベタメタゾンジプロピオン酸エステル(Ph.Eur.); サリチル舫レ軟膏生産能力不足19.06.2024
    乳酸シプロフロキサシンInfusionslung生産における問題18.06.2024
    プレドニカルベートL。生産能力不足18.06.2024
    硫酸モルヒネ(Ph.Eur.)Lung 摂取用その他18.06.2024
    塩酸ベタヒスチンタブレット需要18.06.2024
    ジメシル酸ベタヒスチンタブレット需要18.06.2024
    塩酸ベナゼプリルフィルムコート錠需要18.06.2024
    アジスロマイシン二水和物フィルムコート錠需要18.06.2024
    ベタメタゾン酢酸エステル(Ph.Eur.);ベタメタゾンリン酸二水素二ナトリウム(Ph.Eur.)インジェクション・サスペンション生産能力不足18.06.2024
    メトプロロールコハク酸塩(Ph.Eur.)徐放錠生産における問題18.06.2024
    ヒドロモルフォン塩酸塩徐放錠生産における問題18.06.2024
    硫酸サルブタモール加圧ガスの吸入需要17.06.2024
    グリシン硫酸鉄(II)錯体内服薬その他17.06.2024
    塩酸メチルフェニデート徐放錠需要17.06.2024
    アレンドロン酸ナトリウム(Ph.Eur.)タブレット需要17.06.2024
    ソマトレリン酢酸塩(1:x) y H O ((酢酸および水分含量の詳細))Injektionslung 調製用パウダー生産における問題17.06.2024
    アシクロビル眼軟膏生産における問題17.06.2024
    ヒト由来コルチコレリン17.06.2024
    フルニソリド半水和物鼻腔スプレー生産能力不足17.06.2024
    ベタメタゾン・バレレート(Ph.Eur.)L。生産能力不足17.06.2024
    プレドニカルベートL。生産能力不足17.06.2024
    ベタメタゾン・バレレート(Ph.Eur.)需要17.06.2024
    ヒドロモルフォン塩酸塩注射/輸液ungその他17.06.2024
    セファドロキシル一水和物経口懸濁液調製用粉末需要17.06.2024
    塩酸ベタヒスチンタブレット需要17.06.2024
    クリンダマイシン塩酸塩フィルムコート錠需要17.06.2024
  • 2024.06.17
    有効成分投与形態メッセージタイプ理由最後のメッセージの日付
    シクロペントレート塩酸塩目薬変更通知生産における問題14.06.2024
    フェノキシメチルペニシリンカリウム経口用L製剤用粉末ung変更通知需要14.06.2024
    エピネフリン塩酸塩Injektionslung初回通知生産における問題14.06.2024
    アモキシシリン三水和物経口懸濁液調製用粉末変更通知需要14.06.2024
    アレンドロン酸ナトリウム(Ph.Eur.)タブレット変更通知生産能力不足14.06.2024
    ロスバスタチン-ヘミカルシウムフィルムコート錠変更通知生産における問題14.06.2024
    メサラジン徐放性有効成分含有錠剤変更通知需要14.06.2024
    塩酸レボメタドンタブレット変更通知その他14.06.2024
    オランザピンエンボン酸一水和物パウダー変更通知他メーカーとの問題13.06.2024
    アレンドロン酸ナトリウム(Ph.Eur.)フィルムコート錠変更通知その他13.06.2024
    インスリン・ヒト((製造の詳細を含む)Injektionslung初回通知その他13.06.2024
    ウロキナーゼ注射剤/輸液用粉末ung初回通知需要12.06.2024
    硫酸ゲンタマイシン目薬初回通知生産における問題12.06.2024
    ヒドロクロロチアジド;メトプロロール酒石酸塩(Ph.Eur.)タブレット変更通知その他11.06.2024
    塩酸トリヘキシフェニジルタブレット変更通知生産における問題11.06.2024
    テルビナフィン塩酸塩タブレット変更通知需要11.06.2024
    ヒドロモルフォン塩酸塩注射/輸液ung変更通知その他11.06.2024
    トポテカン塩酸塩ハードカプセル変更通知その他11.06.2024
    アジスロマイシン二水和物フィルムコート錠変更通知その他11.06.2024
    レベチラセタムLung 摂取用変更通知需要11.06.2024
    エトリコキシブフィルムコート錠初回通知需要11.06.2024
    臭化水素酸エレトリプタンフィルムコート錠変更通知需要11.06.2024
    インスリン グラルギンInjektionslung変更通知他メーカーとの問題11.06.2024
    リザトリプタン安息香酸塩タブレット変更通知生産における問題11.06.2024
    塩酸メチルフェニデートタブレット変更通知その他10.06.2024
    リザトリプタン安息香酸塩溶解タブレット変更通知その他10.06.2024
    レベチラセタムLung 摂取用変更通知需要10.06.2024
    酢酸イカティバン(1:x) ((酢酸含有量の詳細))Injektionslung プレフィルドシリンジ入り初回通知需要10.06.2024
  • 2024.06.10
    有効成分投与形態メッセージタイプ理由最後のメッセージの日付
    チモロールマレイン酸塩目薬初回通知生産における問題07.06.2024
    塩酸クロニジン目薬初回通知生産における問題07.06.2024
    シクロペントレート塩酸塩目薬変更通知その他07.06.2024
    アモキシシリン三水和物経口懸濁液調製用粉末変更通知需要07.06.2024
    セファクロル一水和物経口懸濁液調製用顆粒変更通知需要07.06.2024
    ニモジピンフィルムコート錠初回通知需要07.06.2024
    パリカルシトールInjektionslung初回通知需要07.06.2024
    4-ヒドロキシブタン舫レ ナトリウム塩Lung 摂取用変更通知その他07.06.2024
    クラリスロマイシン経口懸濁液調製用顆粒変更通知需要07.06.2024
    塩酸ブプレノルフィン舌下錠変更通知生産における問題07.06.2024
    シスプラチン変更通知07.06.2024
    硫酸サルブタモール加圧ガスの吸入変更通知需要06.06.2024
    塩酸メピバカインInjektionslung変更通知生産における問題06.06.2024
    スコポラミン経皮吸収パッチ変更通知他メーカーとの問題06.06.2024
    フルニソリド半水和物鼻腔スプレー変更通知生産能力不足06.06.2024
    ディエノゲストフィルムコート錠初回通知その他06.06.2024
    酢酸フレカイニドタブレット変更通知生産における問題06.06.2024
    ベタメタゾンジプロピオン酸エステル(Ph.Eur.); サリチル舫レL。変更通知生産能力不足06.06.2024
    セファクロル一水和物経口懸濁液調製用顆粒変更通知その他06.06.2024
    アトモキセチン塩酸塩フィルムコート錠変更通知生産における問題05.06.2024
    フルコナゾールハードカプセル初回通知生産能力不足05.06.2024
    パリカルシトールInjektionslung初回通知需要05.06.2024
    ジメンヒドリナートInjektionslung初回通知その他05.06.2024
    フォル舫レ水和物((含水率情報あり)タブレット初回通知需要05.06.2024
    クエン酸シルデナフィルフィルムコート錠変更通知その他05.06.2024
    酢酸プレドニゾロン点眼液懸濁液変更通知生産における問題05.06.2024
    オランザピンエンボン酸一水和物パウダー変更通知需要04.06.2024
    酢酸プレドニゾロンペースト変更通知生産における問題04.06.2024
    塩酸アルチカイン;塩酸エピネフリンInjektionslung変更通知生産における問題04.06.2024
    リザトリプタン安息香酸塩溶解タブレット変更通知生産における問題04.06.2024
    エゼチミブ; シンバスタチンタブレット変更通知バッチテストの問題点04.06.2024
    プレドニカルベートL。変更通知生産能力不足04.06.2024
    メトトレキサート二ナトリウムInfusionsl調製用濃縮液ung変更通知生産能力不足04.06.2024
    フルオロウラシル変更通知04.06.2024
    メトロニダゾールタブレット初回通知需要03.06.2024
    アミスルプリドタブレット初回通知需要03.06.2024
    セファクロル一水和物経口懸濁液調製用顆粒初回通知その他03.06.2024
    アジスロマイシン二水和物経口懸濁液調製用粉末初回通知需要03.06.2024
    ナロキソン塩酸塩二水和物;オキシコドン塩酸塩(Ph.Eur.)徐放錠初回通知生産能力不足03.06.2024
    ヒドロモルフォン塩酸塩徐放錠変更通知需要03.06.2024
    オランザピンエンボン酸一水和物パウダー初回通知他メーカーとの問題03.06.2024
    リセドロン酸ナトリウム-2変更通知03.06.2024
    臭化メタントリニウム昇圧錠変更通知メーカー変更03.06.2024
    塩酸レミフェンタニル注射剤または輸液用濃縮製剤調製用粉末ung変更通知他メーカーとの問題03.06.2024
    塩化ナトリウム初回通知生産における問題31.05.2024
    ガンシクロビルナトリウム乾物初回通知生産における問題31.05.2024
    オンダンセトロン塩酸塩二水和物Lung変更通知その他31.05.2024
    クラリスロマイシン経口懸濁液調製用顆粒変更通知需要31.05.2024
    セファドロキシル一水和物経口懸濁液調製用粉末変更通知需要31.05.2024
    ヒドロモルフォン塩酸塩注射/輸液ung変更通知その他31.05.2024
    クリンダマイシン塩酸塩フィルムコート錠変更通知需要31.05.2024
    トポテカン塩酸塩ハードカプセル変更通知その他31.05.2024
    ナトリウム(メチルプレドニゾロン-21-コハク酸塩)注射剤または輸液用粉末ung変更通知メーカー変更30.05.2024
    フマル酸フェソテロジン徐放錠変更通知生産における問題30.05.2024
    葉酸カルシウムInjektionslung初回通知生産における問題30.05.2024
    フマル酸フェソテロジン徐放錠変更通知生産における問題30.05.2024
    塩酸メチルフェニデート徐放錠初回通知需要29.05.2024
    ドンペリドン内服薬変更通知メーカー変更29.05.2024
    インスリン・ヒト((製造の詳細を含む)Injektionslung初回通知生産能力不足29.05.2024
    フェロジピン徐放錠変更通知需要29.05.2024
    インスリンデテミルInjektionslung初回通知生産能力不足29.05.2024
    インスリンアスパルトInjektionslung初回通知生産能力不足29.05.2024
    モメタゾンフロエート(Ph.Eur.)L。変更通知生産能力不足28.05.2024
    プレドニカルベートL。変更通知生産能力不足28.05.2024
    塩酸バラシクロビル一水和物フィルムコート錠変更通知生産における問題28.05.2024
    オメプラゾール腸溶性ハードカプセル初回通知需要28.05.2024
    アプレピタント経口懸濁液調製用粉末初回通知需要27.05.2024
    オキシコドン塩酸塩(Ph.Eur.)徐放錠変更通知需要27.05.2024
    トピラマートフィルムコート錠変更通知その他27.05.2024
    レベチラセタムLung 摂取用変更通知需要27.05.2024
    ヒドロモルフォン塩酸塩変更通知需要27.05.2024
    臭化水素酸エレトリプタンフィルムコート錠変更通知需要27.05.2024
    エトリコキシブフィルムコート錠変更通知需要27.05.2024
    ミルタザピンフィルムコート錠変更通知需要27.05.2024
    プロゲステロン膣錠初回通知生産における問題27.05.2024
    スガマデクスナトリウム変更通知27.05.2024
    フェノキシメチルペニシリンカリウム経口用L製剤用粉末ung変更通知需要27.05.2024
  • 2024.05.30
    有効成分投与形態メッセージタイプ理由最後のメッセージの日付
    リファンピシンナトリウムInfusionsl調製用パウダーung初回通知需要24.05.2024
    臭化水素酸エレトリプタンフィルムコート錠変更通知その他23.05.2024
    エリスロマイシンL。初回通知生産能力不足23.05.2024
    フルニソリド半水和物鼻腔スプレー変更通知生産能力不足23.05.2024
    タクロリムス一水和物軟膏変更通知メーカー変更23.05.2024
    尿素;トレチノインクリーム初回通知生産能力不足23.05.2024
    テリフルノミドフィルムコート錠初回通知需要22.05.2024
    ロキシスロマイシンフィルムコート錠変更通知需要22.05.2024
    セファレキシン一水和物フィルムコート錠変更通知需要22.05.2024
    スルファメトキサゾール; トリメトプリムタブレット初回通知需要21.05.2024
    テルビナフィン塩酸塩タブレット初回通知需要21.05.2024
    イダルビシン塩酸塩Infusionsl調製用濃縮液ung初回通知その他21.05.2024
    ヒドロモルフォン塩酸塩注射/輸液ung初回通知その他21.05.2024
    塩酸レボメタドンタブレット変更通知その他21.05.2024
    トポテカン塩酸塩ハードカプセル変更通知その他21.05.2024
    クリンダマイシン塩酸塩フィルムコート錠変更通知需要21.05.2024
    イトラコナゾールハードカプセル変更通知その他21.05.2024
    アムホテリシンB初回通知生産能力不足21.05.2024
    フェンプロクーモンタブレット変更通知需要21.05.2024
    <2>シプロフロキサシン塩酸塩(1:1) 1 H Oフィルムコート錠変更通知需要21.05.2024
    フェンプロクーモンタブレット変更通知需要21.05.2024
    硫酸ゲンタマイシン眼軟膏変更通知生産における問題21.05.2024
  • 2024.05.20
    有効成分投与形態メッセージタイプ理由最後のメッセージの日付
    メトロニダゾールタブレット変更通知生産における問題17.05.2024
    トロピカミド変更通知他の製品の製造中止のため17.05.2024
    ペルメトリン初回通知17.05.2024
    ムピロシン軟膏変更通知需要17.05.2024
    アモキシシリン三水和物経口懸濁液調製用粉末変更通知需要17.05.2024
    フェノキシメチルペニシリンカリウム経口用L製剤用粉末ung変更通知需要17.05.2024
    硫酸サルブタモールLung f・ネブライザー変更通知生産能力不足17.05.2024
    硫酸サルブタモール加圧ガスの吸入変更通知需要17.05.2024
    アレンドロン酸ナトリウム(Ph.Eur.)タブレット変更通知生産における問題16.05.2024
    タクロリムス一水和物軟膏初回通知メーカー変更16.05.2024
    フシジン(Ph.Eur.)クリーム初回通知生産能力不足16.05.2024
    フルオロウラシルナトリウム注射/輸液ung変更通知生産における問題16.05.2024
    ニモジピンフィルムコート錠変更通知Erhte マーク需要 ・他メーカーの納期ボトルネックによる実需以上の需要。16.05.2024
    豚膵臓粉末;パンクレアチン((使用動物種の表示あり)腸溶性ハードカプセル変更通知その他15.05.2024
    アモキシシリン三水和物経口懸濁液調製用粉末初回通知需要15.05.2024
    インスリンリスプロInjektionslung初回通知他メーカーとの問題14.05.2024
    プロピオン酸クロベタゾール(Ph.Eur.)Lung変更通知供給ボトルネックは現在、PG 15mlと30mlで補うことができる。PZNs: 06978020/0697803714.05.2024
    モメタゾンフロエート(Ph.Eur.)L。変更通知生産能力不足14.05.2024
    フェロジピン徐放錠変更通知需要14.05.2024
    リスペリドンフィルムコート錠変更通知生産における問題14.05.2024
    ヒドロモルフォン塩酸塩徐放錠初回通知需要14.05.2024
    塩酸ベタヒスチンタブレット初回通知需要14.05.2024
    アモキシシリン三水和物フィルムコート錠初回通知需要14.05.2024
    ブプレノルフィン経皮吸収パッチ変更通知需要14.05.2024
    ブプレノルフィン経皮吸収パッチ変更通知需要14.05.2024
    メトプロロール酒石酸塩(Ph.Eur.)徐放錠変更通知需要14.05.2024
    ヒドロモルフォン塩酸塩徐放錠変更通知需要14.05.2024
    塩酸シナカルセスフィルムコート錠変更通知需要14.05.2024
    ブプレノルフィン経皮吸収パッチ変更通知需要14.05.2024
    メシル酸ラサギリンタブレット変更通知生産における問題14.05.2024
    クラリスロマイシン経口懸濁液調製用顆粒初回通知生産能力不足13.05.2024
    硫酸ビンデシン変更通知生産における問題13.05.2024
    塩酸ブプレノルフィン舌下錠変更通知生産における問題13.05.2024
  • 2024.05.13
    Active ingredientsDosage formReasonMessage typeDate of the last message
    Erythromycin estolatePowder for the preparation of an oral suspensionErhte DemandInitial notification10.05.2024
    Amoxicillin trihydratePowder for the preparation of an oral suspensionErhte DemandInitial notification10.05.2024
    Sodium alendronate (Ph.Eur.)TabletInsufficient production capacitiesトChange notification10.05.2024
    Sodium alendronate (Ph.Eur.)TabletInsufficient production capacitiesトChange notification10.05.2024
    Insulin glargineInjektionslungProblems with the other manufacturerトChange notification10.05.2024
    トChange notification10.05.2024
    トChange notification10.05.2024
    Trihexyphenidyl hydrochlorideTabletProblems in productionトChange notification10.05.2024
    Trihexyphenidyl hydrochlorideTabletProblems in productionトChange notification10.05.2024
    Levomethadone hydrochlorideOral dropsOtherトChange notification10.05.2024
    Clindamycin hydrochloride monohydrateHard capsuleErhte DemandトChange notification10.05.2024
    Ciprofloxacin hydrochloride (1:1) 1 H<2>OFilm-coated tabletErhte DemandトChange notification10.05.2024
    Cefadroxil monohydratePowder for the preparation of an oral suspensionErhte DemandトChange notification10.05.2024
    Cefadroxil monohydratePowder for the preparation of an oral suspensionErhte DemandトChange notification10.05.2024
    Topotecan hydrochlorideHard capsuleOtherトChange notification10.05.2024
    Clindamycin hydrochloride monohydrateHard capsuleErhte DemandトChange notification10.05.2024
    Clindamycin hydrochloride monohydrateHard capsuleErhte DemandトChange notification10.05.2024
    Clindamycin hydrochloride monohydrateHard capsuleErhte DemandトChange notification10.05.2024
    Clindamycin hydrochloride monohydrateHard capsuleErhte DemandトChange notification10.05.2024
    トChange notification10.05.2024
    トChange notification10.05.2024
    トChange notification10.05.2024
    Azithromycin dihydrateFilm-coated tabletOtherトChange notification10.05.2024
    Azithromycin dihydrateFilm-coated tabletOtherトChange notification10.05.2024
    LevetiracetamLung for ingestionProblems in productionInitial notification08.05.2024
    LevetiracetamFilm-coated tabletProblems in productionInitial notification08.05.2024
    LevetiracetamFilm-coated tabletProblems in productionInitial notification08.05.2024
    LevetiracetamFilm-coated tabletProblems in productionInitial notification08.05.2024
    LevetiracetamFilm-coated tabletProblems in productionInitial notification08.05.2024
    LevetiracetamFilm-coated tabletProblems in productionInitial notification08.05.2024
    LevetiracetamFilm-coated tabletProblems in productionInitial notification08.05.2024
    LevetiracetamFilm-coated tabletProblems in productionInitial notification08.05.2024
    LevetiracetamFilm-coated tabletProblems in productionInitial notification08.05.2024
    LevetiracetamFilm-coated tabletProblems in productionInitial notification08.05.2024
    LevetiracetamFilm-coated tabletProblems in productionInitial notification08.05.2024
    LevetiracetamFilm-coated tabletProblems in productionInitial notification08.05.2024
    LevetiracetamLung for ingestionProblems in productionInitial notification08.05.2024
    LamotrigineTabletProblems in productionトChange notification08.05.2024
    LamotrigineTabletProblems in productionトChange notification08.05.2024
    LamotrigineTabletProblems in productionトChange notification08.05.2024
    LamotrigineTabletProblems in productionトChange notification08.05.2024
    LamotrigineTabletProblems in productionトChange notification08.05.2024
    LamotrigineTabletProblems in productionトChange notification08.05.2024
    LamotrigineTabletProblems in productionトChange notification08.05.2024
    LamotrigineTabletProblems in productionトChange notification08.05.2024
    LamotrigineTablet for the preparation of an oral suspensionProblems in productionトChange notification08.05.2024
    Sodium alendronate (Ph.Eur.)TabletProblems in productionトChange notification08.05.2024
    Flecainide acetateTabletProblems in productionトChange notification08.05.2024
    Flecainide acetateTabletProblems in productionトChange notification08.05.2024
    Flecainide acetateTabletProblems in productionトChange notification08.05.2024
    トChange notification08.05.2024
    トChange notification08.05.2024
    トChange notification08.05.2024
    Salbutamol sulfateCompressed gas inhalationOtherトChange notification08.05.2024
    Salbutamol sulfateCompressed gas inhalationOtherトChange notification08.05.2024
    Salbutamol sulfateCompressed gas inhalationOtherトChange notification08.05.2024
    トChange notification08.05.2024
    Remifentanil hydrochlorideErhte DemandInitial notification08.05.2024
    Remifentanil hydrochlorideErhte DemandInitial notification08.05.2024
    Remifentanil hydrochlorideErhte DemandInitial notification08.05.2024
    ParacetamolErhte DemandトChange notification08.05.2024
    ParacetamolErhte DemandトChange notification08.05.2024
    DimenhydrinateInjektionslungProblems in productionトChange notification08.05.2024
    DimenhydrinateInjektionslungProblems in productionトChange notification08.05.2024
    Metoprolol tartrate (Ph.Eur.)Prolonged-release tabletErhte DemandトChange notification08.05.2024
    Fesoterodine fumarateProlonged-release tabletInsufficient production capacitiesトChange notification07.05.2024
    トChange notification07.05.2024
    Doxycycline hyclateInjektionslungProblems in productionInitial notification07.05.2024
    Metamizole sodium monohydrateInjektionslungOtherトChange notification07.05.2024
    Metamizole sodium monohydrateInjektionslungOtherトChange notification07.05.2024
    Metamizole sodium monohydrateInjektionslungOtherトChange notification07.05.2024
    Betamethasone dipropionate (Ph.Eur.); Salicyls舫reLung for application on the skinInsufficient production capacitiesトChange notification07.05.2024
    Betamethasone dipropionate (Ph.Eur.); Salicyls舫reLung for application on the skinInsufficient production capacitiesトChange notification07.05.2024
    Vindesine sulfateProblems in productionトChange notification07.05.2024
    Buprenorphine hydrochlorideSublingual tabletProblems in productionトChange notification06.05.2024
    Buprenorphine hydrochlorideSublingual tabletProblems in productionトChange notification06.05.2024
    トChange notification06.05.2024
    トChange notification06.05.2024
    LinezolidFilm-coated tabletErhte DemandトChange notification06.05.2024
    LinezolidFilm-coated tabletErhte DemandトChange notification06.05.2024
    Initial notification06.05.2024
  • 2024.05.06
    Active substancesDrug nameDate of last notificationNotification typeReason
    Metalcaptase 150 mg03.05.2024Change notification
    Metalcaptase 150 mg03.05.2024Change notification
    Morphine sulphate (Ph.Eur.)Morphine Aristo 45 mg prolonged-release tablets03.05.2024Change notificationProblems with batch testing
    Morphine sulphate (Ph.Eur.)Morphine Aristo 45 mg prolonged-release tablets03.05.2024Change notificationProblems with batch testing
    Morphine sulphate (Ph.Eur.)Morphine Aristo 45 mg prolonged-release tablets03.05.2024Change notificationProblems with batch testing
    Morphine sulphate (Ph.Eur.)Morphine Aristo 30 mg prolonged-release tablets03.05.2024Change notificationProblems with batch testing
    Morphine sulphate (Ph.Eur.)Morphine Aristo 30 mg prolonged-release tablets03.05.2024Change notificationProblems with batch testing
    Morphine sulphate (Ph.Eur.)Morphine Aristo 30 mg prolonged-release tablets03.05.2024Change notificationProblems with batch testing
    Morphine sulphate (Ph.Eur.)Morphine Aristo 200 mg prolonged-release tablets03.05.2024Change notificationProblems with batch testing
    Morphine sulphate (Ph.Eur.)Morphine Aristo 200 mg prolonged-release tablets03.05.2024Change notificationProblems with batch testing
    Morphine sulphate (Ph.Eur.)Morphine Aristo 200 mg prolonged-release tablets03.05.2024Change notificationProblems with batch testing
    Morphine sulphate (Ph.Eur.)Morphine Aristo 10 mg prolonged-release tablets03.05.2024Change notificationProblems with batch testing
    Morphine sulphate (Ph.Eur.)Morphine Aristo 10 mg prolonged-release tablets03.05.2024Change notificationProblems with batch testing
    Morphine sulphate (Ph.Eur.)Morphine Aristo 10 mg prolonged-release tablets03.05.2024Change notificationProblems with batch testing
    Melperone hydrochlorideMelperon Aristo 25 mg film-coated tablets03.05.2024Change notificationInsufficient production capacities
    Melperone hydrochlorideMelperon Aristo 25 mg film-coated tablets03.05.2024Change notificationInsufficient production capacities
    Melperone hydrochlorideMelperon Aristo 25 mg film-coated tablets03.05.2024Change notificationInsufficient production capacities
    Melperone hydrochlorideMelperon Aristo 10 mg film-coated tablets03.05.2024Change notificationInsufficient production capacities
    Melperone hydrochlorideMelperon Aristo 10 mg film-coated tablets03.05.2024Change notificationInsufficient production capacities
    Melperone hydrochlorideMelperon Aristo 10 mg film-coated tablets03.05.2024Change notificationInsufficient production capacities
    Atomoxetine hydrochlorideAtomoxetine-neuraxpharm 100 mg hard capsules03.05.2024Initial notificationProblems in production
    Atomoxetine hydrochlorideAtomoxetine-neuraxpharm 100 mg hard capsules03.05.2024Initial notificationProblems in production
    LamotrigineLamotrigine Aristo 50 mg tablets for the preparation of an oral suspension03.05.2024Change notificationProblems at the active ingredient manufacturer
    LamotrigineLamotrigine Aristo 50 mg tablets for the preparation of an oral suspension03.05.2024Change notificationProblems at the active ingredient manufacturer
    LamotrigineLamotrigine Aristo 50 mg tablets for the preparation of an oral suspension03.05.2024Change notificationProblems at the active ingredient manufacturer
    LamotrigineLamotrigine Aristo 100 mg tablets for the preparation of an oral suspension03.05.2024Change notificationInsufficient production capacities
    LamotrigineLamotrigine Aristo 100 mg tablets for the preparation of an oral suspension03.05.2024Change notificationInsufficient production capacities
    LamotrigineLamotrigine Aristo 100 mg tablets for the preparation of an oral suspension03.05.2024Change notificationInsufficient production capacities
    CarbamazepineCarbamazepine Aristo 600 mg prolonged-release tablets03.05.2024Change notificationOther
    CarbamazepineCarbamazepine Aristo 600 mg prolonged-release tablets03.05.2024Change notificationOther
    CarbamazepineCarbamazepine Aristo 600 mg prolonged-release tablets03.05.2024Change notificationOther
    Atomoxetine hydrochlorideAtomoxetine-neuraxpharm 80 mg hard capsules03.05.2024Initial notificationProblems in production
    Atomoxetine hydrochlorideAtomoxetine-neuraxpharm 80 mg hard capsules03.05.2024Initial notificationProblems in production
    Atomoxetine hydrochlorideAtomoxetine-neuraxpharm 80 mg hard capsules03.05.2024Initial notificationProblems in production
    Atomoxetine hydrochlorideAtomoxetine-neuraxpharm 60 mg hard capsules03.05.2024Initial notificationProblems in production
    Atomoxetine hydrochlorideAtomoxetine-neuraxpharm 60 mg hard capsules03.05.2024Initial notificationProblems in production
    Atomoxetine hydrochlorideAtomoxetine-neuraxpharm 60 mg hard capsules03.05.2024Initial notificationProblems in production
    Atomoxetine hydrochlorideAtomoxetine-neuraxpharm 40 mg hard capsules03.05.2024Initial notificationProblems in production
    Atomoxetine hydrochlorideAtomoxetine-neuraxpharm 40 mg hard capsules03.05.2024Initial notificationProblems in production
    Atomoxetine hydrochlorideAtomoxetine-neuraxpharm 40 mg hard capsules03.05.2024Initial notificationProblems in production
    Atomoxetine hydrochlorideAtomoxetine-neuraxpharm 40 mg hard capsules03.05.2024Initial notificationProblems in production
    Atomoxetine hydrochlorideAtomoxetine-neuraxpharm 25 mg hard capsules03.05.2024Initial notificationProblems in production
    Atomoxetine hydrochlorideAtomoxetine-neuraxpharm 25 mg hard capsules03.05.2024Initial notificationProblems in production
    Atomoxetine hydrochlorideAtomoxetine-neuraxpharm 25 mg hard capsules03.05.2024Initial notificationProblems in production
    Atomoxetine hydrochlorideAtomoxetine-neuraxpharm 25 mg hard capsules03.05.2024Initial notificationProblems in production
    Atomoxetine hydrochlorideAtomoxetine-neuraxpharm 18 mg hard capsules03.05.2024Initial notificationProblems in production
    Atomoxetine hydrochlorideAtomoxetine-neuraxpharm 18 mg hard capsules03.05.2024Initial notificationProblems in production
    Atomoxetine hydrochlorideAtomoxetine-neuraxpharm 18 mg hard capsules03.05.2024Initial notificationProblems in production
    Atomoxetine hydrochlorideAtomoxetine-neuraxpharm 10 mg hard capsules03.05.2024Change notificationProblems in production
    Atomoxetine hydrochlorideAtomoxetine-neuraxpharm 10 mg hard capsules03.05.2024Change notificationProblems in production
    Atomoxetine hydrochlorideAtomoxetine-neuraxpharm 10 mg hard capsules03.05.2024Change notificationProblems in production
    Fluphenazine-neuraxpharm D 50 mg/ 003.05.2024Change notification
    Promethazine-neuraxpharm forte03.05.2024Change notification
    Promethazine-neuraxpharm forte03.05.2024Change notification
    Hydrocortisone acetate (Ph.Eur.)Hydrocortisone-POS N 1 %03.05.2024Initial notificationProblems in production
    Hydrocortisone-POS N 203.05.2024Initial notification
    Azithromycin dihydrateAzithromycin HEC 500 mg film-coated tablets03.05.2024Initial notificationErhte Demand
    Azithromycin dihydrateAzithromycin HEC 500 mg film-coated tablets03.05.2024Initial notificationErhte Demand
    Amoxicillin trihydrateInfectomox 750 juice03.05.2024Change notificationErhte Demand
    Amoxicillin trihydrateInfectomox 750 juice03.05.2024Change notificationErhte Demand
    Phenoxymethylpenicillin potassiumINFECTOCILLIN 400 juice03.05.2024Change notificationErhte Demand
    Phenoxymethylpenicillin potassiumINFECTOCILLIN 400 juice03.05.2024Change notificationErhte Demand
    PhenprocoumonMarcumar03.05.2024Change notificationProblems in production
    PhenprocoumonMarcumar03.05.2024Change notificationProblems in production
    Ipratropium bromide HEXAL 20 micrograms/spr・sto゚ compressed gas inhalation03.05.2024Change notification
    Ipratropium bromide HEXAL 20 micrograms/spr・sto゚ compressed gas inhalation03.05.2024Change notification
    Cefadroxil monohydrateCefadroxil 500 TS – 1 A Pharma03.05.2024Change notificationErhte Demand
    Cefadroxil monohydrateCefadroxil 500 TS – 1 A Pharma03.05.2024Change notificationErhte Demand
    Amoxicillin trihydrateAmoxihexal 100003.05.2024Change notificationErhte Demand
    Cefadroxil monohydrateCefadroxil 250 TS – 1 A Pharma03.05.2024Change notificationErhte Demand
    Topotecan hydrochlorideHYCAMTIN 1 mg hard capsules – OP1003.05.2024Change notificationOther
    ProgesteroneUtrogest 100 mg soft capsules02.05.2024Change notificationProblems in production
    PenHEXAL juice 002.05.2024Change notification
    PenHEXAL juice 002.05.2024Change notification
    Clindamycin hydrochlorideClindaHEXAL 600 mg film-coated tablets02.05.2024Change notificationErhte Demand
    Azithromycin dihydrateAzithromycin 500 – 1 A Pharma02.05.2024Change notificationOther
    Trimipramine maleateTrimipramine 25 – 1A-Pharma02.05.2024Change notificationErhte Demand
    PenHEXAL 102.05.2024Change notification
    PenHEXAL 102.05.2024Change notification
    PenHEXAL 102.05.2024Change notification
    ClarithromycinClarithromycin – 1 A Pharma 250 mg/5 ml granules for the preparation of an oral suspension02.05.2024Change notificationErhte Demand
    ClarithromycinClarithromycin – 1 A Pharma 250 mg/5 ml granules for the preparation of an oral suspension02.05.2024Change notificationErhte Demand
    ClarithromycinClarithromycin – 1 A Pharma 125 mg/5 ml granules for the preparation of an oral suspension02.05.2024Change notificationErhte Demand
    ClarithromycinClarithromycin – 1 A Pharma 125 mg/5 ml granules for the preparation of an oral suspension02.05.2024Change notificationErhte Demand
    Ondansetron hydrochloride dihydrateZofran Lung02.05.2024Change notificationOther
    ParacetamolParacetamol Kabi 10 mg/ml Infusionslung02.05.2024Change notificationProblems in production
    MirtazapineMirtazapine-Hormosan 30 mg film-coated tablets02.05.2024Change notificationErhte Demand
    MirtazapineMirtazapine-Hormosan 30 mg film-coated tablets02.05.2024Change notificationErhte Demand
    MirtazapineMirtazapine-Hormosan 15 mg film-coated tablets02.05.2024Change notificationErhte Demand
    MirtazapineMirtazapine-Hormosan 15 mg film-coated tablets02.05.2024Change notificationErhte Demand
    MirtazapineMirtazapine-Hormosan 15 mg film-coated tablets02.05.2024Change notificationErhte Demand
    LevetiracetamLevetiracetam-Hormosan 100 mg/ml Lung for oral use02.05.2024Change notificationErhte Demand
    LevetiracetamLevetiracetam-Hormosan 100 mg/ml Lung for oral use02.05.2024Change notificationErhte Demand
    LevetiracetamLevetiracetam-Hormosan 100 mg/ml Lung for oral use02.05.2024Change notificationErhte Demand
    EtoricoxibEtorican 90 mg film-coated tablets02.05.2024Change notificationErhte Demand
    Eletriptan hydrobromideEletrip-Hormosan 20 mg film-coated tablets02.05.2024Change notificationErhte Demand
    Eletriptan hydrobromideEletrip-Hormosan 40 mg film-coated tablets02.05.2024Change notificationErhte Demand
    Eletriptan hydrobromideEletrip-Hormosan 40 mg film-coated tablets02.05.2024Change notificationErhte Demand
    Salbutamol sulfateSultanol metered dose aerosol30.04.2024Change notificationErhte Demand
    Salbutamol sulfateSultanol metered dose aerosol30.04.2024Change notificationErhte Demand
    Salbutamol sulfateSultanol metered dose aerosol30.04.2024Change notificationErhte Demand
    Amlodipine besylate; perindopril-tert-butylaminePerindopril/Amlodipine Denk 8 mg/5 mg tablets30.04.2024Change notificationProblems in production
    DimenhydrinateVomex A i.v. Injektionslung30.04.2024Initial notificationProblems in production
    DimenhydrinateVomex A i.v. Injektionslung30.04.2024Initial notificationProblems in production
    DesfluraneDesflurane Piramal 100 % liquid for the preparation of a vapor for inhalation30.04.2024Initial notificationOther
    Suboxone 2 mg/030.04.2024Change notification
    Suboxone 2 mg/030.04.2024Change notification
    Rizatriptan benzoateRizatriptan Glenmark 10 mg orodispersible tablets30.04.2024Initial notificationProblems in production
    Rizatriptan benzoateRizatriptan Glenmark 5 mg orodispersible tablets30.04.2024Change notificationOther
    Rizatriptan benzoateRizatriptan Glenmark 5 mg orodispersible tablets30.04.2024Change notificationOther
    Rizatriptan benzoateRizatriptan Glenmark 5 mg orodispersible tablets30.04.2024Change notificationOther
    Rizatriptan benzoateRizatriptan Glenmark 10 mg tablets30.04.2024Initial notificationProblems in production
    Rizatriptan benzoateRizatriptan Glenmark 5 mg tablets30.04.2024Initial notificationProblems in production
    Hydromorphone HCl Glenmark 8 mg hard capsules30.04.2024Change notification
    Oxycodone hydrochloride (Ph.Eur.)Oxyconoica 80 mg prolonged-release tablets30.04.2024Initial notificationProblems in production
    Buprenorphine Glenmark 5230.04.2024Initial notification
    Tamsublock Duo 030.04.2024Change notification
    Ezetimibe; SimvastatinEzetimibe/Simvastatin Glenmark 10 mg/20 mg tablets30.04.2024Change notificationProblems with batch testing
    Ezetimibe; SimvastatinEzetimibe/Simvastatin Glenmark 10 mg/20 mg tablets30.04.2024Change notificationProblems with batch testing
    Cefalexin monohydrateCephalexin-ratiopharm 500 mg film-coated tablets30.04.2024Change notificationErhte Demand
    RoxithromycinRoxithromycin-ratiopharm 150mg film-coated tablets30.04.2024Change notificationErhte Demand
    Memantine ratiopharm 5 mg30.04.2024Change notification
    Eletriptan hydrobromideEletriptan Bluefish 20 mg film-coated tablets30.04.2024Change notificationOther
    RoxithromycinRoxithromycin AbZ 150mg film-coated tablets30.04.2024Change notificationErhte Demand
    RoxithromycinRoxithromycin AbZ 150mg film-coated tablets30.04.2024Change notificationErhte Demand
    CinacalcethydrochlorideCinacalcet Ascend 90mg film-coated tablets29.04.2024Initial notificationOther
    CinacalcethydrochlorideCinacalcet Ascend 90mg film-coated tablets29.04.2024Initial notificationOther
    CinacalcethydrochlorideCinacalcet Ascend 60mg film-coated tablets29.04.2024Initial notificationOther
    CinacalcethydrochlorideCinacalcet Ascend 60mg film-coated tablets29.04.2024Initial notificationOther
    CinacalcethydrochlorideCinacalcet Ascend 30mg film-coated tablets29.04.2024Initial notificationOther
    CinacalcethydrochlorideCinacalcet Ascend 30mg film-coated tablets29.04.2024Initial notificationOther
    Flunisolide hemihydrateSyntaris29.04.2024Initial notificationInsufficient production capacities
    Soderm plus Lung 029.04.2024Change notification
    Soderm plus Lung 029.04.2024Change notification
    Soderm plus Lung 029.04.2024Change notification
    Clindamycin hydrochlorideClindamycin AL 30029.04.2024Change notificationErhte Demand
    Clindamycin hydrochlorideClindamycin AL 30029.04.2024Change notificationErhte Demand
    Clindamycin hydrochlorideClindamycin AL 30029.04.2024Change notificationErhte Demand
    Clindamycin hydrochlorideClindamycin AL 30029.04.2024Change notificationErhte Demand
    Benazepril hydrochlorideBenazepril AL 20 mg film-coated tablets29.04.2024Change notificationErhte Demand
    Benazepril hydrochlorideBenazepril AL 20 mg film-coated tablets29.04.2024Change notificationErhte Demand
    Benazepril hydrochlorideBenazepril AL 10 mg film-coated tablets29.04.2024Change notificationErhte Demand
    Benazepril hydrochlorideBenazepril AL 10 mg film-coated tablets29.04.2024Change notificationErhte Demand
    Benazepril hydrochlorideBenazepril AL 5 mg film-coated tablets29.04.2024Change notificationErhte Demand
    Benazepril hydrochlorideBenazepril AL 5 mg film-coated tablets29.04.2024Change notificationErhte Demand
    Betahistine dihydrochlorideBetahistine AL 8 mg tablets29.04.2024Change notificationErhte Demand
    Betahistine dihydrochlorideBetahistine AL 8 mg tablets29.04.2024Change notificationErhte Demand
    Betahistine dihydrochlorideBetahistine AL 8 mg tablets29.04.2024Change notificationErhte Demand
    Betahistine dihydrochlorideBetahistine AL 8 mg tablets29.04.2024Change notificationErhte Demand
    Betahistine dimesilateBetahistine AL 1229.04.2024Change notificationErhte Demand
    Betahistine dimesilateBetahistine AL 1229.04.2024Change notificationErhte Demand
    Betahistine dimesilateBetahistine AL 1229.04.2024Change notificationErhte Demand
    Betahistine dimesilateBetahistine AL 1229.04.2024Change notificationErhte Demand
    Betamethasone valerate (Ph.Eur.)Soderm crinale29.04.2024Initial notificationInsufficient production capacities
    PrednicarbatePrednitop Crinale29.04.2024Initial notificationInsufficient production capacities
    Phenoxymethylpenicillin potassiumInfectocillin 500 juice29.04.2024Change notificationErhte Demand
    Phenoxymethylpenicillin potassiumInfectocillin 500 juice29.04.2024Change notificationErhte Demand
    Phenoxymethylpenicillin potassiumInfectocillin 500 juice29.04.2024Change notificationErhte Demand
    Phenoxymethylpenicillin potassiumInfectocillin 500 juice29.04.2024Change notificationErhte Demand
    Cefadroxil monohydrateGr・cef 1 g29.04.2024Change notificationErhte Demand
    Cefadroxil monohydrateGr・cef 1 g29.04.2024Change notificationErhte Demand
    TropicamideMydriaticum Stulln UD29.04.2024Change notificationProblems in production
    TropicamideMydriaticum Stulln UD29.04.2024Change notificationProblems in production
    TropicamideMydriaticum Stulln UD29.04.2024Change notificationProblems in production
    TropicamideMydriaticum Stulln UD29.04.2024Change notificationProblems in production
    Gentamicin sulphateGentamicin-POS29.04.2024Change notificationProblems in production
    Gentamicin sulphateGentamicin-POS29.04.2024Change notificationProblems in production
    NimodipineNimotop29.04.2024Change notificationOther
    NimodipineNimotop S29.04.2024Change notificationOther
  • 2024.04.29
    Message type
    Start dateEnd dateDate of last notificationType of reasonAM designationATCActive ingredients
    Change notification21.08.202331.05.202426.04.2024Production problemTrazodone Glenmark 100 mg tabletsN06AX05Trazodone hydrochloride
    Change notification29.01.202431.05.202426.04.2024Production problemEzetimibe/Simvastatin Glenmark 10 mg/80 mg tabletsC10BA02Ezetimibe; simvastatin
    Change notification02.01.202331.05.202426.04.2024Production problemDutasteride/tamsulosin Glenmark 0.5 mg/0.4 mg hard capsulesG04CA52Dutasteride; tamsulosin hydrochloride
    Change notification20.11.202301.07.202426.04.2024OtherSuboxone 2 mg/0.5 mg sublingual tablets – OP28N07BC51Buprenorphine hydrochloride; naloxone hydrochloride dihydrate
    Change notification03.06.202331.10.202426.04.2024OtherLOCACORTEN-VioformD07BB01Clioquinol; flumetasone pivalate (Ph.Eur.)
    Change notification23.10.202330.09.202426.04.2024OtherAriline 500 mgJ01XD01, P01AB01Metronidazole
    Change notification09.03.202303.05.202425.04.2024OtherIpratropium bromide HEXAL 20 micrograms/spray Compressed gas inhalation, solutionR03BB01Ipratropium bromide (Ph.Eur.)
    Change notification22.12.202230.04.202425.04.2024OtherHYCAMTIN 1 mg hard capsules – OP10L01XX17Topotecan hydrochloride
    Change notification10.01.202430.06.202425.04.2024OtherL-Poladdict 30 mg tabletsTERM_ID_NA_2090005949Levomethadone hydrochloride
    Change notification06.09.202330.06.202425.04.2024OtherL-Poladdict 20 mg tabletsTERM_ID_NA_2090005949Levomethadone hydrochloride
    Change notification25.09.202313.05.202425.04.2024OtherMetronidazole Aristo 400 mg tabletsJ01XD01Metronidazole
    Change notification01.12.202331.05.202425.04.2024OtherMetronidazole AL 400J01XD01Metronidazole
    First notification17.04.202431.07.202424.04.2024OtherCLARITHROMYCIN BASICS 250 mg/5 ml granules for the preparation of an oral suspensionJ01FA09Clarithromycin
    First notification30.04.202430.06.202424.04.2024OtherNovoNorm 0.5 mg tablets – OP30A10BX02Repaglinide
    Change notification02.05.202415.10.202424.04.2024Production problemMetalcaptase 300 mgM01CC01, TERM_ID_NA_2090010126, V03ABPenicillamine
    First notification23.04.202415.05.202424.04.2024OtherMST 10mg MundipharmaN02AA01Morphine sulphate (Ph.Eur.)
    Change notification14.02.202331.05.202424.04.2024OtherOxycodone/Naloxone Krugmann 40 mg/20 mg prolonged-release tabletsN02AA55Naloxone hydrochloride dihydrate; oxycodone hydrochloride (Ph.Eur.)
    Change notification27.02.202427.05.202423.04.2024Production problemTimo-COMOD 0.25%S01ED01Timolol maleate
    Change notification24.11.202326.06.202423.04.2024Production problemGentamicin-POSS01AA11Gentamicin sulphate
    Change notification20.02.202420.06.202423.04.2024Production problemDexa-GentamicinS01CA01Dexamethasone; gentamicin sulphate
    First notification16.04.202410.05.202423.04.2024OtherLamotrigine acis 50 mg tabletsN03AX09Lamotrigine
    Change notification01.01.202331.03.202523.04.2024Production problemORENCIA 125 mg solution for injection in prefilled syringe – OP(12x1ml)L04AA24Abatacept
    First notification18.04.202424.05.202423.04.2024OtherDiclofenac acis 30 mg/g gelD11AX18Diclofenac sodium
    Change notification01.01.202331.03.202523.04.2024Production problemORENCIA 125 mg solution for injection in prefilled pen – OP(4x1ml)L04AA24Abatacept
    Change notification01.03.202231.03.202523.04.2024Production problemORENCIA 125 mg solution for injection in prefilled pen – OP(12x1ml)L04AA24Abatacept
    Change notification01.06.201830.09.202523.04.2024Production problemLiMAxetine 4 mg/ml solution for injectionV04CE03(4′-O-(13)C)Methacetin
    First notification11.04.202420.05.202423.04.2024OtherKarison CrinaleD07AD01Clobetasol propionate (Ph.Eur.)
    First notification01.01.202401.04.202523.04.2024Production problemCalcium folinate onkovis 10 mg/ml solution for injectionV03AF03Calcium folinate hydrate
    First notification23.04.202430.06.202423.04.2024OtherDiprosone Depot 1 ml ampouleH02AB, RBetamethasone dihydrogen phosphate disodium (Ph.Eur.); Betamethasone dipropionate (Ph.Eur.)
    Change notification15.12.202301.06.202423.04.2024Production problemFluorouracil Accord 50 mg/ml solution for injection/infusionL01BC02Fluorouracil sodium
    Change notification31.01.202430.04.202423.04.2024Production problemMarcumarB01AA04Phenprocoumon
    Change notification18.01.202303.05.202422.04.2024OtherCefaclor 125 TS – 1 A PharmaJ01DC04Cefaclor monohydrate
    Change notification15.03.202431.07.202422.04.2024OtherAlendronic acid – 1 A Pharma 70 mg film-coated tabletsM05BA04Sodium alendronate (Ph.Eur.)
    First notification10.05.202406.06.202422.04.2024OtherKeppra 100 mg/ml oral solution – OP300mlN03AX14Levetiracetam
    First notification29.04.202431.05.202422.04.2024Production problemRevestive 5 mg powder and solvent for solution for injection – OP[28x(27,96mg+0,5ml)]A16AX08Teduglutide

フランス

  • 2024.11.11
    StatusUpdateSpecialty
    AvailabilityNov. 8, 2024Depakine Chrono 500 mg, extended-release scored film-coated tablet – [sodium valproate]
    Supply tensionNov. 8, 2024Lantus Solostar 100 units/ ml, solution for injection in pre-filled pen – [insulin glargine].
    AvailabilityNov. 8, 2024Fasturtec 1.5 mg/ml, powder and solvent for solution to be diluted for infusion 1 ml glass ampoule – [rasburicase]
    Supply tensionNov. 8, 2024Sinemet 250 mg/25 mg, scored tablet – [levodopa – carbidopa]
    Supply tensionNov. 8, 2024Sinemet 100 mg/10 mg, tablet – [levodopa – carbidopa] [levodopa – carbidopa] [levodopa – carbidopa] [levodopa – carbidopa
    Out of stockNov. 8, 2024Etoposide Accord 20 mg/ml, dilutable solution for infusion – [etoposide]
    Supply tensionNov. 7, 2024Cyanokit 5 g, powder for solution for infusion – [hydroxocobalamin]
    Out of stockNov. 7, 2024Marsilid 50 mg, scored tablet – [iproniazide]
    Supply tensionNov. 7, 2024Vitamin B12 Gerda 1000 µg/4 ml, solution for injection (IM) and oral use – [cyanocobalamine]
    Supply tensionNov. 7, 2024Vitamin B12 Delagrange 1000 micrograms/2 ml, solution for injection (IM) and oral use – [cyanocobalamin]
    Supply tensionNov. 7, 2024Fluorouracil Teva 50 mg/ml, dilutable solution for infusion, 100 ml bottle – [fluorouracil]
    Out of stockNov. 6, 2024Zophren 2 mg/ml, solution for injection in ampoule (IV) (box 1 ampoule of 4 ml) – [ondansetron].
    Supply tensionNov. 5, 2024Pegasys 90 micrograms, 135 micrograms and 180 micrograms solution for injection in pre-filled syringe – [peginterferon alfa-2a].
    Out of stockNov. 5, 2024Potassium citrate AP-HP 1 g, sachet of 100 capsules – [potassium citrate]
    AvailabilityNov. 5, 2024Abacavir, Lamivudine, Zidovudine Viatris 300 mg/150 mg/300 mg, film-coated tablet – [abacavir (sulfate d’), lamivudine, zidovudine]
    Out of stock5-Nov-24Icatibant Viatris 30 mg, solution for injection in pre-filled syringe – [icatibant (acetate)
    Supply tensionNov. 4, 2024Normal human immunoglobulin IV and SC (based on) – [Normal human immunoglobulin (IgG)].
    Supply tensionNov. 4, 2024Concerta LP, extended-release tablet – [methylphenidate (hydrochloride)
    Marketing discontinuationNov. 4, 2024Tsoludose, oral solution in unidose container – [levothyroxine]
    Supply tensionNov. 4, 2024Furosemide Zentiva 500 mg, scored tablet – [furosemide]
    Supply tensionNov. 4, 2024Methylphenidate Biogaran LP, extended-release tablet – [methylphenidate (hydrochloride)
  • 2024.11.04
    StatusUpdateSpecialty
    End of commercializationOct. 31, 2024Ribarivine Biogaran 200 mg/400 mg, film-coated tablet – [Ribavirin]
    Supply tensionOct. 31, 2024Ultratechnekow FM, 2.15 – 43 GBq, radiopharmaceutical generator – [sodium (molybdate (VI) [99 Mo] de)
    Supply voltageOct. 31, 2024Tekcis 2-50 GBq, radiopharmaceutical generator – [sodium (molybdate (VI) [99 Mo] de)
    ReleaseOct. 31, 2024Hydrocortisone Upjohn 500 mg, injectable preparation – [hydrocortisone (sodium hydrogen succinate)]
    Supply tensionOct. 30, 2024Gardenal 200 mg/4 ml, powder and solvent for solution for injection – [phenobarbital sodium].
    Supply tensionOct. 30, 2024Immunoglobulin normal human IV and SC (based on) – [Immunoglobulin normal human (IgG)
    AvailabilityOct. 29, 2024NovoEight 3000 IU powder and solvent for injectable solution – [turoctocog alfa]
    Out of stockOct. 29, 2024Kanokad 25 IU/mL factor IX, powder and solvent for solution for injection – Vials of 250 IU (10 ml) and 500 IU (20 ml)
    Supply tensionOct. 28, 2024Ritalin LP 40 mg, sustained-release capsule – [methylphenidate (hydrochloride)
    AvailabilityOct. 28, 2024Ritalin LP 20 mg and 30 mg, extended-release capsule – [methylphenidate (hydrochloride)]
    Supply tensionOct. 25, 2024Cynomel 0.025 mg, scored tablets- [liothyronine sodium].
    Marketing discontinuationOct. 25, 2024Heparin Choay 25 000 IU/5 ml, solution for injection, 1 glass vial(s) of 5 ml – [heparin sodium].
  • 2024.10.29
    StatusUpdateSpecialty
    Supply tensionOct. 25, 2024Cynomel 0.025 mg, scored tablet- [liothyronine sodium]
    Supply tensionOct. 25, 2024Ultratechnekow FM, 2.15 – 43 GBq, radiopharmaceutical generator – [sodium (molybdate (VI) [99 Mo] de)
    Supply voltageOct. 25, 2024Tekcis 2-50 GBq, radiopharmaceutical generator – [sodium (molybdate (VI) [99 Mo] de)
    Marketing discontinuedOct. 25, 2024Heparin Choay 25 000 IU/5 ml, solution for injection, 1 glass vial(s) of 5 ml – [heparin sodium].
    Marketing discontinuationOct. 24, 2024Tsoludose, oral solution in unidose container – [levothyroxine]
    Supply tension24-Oct-24Clarithromycin 25 mg/ml and 50 mg/ml, granules for oral suspension – [clarithromycin]
    Supply tensionOct. 24, 2024Clarithromycin, 250 and 500 mg, modified-release film-coated tablet and film-coated tablet – [clarithromycin]
    Supply tensionOct. 23, 2024Amikacine Viatris 250 mg, 500 mg and 1g, powder for injectable solution in vial – [amikacine (sulfate d’)
    AvailabilityOct. 23, 2024Hospira sodium pamidronate 9 mg/ml, dilutable solution for infusion – [sodium (pamidronate de)]
    AvailabilityOct. 23, 2024Ultiva 1 mg, powder for solution for injection or infusion – [remifentanil (hydrochloride)]
    Supply tensionOct. 22, 2024Zypadhera 210, 300, 405 mg, powder and solvent for prolonged-release suspension for injection – [olanzapine (pamoate) monohydrate].
    Supply tensionOct. 22, 2024Pegasys 90 micrograms, 135 micrograms and 180 micrograms solution for injection in pre-filled syringes – [peginterferon alfa-2a] [peginterferon alfa-2a] [peginterferon alfa-2a] [peginterferon alfa-2a
    Out of stockOct. 21, 2024Icatibant Viatris 30 mg, solution for injection in pre-filled syringe – [icatibant (acetate)
    Supply tensionOct. 21, 2024Hexatrione 2 per cent, suspension for injection (intra-articular) – [Triamcinolone Hexacetonide].
  • 2024.10.23
    StatusUpdateSpecialty
    Out of stockOct. 18, 2024Cyanokit 5 g, powder for solution for infusion – [hydroxocobalamin]
    Supply voltageOct. 18, 2024Isocard, sublingual solution in spray bottle – [isosorbide dinitrate]
    Supply tensionOct. 18, 2024Paliperidone Teva, prolonged-release suspension for injection – [paliperidone]
    Supply tensionOct. 17, 2024Levodopa Carbidopa Teva 100 mg/10 mg, scored tablet – [levodopa – carbidopa]
    Supply tensionOct. 17, 2024Levodopa Carbidopa Teva 250 mg/25 mg, scored tablet – [levodopa – carbidopa]
    Out of stockOct. 17, 2024NovoEight 3000 IU powder and solvent for solution for injection – [turoctocog alfa] [turoctocog alfa] [turoctocog alfa] [turoctocog alfa
    AvailabilityOct. 16, 2024Solumedrol 120 mg/2 ml, lyophilisate and solution for parenteral use – [methylprednisolone (hydrogen succinate)]
    Supply tensionOct. 16, 2024Atropine 1%, eye drops – [atropine (sulfate)
    AvailabilityOct. 16, 2024Tofranil 25 mg, coated tablet – [Imipramine]
    Out of stockOct. 16, 2024Zophren 2 mg/ml, solution for injection in ampoule (IV), (box 1 ampoule of 4 ml) – [ondansetron].
    Remise à dispositionOct. 16, 2024Irinotecan Sun 1.5 mg/ml, solution for infusion – [irinotecan (hydrochloride) trihydrate]
    AvailabilityOct. 15, 2024Solumedrol 40 mg/1 mL, powder and solvent for solution for injection – [methylprednisolone hemisuccinate]
    Supply tensionOct. 15, 2024Ondansetron Viatris 2 mg/ml, solution for injection (I.V.) – [ondansetron]
    Supply tensionOct. 14, 2024Fluorescein Faure 0.5%, eye drops solution in single-dose container – [fluorescein sodium].
    AvailabilityOct. 11, 2024Nozinan 100 mg, scored film-coated tablet – [levomepromazine (maleate)]
    Supply tensionOct. 11, 2024Noyada 25 mg/5 ml, oral solution – [captopril]
    Out of stockOct. 11, 2024Yellox 0.9 mg/ml, eye drops solution – [bromfenac sodium sesquihydrate].
    Supply tensionOct. 11, 2024Praluent 75 mg, 150 mg and 300 mg, solution for injection in pre-filled pen – [alirocumab (mammalian/hamster/ cho cells)].
    AvailabilityOct. 10, 2024NovoEight 2000 IU powder and solvent for injectable solution – [turoctocog alfa]
  • 2024.10.10
    ステータス (英語)アップデートスペシャルティ
    回復2024年10月9日トリフルカン 40mg/ml、経口懸濁用粉末 – [フルコナゾール]
    回復2024年10月9日フレカイニド100mg、点滴静注用 – [フレカイニド(酢酸塩]
    回復2024年10月9日ノボセブン8mg(400KUI)、注射用粉末および溶液用溶剤-[エプタコグ アルファ(活性化)-(哺乳類/ハムスター/BHK細胞)]について
    在庫切れ2024年10月7日トキシカーブ 飲む懸濁液 【活性炭
    在庫切れ2024年10月7日メトトレキサート・アコード 100mg/mL、輸液用希釈液 – [メトトレキサート]
    供給の緊張2024年10月4日アトロピン1%点眼液 – [アトロピン(硫酸塩)
    回復2024年10月4日コアガデックス500IU、注射用溶液の粉末および溶媒 – [ヒト凝固第X因子]
    在庫切れ2024年10月3日パクリタキセルAHCL 6 mg/ml、輸液用希釈液 – 100 ml バイアル – [パクリタキセル]
    供給の緊張2024年10月3日トランキセン 20mg/2mL、凍結乾燥品および非経口用溶液 – [クロラゼプ酸ジカリウム]
    在庫切れ2024年10月3日エトポシド・アコード 20mg/ml、輸液用希釈液 – [エトポシド]
    供給の緊張2024年10月3日トルリシティ 0.75mg、1.5mg、3mg、4.5mg、プレフィルドペン注射液 – [デュラグルチド]
    供給の緊張2024年10月2日トランドラプリル0.5mg、カプセル – [trandolapril]
    供給の緊張2024年10月2日パリペリドン・テバ、注射用徐放性懸濁液 – [パリペリドン]
    供給の緊張2024年10月2日免疫グロブリン点滴静注用・静注用(ベース)-[免疫グロブリン点滴静注用(IgG)]。
    供給の緊張2024年10月1日タイエン162mg、プレフィルドペンおよびプレフィルドシリンジ入り注射液 – [トシリズマブ]
    回復2024年10月1日ジナート125mg/5ml小児・乳児用、経口懸濁用顆粒80ml入りボトル – [セフロキシム・アキセチル]
    供給の緊張2024年10月1日ロピニロールLP 2mg、4mg、8mg フィルムコーティング錠 – [ロピニロール(塩酸塩)
    供給の緊張2024年9月30日リネゾリド 2mg/ml、輸液用 – 【リネゾリド
    在庫切れ2024年9月30日トランドラプリル2mg、4mg – [trandolapril]
  • 2024.09.30
    ステータス (英語)アップデートスペシャルティ
    回復2024年9月27日レミフェンタニルビアトリス1mg、注射・輸液用粉末 – [レミフェンタニル(塩酸塩]
    在庫切れ2024年9月27日ラシリクス リタード 60mg、カプセル – [フロセミド]
    供給の緊張2024年9月27日シムレクト 20mg、注射用または輸液用粉末および溶剤 – [バシリキシマブ(哺乳類/マウス/Sp2/O)
    供給の緊張2024年9月27日マキシドロール眼軟膏 – [デキサメタゾン、ネオマイシン(硫酸塩)、ポリミキシンB(硫酸塩)
    供給の緊張2024年9月27日トラボプロスト/チモロール40μg/mL+5mg/mL、点眼液-[チモロール(マレイン酸塩)、トラボプロスト]。
    供給の緊張2024年9月27日ヒドロコルチゾン・アップジョン 500mg、注射剤 – (ヒドロコルチゾン(コハク酸水素ナトリウム))
    回復2024年9月27日ジペンタム錠500mg「オルサラジンナトリウム
    回復2024年9月27日アビラテロンアロー500mg、フィルムコーティング錠 – [abiraterone]
    回復2024年9月27日ノジナン25mg/ml、アンプル注射液(I.M.)-[レボメプロマジン(塩酸塩]
    供給の緊張2024年9月27日リネゾリド 600mg、フィルムコーティング錠 – [linezolid]
    供給の緊張2024年9月27日ロバマイシン150万国際単位、非経口用凍結乾燥品 – [スピラマイシン(アジピン酸塩)
    在庫切れ2024年9月26日ゾフレン2mg/ml、アンプル注射液(静注)、(1箱1アンプル4ml)-[オンダンセトロン]。
    供給の緊張2024年9月26日クエチアピンLP(ゼロケルLP)50mg、300mg、400mg徐放錠 – [クエチアピン(フマル酸塩)
    供給の緊張2024年9月25日ロピニロール0.25mg、0.5mg 1mg、2mg、5mgフィルムコート錠 – [ropinirole]
    在庫切れ2024年9月25日ジナート125mg/5ml小児・乳児用、経口懸濁用顆粒40ml入りボトル – [セフロキシム・アキセチル]
    回復2024年9月24日ラモトリギン 5mg、25mg、50mg 100mg、200mg、散剤またはチュアブル錠 – [lamotrigine]
    供給の緊張2024年9月24日クラリスロマイシン、250mgおよび500mg、徐放性フィルムコーティング錠、フィルムコーティング錠 – [クラリスロマイシン]
    回復2024年9月23日オンダンセトロン アコード 2mg/ml、注射用液 – [オンダンセトロン]
    供給の緊張2024年9月23日Tcaps62.5マイクログラム、ソフトカプセル – [レボチロキシン]
  • 2024.09.24
    ステータス (英語)アップデートスペシャルティ
    回復2024年9月23日オンダンセトロン アコード 2mg/ml、注射用液 – [オンダンセトロン]
    供給の緊張2024年9月23日Tcaps 62.5マイクログラム、ソフトカプセル – [レボチロキシン]
    供給の緊張2024年9月20日メチルフェニデート・アローLP、徐放カプセル – [塩酸メチルフェニデート]。
    回復2024年9月20日ジプロステン、プレフィルドシリンジ注射用懸濁液 – [ベタメタゾン(ジプロピオン酸エステル)、ベタメタゾン(リン酸エステルナトリウム]
    回復2024年9月19日スガマデクス100mg/mL、注射用液2mLおよび5mLバイアル – [スガマデクスナトリウム]
    供給の緊張2024年9月19日ビタミンB12デラグランジュ 1000μg/2mL、注射剤(IM)およびドリンク剤 – [シアノコバラミン]
    供給の緊張2024年9月19日ビタミンB12ゲルダ1000μg/4mL、注射剤(IM)およびドリンク剤 – [シアノコバラミン]
    回復2024年9月18日コンフェロポート0.5mg徐放カプセル – [タクロリムス]
    回復2024年9月18日キシロカイン10mg/ml アドレナリン0.005mg/ml、注射用溶液 – [リドカイン-アドレナリン]
    販売終了2024年9月18日アンコチル1%輸液 – [フルシトシン]
    回復2024年9月17日リアメット20mg/120mg、錠剤 – [アルテメテル、ルメファントリン]
    回復2024年9月17日エスペラル500mg、錠剤 – [ジスルフィラム]
    供給の緊張2024年9月16日アミカシンビアトリス250mg、500mg、1g、バイアル入り注射液用粉末 – [アミカシン(硫酸塩)
    回復2024年9月16日フレカイニドLP 50mg、100mg、150mg、200mg徐放カプセル – [フレカイニド(酢酸塩]
    回復2024年9月16日クチナール200mg/4mL、注射用液の粉末および溶剤 – [フェノバルビタールナトリウム]
    供給の緊張2024年9月16日ターシャン50mg/5ml、アンプル入り注射液 – [シアメマジン]
    供給の緊張2024年9月16日ビクトーザ 6mg/ml、プレフィルドペン注射液 – [リラグルチド]
  • 2024.09.17
    ステータス (英語)アップデートスペシャリティ (英語)
    供給の緊張16 2024年9月アミカシンビアトリス250mg、500mg、1g、バイアル入り注射液用粉末 – [アミカシン(硫酸塩)
    販売中止16 9月 2024フレカイニドLP 50mg、100mg、150mg、200mg徐放カプセル – [フレカイニド(酢酸塩]
    販売中止2024年9月16日クチナール200mg/4mL、注射用液の粉末および溶剤 – 【フェノバルビタールナトリウム
    供給の緊張16 9月 2024エスペラル500mg、錠剤 – [ジスルフィラム]
    供給の緊張16 9月 2024ターシャン50mg/5ml、アンプル入り注射液 – [シアメマジン]
    供給の緊張16 9月 2024ビクトーザ 6mg/ml、プレフィルドペン注射液 – [リラグルチド]
    供給の緊張13 2024年9月モキシフロキサシン 400 mg フィルムコート錠 – [moxifloxacin]
    供給の緊張2024 年 9 月 12 日コンサータLP、徐放錠 – [塩酸メチルフェニデート]。
    販売中止2024年9月12日ホメピゾールAP-HP 5mg/mL、輸液用希釈液 – [ホメピゾール(硫酸塩デ]
    供給の緊張2024 年 9 月 12 日オゼンピック0.25mg、0.5mg、1mg、プレフィルドペン注射液 – [セマグルチド(酵母/サッカロマイセス・セレビシエ)]。
    販売中止2024年9月11日三酸化ヒ素マイラン 1 mg /ml、輸液用希釈液 – [三酸化ヒ素]
    在庫切れ2024年9月11日ゾフレン2 mg/ml、注射用アンプル(静注)2 mlおよび4 mlアンプル入り溶液 – [オンダンセトロン]
    供給の緊張10 9月 2024ビルトリシド 600mg、フィルムコーティング錠、四分包 – [Praziquantel]
    販売中止2024年9月9日リドカイン 20mg/ml アドレナリン 0.005mg/ml アゲタント、注射液 – [リドカイン-アドレナリン]
    販売中止2024 年 9 月 9 日リドカイン 10mg/ml アドレナリン 0.005mg/ml アグエタント、注射用液 – [リドカイン-アドレナリン]
    販売中止2024年9月9日パゼニール5mg/mL、輸液用散剤 – [パクリタキセル]
  • 2024.09.10
    ステータス (英語)アップデートスペシャルティ
    供給の緊張2024年9月6日Tercian 40 mg/ml, solution buvable en gouttes – [cyamémazine]
    在庫切れ2024年9月6日Étoposide Accord 20 mg/ml, solution à diluer pour perfusion – [étoposide]
    在庫切れ2024年9月6日Méthotrexate Accord 100 mg/mL, solution à diluer pour perfusion – [méthotrexate]
    供給の緊張2024年9月5日Calcidia 1,54 g, granulé pour suspension buvable en sachet-dose – [calcium (carbonate de)]
    在庫切れ2024年9月5日Lasilix Retard 60 mg, gélule – [furosémide]
    在庫状況2024年9月5日Étoposide Teva 20 mg/ml, solution à diluer pour perfusion – [étoposide]
    供給の緊張2024年9月4日Praluent 300 mg, solution injectable en stylo pré-rempli – [alirocumab (mammifere/hamster/cellules cho)]
    在庫切れ2024年9月4日Pamidronate de sodium Hospira 9 mg/ml, solution à diluer pour perfusion – [sodium (pamidronate de)]
    供給の緊張2024年9月4日Rythmodan 250 mg à libération prolongée, comprimé enrobé – [disopyramide (phosphate de)]
    在庫切れ2024年9月4日Ultiva 1 mg, poudre pour solution injectable ou pour perfusion – [rémifentanil (chlorhydrate de)]
    供給の緊張2024年9月4日Palipéridone Teva, suspension injectable à libération prolongée – [palipéridone]
    在庫切れ2024年9月4日Rémifentanil Viatris 1 mg, poudre pour solution injectable ou pour perfusion – [rémifentanil (chlorhydrate de)]
    販売中止2024年9月3日Androtardyl 250 mg/1 ml, solution injectable intramusculaire – [testostérone (énantate de)]
    供給の緊張2024年9月2日Héparine calcique 25 000 UI/mL, solution injectable en seringue pré-remplie (S.C.) de 0,2 mL et 0,3 ml, Calciparine 5 000 UI/0,2 ml et 7 500 UI/0,3 ml, solution injectable en seringue pré-remplie (S.C.) – [héparine calcique]
    発売日2024年9月2日Thérasolv 100 000 U et 500 000 UI, poudre pour solution injectable/pour perfusion – [urokinase]
    引き渡し2024年9月2日Tranxène 20 mg/2 ml, lyophilisat et solution pour usage parentéral – [clorazépate dipotassique]
  • 2024.09.02
    ステータス (英語)アップデートスペシャリティ (英語)
    供給の緊張2024年8月30日コアガデックス500 IU、注射用溶液の粉末および溶媒 – [ヒト凝固第X因子]。
    供給の緊張2024年8月30日ファストルテック 1.5mg/ml、粉末、輸液希釈用溶剤 1mlガラスアンプル – 【ラスブリカーゼ
    在庫切れ2024年8月30日アトラキュリウム ホスピーラ 10mg/ml、注射用溶液(50mg/5mlアンプル×5箱) – [atracurium]
    在庫切れ2024年8月27日リアメット 20mg/120mg、錠剤 – [アルテメテル、ルメファントリン]
    供給の緊張2024年8月27日ペガシス90マイクログラム、135マイクログラムおよび180マイクログラム注射液(プレフィルドシリンジ)-[ペグインターフェロン アルファ-2a
    再出荷2024年8月27日オンダンセトロン ビアトリス 2mg/ml、注射用液(I.V.) – [オンダンセトロン]
    供給の緊張2024年8月26日リタリンLP 20mg、30mg、40mg、徐放性カプセル – [塩酸メチルフェニデート
    供給の緊張2024 年 8 月 22 日メチルプレドニゾロン ビアトリス 40mg、注射液用粉末(IM-IV)-(メチルプレドニゾロン(コハク酸水素塩)
    供給の緊張2024 年 8 月 21 日コンサータLP、徐放錠 – (塩酸メチルフェニデート)
    供給の緊張2024 年 8 月 21 日チベラル500mg、輸液 – [オルニダゾール]
    再出荷2024年8月20日フルオロウラシル テバ 50mg/ml、輸液用希釈液、100ml瓶 – [フルオロウラシル]
    再出荷2024年8月20日Celestene Chronodose 5.70mg/ml、注射用懸濁液 – Celestene 4mg/1ml、注射用溶液 – [ベタメタゾン(リン酸エステルナトリウム]
    供給の緊張2024年8月20日プラルエント300mg、プレフィルドペン注射液 – [アリロクマブ(哺乳類/ハムスター/cho細胞)
    供給の緊張2024年8月20日プラルエント150mg、プレフィルドペン注射液 – [アリロクマブ(哺乳類/ハムスター/cho細胞)
    供給の緊張2024年8月20日トリフルカン 40mg/ml、経口懸濁用粉末 – [フルコナゾール]
    在庫切れ2024年8月19日マイコスタチン 100 000 IU/ml、経口懸濁液 – [ナイスタチン]
  • 2024.08.20
    在庫切れ2024年8月19日マイコスタチン 100 000 IU/ml、経口懸濁液 – [ナイスタチン]
    継続中2024年8月12日ミダゾラムビアトリス5mg/ml、注射用または直腸用溶液 – [ミダゾラム]
    供給の緊張2024年8月12日アミカシンビアトリス250mg、500mg及び1g、バイアル入り注射用粉末製剤 – [アミカシン(硫酸塩)
  • 2024.08.12
    ステータスアップデートスペシャリティ
    供給の緊張2024年8月9日アルベスコ80μg/回・160μg/回加圧吸入液 – [シクレソニド]
    供給の緊張2024年8月9日ロバルサイト 50mg/ml、経口液用粉末 – [バルガンシクロビル]
    供給の緊張2024年8月9日イリノテカンサン 1.5mg/ml、輸液(イリノテカン(塩酸塩)三水和物)
    供給の緊張2024年8月9日ブリカニール0.5mg/1ml、アンプル入り注射用溶液 – [テルブタリン(硫酸塩)
    在庫切れ2024年8月8日イカティバント・ビアトリス 30mg、プレフィルドシリンジ注射液 – [イカティバント(酢酸塩)
    回復2024年8月8日プレギゾール、バッグ入り冠動脈内投与用心筋保護液 – [カルシウム(塩化物)二水和物/マグネシウム(塩化物)六水和物/カリウム(塩化物)/ナトリウム(塩化物]
    供給の緊張2024年8月8日リスペリドンL.P. 37.5mg/2mL、プレフィルドシリンジ注射用徐放性懸濁液の粉末および溶剤 – [リスペリドン]
    供給の緊張2024年8月7日ヘパリンカルシウム25 000 IU/mL、0.2 mL及び0.3 mLのプレフィルドシリンジ(S.C.)中の注射用溶液、カルシパリン5 000 IU/0.2mL及び7 500 IU/0.3mL、プレフィルドシリンジ(S.C.)中の注射用溶液-[ヘパリンカルシウム]。
    供給の緊張2024年8月7日ミダゾラム ビアトリス 5mg/ml、注射用または直腸用溶液 – [ミダゾラム]
    供給の緊張2024年8月7日アスペジック注射用500mg/5ml、非経口用粉末・溶液-[アセチルサリチル酸リジン]
    在庫切れ2024年8月6日クラベンチン 3g/200mg、5g/200mg、注射用粉末(I.V.) – [チカルシリン(ナトリウム)、クラブラン酸]
    供給の緊張2024年8月6日フルオレセインフォーレ0.5% 1回量容器入り点眼液 – [フルオレセインナトリウム]
    供給の緊張2024年8月6日ベビチン100mg/2mlおよび500mg/10ml、アンプル入り注射用溶液-[チアミン塩酸塩]。
    在庫切れ2024年8月5日バイパーファブ、輸液用希釈液 – [ヨーロッパ毒蛇抗毒素免疫グロブリンウマF(ab’)2フラグメント]
    供給の緊張2024年8月5日リタリンLP 20mg、30mg、40mg徐放カプセル – [塩酸メチルフェニデート
    供給の緊張2024年8月5日コンサータLP、徐放錠 – [塩酸メチルフェニデート] (メチルフェニデート)
    回復2024年8月5日フルオロウラシル・アコード 50mg/ml、希釈可能輸液、5ml、20ml、100mlバイアル – [フルオロウラシル]
  • 2024.08.06
    ステータス (英語)アップデートスペシャルティ
    供給の緊張2024年8月2日ミバクロン20mg/10ml、注射用液(静注) – [ミバクリウム塩化物]
    供給の緊張2024年8月2日Mydriaticum 2mg/0.4ml、1回量容器入り点眼薬 – [tropicamide]
    供給の緊張2024年8月2日アンアルファ 1μg/0.5ml、アンプル入り静注用溶液 – [アルファカルシドール]
    在庫切れ2024年8月1日アカルボース50mg(医療用医薬品)-[アカルボース]
    供給の緊張2024年8月1日バルプロ酸ナトリウム・L.P. 500 mg、長時間作用型ペリキュラー製剤 – (バルプロ酸ナトリウム)
    在庫切れ2024年8月1日フルオロウラシル テバ 50mg/ml、輸液用希釈液、100mlバイアル – [フルオロウラシル]
    在庫切れ2024年8月1日フルオロウラシル テバ 50mg/ml、輸液用希釈液、20mlバイアル – [フルオロウラシル]
    在庫切れ2024年8月1日キシロカイン20mg/ml アドレナリン0.005mg/ml、注射用溶液 – [リドカイン-アドレナリン]
    供給の緊張2024年8月1日チアプリダール100mg/2ml、注射用液 – [チアプリド(塩酸塩)
    在庫切れ2024年8月1日コリジェンタAP-HP 27mg – 50mg小児用カプセル – [コリスチン、ゲンタマイシン]
    在庫切れ2024年8月1日エトポシド・テバ20mg/ml、希釈輸液用溶液-[エトポシド]
    販売中止2024年7月31日メトトレキサート・テバ10%、注射用溶液 – [メトトレキサート]
    供給の緊張2024年7月31日リスペリドンL.P. 37.5mg/2mL、プレフィルドシリンジ注射用徐放性懸濁液用粉末および溶剤 – [risperidone]
    在庫切れ2024年7月31日エトポシド・アコード 20mg/ml、輸液用希釈液 – [エトポシド]
    供給の緊張2024年7月30日ノボエイト2000IU注射液用粉末・溶剤 – [ツロクトコグ アルファ] [ツロクトコグ アルファ
    在庫切れ2024年7月30日メトトレキサート・アコード 100mg/mL 点滴用希釈液 – [メトトレキサート]
    在庫切れ2024年7月30日オンダンセトロン アコード 2 mg/ml、注射用溶液 – [オンダンセトロン]
    供給の緊張2024年7月30日免疫グロブリン点滴静注用・SC用(ベース) – [免疫グロブリン点滴静注用(IgG)
    在庫切れ2024年7月30日ゾフレン2mg/ml、注射用アンプル(静注用)2mlおよび4mlアンプル – [オンダンセトロン]
    供給の緊張2024年7月29日ペガシス90μg、135μg、180μg注射液(プレフィルドシリンジ) – [peginterferon alfa-2a
    在庫切れ2024年7月29日アンアルファ 2μg/1ml、アンプル入り静注用溶液 – [アルファカルシドール]
    供給の緊張2024年7月29日トフラニール 10mg、コーティング錠 – [イミプラミン]
  • 2024.07.29
    ステータス (英語)アップデートスペシャルティ (英語)
    供給の緊張2024年7月26日サルブタモール2.5mg/2.5mlおよび5mg/2.5mlネブライザー吸入用液(1回量容器入り) – [サルブタモール
    供給の緊張2024年7月26日オンダンセトロン ビアトリス 2mg/ml、注射用溶液(I.V.)-[オンダンセトロン]
    供給の緊張2024年7月25日ラシリクス リタード 60mg、カプセル – [フロセミド]
    供給の緊張2024年7月25日パリペリドン・テバ、注射用徐放性懸濁液 – [パリペリドン]
    販売中止2024年7月25日Hycamtin 0.25mg、1mg、カプセル – [トポテカン(塩酸塩]
    在庫切れ2024年7月24日オザリン2mg/mL、単回経口投与液 – [ミダゾラム]
    供給の緊張2024年7月24日ゲンタマイシン 40 mg、注射用溶液 2 ml入りガラスアンプル1本 – (ゲンタマイシン(硫酸塩))
    供給の緊張2024年7月23日コンフェロポート 0.5mg、徐放性カプセル – [タクロリムス]
    供給の緊張2024年7月23日オドリック 2mg、4mg 30カプセル、90カプセル入り – (トランドラプリル)
    在庫切れ2024年7月23日トランドラプリル2mgおよび4mg、28および84カプセル入り箱 – (トランドラプリル)
    供給の緊張2024年7月23日トランドラプリル 2mg、4mg 28カプセル入り – (trandolapril)
    供給回復2024年7月23日ユムリンラピード100IU/1mL、バイアル注射液 – [可溶性遺伝子組換えヒトインスリン製剤]
    在庫切れ2024年7月22日アクチリス2mg、注射・輸液用粉末 – [アルテプラーゼ]
    在庫切れ2024年7月22日タイエン162mg、プレフィルドペンおよびプレフィルドシリンジ入り注射液 – [トシリズマブ]
    在庫切れ2024年7月22日アナペン、プレフィルドシリンジ入り注射用溶液 – [アドレナリン]
  • 2024.07.22
    ステータス (英語)アップデートスペシャリティ (英語)
    供給の緊張2024年7月19日免疫グロブリン点滴静注用・SC用(ベース) – [免疫グロブリン点滴静注用(IgG)
    在庫切れ2024年7月19日ノボセブン8mg(400KUI)、注射用溶液の粉末および溶媒 – (エプタコグ アルファ(活性化) – (哺乳類/ハムスター/BHK細胞)
    供給の緊張2024年7月19日ゼプリオン、注射用徐放性懸濁液 – [パリペリドン]
    処方変更2024年7月19日デキストリオンG 5 ラボアジェ、注射液(静注)250mLバイアル – [カルシウム(グルコン酸塩)、グルコース、カリウム(塩化物)、ナトリウム(塩化物]
    供給の緊張2024年7月19日パクリタキセルAHCL 6 mg/ml、輸液用希釈液 – 100 ml バイアル – [パクリタキセル]
    在庫切れ2024年7月18日トフラニール 10mg、コーティング錠 – [イミプラミン]
    在庫切れ2024年7月18日ゲムシタビンサン 10mg/mL、輸液 160mLバッグ – [ゲムシタビン(塩酸塩)
    供給の緊張2024年7月18日イエロックス 0.9mg/ml、点眼液 – [ブロムフェナクナトリウム四水和物]。
    在庫切れ2024年7月18日キシロカイン5mg/ml防腐剤フリー、注射用溶液 – [塩酸リドカイン]
    継続中2024年7月18日キシロカイン10mg/ml防腐剤フリー、注射用溶液 – [塩酸リドカイン]
    在庫切れ2024年7月18日ジパデラ210、300、405mg、注射用徐放性懸濁液用粉末および溶剤-[オランザピン(パモ酸塩)一水和物]
    供給の緊張2024年7月18日ビタミンB12デラグランジュ 1000μg/2ml、注射剤(IM)および飲用液 – [シアノコバラミン]
    供給の緊張2024年7月18日アトロピン0.5%点眼液 – [アトロピン(硫酸塩)
    在庫切れ2024年7月17日トランキセン10mg、カプセル – [クロラゼプ酸ジカリウム]
    供給の緊張2024年7月17日ビタミンB12ゲルダ 1000μg/4ml 注射剤(IM)・ドリンク剤 – [シアノコバラミン]
    在庫切れ2024年7月17日オンダンセトロン アコード 2mg/ml、注射用溶液 – [オンダンセトロン]
    供給の緊張2024年7月16日リタリンLP 40mg、徐放カプセル、リタリンLP 30mg、徐放カプセル – [塩酸メチルフェニデート]。
    在庫切れ2024年7月15日レボメプロマジン(マレイン酸塩) – ノジナン25mg、有核フィルムコーティング錠
    在庫切れ2024年7月15日フロセミド テバ 500mg、スコア錠 – [フロセミド]
    処方変更2024年7月15日クエストラン4g、経口粉末小袋入り – [コレスチラミン]
    在庫切れ2024年7月15日メチルフェニデート バイオガランLP、徐放錠 – [メチルフェニデート(塩酸塩)
    供給の緊張2024年7月15日ソルメドロール120mg/2ml、凍結乾燥品及び非経口用液剤 – [メチルプレドニゾロン(コハク酸水素塩)
  • 2024.07.16
    ステータス (英語)アップデートスペシャルティ
    供給の緊張2024年7月12日パリペリドン・バイオガラン、プレフィルドシリンジ注射用徐放性懸濁液 – [パリペリドン]
    供給の緊張2024年7月12日オドリック-トランドラプリル2mgおよび4mg、カプセル-(トランドラプリル)
    供給の緊張2024年7月12日オンダンセトロン ビアトリス 2mg/ml、注射用液(I.V.)- [オンダンセトロン]
    供給の緊張2024年7月12日プレギゾール、バッグ入り冠動脈内投与用心筋保護液-[カルシウム(塩化物)二水和物/マグネシウム(塩化物)六水和物/カリウム(塩化物)/ナトリウム(塩化物)]
    供給の緊張2024年7月11日アミカシンビアトリス250mg、500mg、注射用粉末バイアル中 – [アミカシン(硫酸塩)
    在庫切れ2024年7月10日マイコスタチン 100 000 IU/ml, 経口懸濁液 – [ナイスタチン]
    在庫切れ2024年7月10日エトポシド・アコード 20mg/ml、輸液用希釈液 – [エトポシド]
    在庫切れ2024年7月9日ファストルテック1.5mg/ml、輸液用希釈液用粉末および溶剤 – [rasburicase]
    在庫切れ2024年7月8日B.A.L.、注射用液I.M. – [ブタカイン-ジメルカプロール]
    在庫切れ2024年7月8日アザクタム1g、非経口用粉末および溶液 – [アズトレオナム]
    在庫切れ2024年7月8日メノパー 75 IU/ml、注射用溶液の粉末および溶剤 – [menotropin]
    在庫切れ2024年7月8日メノピュール600IU/ml、注射用溶液の粉末および溶剤 – [menotropin]
  • 2024.07.08

    ANSM2024年6月25日発表

    https://ansm.sante.fr/actualites/fortes-tensions-dapprovisionnement-en-methotrexate-injectable-1g-et-5g-des-alternatives-pour-pallier-la-rupture

    (ChatGPTによる要約)

    メトトレキサート注射剤(1gおよび5g)の供給不足に対する代替手段

    フランスにおいて、高用量のメトトレキサート(MTX)注射剤(1gおよび5g)の供給が非常に逼迫している中、代替手段が国内に到着しました。これにより、Accord、Teva、Viatrisの3社が関与する生産問題が解決するまでの間、患者の治療を継続することが可能になります。供給の回復は2024年7月中旬に予定されています。

    MTX注射剤は、急性白血病、非ホジキンリンパ腫、骨肉腫、絨毛癌など、多くの重要な適応症に使用されています。

    2024年6月中旬から7月中旬にかけての供給不足の宣言が行われた際、我々は輸入経路の模索から欧州連合の自発的連帯メカニズムの活用に至るまで、すべての代替手段を検討しました。この新しい可能性は、薬品の供給不足を補うために欧州連合内で開発されたツールの一部です。2023年10月以来、加盟国は深刻な不足時に相互に支援することができます。このように、すべての他の選択肢が検討された後、最終手段として一国が欧州連合の自発的連帯メカニズムを活用することができ、フランスは1gおよび5gのメトトレキサート注射剤のためにこれを行いました。

    この枠組みの中で、2024年6月3日以降、Accord社によってMetotreksat Ebewe 100 mg/ml Koncentrat za raztopinoza infundiranjeが病院に提供されています。輸入されたユニットの使用期限は2024年8月31日です。輸入されたバイアルは使用期限が短く、2024年8月31日までとなっているため、他のMTX在庫よりも優先的に使用される必要があります。

    これらのボックスは元々スロベニア向けであり、誤薬を防ぐために比較表と視覚資料を含む案内文が同梱されています。

    さらに、元々イギリス向けの5gメトトレキサート Medacが、Accord社によって輸入され、6月末に医療施設に提供される予定です。

    他の供給源も引き続き検討中です。

    我々は、この重要な製品へのアクセスを保証するために非常に専心しており、新たな困難が発生した場合に備えて、病院製剤の実現可能性も検討しています。

     

  • 2024.07.08
    ステータスアップデートスペシャリティ
    需給ひっ迫2024年7月5日マキシドロール眼軟膏 – [デキサメタゾン、ネオマイシン(硫酸塩)、ポリミキシンB(硫酸塩)
    需給ひっ迫2024年7月5日ペガシス90μg、135μg、180μg注射液(プレフィルドシリンジ) – [peginterferon alfa-2a
    在庫切れ2024年7月4日グラヌパス4g、胃溶性顆粒 – (アミノサリチル酸)
    処方変更2024年7月3日フルオロウラシル ファイザー 50mg/ml、輸液用希釈液、100mlバイアル – 【フルオロウラシル
    需給ひっ迫2024年7月3日ロバルサイト50mg/ml、経口液用粉末 – [バルガンシクロビル]
    販売中止2024年7月3日ガバペンチン100mg、400mg、カプセル – [ガバペンチン]
    需給ひっ迫2024年7月2日ジスロマック40mg/ml小児用、飲用懸濁液用粉末 – [アジスロマイシン二水和物]。
    需給ひっ迫2024年7月2日スコポダームTTS 1mg/72時間、経皮吸収デバイス – [スコポラミン]
    在庫切れ2024年7月1日メトトレキサート・アコード100mg/mL、輸液用希釈液 – [メトトレキサート]
    在庫切れ2024年7月1日カムジオス5mg、カプセル – [マバカムテン]
    在庫切れ2024年7月1日カムジオス2.5mg、カプセル – [マバカムテン]
    需給ひっ迫2024年7月1日アトロピン0.5%点眼液 – [アトロピン(硫酸塩)
    在庫切れ2024年7月1日ミンパラ 30mg、60mg、90mg フィルムコーティング錠 – [シナカルセト(塩酸塩)
  • 2024.07.02
    ステータス更新スペシャリティ
    需給ひっ迫2024年6月28日スコポダームTTS 1mg/72時間、経皮デバイス – [スコポラミン]
    需給ひっ迫2024年6月28日タルゴシド200mg、400mg、注射液・輸液用粉末および溶剤、内服液 – (テイコプラニン)
    継続2024年6月28日ペディアベンAP-HP G20、輸液
    在庫切れ2024年6月28日ジペンタム錠500mg – [オルサラジンナトリウム]
    継続2024年6月27日ベンリスタ400mg、輸液希釈用粉末 – [ベリムマブ]
    継続2024年6月27日ヘパリンナトリウムパンファーマ5000IU/ml、注射用溶液5mLバイアル中 – [ヘパリンナトリウム]。
    在庫切れ2024年6月27日パンファーマ ヘパリンカルシウム 25 000 IU/mL、0.2 mLのプレフィルドシリンジ(S.C.)注射用溶液 – [ヘパリンカルシウム]。
    継続2024年6月27日メトロニダゾール250mgおよび500mg、フィルムコーティング錠 – [métronidazole]
    在庫切れ2024年6月27日コンサータLP、徐放錠 – [塩酸メチルフェニデート]。
    需給ひっ迫2024年6月26日ベビチン100mg/2mlおよび500mg/10ml、アンプル入り注射用溶液-[チアミン塩酸塩]。
    継続2024年6月25日ジゴキシンナチベル0.25mg、錠剤 – [ジゴキシン]
    需給ひっ迫2024年6月25日リネゾリド2mg/ml、輸液-[リネゾリド]。
    継続2024年6月25日Albey Apis melliferaの蜂毒120と550マイクログラム、注射用溶液のための粉末と溶媒 – [蜂毒]。
    継続2024年6月25日Albey Vespula spp.スズメバチ毒120マイクログラム及び550マイクログラム、注射用溶液の粉末及び溶媒-[スズメバチ(毒)]。
    在庫切れ2024年6月24日アカルボース50mg(特殊製品)
    在庫切れ2024年6月24日アザクタム1g、非経口用粉末および溶液 – [aztreonam]
    継続2024年6月24日ミトキサントロンアコード2mg/mL、輸液用希釈液(5mlバイアル)-[ミトキサントロン(塩酸塩)]。
  • 2024.06.24
    ステータス更新スペシャリティ
    需給ひっ迫2024年6月21日トムデックス2mg、輸液用粉末-[ラルチトレキセド]
    需給ひっ迫2024年6月21日バシリキシマブ(哺乳類/マウス/Sp2/O) – シムレクト20mg、注射用または輸液用粉末および溶剤 – [basiliximab (mammal/mouse/Sp2/O)
    需給ひっ迫2024年6月21日ガバペンチン100mg、400mg、カプセル – [ガバペンチン]
    継続2024年6月21日ガバペンチン300mg、カプセル – [gabapentin]
    継続2024年6月21日チモプトール0.25%、点眼液-[チモロール(マレイン酸塩)]
    在庫切れ2024年6月21日ジナート125mg/5ml小児・乳児用、経口懸濁用顆粒80mlボトル – [cefuroxime axetil].
    在庫切れ2024年6月21日ジナート125mg/5ml小児・乳児用、40mlボトル入り経口懸濁用顆粒-[セフロキシム・アキセチル]
    在庫切れ2024年6月19日エルジシン5mg、注射液用粉末 – [硫酸ビンデシン]
    需給ひっ迫2024年6月18日イオメロン150、250、300、350および400mgヨウ素/mL、100-150-200-250および500mL注射用溶液-[イオメプロール]
    需給ひっ迫2024年6月18日イオパミロン370mgヨウ素/mL、注射用液100~200および500mL – [イオパミドール]
    継続2024年6月18日グルカンタイム1.5g/5ml、注射液 – [メグルミン(アンチモン酸塩)
    継続2024年6月18日充填済みペン型アドレナリン注射液(アナペン-エピペン-ジェクスト)-[アドレナリン]
    在庫切れ2024年6月18日アカルボース50mg(特殊製品)
    需給ひっ迫2024年6月17日ペディアベンAP-HP G25、輸液
    継続2024年6月17日ミカファンギン・ビアトリス100mg、希釈輸液用粉末-[ミカファンギンナトリウム]
  • 2024.06.17
    ステータス更新スペシャリティ
    継続2024年6月14日ラルガクチル25mg/5ml、アンプル入り注射用溶液 – [クロルプロマジン]
    継続2024年6月14日ミカファンギン・ビアトリス50mg、希釈輸液用粉末-[ミカファンギンナトリウム]
    需給ひっ迫2024年6月14日ペガシス90μg、135μg、180μg注射液(プレフィルドシリンジ)-[ペグインターフェロン アルファ-2a]
    継続2024年6月13日ウムリンプロフィル30 100IU/mL、バイアル入り注射用懸濁液-[二相性イソフェン組換えヒトインスリン]
    継続2024年6月13日エリガード7.5mg、注射用粉末及び注射用溶剤-[リュープロレリン(酢酸塩)]
    需給ひっ迫2024年6月11日エトポシド・アコード20mg/ml、輸液用希釈液-[エトポシド]
    在庫切れ2024年6月11日Methotrexate Teva 10 percent, solution for injection (50 ml vial) – [メトトレキサート]
    継続2024年6月11日トランデート5mg/ml、注射用溶液-[塩酸ラベタロール]
    継続2024年6月11日チルディエム25mg、静脈内注射用粉末および溶液-[ジルチアゼム塩酸塩]
    需給ひっ迫2024年6月11日エトポシド・テバ20mg/ml、輸液用希釈液(25ml×1本)-[エトポシド]
    需給ひっ迫2024年6月10日キシロカイン 5 mg/ml 防腐剤フリー、注射用溶液 – [塩酸リドカイン]
    継続2024年6月10日ニューレプチル1%内用液 – [プロペリシアジン]
    継続2024年6月10日ゾフレン4mg/5mlシロップ – [オンダンセトロン]
    需給ひっ迫2024年6月10日イリノテカンサン1.5mg/ml、輸液用溶液-[イリノテカン(塩酸塩)三水和物]
    需給ひっ迫2024年6月10日アザクタム1g、非経口用粉末および溶液 – [aztreonam]
    継続2024年6月10日リズムダン250mg徐放性コーティング錠-[ジソピラミド(リン酸塩)]
  • 2024.06.10
    ステータス更新スペシャリティ
    継続7 2024年6月ラルガクチル100mg、有核フィルムコーティング錠 – [クロルプロマジン]
    継続7 2024年6月ラルガクチル25mg、フィルムコーティング錠-[クロルプロマジン]。
    継続6 2024年6月ニューレプチル10mg、カプセル – [プロペリシアジン]
    供給ひっ迫6 2024年6月ペディアベンAP-HP G20、輸液
    供給ひっ迫6 2024年6月ペディアベンAP-HP G25、輸液
    供給ひっ迫6 2024年6月ガバペンチン100mg、300mg、400mg、カプセル- [ガバペンチン]
    供給ひっ迫5 2024年6月ヒューマログ 100 IU/ml、バイアル注射液 – [インスリンリスプロ]
    在庫切れ4 2024年6月ゾフレン2mg/ml、注射用アンプル(点滴静注用)アンプル2mlおよび4ml-[オンダンセトロン]。
    供給ひっ迫4 2024年6月オンダンセトロン・ビアトリス2mg/ml、注射用溶液(I.V.)-[オンダンセトロン]。
    供給ひっ迫4 2024年6月オンダンセトロン アコード 2mg/ml、注射用溶液 – [オンダンセトロン]
    在庫切れ4 2024年6月マロサイド50mgフィルムコート錠 – [ピリメタミン]
    在庫切れ3 2024年6月メトトレキサート・アコード100mg/mL、輸液用希釈液-[メトトレキサート]。
    在庫切れ3 2024年6月コロフォーム、直腸用フォーム – [酢酸ヒドロコルチゾン]
    継続3 2024年6月リタリンL.P. 10mg、20mg、30mg、40mg、徐放性カプセル – [メチルフェニデート(塩酸塩)]。
    供給ひっ迫3 2024年6月正常ヒト免疫グロブリンIVおよびSC(ベース)-[正常ヒト免疫グロブリン(IgG)]。
  • 2024.06.02
    ステータス更新スペシャリティ
    供給緊張2024年5月31日メチルフェニデート・アローLP、徐放性カプセル-[メチルフェニデート塩酸塩]。
    供給緊張2024年5月31日アミカシンビアトリス250mg、500mg、1g、注射用粉末バイアル中 – [アミカシン(硫酸塩)
    継続2024年5月31日フルダラビンアコード25mg/ml、注射用/輸液用希釈液-[フルダラビン]。
    在庫切れ2024年5月31日アセチルサリチル酸パンファーマ500mg、注射液用粉末(旧カルデジック500mg/5ml、注射液用粉末)-[アセチルサリチル酸]。
    在庫切れ2024年5月30日ユーロビオール12 500U、胃耐性カプセル- [膵臓粉末]。
    供給緊張2024年5月30日オンダンセトロン・ビアトリス2mg/ml、注射用溶液(I.V.)-[オンダンセトロン]。
    継続2024年5月30日イエロックス0.9mg/ml、点眼液-[ブロムフェナクナトリウム四水和物]。
    継続2024年5月30日ザイボキシド 100mg/5ml、経口懸濁用顆粒 – [リネゾリド]
    供給緊張2024年5月30日モノプロスト50μg/ml、単回用量容器入り点眼液 – [ラタノプロスト]
    供給緊張2024年5月30日アビラテロンアロー500mg、フィルムコーティング錠-[アビラテロン]。
    在庫切れ2024年5月30日ミバクロン20mg/10ml、注射用溶液(静注)-[塩化ミバクリウム]。
    供給緊張2024年5月30日トラボプロスト/チモロール40μg/mL+5mg/mL、点眼液-[チモロール(マレイン酸塩)、トラボプロスト]。
    供給緊張2024年5月30日クチナール200mg/4mL、注射用溶液の粉末および溶剤-[フェノバルビタールナトリウム]。
    供給緊張2024年5月30日ヒドロコルチゾン・アップジョン500mg、注射製剤-[ヒドロコルチゾン(コハク酸水素ナトリウム)]。
    継続2024年5月29日イグザレルト2.5mg、フィルムコーティング錠(56錠入り) – [リバーロキサバン]。
    在庫切れ2024年5月27日オザリン2mg/mL、単回内用液-[ミダゾラム]。
    継続2024年5月27日ガストログラフィン370mgヨウ素/mL、経口液又は直腸液-[アミドトリゾ酸ナトリウム、メグルミン(アミドトリゾ酸塩)]。
    供給緊張2024年5月27日バクシミ3mg、単回用量容器入り点鼻薬 – [グルカゴン]
  • 2024.05.27
    ステータス更新スペシャリティ
    新たな供給緊張2024年5月24日ノジナン25mg/ml、アンプル注射液(I.M.)-[レボメプロマジン(塩酸塩)]
    新たな供給緊張2024年5月24日Cidermex眼軟膏-[ネオマイシン硫酸塩、トリアムシノロンアセトニド]
    新たな供給緊張2024年5月24日リマクタン300mg、カプセル – [リファンピシン]
    新たな供給緊張2024年5月24日リフィナ300mg/150mg、コーティング錠-[イソニアジド、リファンピシン]
    新たな供給緊張2024年5月24日リファター、コーティング錠-[イソニアジド、ピラジナミド、リファンピシン]
    新たな供給緊張2024年5月24日リファジン2%、飲用懸濁液-[リファンピシン]
    新たな供給緊張2024年5月24日リファジン300mg、カプセル – [リファンピシン]
    在庫切れ2024年5月24日ミカファンギン・ビアトリス100mg、希釈輸液用粉末-[ミカファンギンナトリウム]
    在庫切れ2024年5月24日ミカファンギン・ビアトリス50mg、希釈輸液用粉末-[ミカファンギンナトリウム]
    新たな供給緊張2024年5月24日ベビチン100mg/2mlおよび500mg/10ml、アンプル入り注射用溶液-[チアミン塩酸塩]
    在庫切れ2024年5月23日キシロカイン 10 mg/ml 防腐剤フリー、注射用溶液 – [塩酸リドカイン]
    新たな供給緊張2024年5月23日デパキン・クロノ500mg、徐放性スコア付きフィルムコーティング錠 – [バルプロ酸ナトリウム]
    新たな供給緊張2024年5月23日Rifamycin Chibret 1000 000 IU per cent, eye drops solution – [rifamycin sodium].
    継続2024年5月23日セベラマー炭酸塩2.4g、経口懸濁用粉末 – [セベラマー(炭酸塩)
    継続2024年5月23日セベラマー炭酸塩800mg、フィルムコーティング錠-[セベラマー(炭酸塩)]
    継続2024年5月23日ラシリクス・リタード60mg、カプセル、箱30 – [フロセミド]
    新たな供給緊張2024年5月22日キシロカイン10mg/ml、アドレナリン0.005mg/ml、注射液-[リドカイン-アドレナリン]
    新たな供給緊張2024年5月22日キシロカイン20mg/ml、アドレナリン0.005mg/ml、注射液-[リドカイン-アドレナリン]
    新たな供給緊張2024年5月22日リドカイン20mg/ml、アドレナリン0.005mg/ml、注射用液-[リドカイン-アドレナリン]
    新たな供給緊張2024年5月22日リドカイン10mg/ml、アドレナリン0.005mg/ml、注射用液-[リドカイン-アドレナリン]
    在庫切れ2024年5月22日フルオロウラシル テバ 50 mg/ml、輸液用希釈液、20 ml および 100 ml ボトル – [フルオロウラシル]
    新たな供給緊張2024年5月21日クアシムL.P.、徐放性カプセル – [メチルフェニデート]
  • 2024.05.20

     

    ステータス更新日製品
    新たな供給緊張2024年5月17日メトロニダゾール250mgおよび500mg、フィルムコーティング錠 – [métronidazole]
    新たな供給緊張2024年5月17日クチナール200mg/4mL、注射用溶液の粉末および溶剤-[フェノバルビタールナトリウム]。
    継続2024年5月17日グルコース30%ラヴォアジェ、バイアル入り輸液-[グルコース一水和物]。
    在庫切れ2024年5月17日ジゴキシンナチベル0.25mg、錠剤 – [ジゴキシン]
    新たな供給緊張2024年5月16日ミダゾラムビアトリス5mg/ml、注射用または直腸用溶液-[ミダゾラム]。
    在庫切れ2024年5月16日チモプトール0.25%、点眼液-[チモロール(マレイン酸塩)]。
    継続2024年5月16日Extencillin 1.2MIU、注射用IM懸濁液のための粉末および溶媒 – [benzathine benzylpenicillin]。
    在庫切れ2024年5月15日シバロン 136mmol/L、輸液(クエン酸ナトリウム)
    新たな供給緊張2024年5月15日トフラニール10mg、コーティング錠 – [イミプラミン]
    継続2024年5月14日プレバイミス 480mg、輸液用希釈液 – [レテルモビル]
    新たな供給緊張2024年5月14日Tiapridal 100 mg/2 ml、注射用溶液 – [tiapride (hydrochloride)]。
    在庫切れ2024年5月14日アルコナートレム150mg、カプセル-[デメクロサイクリン塩酸塩]
    新たな供給緊張2024年5月13日トランデート5mg/ml、注射用溶液-[塩酸ラベタロール]。
  • 2024.05.13
    STATUSUPDATESPECIALITY
    SUPPLY VOLTAGE7-May-24Amikacine Viatris 1 g, powder for solution for injection in vial – [amikacine (amikacin sulfate)].
    OUT OF STOCK7-May-24Tomudex 2 mg, powder for solution for infusion – [raltitrexed]
    SUPPLY VOLTAGE7-May-24Humalog 100 IU/ml, solution for injection in vial – [insulin lispro]
    OUT OF STOCK7-May-24Zophren 2 mg/ml, solution for injection (IV) ampoules of 2 ml and 4 ml – [ondansetron].
    SUPPLY VOLTAGE6-May-24Fluorouracil Pfizer 50 mg/ml, dilutable solution for infusion, 100 ml bottle – [fluorouracil]
    SUPPLY VOLTAGE6-May-24Ritalin L.P. 10 mg, 20 mg, 30 mg and 40mg, extended-release capsule – [methylphenidate hydrochloride].
    SUPPLY VOLTAGE6-May-24Methylphenidate Arrow LP, sustained-release capsule – [methylphenidate hydrochloride].
    OUT OF STOCK6-May-24Fomepizole AP-HP 5 mg/mL, solution for diluted infusion – [fomepizole (sulfate de)].
    HANDOVER6-May-24Metalyse 10000 unités, poudre et solvant pour solution injectable – [ténectéplase] [tenecteplase].
    HANDOVER6-May-24Actilyse 10, 20, 50 mg , powder for solution for injection and infusion – [altéplase] [altéplase] [altéplase] [altéplase] [altéplase] [altéplase
  • 2024.05.06
    STATUSUPDATESPECIALITY
    OUT OF STOCK3-May-24Micafungin Viatris 100 mg, powder for solution for diluted infusion – [micafungin sodium].
    OUT OF STOCK3-May-24Micafungin Viatris 50 mg, powder for solution for infusion – [micafungin sodium].
    HANDOVER3-May-24Amikacin Viatris 50 mg/1 ml, solution for injection – [amikacin (amikacin sulfate)].
    SUPPLY VOLTAGE3-May-24Mycostatin 100,000 IU/ml, oral suspension – [nystatin]
    OUT OF STOCK3-May-24Camzyos 2.5 mg, capsule – [mavacamten]
    SUPPLY VOLTAGE2-May-24Neuleptil 10 mg, capsule – [propériciazine]
    SUPPLY VOLTAGE2-May-24Neuleptil 1 per cent, oral solution – [propériciazine]
    HANDOVER2-May-24Surmontil 4 pour cent, solution buvable, flacon – [trimipramine (mesilate)].
    SUPPLY VOLTAGEAPR. 30, 2024Umuline Profil 30 100 IU/mL, suspension for injection in vial – [biphasic isophane recombinant human insulin].
    SUPPLY VOLTAGEAPR. 30, 2024Umuline Rapide 100 IU/1 mL, solution for injection in vial – [soluble recombinant human insulin].
    OUT OF STOCKAPR. 30, 2024Mitoxantrone Accord 2 mg/mL, solution for diluted infusion (5ml vial) – [mitoxantrone (hydrochloride)].
    SUPPLY VOLTAGEAPR. 30, 2024Prevymis 480 mg, solution for diluted infusion – [letermovir].
    SUPPLY VOLTAGEAPR. 30, 2024Cresemba 200 mg, powder for solution to be diluted for infusion – [isavuconazonium (sulfate)].
    OUT OF STOCKAPR. 29, 2024Xylocaine 5 mg/ml preservative-free, solution for injection – [lidocaine hydrochloride].
    SUPPLY VOLTAGEAPR. 29, 2024Zithromax 40 mg/ml children, powder for drinkable suspension – [Azithromycin dihydrate]
    OUT OF STOCKAPR. 29, 2024Glucose 30% Lavoisier, solution for infusion in bottle – [glucose monohydrate].
    OUT OF STOCKAPR. 29, 2024Heparin calcium Panpharma 25 000 IU/mL, solution for injection in pre-filled syringe (S.C.) of 0.2 mL – [heparin calcium].
    SUPPLY VOLTAGEAPR. 29, 2024Pegasys 90 micrograms, 135 micrograms and 180 micrograms solution for injection in pre-filled syringe – [peginterferon alfa-2a].
  • 2024.04.29
    STATUSUPDATESPECIALITY
    SUPPLY VOLTAGEAPR. 26, 2024Pegasys 90 micrograms, solution for injection in pre-filled syringe 1 glass pre-filled syringe with 1 0.5 ml needle – [peginterferon alfa-2a ((bacterial/escherichia coli)]
    SUPPLY VOLTAGEAPR. 25, 2024Esperal 500 mg, tablet – [disulfiram] [disulfiram] [disulfiram] [disulfiram] [disulfiram
    SUPPLY VOLTAGEAPR. 25, 2024Fluorouracil Teva 50 mg/ml, solution for diluted infusion, 20 ml and 100 ml bottles – [fluorouracil].
    OUT OF STOCKAPR. 25, 2024Zinnat 125 mg/5 ml children and infants, granules for oral suspension in 80 ml bottle – [cefuroxime axetil].
    OUT OF STOCKAPR. 25, 2024Zinnat 125 mg/5 ml children and infants, granules for oral suspension in 40 ml bottle – [cefuroxime axetil].
    OUT OF STOCKAPR. 24, 2024Extencillin 1.2 MIU, powder and solvent for IM suspension for injection – [benzathine benzylpenicillin].
    SUPPLY VOLTAGEAPR. 24, 2024Benlysta 400 mg, powder for solution to be diluted for infusion – [Belimumab]
    OUT OF STOCKAPR. 24, 2024Paclitaxel AHCL 6 mg/ml, solution for diluted infusion – 100 ml vial – [paclitaxel].
    OUT OF STOCKAPR. 24, 2024Rovalcyte 50 mg/ml, powder for oral solution – [valganciclovir]
    HANDOVERAPR. 23, 2024Ganciclovir Sandoz 500 mg, powder for solution for infusion – [Ganciclovir].
    OUT OF STOCKAPR. 23, 2024Tildiem 25 mg, powder and solution for I.V. injection – [diltiazem hydrochloride].
    SUPPLY VOLTAGEAPR. 22, 2024Iomeron 150, 250, 300, 350 and 400 mg Iodine/mL, solution for injection in 100-150-200-250 and 500 mL – [iomeprol].

英国

EU

  • 2024.09.04

    9月2日公開のEMAによる公開書簡:当初2024年9月には改善予定であったが、特に低用量での供給不足が継続。

    https://www.ema.europa.eu/en/documents/dhpc/direct-healthcare-professional-communication-dhpc-update-ozempic-semaglutide-victoza-liraglutide-supply-shortage_en.pdf

     

    所管の要約(Summary)の日本語訳

    • 注射用グルカゴン様ペプチド-1受容体作動薬(GLP-1 RA)であるオゼンピックOzempicに対する需要の高まりと、一部の製造拠点における生産能力の制約により、品切れや在庫切れを含む供給不足が生じている。
    • Ozempicの低用量製剤である0.25mgおよび0.5mgの供給状況は悪化しており、2024年第4四半期まで全用量で断続的な品薄状態が予想される。
    • そのため、供給状況が改善するまで、Ozempicによる新規患者の治療開始を制限することを継続することが推奨される。これは2024年9月までに改善する見込みである。
    • ノボ ノルディスクは、Ozempic(週1回)の供給量を増やすため、2023年第4四半期に一時的にヴィクトーザVictoza(1日1回)の供給量を減らした。これにより、生産能力の最適化が図られる。これにより、より多くの患者の治療が可能になることが期待される。2024年第1四半期以降、EU/EEA諸国ではVictozaの供給状況が改善しているが、一部の国では依然として断続的な品薄状態が続いている。すでに治療を受けている患者が治療を継続できるよう、新規患者にはVictozaの投与を開始すべきではない。
    • 供給不足は品質上の欠陥や安全性の問題とは関係ない。
    • 現在治療中の患者にOzempicまたはVictozaが入手できない場合は、臨床判断と現地のガイドラインに基づき、患者を別のGLP-1受容体作動型注射薬または他の適切な代替薬に安全に切り替えるべきである。

     

  • 2024.09.04
  • 2024.04.29

    19 April 2024

    EMA/112991/202424 Rev. 11

     

    Shortage of Emend (aprepitant)

    powder for oral suspension

    What is Emend used for?Emendは制吐剤で、吐き気(気分が悪くなること)や嘔吐を予防する薬です。この粉末経口懸濁液(飲む液体)は、化学療法(がんの治療に使用される薬)によって引き起こされる吐き気や嘔吐を予防するために、6ヵ月から12歳までの小児に使用されます。

    薬の使用に関する詳しい情報は、すべての薬局で入手できる薬の概要ページを参照してください。medicine’s overview page available in all EU languages.

    Reason for shortageEmendを販売している会社では、医薬品の製造に使用される着色剤の変更に関連して、製造工程に遅れが生じています。このため、エメンド経口懸濁用粉末製剤が不足しています。

    この品不足は、製品の品質欠陥や安全性の問題とは無関係である。供給不足は2024年7月末まで続く見込みです。

    Member States affected本不足は、本製品が販売されているすべてのEU/EEA加盟国に影響を及ぼす: ベルギー、フランス、ドイツ、ルクセンブルグ、オランダ。

    この情報は変更される可能性があります。特定のEU/EEA加盟国における医薬品の供給不足に関する最新情報については、各国の供給不足登録簿を参照するか、各国の所轄官庁にお問い合わせください。

    Monitoring of shortageEMAのSPOC作業部会は、EU/EEAにおけるエメンドの供給状況を注意深く監視し、販売承認者および各国所轄当局と連携して、供給不足の影響を緩和するための対策を特定しています。

    SPOC作業部会は、EU域内の医薬品供給に影響を及ぼす可能性のある事象を監視し、報告する責任を負っています。SPOC作業部会の会議の要約は、EMAのウェブサイトでご覧いただけます。

     

     

このページの先頭へ戻る